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The natural product celastrol (1) possesses a wide array of promising biological 
activities related to diseases characterized by protein misfolding including those 
associated with neuronal degradation, inflammation, and cancer.  Relevant to cancer, 
celastrol functions as a non-ATP-competitive inhibitor of heat shock protein-90, 
providing a potential lead for the development of new inhibitors with improved 
pharmacology.  A laboratory preparation of the small molecule was undertaken to 
provide access to the unnatural enantiomer of celastrol.  The lack of understanding of the 
chemistry and biology of the growing class of celastroids is attributed to the 
incompatibility of biologically inspired polyene cyclization strategies to assemble 
friedelin triterpenoids.  As a result of these problems residing at the interface of 
chemistry and biology, a purely synthesis-based strategy for polyene cyclizations to 
rapidly construct the pentacyclic core of the friedelin and celastroid natural products has 
been developed.  This efficient strategy is gram scalable culminating in the first total 
synthesis of wilforic acid (127) and an advanced intermediate capable of delivering 
celastrol (1) as well as numerous celastroid natural products. 
 ix
Phenols possess broad utility serving as key materials in all facets of chemical 
industries, especially the pharmaceutical industry.  The ideal synthesis of a phenolic 
compound entails the direct oxidation of an aryl C-H bond remains to be a difficult 
synthetic challenge.  Following our initial report describing the hydroxylation of arenes 
using phthaloyl peroxide, new peroxide derivatives were investigated to probe their 
reactivity in an effort to hydroxylate aromatics which were previously unreactive.  
Electronically poor to moderately rich arenes were successfully hydroxylated with a 
broad functional group tolerance using 4,5-dichlorophthaloyl peroxide.  This protocol has 
been applied toward the rapid synthesis of phenolic analogs and metabolites of current 
pharmaceuticals as well as biocides.  Mechanistic studies using kinetic isotope effect, 
competition, and benzylic oxidation experiments indicate that a novel diradical reverse-
rebound mechanism is the likely pathway.  Further examination of the transition-state 
using linear free energy relationships with vs. values established a linear trend with a 
low negative rho value (- 3.92) corresponding best using values supporting a diradical 
reverse-rebound addition.    
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Chapter 1 – Significance of Celastrol and  
Evolution of the Polyene Cyclization 
 
 Molecular chaperones play an integral role in maintaining proteostasis, in 
particular, protein folding and conformation.1  Chaperone malfunction triggers several 
diseases which includes cancers as well as those associated with neurodegeneration such 
as Huntington’s, Parkinson’s, Alzheimer’s, and amyotrophic lateral sclerosis (ALS).2,3  
Quintessential to the proper folding of various proteins is the heat-shock transcription 
factor-1 (HSF-1).  Activation of HSF-1 by external stresses, either physiological or 
environmental, induces the rapid manufacture of heat shock proteins (HSPs) which serve 
as molecular chaperones procuring a surveillance role in maintaining protein 
homeostasis.4-11  Suppression of neurodegenerative diseases, lysosomal storage diseases 
(Gaucher and Tay-Sachs), and cancers (i.e. pancreatic, breast, leukemia, and hepatic) has 
been observed through the upregulation of molecular chaperones including HSP90.  
Modulation of the heat shock response (HSR) and HSPs through the use of small 
molecules and natural products has gained enormous pharmacological focus due to the 
potential therapeutic modalities in human diseases.1,2,12-19   
 The small molecule celastrol (1), which belongs to the friedelin family of natural 
products, possesses a potent, broad array of promising biological activities in the diseases 
triggered by malfunctioning chaperones.2  One of the protein targets of celastrol is 
HSP90, but unlike other small molecules that target this protein, celastrol acts as a non-
ATP-competitive inhibitor.  This provides a different avenue for the development of new 
inhibitors with improved pharmacology.17,20  Celastrol also induces neuronal and tissue 
2 
 
regeneration by invoking an immunosuppressant response during refractory periods.21  In 
vitro analyses has found that the various biological effects are caused through covalent 
modification via conjugate addition of biological nucleophiles, such as cysteine residues, 
into the quinone methide.2,22-26  Since other molecules that possess quinone methides do 
not interact with HSP90 or provoke HSR, celastrol possesses special structural features 
that facilitate the induction of HSR and cause the reaction with certain proteins.  These 
features are unknown, and the true mechanism by which celastrol interacts with its targets 
in their native environment also remains elusive.2   
 The development of a scalable concise synthetic approach could help solve these 
issues.  A platform that constructs celastrol, its unnatural enantiomer, a variety of 
celastroid natural products as well as their antipodes, and structural derivatives 
inaccessible through semi-synthesis provides a new biological tool to investigate the 
mechanisms of action of this natural product.  Developing a synthetic platform is, 
however, not easily accomplished as the molecule’s complex topology is comprised of 
several all-carbon quarternary stereocenters including angular methyls.  Despite the 
evolution of triterpenoid synthesis and the cationic polyene cascades used to access a 
variety of pentacyclic triterpenes, there remain difficult synthetic problems in regards to 
constructing the friedelin family of natural products.  Therefore, the laboratory synthesis 
of celastrol and its enantiomer could provide an important tool to investigate its 
biological mode of action affording valuable information regarding HSP90 while 
simultaneously solving longstanding synthetic problems.   
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Isolation, Characterization, Biological Activity 
 
 For centuries extracts of the Tryptergium wilfordii Hook F. vine (Thunder of God 
or lei gong teng) have provided remedies used in chinese traditional medicine for various 
ailments including adema, fever, chills, joint pain, inflammation, and rheumatoid 
arthritis.2,27  In 1930 cultivation of the vines’ roots was requested to be forbidden in the 
Chekiang province.  Resistant local farmers argued that they were unable to successfully 
harvest their crops without using the powdered roots as an insecticidal agent.  These 
disputes inspired entomologists to extract the natural products from the vine; culminating 
in 1936 when Chou and Mei published their findings concluding that the major 
constituent of the orange extract is -carotene.  This was proven to be incorrect in 1939 
by the work of Gisvold, but the actual structure remained elusive for 36 years.  Over this 
time period, structural characterization of celastrol and the methyl ester pristimerin (2) 
indicated the presence of the distinct quinone methide chromophore (425 nm and 255 
nm).  IR spectroscopy showed the presence of a chelated hydroxyl (3380 cm-1), ester 
carbonyl (1740 cm-1), and the quinone methide (1607 cm-1).  The extract also proved to 
be chiral as the observed optical rotation of pristimerin is []D −168°.  The limited NMR 
studies of celastrol and pristimerin had shown six methyls represented as singlets, two 
coupled olefinic protons, and unresolved aliphatic protons suggesting a natural product 
belonging to the friedelin family.27  Then in a landmark publication in 1972 Ham and 
Whiting extracted pristimerin (2), performed a conjugate reduction with NaBH4, and 
subsequently esterified the catechol to afford the p-bromobenzoate (3).  After several 
recrystallization attempts, they discovered that rapidly cooling a hot benzene/ethanol 
solution of 3 produced crystals suitable for X-ray diffraction which unambiguously 
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confirmed the structure of 3 and as a result celastrol (1) as well as pristimerin (2).28  The 
absolute configuration revealed the sterically encumbered friedelanyl triterpenoid core 
possessing the trans-angular disposed methyls residing in the C-D ring juncture, three 
other all-carbon quaternary stereocenters, and the discrete quinone methide functionality 
which ultimately provides the red-orange color of celastrol.  The isolation and 
purification process to extract celastrol has been extensively examined and perfected so 
that starting from 15 kg of raw dry roots, 798 mg of celastrol (1) is isolated in 99.5% 
purity.29 
 
 
Figure 1.1. Celastrol, pristimerin, tingenone, and the p-bromobenzoate of pristimerin. 
  
 Celastrol exhibits a broad array of potent biological activities.  Diseases 
associated with cancers, neurodegeneration, and inflammation can be reversed, either in 
vitro or in vivo.2-27  A major protein target of celastrol is HSP90, but it can also act as an 
antioxidant provoking an autoimmune response which induces neural and tissue 
regeneration during dormant periods at potencies as low as 50 nM in tadpoles.21  Other 
members of the celastroid family of natural products (i.e. tingenone (4)) also exhibit 
cytotoxicity towards skin, stomach, uterine, and lymphoepithelioma cancers in clinical 
trials with minimal side effects.27,30,31  The therapeutic effects of the whole extracts from 
Tryptergium wilfordii are also being examined in over 20 clinical trials ranging from 
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HIV, Lupus, Crohn’s disease, kidney disease, and rheumatoid arthritis which are at 
various stages of completion.32 
 Despite the spectrum of biological activity, the mode of action of celastrol and the 
related natural products remains elusive.2  Recently, in vitro analysis has shown that 
biological nucleophiles, such as cysteine residues, add conjugately in a 1,6-Michael-like 
fashion into the quinone-methide (Figure 1.2).24  Silverman and co-workers showed that 
this addition is stereospecific with facial selectivity, potentially leading to specificity.23  
Covalent modification of biological targets has also been studied in the context of 
celastrol and tingenone interacting with DNA as well as modifying cysteine residues of 
protein targets.22,23,33,34  Researchers have discovered that the signaling pathways and 
proteins affected by celastrol include HSP90, Cdc37, p23, NF-B, and IKK In regards 
to HSP90, unlike other small molecule quinone and quinone methide modulators, 
celastrol does not act as an ATP-competitive inhibitor.  Binding to the C-terminus, not 
the N-terminus like other modulators, causes a conformational change which inhibits the 
docking of Cdc37.  This enhances client protein degradation inducing cellular 
apoptosis.20  Despite their potency, no ATP-competitive inhibitor of HSP90 has been 
FDA approved because of low selectivity which leads to undesirable side effects.  
Therefore, celastrol represents a new class of inhibitors as therapeutic targets, especially 
in a variety of cancers including pancreatic cancer due to the high expression of HSP90 
in tumor cells.17 
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Figure 1.2. Stereospecific formation of celastrol/protein adducts through conjugate  
addition reactions of nucleophiles into the quinone methide.23 
   
 There are inherent structural features that celastrol possesses besides the quinone 
methide functionality which facilitate the small molecule’s interaction with its protein 
targets.  These features are still unknown and therefore many questions regarding the 
biological mode of action, native protein targets, how celastrol affects these numerous 
targets, the relationship between the varied biological effects, and if the small molecule is 
a specific alkylating agent remain unanswered.2  Synthetic access to the enantiomer 
would provide a tool to further study the small molecule’s mode of action through 
determining if the effects are promoted by specific covalent modification.  This in turn 
reveals the important structural features for future potential therapeutics which are non-
ATP competitive inhibitors of HSP90 as well as provide a strategic direction for the 
synthesis of celastroid analogs.   
 
Biosynthesis    
 
 Celastrol is a triterpenoid belonging to the D:A-friedo-nor-oleananes, a subgroup 
of the friedelin family of natural products.27  The celastroids bear structurally similar 
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characteristics, but differ mainly in oxygenation states in the A, B, and E rings.  
Friedelins are characterized by the fused pentacyclic framework, and more distinctly, the 
vicinal trans-angular methyl groups positioned in the C-D ring juncture.  Severe 1,3-
diaxial strain occurs between both methyls and their adjacent sterically condensed 
environment.  For this reason, as well as the number of stereocenters and all-carbon 
quaternary centers, there is a lack of synthetic routes to the perpetually growing class of 
celastroid natural products which has limited the understanding of their chemistry and 
biology.  The absence of a synthesis can in part be attributed to the incompatibility of 
biologically inspired polyene cyclization strategies to assemble the celastroid or friedelin 
natural products.35  The implementation of these reactions for the syntheses of polycyclic 
triterpenoids is highly desirable as they provide rapid access to relatively large molecules 
with multiple stereogenic centers in a single transformation.36,37  Due to the vast number 
of friedelin natural products that are co-isolated with celastrol it has been postulated that 
celastrol is biosynthetically derived from friedelin.27  Unfortunately, the polyene 
cyclization leading to friedelin is exceedingly challenging to reproduce in the laboratory 
due to a set of complex, energetically unfavorable methyl and hydride shifts (Scheme 
1.1).35 
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Scheme 1.1. Proposed biosynthesis of celastrol.27,35 
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 The biosynthesis of celastrol commences in the friedelin cyclase enzyme which 
converts 2,3-(S)-oxidosqualene (6) into the lupanyl cation (7).  The epoxide is initially 
ionized by a proton transfer from an aspartic acid residue in the active site.  The lupanyl 
cation then undergoes a series of [1,2] hydride and methyl shifts in a suprafacial manner 
to arrive at the friedelanyl cation (12) (Scheme 1.1).  Next, an oxidative hydride 
migration affords friedelin, which is oxidized in the A, B, and E rings to generate 
celastrol.  The energetics of the suprafacial [1,2]-shifts proceeding from the lupanyl 
cation (7) have been examined by E. J. Corey.  The friedelanyl cation is the highest 
energy species as determined by B3LYP 6-31 G* DFT and ab initio Hartree-Fock (6-31* 
or 3-21(*) levels) calculations.  This calls into question if the friedelin-based natural 
products are derived from other pentacyclic triterpenes.  The formation of the friedelanyl 
cation is thermodynamically unfavored by ~20 kcal/mol.  Corey and co-workers propose 
that the same cyclase enzyme which induces the cyclization of 2,3-(S)-oxidosqualene also 
promotes the subsequent rearrangements driving the reaction forward.  Friedelin cyclase 
uses the exothermicity of the cyclization to perform a nonstop sequence of cyclization 
and multistep [1,2] rearrangements.  The energy gained in the formation of the 
pentacyclic framework from 2,3-(S)-oxidosqualene (~30 kcal/mol) compensates for the 
high-energy friedelanyl cation (12).  They also propose that the other natural products 
(i.e. lupeanes, oleananes, and ursanes) are not generated in the friedelin cyclase due to the 
lack of correctly positioned proton acceptors in the catalytic site which would facilitate 
elimination or diversion to the other cations.35 
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The Evolution of Cationic Polyolefin Cyclizations and Polyprenoid Synthesis 
  
 Extensive investigation in the biosynthesis of lanosterol and cholesterol ultimately 
led to the finding that 2,3-(S)-oxidosqualene (6) was cyclized upon acid activation to 
generate the lanosterol cation (14) through a cationic polyolefin cyclization or polyene 
cascade (Scheme 1.2).  Stork and Eschenmoser postulated that upon activation of the 
epoxide in the active site, the tethered alkenes engage in a concerted manner producing a 
highly delocalized cation in the transition state.  This results in the formation of several 
carbon-carbon bonds in a single diastereoselective operation to afford the protosterol 
cation 14.  The landmark insight of these findings is that the reaction is stereospecific.  
The configuration of the alkene, either cis or trans, leads to different cyclized 
products.38,39 
 
Scheme 1.2. Biosynthesis of the protosterol cation (14) from 2,3-(S)-oxidosqualene. 
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 Early pioneers in steroid synthesis examined the synthetic plausibility of this 
theory to rapidly construct a variety of terpenoids in a biomimetic fashion starting from 
the readily accessible linear precursors.  During the course of elucidating the structure of 
the sesquiterpenoid pyrethrosin (15) Barton discovered that under mild acidic conditions 
the activated epoxide underwent a transannular ene-cyclization to rapidly generate the 
fused tricyclic lactones 16 and 17 (Scheme 1.3).40,41  The viability of this strategy towards 
steroid synthesis was then investigated by Goldsmith, van Tamelen, and Johnson through 
the syntheses of various mono-,  di-, and tri-terpenoids.  They examined several initiators 
(i.e. epoxides, acetals, and allylic alcohols), the optimal acid promoters (i.e. BF3-OEt2, 
SnCl4, and HCO2H), and solvents (i.e. PhH or CH2Cl2).42-46  These original accounts are 
exceedingly important because they set the precedent for utilizing these types of cation 
initiated polyolefin cyclizations in a non-enzymatic environment.  The experiments also 
provide significant information regarding the use of BF3-OEt2 and solvent comparisons 
between methylene chloride and benzene.  BF3-OEt2 proved to be a poor Lewis acid for 
these cyclizations because it prompted the formation of byproducts such as rearranged 
ketones, fluorohydrins, and fluorination adducts of the subsequent carbonium ions 
formed after the initial cyclization.      
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Scheme 1.3. Early examples of ene-cascade cyclizations in terpenoid synthesis. 
 
 
 
 Using polyene cascade strategies to access natural pentacyclic triterpenoids is 
capricious in the laboratory setting as compared to the controlled enzymatic environment.  
The challenges reside in the construction of the polyprenoid precursors and successfully 
performing the cationic cyclizations to provide advanced intermediates in appreciable 
yields and adequate scalabality.  The pentacycles possess strain energy due to the steric 
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constraints of the angular methyls and the distortion of the cyclic backbone which make 
these cyclizations a daunting task (See Scheme 1.1).  Early studies by van Tamelen on 
the cyclization of oxidosqualene (6) proved vital illustrating that upon activation 6 folds 
preferentially to form a 5-member ring over the desired 6-member ring after the initial 
cyclization to provide the trans-decalin adduct 28 (Scheme 1.4.).46  The second 
annulation generates the carbonium intermediate 29 which possesses a more stable 
tertiary carbocation as compared to the 6-membered tricyclic adduct 30 which possesses 
the less stable secondary carbocation.  The cation 29 can then undergo elimination or a 
combination of [1,2] methyl and hydride shifts with a subsequent elimination to afford 
the trienes 31 and 32.   
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Scheme 1.4. Enzymatic and non-enzymatic cyclizing pathways for 2,3-(S)-oxidosqualene  
(6). 
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 This finding prompted the joint efforts of the Ireland and Johnson laboratories to 
conduct the total synthesis of (±)-germanicol (33) in a non-biomimetic linear strategy 
(Scheme 1.5).47  Commencing from diketone 34, the tricyclic acetate 35 was synthesized 
in 7 steps with an overall yield of 25% using a Robinson annulation approach.  
Compound 35 was elaborated through a low yielding 11 step sequence culminating with 
the ene-cyclization generating pentacycle 36 from arene 37.  Another highlight of this 
sequence is the conjugate Grignard addition and trapping of the insipient enolate to 
construct the tetrasubstituted enol acetate 38.  This was used to deliver the angular methyl 
in a diastereoselective fashion using an in situ acetate cleavage/alkylation protocol to 
afford 37.  The total synthesis of racemic germanicol (33) was then concluded in a 13 
step sequence highlighted by the installation of the last angular methyl in the D-E ring 
juncture through a novel hydrocyanation/reduction protocol developed by Nagata to 
arrive at ketone 39.48,49  The 31 step synthesis afforded racemic germanicol with an 
overall yield of 0.001% starting from the enone 34.  This underscores the power of the 
cyclase enzyme and the disparity between the biosynthetic, single step operation versus 
the multi-step conventional synthesis required to construct these complex terpenoids.    
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Scheme 1.5. Ireland and Johnson’s collaborative total synthesis of (±)-germanicol.47 
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 Ireland and Johnson’s synthesis of germanicol represents a landmark in terpenoid 
synthesis.  This single ring annelation strategy as well as van Tamelen’s tactic to 
construct the A,B,C rings through an epoxide activated cascade proved optimal to access 
these highly complex pentacyclic targets.50  Overriding the inherent selectivity with the 
polyolefin cyclization to deliver these natural products in a more efficient, higher 
yielding fashion remained an elusive problem for some time.  Corey, in 1993, provided a 
unique solution in the total syntheses of -amyrin (46), oleanolic acid (47), and 
erythrodiol (48) from polyene 49 in a strategy reminiscent of the biosynthesis of these 
natural products.  Corey and Lee used a highly stabilized tertiary allylic carbocation to 
force the desired 6-member ring formation under very mild conditions (MeAlCl2 in 
CH2Cl2 at −78 °C) to access the pentacycle 50 in a modest yield of 25% (Scheme 1.6).51  
The low yield is superseded by the ability to construct the polyene 49 rapidly on 
multigram scale as well as the number of stereocenters and angular methyls installed in a 
single operation.  This synthesis also highlights the utility of a stereoselective 
cyclopropanation strategy to install the angular methyl from intermediate 51.  This was a 
strategy originally developed by Wenkert and then exploited by Ireland in the total 
synthesis of (±)-shionone.52,53 The cyclopropane was then opened using a Kharasch free 
radical chain oxygenation.  Then, a dissolving metal reduction delivered a proton with the 
desired -facial selectivity due to an internal proton transfer from the free hydroxyl to a 
π-radical anion to form the alcohol 52.  From this intermediate, varying the set of reaction 
conditions completed the total syntheses of oleanolic acid, erythrodiol, and -amyrin in 
24, 24, and 27 steps respectively with a 0.01% overall yield.   
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Scheme 1.6. Corey’s total syntheses of oleanolic acid, erythrodiol, and -amyrin.50 
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 Still a biomimetic approach could cut down the number of synthetic steps to 
deliver a more economic, ideal strategy.  However, due to the intrinsic nature of 
following a Markovnikov pathway outside of enzymatic control, the cyclization of 
squalene-type precursors to form pentacyclic triterpenoids remained an elusive problem 
until 1994.  Johnson and co-workers developed the first non-enzymatic, biomimetic 
pentacyclization using fluorine as an auxiliary to stabilize carbocations.  The formal 
synthesis of (±)-β-amyrin (46) and the total synthesis of (±)-sophoradiol (60) utilizing a 
polyolefin cascade showcases the first example of constructing these complex natural 
products in a single diastereoselective operation from completely acyclic precursors 
(Scheme 1.7).54,55  Commencing from mesityl oxide (61), 62 was constructed in a 
scalable 22 step sequence highlighted by the utilization of an Ireland-Claisen 
rearrangement and three separate cyclopropane-mediated rearrangements to ultimately 
deliver the polyene 62 with excellent selectivity.  Under mild conditions the tertiary 
allylic carbinol was ionized with TFA in CH2Cl2 at −78 °C to initiate the polyolefin 
cascade to generate the pentacycle in 33% yield.  After a ruthenium-mediated oxidation, 
stannic chloride facilitated the elimination of the fluoride to provide the desired alkene.  
Lastly, a stereoselective double reduction provided the natural product sophoradiol (60) 
in 26 steps with an overall yield of 0.004%.  Johnson’s biomimetic strategy represents a 
large advancement in terpenoid synthesis; showcasing the plausibility of accessing these 
pentacyclic targets in a single diastereoselective operation from completely acyclic 
precursors utilizing a functional group stabilized cation to promote the desired 
Markovnikov cyclization pathway. 
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Scheme 1.7. Johnson’s total synthesis of sopharadiol. 
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 The major drawbacks of Johnson’s strategy are the length (22 steps) and 
complexity of the synthesis of the polyene 62.  This warranted further development of 
shorter, more efficient approaches to construct these precursors and ultimately the natural 
products in appreciable yields.  Recently, in two elegant syntheses Corey solved these 
problems by constructing the polyolefin precursor in only nine steps.  Starting from 
farnesyl acetate (74), a rapid enantioselective formal synthesis of (+)-germanicol (33) and 
the total synthesis of (+)-lupeol (75) were conducted utilizing biomimetic polyolefin 
cascades (Scheme 1.8).56,57  An asymmetric dihydroxylation provided the chiral epoxide 
76 in a three step sequence.58  Alkylation of the silyl imine 77 followed by hydrolysis 
delivered the acyl silane 78.  The desired oxirane 79 was then assembled in a three step, 
single flask operation.  Beginning with the addition of 2-propenyllithium followed by a 
[1,2]-Brook rearrangement facilitated by BaI2, the corresponding allyl lithium species 
was alkylated by 3-methoxybenzyl bromide to provide the polyene.  Enol ether 79 was 
then cyclized using MeAlCl2 to afford the ketone 80, which after silylation underwent a 
smooth annulation promoted by polyphosphoric acid to generate the pentacycle 81.56  
This advanced intermediate could be used to finish the total synthesis of (+)-germanicol 
(33) using the known procedures originally developed by Ireland.47   
 The epoxy triene 82 was synthesized in an alternative strategy employing a 
Suzuki-Miyaura cross-coupling, and then cyclized using MeAlCl2 at −94 °C to produce 
the pentacycle 81.  Similar to the total synthesis of (+)-oleanolic acid (47), a benzyl-
tetrasubstituted olefin was utilized to direct the desired cyclization.  This reaction 
produced a 7:3 mixture of the diene 83 and the desired pentacycle 81 which was 
subsequently treated with triflic acid (5 equiv.) to convert the diene into 81.  The 
formation of 83 under the reaction conditions warranted further investigation.  After 
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significant probing, they discovered that the polyene 82 undergoes a rare intramolecular 
1,5-migration of a proton to form a highly stabilized benzylic cation which elimination 
produced the byproduct 83.56 
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Scheme 1.8. Corey’s formal synthesis of (+)-germanicol.56 
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 The efficiency of the biosynthesis of the natural triterpenoid lupeol (75) is truly 
remarkable.  Chemical emulation of these biosynthetic transformations has been a major 
synthetic challenge existing since Stork and Eschenmoser first postulated lupeol’s native 
synthesis.38,39  Recently, the evolution of the synthetic success and overall efficiency of 
not only the polyene cascade, but also the polyolefin precursors culminated in the 
enantioselective total synthesis of (+)-lupeol.57  Corey and Surendra devised a seven step 
synthesis of the epoxy-triene 88, the shortest to date.  The natural product is accessed in a 
scalable 20 step synthesis (Scheme 1.9).   
 Polyene 88 was assembled using a copper-mediated coupling of Grignard 89 and 
the epoxy-acetate 90.  Grignard 89 was generated in a 6 step sequence, whereas acetate 
90 was constructed in 4 steps.  Polyene cyclization of the activated epoxide, followed by 
desilylation yielded tetracyclic dienone 91 in 43% yield.  Reduction, addition of methyl 
lithium, isomerization mediated by trifluoromethane sulfonic acid, and subsequent 
epimerization furnished the enone 92 in good yield over four steps.  A dissolving metal 
reduction using the Birch protocol followed by a second epimerization and a TBS 
protection yielded the silyl ether.  Alkylation of the insipient enolate generated the ketone 
93, which after reduction, the activated alcohol was cyclized and deprotected to complete 
the total synthesis of lupeol.57   
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Scheme 1.9. Corey’s total synthesis of (+)-lupeol.57 
 
 
 
 With adequate material in hand, chemically emulating the biosynthesis of various 
triterpenoids from lupeol through cationic rearrangements was investigated.  This 
reaction is postulated to occur in the active site of various cyclase enzymes due to the 
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exact positioning of a proton accepting group which channels the synthesis of various 
pentacyclic triterpenes.35  At equilibrium, carbocation formation was promoted by 
catalytic trifluoromethane sulfonic acid at 23 °C in deuterated chloroform.  Observed by 
1H-NMR, lupeol rearranged to six different pentacyclic natural products: (+)-germanicol 
(33), (+)-δ-amyrin (96), (+)-18-epi-β-amyrin (97), (+)-α-amyrin (98), (+)-taraxasterol 
(99), and (+)-ψ-taraxasterol (100) (Scheme 1.10).57  This illustrates the capacity at which 
lupeol can be diverted to various natural triterpenoids.  However, further backbone 
rearrangement to reveal friedelin was not observed due to the high energy associated with 
the strain of the conformation primarily caused by the steric encumbrance of the angular 
methyls.  Enzymatically this rearrangement can occur as previously discussed, but 
outside of enzymatic control this has not been observed indicating that alternative 
strategies must be developed in order to construct these triterpenoids. 
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Scheme 1.10. Natural products accessed via cationic rearrangements of (+)-lupeol.57 
 
 
  
 The lack of synthetic routes to the growing class of friedelin natural products, 
including celastroids, has limited the understanding of their chemistry and biology.  
Unlike other terpenoids, the absence of a synthesis is attributed to the incompatability of 
biologically inspired polyene cyclization strategies to efficiently assemble the pentacyclic 
core.  Implementation of these reactions is highly desirable as it provides rapid access to 
relatively large molecules possessing a complex topology including several stereogenic 
centers and the angular methyls in a single transformation.  The biological polyene 
cyclization leading to friedelin (13), however, is exceedingly challenging to reproduce 
chemically due to a set of complex energetically unfavorable methyl and hydride shifts 
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(see Scheme 1.1).35  In a non-enzymatically controlled environment the friedelin-based 
cationic intermediate 12 undergoes remarkable reversion to the more stable oleanyl 
cation (9).59,60  In structural elucidation studies of friedelin, (13) Corey and Ursprung 
reduced the natural product with LiAlH4 and heated the alcohol in acid which induced a 
deep-seated rearrangement.  The shifts proceeded in the reverse direction of the 
biosynthesis to provide olean-13(18)-ene (101) in a single operation showcasing the 
instability of the carbocyclic core under cation promoting conditions (Scheme 1.11). 
 
Scheme 1.11. Rearrangement of friedelin in the reverse direction promoted by acid.59,60 
 
 
  
 Ireland’s total syntheses of (±)-alnusenone (103) and (±)-friedelin (13) fully 
delineate the synthetic challenges that this class of triterpenoids possess.59-61  Alnusenone 
was constructed in 21 linear steps beginning with a Robinson annulation to generate the 
tricycle 104 from the enone 105 and ethoxytetralone 106 (Scheme 1.12).  After intense 
investigation, a modified Nagata hydrocyanation protocol was developed to afford the 
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nitrile 107.  This served as a functional handle to install the trans-vicinal angular methyls 
at the C-D ring juncture.  Acid mediated annulation, selective methyl ether cleavage, 
chemoselective Birch reduction, and then a diastereoselective reduction generated the 
alcohol 108.  The alcohol directed the cyclopropanation which was employed to install 
the last angular methyl positioned in the E-ring. After oxidation manipulations and a 
double alkylation of the thermodynamic enolate, the total synthesis of alnusenone was 
completed in an overall 0.006% yield.59,60   
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Scheme 1.12. Ireland’s total synthesis of (±)-alnusenone (103).59,60 
 
 
 
  
 The total synthesis of (±)-friedelin (13) was completed in a similar fashion where 
the  pentacyclic diether 111 was accessed in an analogous seven step sequence beginning 
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with the Robinson annulation depicted in Scheme 1.12 (Scheme 1.13).61  The only 
difference was the methyl and ethyl groups were swapped to functionalize the A ring 
prior to the E ring thereby circumventing backbone rearrangement which proved to be an 
insurmountable issue.  Selective deprotection and Birch reduction followed by re-
etherification and hydrolysis generated the enone 112 which underwent epoxidation and 
then Eschenmoser fragmentation.  Addition of methyl lithium to the insipient ketone 
provided the alkynol 113 in seven steps from 111.  Cationic annulation promoted by 
trifluoroacetic acid followed by cyclopropanation afforded the desired alcohol 114.  This 
installed the angular methyl in the A-B ring juncture where cuprate addition strategies 
generated the undesired cis-fused decalin.62  The synthesis was concluded through a 13 
step sequence involving several oxidation manipulations to provide (±)-friedelin (13) in 
31 steps with an overall yield of 0.007%.61 
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Scheme 1.13. Ireland’s total synthesis of friedelin (13).61 
 
 In addition to the annulation strategies presented in schemes 1.12 and 1.13, a 
series of attempts were made to implement polyene cyclizations to provide a faster, more 
efficient synthesis of (±)-alnusenone (103).63-65  These cyclizations proceeded in the 
opposite direction of the biosynthesis, where the E-ring bore the initial cation.  The 
polyolefin cascades were initiated through ionizing the allylic alcohols of the 
cyclohexenol 117 or the cyclopentenol 118.  These transformations provided the 
pentacyclic adducts in low yield, either 12% in the case of the cyclohexenol or an 
estimated 33% for the cyclopentenol (Scheme 1.14).  The low yields in the cyclization 
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forming the pentacycle 119 prevented this advanced intermediate from being converted 
to alnusenone (103) or any of the synthetic intermediates in the previous synthetic route.  
Conversion of the cyclopentene 120 to cyclohexenone 121 permitted a formal synthesis 
of (±)-alnusenone (103), although this approach did not improve upon the group’s 
existing route due to lower yields and scalability.  Both approaches utilized 
tetrasubstituted olefins to engage the initial cation to form the trans-fused C-D decalin 
core thereby installing the angular methyls in a single transformation.  This approach was 
inferior, however, to the linear annulation strategies since the syntheses of the polyenes 
117 and 118 were not higher yielding, as scalable, or more efficient. 
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Scheme 1.14. Ireland’s polyene cyclization approaches toward (±)-alnusenone.63-65 
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Conclusion 
 
 Since the initial postulate regarding (+)-lupeol’s biosynthesis, intense research has 
been conducted to provide strategies that chemically emulate the biosyntheses of various 
natural tetracyclic and pentacyclic triterpenoids.  The polyene cyclization has evolved 
into a new successful, efficient strategy to access these natural products substantiated by 
the recent work of Corey and Surendra.56,57  However, there has not been significant 
progress utilizing this strategy to access the friedelin natural products thereby alternative 
approaches have been required to synthesize this class of terpenes.  These strategies are 
longer, inefficient syntheses that implement a high number of oxidation manipulation 
steps.59-61  This warrants in-depth investigation to develop a more efficient, scalable route 
to provide access to these small molecules in a manner which maximizes C-C bond 
formation, and installs the angular methyls as well as the all-carbon quaternary centers in 
a stereoselective fashion while minimizing protecting group and oxidation steps.  The 
polyene cascade provides this solution, but minimal success has been observed utilizing 
this strategy.63-65  Developing a novel polyolefin cyclization employing new initiators as 
well as milder Lewis or Brønsted acid promoters could change these outcomes ultimately 
providing a successful protocol to rapidly access this class of natural products.  This 
would allow the synthesis of celastrol (1), its enantiomer, and other celastroids in 
appreciable amounts.  On the biological front, access to these small molecules would 
provide tools to investigate their modes of action thereby providing answers to important 
biological questions and directing the future development of this growing class of 
compounds. 
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Chapter 2 – Studies Toward the Synthesis of Celastrol 
 
Retrosynthetic Analysis 
 
 The optimal synthetic strategy to construct (±)-celastrol (1) was planned with the 
goal of installing the reactive quinone methide functionality in the last step through 
oxidation of (±)-wilforic acid (127), which in turn could be derived from the 
permethylated pentacycle 128 (Figure 2.1).  Introduction of the fully substituted carbon 
center at C-20 from a ketone simplified the molecule providing the pentacycle 129 as a 
subtarget accessed through the polyene cyclization of an achiral cyclohexadienone (130).  
The polyolefin cascade rapidly constructs the friedelin core installing each angular 
methyl and six contiguous stereocenters in a single diastereoselective operation.  
Strategic use of a chiral Lewis or Brønsted acid could impart stereoinduction to provide 
access to either enantiomer of celastrol (1) making this strategy highly desirable.  The 
electron rich tetrasubstituted arene provides a trap for the cyclization, and due to 
substitution it is forced to react at a single position.  The cyclization precursor was 
envisioned to be assembled in a convergent manner using three separate fragments: the 
arene, the tetrasubstituted olefin fragment, and the dienone.  The crux of the strategy 
relied on a precedented olefination protocol to provide the tetrasubstituted alkene 131.65  
The dienone was to be synthesized through a Birch reduction/alkylation sequence using 
benzoic acid (132) followed by a Wolff-Kishner reduction and a site-selective allylic 
oxidation.59,66-72  Olefin 131 was foreseen to be derived from the ketone 133 which is 
accessed through the copper-mediated coupling of arene 134 to acetate 135.57  The arene 
was to be derived from the cheap, commercially available vanillin (136), while 135 could 
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be synthesized from geraniol acetate (137) through a simple selective oxidation 
approach.73,74 
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Figure 2.1. Key disconnections of celastrol and the linear precursors for the polyene  
cyclization. 
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Forward Synthesis  
 
 Starting from geraniol acetate, selective oxidation of the exterior olefin by 
treatment with m-CPBA in methylene chloride at 0 °C provided the epoxide; which 
underwent smooth oxidative cleavage with periodic acid in THF/water to provide the 
aldehyde 138 in good yield over two steps (Scheme 2.1).73  This provided the aldehyde 
cleanly with no purification required.  Ozonolysis also generated the aldehyde in a single 
step, but suffered from long reaction times and poor scalability.  Addition of a 3 M 
solution of methylmagnesium bromide in diethyl ether at 0 °C provided the alcohol 
which was then subjected to a Swern oxidation in THF at −78 °C to provide the desired 
ketone 135 in four scalable steps.74 
 
Scheme 2.1. Synthesis of the ketone fragment.73,74 
 
 
 
 The main synthetic challenge was selectively installing the tetrasubstituted alkene 
in appreciable yield.  Bestmann demonstrated that Horner-Wadsworth-Emmons (HWE) 
olefinations were a viable approach to access tetrasubstituted olefins.65  To test the 
plausibility of this transformation, 135 was submitted to a number of conditions.  
Initially, the HWE olefination between 135 and the phosphonate 139 was examined to 
access the desired alkene 140.  The ketone, however, was recalcitrant toward olefination 
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using HWE, Wittig, Julia, or even Corey-Fuchs protocols.65,75-78  The use of different 
bases, counter ions, additives, solvents, and temperatures did not affect any appreciable 
conversion of the starting ketone; only unreacted starting material was returned (Table 
2.1).  The Corey-Fuchs reaction would have provided the tetrasubstituted dibromo-olefin 
141 which would have served as a functional handle for selective cross-coupling 
reactions.  Literature precedence in the total syntheses of FR182877 by Evans and 
kedarcidin by Myers illustrated that 1,1-dibromo-alkenes can be differentiated using 
cross-couplings mitigated by palladium catalysis.79,80 
 
Table 2.1. Survey of olefination conditions to synthesize the tetrasubstituted alkene 140. 
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 An alternative approach to the polyene utilizing a B-alkyl Suzuki-Miyaura cross 
coupling was devised to construct the tetrasubstituted olefin from the iodo-enoate 143 
and the alkyl boronate 144 (Figure 2.2).81,82  Subjecting the aldehyde 145 to a Seyferth-
Gilbert homologation followed by lithiation and trapping with ethyl chloroformate 
affords the ynoate.83,84  Addition of Gilman’s reagent and trapping the insipient copper 
allenolate with iodine would provide the enoate 143 using a landmark protocol developed 
by Corey and Katzenellenbogen.85,86  The boronate 144 could be generated from benzoic 
acid through a sequence utilizing a Birch reduction/alkylation, selective reductions as 
well as oxidations, and then a selective hydroboration.66-71,87-89 
41 
 
 
Figure 2.2. New bond disconnections to construct the desired tetrasubstituted olefin.  
  
Accessing the key diene 143 required the synthesis of the aryl fragment which 
was conducted in a highly scalable, five step sequence (Scheme 2.2).  Reduction of 
vanillin with NaBH4 in methanol at 0 °C furnished the diol.  Selective protection using 
catalytic p-toluenesulfonic acid in methanol provided the ether 147 in 97% yield over two 
steps on 60 gram scale.  The ether was then subjected to a directed ortho-metallation 
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protocol using n-butyllithium in THF at −20 °C.  After 2.5 hours iodomethane was added 
to the resultant red-orange colored solution alkylating the dianion to install the tolyl 
methyl.  The crude phenol was then etherified using dimethyl sulfate and potassium 
carbonate in acetone heated to reflux to generate the arene 148 in an 84% yield over two 
steps on 63 gram scale.72  Unfortunately, the dianion could not be alkylated and etherified 
in a single operation thus requiring the two separate steps.  Bromide 134 was then 
accessed through a reaction using concentrated hydrobromic acid in toluene at 0 °C.  The 
biphasic mixture was stirred vigorously for two hours, and after an aqueous work-up the 
crude brown solid was recrystallized from hexane to afford 134 as a white crystalline 
solid in 80% yield. 
 
Scheme 2.2. Synthesis of the aryl fragment. 
 
 
  
 The aryl fragment was ready to be installed through a copper mediated coupling 
of the Grignard 149 and the allylic acetate.57  This warranted protection of the aldehyde 
therefore the dioxolane 146 was synthesized in 95% yield using catalytic p-
toluenesulfonic acid and ethylene glycol in benzene heated to reflux (Scheme 2.3).  
Unfortunately, the coupling of the two fragments failed due to the inability to form the 
Grignard.  After surveying a variety of conditions to generate the Grignard (149), only 
minimal quantities could be generated due to extensive Wurtz coupling which formed the 
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dimer 150.   This occurred despite the slow addition of the bromide as a solution in THF 
over 12 hours to activated magnesium.90  After titration, the freshly prepared green 
colored solution of the Grignard 149 was subjected to acetate 146 in the presence of 
Kochi’s catalyst in THF at a range of temperatures.57  This reaction did not render the 
desired coupled adduct 151, however, only the benzyl dimer and the unreacted acetate 
146 were isolated warranting a new coupling strategy.   
 
Scheme 2.3. Attempted Grignard formation and fragment coupling. 
 
 
  
 With problematic Grignard formation, tin was installed to provide a functional 
handle to couple the fragments avoiding significant Wurtz coupling.  Stannane 152 was 
synthesized in the variable yields of 40-70% by alkylating lithium tri-n-butylstannane in 
THF with the benzyl bromide (Scheme 2.4).  The stannyl lithium reagent was initially 
generated by stirring a heterogeneous mixture of lithium metal and tri-n-butylstannyl 
chloride in THF at 0 °C.91  However, use of this green mixture afforded 152 in variable 
yields (40-70%) due to Wurtz coupling.  After experimentation, I discovered that freshly 
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preparing the lithium tri-n-butylstannane proved optimal.  Deprotonating tri-n-butyltin 
hydride with freshly prepared LDA at 0 °C in THF and then slowly adding a 0.2 M 
solution of the bromide 134 in THF at −78 °C over three hours afforded the desired 
product in 83% yield.92   
 Using palladium or zinc catalysis the dioxolane 151 was inaccessible through a 
Stille coupling approach.  However, treating two equivalents of the stannane with the 
freshly prepared higher order cuprate Me2CuCNLi2 in THF at −78 °C followed by 
warming the golden-yellow solution to 0 °C afforded the desired benzyl cuprate.  Slowly 
adding the allylic acetate to the cuprate successfully coupled the fragments together to 
provide the arene 151 in 30% yield.  The yields of this reaction varied, and using excess 
stannane was not ideal.  Attempts to improve the reaction by using one equivalent of the 
benzyl tin reagent or a thio-cuprate unfortunately failed to provide the coupled product.  
It is important to note that this is a modification of the established protocol developed by 
Lipshutz, representing an extension of his work in the coupling of allylic acetates and 
alkyl halides to allylic stannanes.93-95   
 Despite successful coupling, the low variable yields and the required use of 
excess stannane proved inadequate to generate sufficient material.  So, a new coupling 
strategy was devised employing a hard alkylation of the lithiated arene which was 
generated through a tin-lithium exchange.  Treating the benzyl stannane with n-
butyllithium in deoxygenated THF at −78 °C provided an orange colored solution 
containing the benzyl lithium species.  The bromide 154 was then added to this solution 
to afford the desired coupled product in 57% yield.  It is imperative that deoxygenated 
THF was used and the bromide was added slowly over the course of 1 hour or else 
significant Wurtz coupling was observed.  Bromide 154 was prepared in two steps by 
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treating the acetate with a mixture of potassium carbonate in methanol and then 
subjecting the allylic alcohol to an Appel reaction to generate the bromide using carbon 
tetrabromide and triphenylphosphine in methylene chloride.  The byproduct, 
triphenylphosphine oxide, complicated the purification because the crude bromide rapidly 
decomposed on silica gel, basic alumina, and during distillation.  However, triturating the 
mixture with cold pentane delivered the bromide after filtration as a pale yellow oil in 
>95% purity and 94% yield.  
 
Scheme 2.4. Synthesis of aryl dioxolane 151. 
 
 
 
 The dioxolane was hydrolyzed using a solution of 1 N HCl and THF heated to 65 
°C to deliver the aldehyde 145 (Scheme 2.5).  Treatment with the Bestmann-Ohira 
reagent (156) and potassium carbonate in methanol generated the terminal acetylene 157 
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through a Seyferth-Gilbert homologation.83,84  The alkyne was then metalated using n-
butyllithium in THF at −78 °C, and the resultant lithium acetylide was trapped with ethyl 
chloroformate to afford the ynoate in 83% yield.  Conjugate addition using freshly 
prepared Gilman’s reagent in THF at −78 °C generated the copper allenolate which was 
iodinated to provide the tetrasubstituted iodo-enoate 143 in 61% yield using the protocol 
developed by Corey and Katzenellenbogen.85,86  The observed side products were over 
addition of Me2CuLi and those associated with adducts of halo-ene cyclizations.  It was 
imperative that this reaction be conducted at temperatures lower than −45 °C as 
isomerization of the copper allenolate would occur to provide the undesired cis-vinyl 
iodide.85  Unfortunately, the copper allenolate could not be alkylated using alkyl halides 
thereby eliminating the potential to assemble the polyene in a single operation.   
 The capability of 143 to participate in a Suzuki-Miyaura cross-coupling was then 
examined.  Subjection to catalytic palladium(dppf) dichloride and cesium carbonate in a 
THF/water mixture heated to 80 °C, the iodide could be coupled to the pinacolate ester of 
phenyl boronic acid in near quantitative yield to afford the styrene 158.96,97,82  At this 
point the ester was reduced with lithium aluminum hydride in ether to access the allylic 
alcohol 159 in 90% yield with the desired trans-alkene confirmed by NOE spectroscopy.     
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Scheme 2.5. Synthesis of iodo-enoate fragment. 
 
 
  
 With access to 143 and proof of its excellent potential as a partner in cross-
couplings, attention was directed towards constructing the alkyl boronate fragment 144 
and examining its reactivity in B-alkyl Suzuki reactions.  Birch reduction of benzoic acid 
using lithium metal in THF and liquid ammonia at −78 °C and then addition of 
iodomethane to the dark blue mixture to alkylate the resultant dianionic enolate afforded 
the cyclohexadiene 160 in 97% yield.66-70  The acid was reduced with lithium aluminum 
hydride in ether at −78 °C to render the alcohol which was then immediately protected 
without purfication as the acetate using DMAP, triethylamine, and acetic anhydride to 
provide the acetate 161 in 88% over two steps.  It was imperative to conduct the 
reduction at −78 °C due to the facile nature of isomerization to the conjugated diene.  
Also, the acetate was a vital protecting group because of its easy deprotection in later 
stages where other protecting groups facilitated decomposition during their removal.  
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Employing the protocol developed by Shing and co-workers, allylic oxidation mediated 
by manganese triacetate and tert-butylhydrogen peroxide in ethyl acetate heated to reflux 
under an aerobic atmosphere afforded the dienone 162 in near quantitative yield.71  This 
material was extremely sensitive to acidic and basic conditions primarily decomposing 
through a 1,4-phenolic rearrangement pathway.  It was therefore subjected to a Luche 
reduction using sodium borohydride and cerium trichloride heptahydrate in methanol at 
−60 °C to deliver the alcohol.89  The temperature of this reaction was critical because 
significant 1,4-reduction was observed without proper cooling of the reaction.  The allylic 
alcohol was then protected as the silyl ether with tert-butyldimethyl chlorosilane and 
imidazole in acetonitrile which was subjected to methanolysis to generate the alcohol 163 
in 69% yield over three steps.   
 The use of Dess-Martin periodinane to oxidize the alcohol was problematic 
because the aldehyde rapidly decomposed under these conditions despite buffering the 
reaction.  However, a modified Swern oxidation successfully generated the aldehyde 164 
in near quantitative yield.74  Lastly, Wittig olefination of the aldehyde with the freshly 
prepared methyl triphenylphosphorane ylide in THF at 0 °C delivered the triene 165 in 
93% yield.77  Despite undesired oxidation and protecting group manipulation steps, this 
route worked successfully on multigram scale to provide the triene.  Attempts to 
minimize these unwanted steps were unsuccessful because of the volatility of triene 166.  
Wittig olefination of the aldehyde 167 did work, but 166 could not be purified.  The 
triene forms a positive azeotrope with THF and distillation caused decomposition to a 
black tar substance even in the presence of BHT.  Hydroborating the crude material 
directly also did not work thereby prompting the lengthy oxidation strategy. 
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Scheme 2.6. Synthesis of triene fragment. 
 
 
 Employing the protocol developed by Evans, the triene 165 was selectively 
hydroborated using Wilkinson’s catalyst and pinacolborane in deoxygenated THF to 
provide the desired alkylboronic ester 168 in 73% yield (Scheme 2.7).  This moiety was 
initially reluctant to couple to simple aryl halides through a B-alkyl Suzuki coupling, but 
eventually I discovered that using a mixture of stoichiometric silver (I) oxide, catalytic 
palladium(dppf) dichloride, and cesium carbonate in hot THF/water, the alkyl boronic 
ester couples to simple aryl halides such as bromobenzene in modest yield.  The silver (I) 
oxide is critical as no coupling occurs in its absence; only unreacted starting material is 
returned.  Unfortunately, treating the mixture of boronate 168 and iodide 143 to these 
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same conditions caused decomposition of the starting materials with no observation of 
the coupled product.  At this stage, due to the difficulty of coupling the pinacolate to even 
simple substrates, boronate 144 was envisioned to be a better coupling partner due to the 
enhanced reactivity of these entities in cross-couplings.81,82 Boronate 144 was accessed 
by selectively hydroborating the triene 165 with crystalline 9-BBN in THF at 0 °C.  After 
examination of the key coupling reaction, however, the two fragments did not couple 
using this strategy thereby warranting a different approach to the polyene. 
 
Scheme 2.7. Failed B-alkyl Suzuki-Miyaura to couple fragments. 
 
 
  
 Constructing the tetrasubstituted alkene remained elusive, so installing the olefin 
at the beginning became the focus.  Originally, I sought to construct the alkene using a 
51 
 
protocol developed by Maercker entailing the stereoselective reduction of an internal 
alkyne which generates a vicinal dimetallated olefin.  Alkylation of the dianion with 
iodomethane would then deliver the desired alkene.100-103  Unfortunately, this procedure 
failed.  It was foreseen that the desired olefin could be synthesized in the initial step 
through a bromination of 2,3-dimethyl butadiene to afford the bromide 123.104,53  This 
provides a synthon to access the symmetrical diketone 171 which installs the 
functionality required to obtain the alcohol 172.  Coupling this moiety to the aryl 
fragment through a tin-lithium exchange mediated alkylation sequence would deliver the 
triene 173.  A selective oxidation and annulation installs the cyclohexenone fragment 
ultimately to afford the desired polyene 174.  This new strategy maximizes C-C bond 
formation and eliminates undesired oxidation and protecting group manipulation steps. 
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Figure 2.3. New strategy for the synthesis of the polyene 174. 
  
 Slow addition of one equivalent of bromine to 2,3-dimethyl butadiene in 
methylene chloride at −78 °C afforded the dibromide 123 as a crystalline, lacrimating 
solid.104  Desymmetrization proved unsuccessful using one equivalent of allylmagnesium 
bromide and methylallyl lithium (Scheme 2.8).  However, allylation of the bromide with 
two equivalents of allylmagnesium bromide in ether heated to reflux provided the triene 
178 in quantitative yield.  Double Wacker oxidation using the Tsuji protocol produced 
the diketone, albeit in modest yields with moderate scalability.105   
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Scheme 2.8. Wacker oxidation strategy to access diketone 171. 
 
 The long reaction times and low yields on appreciable scales warranted 
investigation into a more efficient process.  The Wacker protocol developed by Sigman 
and co-workers was then employed using the quinox ligand 180, catalytic palladium, 
TBHP, and silver hexafluoroantimonate in methylene chloride (Scheme 2.9).106,107  These 
conditions induced rapid decomposition only to afford the desired diketone in low yields. 
 
Scheme 2.9. Wacker oxidation of triene 178 using the Sigman protocol. 
 
  
 Heavy focus was now placed on alkylating enolates with the dibromide to install 
the desired carbonyl functionality.  This was not a trivial task due to the formation of 
undesired cyclopropanated products (Table 2.2).  Using the enolate of 
dimethylacetamide, however, the formation of these undesired adducts was minimized.  
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The steric bulk and the difficult nature of deprotonating the α-carbon of amides compared 
to esters, malonates, and –keto esters facilitated the alkylation to generate the diamide 
181 in high yield forestalling intramolecular cyclopropanation.  Slow addition of 
dimethylacetamide to a freshly prepared solution of LDA in THF at −78 °C followed by 
the slow dropwise addition of bromide 123 as a solution in THF generated the diamide as 
a white crystalline solid in 91% yield after recrystallization.  This reaction was 
successfully repeated on 15 gram scale to provide appreciable quantities of 181.   
 Subjecting the amide to methylmagnesium bromide either alone or in combination 
with anhydrous cerium trichloride as well as BF3-OEt2 at various temperatures returned 
the unreacted starting material.  Using methyl lithium at different temperatures in THF 
was unselective, but combined with freshly dried zinc bromide in ether at −10 °C 
afforded the desired ketone, albeit in variable yields with moderate scalability.108,109  
However, after examining the solubility of the diamide in ethereal solvents I discovered 
that prolonged cooling in THF at −78 °C produced a white heterogeneous mixture, and 
slow addition of methyl lithium to the mixture facilitated the synthesis of the diketone 
selectively in high yields reliably on multigram scales.  The selective delivery of one 
equivalent of an alkyl lithium or a lithium acetylide into amides to generate ketones in a 
single operation has also been observed by Trost.110,111  At −78 °C the tetrahedral 
intermediate, formed after the initial nucleophilic addition, is persistent which causes a 
selective addition to occur as long as the temperature remains at −78 °C.  This was 
confirmed by Trost and Phan when they attempted to add a lithium acetylide into an 
amide.110  Upon neutralization of the reaction media with water the starting amide was 
returned.  However, when BF3-OEt2 was added at −78 °C the propargyl ketone was 
afforded in high yield after neutralization.  Alkyl lithium reagents, however, do not 
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require the use of Lewis acids prior to neutralization.  This predicates the minimal 
selectivity originally observed at reaction temperatures warmer than −78 °C when using 
methyl lithium.  However, upon properly cooling the reaction mixture to −78 °C through 
equilibration over one hour and maintaining this temperature through a controlled 
dropwise addition of methyl lithium, the diketone could be synthesized in high yield.  
Recrystallization from hexane produced a white crystalline solid which X-ray diffraction 
unambiguously confirmed as the diketone 171 (see Experimental Section). 
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Table 2.2. Alkylation of different enolates using bromide 123 ultimately providing  
diketone 171. 
 
  
 A Horner-Wadsworth-Emmons olefination was employed to desymmetrize the 
ketone (Table 2.3).112  After varying the phosphonates, bases, solvents, and temperatures 
I discovered the ideal conditions, in regards to yield and E/Z selectivity, were triethyl 
acetophosphonate and sodium bis(trimethylsilyl) amide in warm toluene.  The enoate 176 
was provided in a 60% isolated yield with a 6:1 E/Z selectivity using this protocol.  The 
remaining material consisted of the undesired dienoate 182 isolated in 26% yield and 
recovered starting material isolated in 14%.  This yield varies from the expected 
statistical outcome possibly due to the slow elimination of the insipient alkoxy 
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phosphonate after the initial nucleophilic addition.  This produces an intermediate which 
is reluctant to form the high energy dianion generated through a second addition of the 
remaining acetophosphonate. 
 
Table 2.3. Differentiation of symmetrical ketone 171 via HWE olefination. 
 
 
 
 The fidelity of this transformation was preserved on multigram scale with 
minimal loss in yield, but at this stage the olefin isomers were inseparable.  Subjecting 
the ketone 176 to a Wittig olefination using the freshly prepared methyl 
triphenylphosphorane ylide in THF at 0 °C, the triene 183 was generated in quantitative 
yield (Scheme 2.10).  After examination of different solvent conditions, the E/Z isomers 
could be separated chromatographically using benzene as the eluent, and the correct 
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isomer was confirmed through NOE spectroscopy (see Experimental Section).  In order 
to maximize material pushed to the forefront, the isomerization of the cis-isomer 184 was 
investigated.  Usually iodine or transition metal catalysis is employed to isomerize these 
types of olefins, but these conditions are detrimental.  So, different nucleophiles which 
add in a conjugate fashion to facilitate formation of the thermodynamic trans-isomer 
were examined.  However, phosphine, thiol, and nitrogen nucleophiles were recalcitrant 
to reacting with this moiety.  Focus was then placed on using bases to promote extended 
enolization.  Subjecting the cis-enoate 184 to freshly prepared sodium ethoxide in ethanol 
at 23 °C generated the desired product in 51% isolated yield.  The remaining recovered 
material was the cis-isomer. 
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Scheme 2.10. Synthesis of trienoate 183. 
 
 
 
 Addition of lithium aluminum hydride to an ethereal solution of the ester, and 
allowing the pale yellow homogeneous solution to warm gradually from −78 to −20 °C 
over five hours provided the alcohol 172 in 93% yield (Scheme 2.11).  Careful analysis 
of the reaction progress by TLC proved necessary because significant 1,4-reduction was 
observed when the temperature rose above −10 °C.  Halogenation of the alcohol using 
phosphorus tribromide in ether provided the allylic bromide.112  After aqueous work-up, 
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the crude bromide was used directly in the alkylation step without purification.  Addition 
of n-butyllithium to a solution of the benzyl stannane 152 in deoxygenated THF at −78 
°C generated a red-orange solution of the benzyl lithium species 155.  This was then 
alkylated by the bromide to couple the two fragments together, generating the aryl triene 
173 in 79% yield starting from the alcohol.  Selective hydroboration of the 1,1-
disubstituted olefin with crystalline 9-BBN dimer in THF at 0 °C proceeded smoothly.88  
NMR analysis of an aliquot from the crude reaction solution determined complete 
conversion after four hours upon which a solution of 4 N NaOH with 30% H2O2 in water 
was added.  The biphasic mixture was stirred vigorously for 60 hours to produce the 
desired alcohol 185 in 88% yield.  Oxidation using Dess-Martin periodinane with solid 
sodium bicarbonate in methylene chloride at 0 °C afforded the aldehyde 186 in 88% 
yield.113  Treatment with pyrrolidine in toluene and heating the solution to 140 °C for 24 
hours generated the enamine 187.  After concentrating the reaction solution, analysis of 
the crude orange viscous oil by 1H-NMR in C6D6 revealed the enamine was 
approximately 95% pure with 4% of the starting aldehyde remaining.  Treatment with 
two equivalents of methyl vinyl ketone in toluene at 82 °C afforded the resultant 
annulated β-pyrrolidine adduct which was hydrolyzed with an acetic acid/sodium acetate 
buffer to deliver the desired enone 174 in 83% yield from the starting aldehyde.64,115 
 Commencing from 2,3-dimethyl butadiene, the polyene 174 was synthesized in 11 
steps in an overall 21% yield.  It is a highly scalable strategy capable of reliably 
providing the enone in quantities greater than five grams representing one of the most 
efficient, highest yielding syntheses of a polyene precursor to date.   
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Scheme 2.11. Synthesis of the polyene enone 174. 
 
 
  
 Significant examination of the polyolefin cyclization ensued (Table 2.4).  As a 
new type of initiator, this transformation is highly desirable not only to rapidly construct 
the carbocyclic core in a diastereoselective fashion, but also to deliver the pentacycle at 
the correct oxidation state.  Heating the enone to various temperatures in methylene 
chloride, dichloroethane or even chlorobenzene under pressure promoted no reactivity.  
62 
 
The use of BF3-OEt2 or titanium tetrachloride at a range of temperatures only promoted 
decomposition of the starting material with no observation of the cyclized product.  
Titanium iso-propoxide induced no conversion of starting material despite heating the 
reaction mixture to reflux in methylene chloride.   
 Treating the enone with tert-butyldimethylsilyl trifluoromethane sulfonate in a 
dilute solution of methylene chloride at 0 °C afforded what was initially believed to be 
the cyclized product 175 in an isolated 5% yield.  No increase in yield was attained 
despite conducting the reaction at lower temperatures in a more dilute solution.  
Throughout the course of the reaction the silyl enol ether was never observed dictating 
that it was either being hydrolyzed or trifluoromethane sulfonic acid was actually 
promoting the cyclization.  To confirm the latter, two control experiments were 
conducted.  First, the enone was treated with the silyl triflate in the presence of freshly 
distilled Hunig’s base.  No cyclization was observed, only unreacted starting material was 
returned.  Second, the enone was treated with catalytic and stoichiometric quantities of 
trifluoromethane sulfonic acid.  Stoichiometric amounts of the acid prompted swift 
decomposition of the polyene, but the cyclized adduct was attained in 5% yield by 
treating the enone with 10 mol% of the acid.  The remainder of the material consisted of 
products which were beyond structural assignment.   
 The use of milder Brønsted acids such as pyridinium p-toluenesulfonate, diphenyl 
phosphoric acid, or p-toluenesulfonic acid did not induce any reaction.  Switching to 
concentrated hydrochloric acid in methylene chloride at 23 °C generated the product in a 
35% yield as a 2:1 mixture of diastereomers.  This result was somewhat surprising as in 
theory the cyclization should occur in a stereospecific manner.  The diastereomers are 
formed as the aryl ring engages the trisubstituted olefin, which was determined by 
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subjecting the isomerically impure starting material (6:1, trisubstituted alkene) to the 
identical reaction conditions.  The product was isolated in the exact same yield and d.r. as 
when isomerically pure material was used.  This was also unambiguously confirmed by 
2D-NMR spectroscopy. 
 The lower yields and diastereoselectivity warranted further probing of milder 
Lewis acids to improve the yield.  Despite literature precedence on promoting ene-type 
reactions with enones, aluminum reagents showed modest improvements in yield or 
diastereoselectivity.115  Sen and co-workers showcased the use of anhydrous ferric 
chloride as well as its hexahydrate to promote polyene cyclizations with epoxides which 
prompted exploration of these reagents in the cyclization of enone 174.116  Treating a 
highly dilute solution of the enone in deoxygenated methylene chloride with 1.5 
equivalents of anhydrous ferric chloride promoted the cyclization to afford the product in 
an isolated 77% yield on 20 milligram scale.   
 At this stage only 1H-NMR analysis in a variety of deuterated solvents as well as 
IR spectroscopy and mass spectrometry were used to assign the structure because the 
mixture of diastereomers severely complicated the 13C-NMR spectra.  Therefore, the 
tentative structural assignment remained invalidated.  After an exhaustive investigation, I 
discovered that using an isochratic solution of dioxane in hexane the diastereomers could 
be separated by silica gel chromatography.  X-ray diffraction could not be used to 
confirm the structure because the ketone was an amorphous foam.  Reducing the ketone 
and protecting the alcohol as the tosylate, conversion to the tosyl hydrazone, or protecting 
the catechol as either the m-dinitro or p-bromo benzoates only produced foams unworthy 
of X-ray diffraction.  However, the fidelity of the cyclization translated excellently above 
the milligram scale.  On one gram scale, the cyclized adduct was provided in 65% yield 
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as a 3:1 mixture of diastereomers.  The scalability of the reaction provided a surplus of 
material and the ability to separate the diastereomers allowed the structure to be 
elucidated by 2D-NMR: COSY, DEPT, NOESY, HSQC, HMBC, and 13C-
INADEQUATE.  The results of these experiments clearly indicated that the 
cyclohexanone 188 was the actual product of these cyclizations, not the desired 
pentacycle 175.  This molecule was produced through a cationic [2+2] pathway to 
generate the 4,5,6-tricycle which then undergoes a second annulation between the arene 
and the trisubstituted olefin, ultimately generating the diastereomers of the reaction.117-119  
This heartbreaking result nearly thwarted future endeavors.   
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Table 2.4. Selected examples of the cationic cyclization of cyclohexenone 174. 
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 Inability to emulate the friedelin biosynthesis combined with the synthetic 
difficulties observed by Ireland and co-workers inspired the examination of new initiators 
for cationic polyolefin cyclizations which provide products at the desired oxidation state.  
The result of the cationic [2+2] prompted the use of an allylic epoxide as the initiator.  
However, this strategy was unsuccessful because the linear enone 174 could not be 
converted into the epoxide 189 (Table 2.5).  Steric encumberance of the 4,4-disubstituted 
cyclohexenone prevents proper orbital alignment for addition of various nucleophiles 
thereby promoting enolization of the readily accessible -protons as the sole pathway.  
Due to the presence of multiple alkenes I did not foresee selective epoxidation to occur 
though another manifold so this strategy was abandoned.   
 Ireland’s work on polyene cascades using allylic alcohols coupled with the 
observations I had made attempting this reaction on the enone 174 led me to hypothesize 
that this transformation using the allylic alcohol would be viable.  The use of strong 
protic acids as well as Lewis acids that strongly promote discrete cation formation (i.e. 
boron, aluminum, and tin) proved deleterious to the polyene causing degradation of the 
alkenes.  However, iron induced the cyclization, albeit through the wrong pathway, in 
mild manner which did not decompose the olefins.  High dilution also proved to be 
critical.  Ireland’s protocol used a concentration of 25 mM in methylene chloride.  The 
enone 174 underwent massive degradation at this concentration, but this decomposition 
was not observed at 1 mM inspiring deeper experimentation.   
 Enone 174 was reduced using lithium aluminum hydride in ether at 0 °C to 
provide the allylic alcohol 190 in quantitative yield (Table 2.5).  Under the identical 
conditions used by Ireland, the alcohol was treated with 1.5 equivalents of stannic 
chloride in a 25 mM solution of methylene chloride at −78 °C to afford the desired 
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pentacyclic product 191 in a 15% isolated yield.  Diluting the reaction concentration to 1 
mM generated the cyclized product in 26% yield.  Switching to ferric chloride and 
increasing the temperature to 0 °C, the pentacycle 191 was obtained in 33% yield.  
Increasing the amount of ferric chloride and allowing the temperature to warm from −78 
to −30 °C provided the product in 38% yield, and finally, diluting the reaction to 500 μM 
with careful monitoring by TLC as the reaction warmed to −30 °C the pentacycle was 
afforded in a hard earned yield of 51%.  The remainder of the material consisted of 
interrupted cyclized adducts as well as a small amount of polymerized products.  It is 
important to note that the reaction occurred stereospecifically to provide a single 
diastereomer as initially postulated.  When the isomerically impure material (6:1 at the 
trisubstituted olefin) was subjected to the reaction conditions, the pentacycle was 
generated as a diastereomeric mixture matching that of the starting material. 
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Table 2.5. Polyene cyclization of the allylic alcohol 190. 
 
 
 
 Fortunately, the polyene cyclization proceeded smoothly on scales up to 1 gram 
with minimal loss in yield (Scheme 2.12).  In regard to my knowledge of the literature 
this is the largest scale a polyolefin cascade has been conducted to generate either a 
tetracyclic or pentacyclic triterpenoid.  Reactions larger than 1 gram scale were not 
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conducted due to the lack of a flask large enough to accommodate the amount of solvent 
needed for the reaction at the optimal concentration.  For instance, on 1 gram scale 4.7 L 
of methylene chloride is needed in order to produce the pentacycle 191 in a 38% yield.  
This warranted further improvement in order to decrease the amount of solvent required 
to perform the cyclization successfully on larger scale in good yield while still 
maintaining the effective molarity of the substrate.  Utilizing the concept of effective 
molarity, a protocol employing the syringe pump addition of a dilute solution of the 
substrate in a slow dropwise manner to a dilute solution of FeCl3 in methylene chloride 
was investigated.  While maintaining the reaction temperature at −30 °C the 
concentration of the substrate, addition rate, and concentration of ferric chloride were 
variables that were systematically examined, and they all proved to be critical.  After 
optimization, the cyclization proceeded well on 100 mg scale to afford the cyclized 
product in 51% yield (Table 2.6).  This proof of concept warranted further probing of the 
protocol’s scalability.  On 1 gram scale the starting alcohol was added as a dilute solution 
in methylene chloride over 6 hrs using a syringe pump to a solution of ferric chloride 
maintained at −30 °C, however, this only produced the pentacycle 191 in 26% yield.  
Although successful the yield is much lower on gram scale as compared to the original 
method to conduct the cyclization using very high dilution and a gradual warming of the 
temperature from −78 °C.  It is important to note that using this strategy only 1.2 L of 
methylene chloride was required to perform the cyclization which represents a 4-fold 
decrease in the amount of solvent used for this reaction. 
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Table 2.6. Slow addition protocol for the polyolefin cascade of allylic alcohol 190. 
 
MeO
MeO
Me
Me
Me
H MeH
Me
FeCl3
CH2Cl2, 30 °C
Me
Me
Me
Me
Me
MeO
OMe
OH
Scale Substrate Solution Addition Rate FeCl3 Solution Concentration Isolated Yield (%)
1 mM 432.5 mL / hr100 mg 2.5 mL 225 mL
2 mM 412.5 mL / hr100 mg 2.5 mL 110 mL
480.8 mL / hr100 mg 2.5 mL 225 mL 1 mM
2 mM 4710 mL / hr100 mg 5 mL 110 mL
4 mM 425 mL / hr100 mg 5 mL 55 mL
4 mM 3510 mL / hr100 mg 5 mL 55 mL
2 mM 5120 mL / hr100 mg 10 mL 110 mL
2 mM 4840 mL / hr100 mg 20 mL 110 mL
2 mM 4220 mL / hr300 mg 30 mL 330 mL
2 mM20 mL / hr1 gram 100 mL 1.1 L 26
190 191
 
  
 With adequate access to the pentacycle 191, a bifurcated retrosynthetic analysis to 
install the remaining carbons and stereocenter was devised (Figure 2.4).  Hydroboration 
of the alkene followed by oxidation would generate a carbonyl at C-20 which could 
provide the desired quaternary center (path A).  However, the installation of a ketone at 
C-21 through an allylic oxidation could also provide a functional handle to install the 
remaining carbons.  The latter was ideal as reduction and alkylation of an enolate was 
foreseen to generate the quaternary center at C-20 more selectively and in higher yield.  
The resultant molecule would be stable to a Wolff-Kishner reduction due to the saturated 
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hydrocarbon backbone and literature precedence in regard to these moieties in these 
reductions. 
 
 
 
Figure 2.4. New retrosynthetic analysis through a bifurcated strategy from the alkene  
191. 
 
 Subjecting this material to a myriad of conditions to facilitate allylic oxidation 
failed because of selective benzylic oxidation.  Treating 191 with 1.1 equivalents of Jones 
reagent in acetone at 0 °C and allowing the mixture to gradually warm generated the 
benzyl ketone 194 in 82% yield.  Unfortunately, treating 191 with other oxidants or re-
subjecting 194 to oxidizing conditions did not deliver the desired -unsaturated ketones 
192 or 195.  Only returned starting benzyl ketone or decomposed material was obtained.  
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Attempts to protect the benzyl ketone as a ketal or thio-ketal failed, and due to the 
observed adverse reactivity this strategy was abandoned. 
 
Scheme 2.12. Attempted allylic oxidations of pentacycle 191 or benzyl ketone 194. 
 
 
  
 Hydroboration of the pentacycle 191 proceeded with moderate selectivity using 
borane in THF while allowing the reaction to gradually warm to 23 °C from −78 °C.  
Steric compression of the E-ring prevented the use of larger hydroborating agents such as 
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9-BBN, which after heating to reflux in THF over 24 hours only returned unreacted 
starting material.  After oxidative work-up the crude alcohol was oxidized with Jones 
reagent in acetone to afford the desired ketone 175 as a white solid in 60% yield over two 
steps (Scheme 2.13).  The temperature of the reaction was critical due to competing 
benzylic oxidation, but this pathway was minimized by allowing the reaction to warm 
gradually from −78 °C to −10 °C with careful monitoring of the reaction’s progress by 
TLC.   
  
Scheme 2.13. Synthesis of ketone 175. 
 
 
 Initially, the structure of the ketone was assigned using 2D-NMR (COSY, 
NOESY, HSQC, HMBC, and DEPT, see Experimental Section) as well as through 
subsequent reactions and full characterization of those products (see Scheme 2.14).  
Later, I fortuitously discovered that dissolving the white solid in hot methanol and 
patiently allowing the clear colorless solution to cool to 23 °C, a crystalline solid slowly 
formed.  These colorless crystals were suitable for X-ray diffraction which 
unambiguously confirmed the structure as the ketone 175 (Figure 2.5).  Analysis of the 
crystal structure clearly shows the sterical arrangement of the carbocyclic core and the 
twisting of the B, C, and D rings out of traditional chair conformity, preventing clashes 
between the angular methyls.  Also observed is the half-chair conformation in which the 
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E-ring resides thereby forestalling the backside angular methyl at the C-D ring juncture 
from colliding with C-19 and C-21, their hydrogens, as well as C-20.  This dictates that 
nucleophilic addition should occur diastereoselectively from the top face and 
electrophiles appended in a similar fashion.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5. View of cyclized ketone 175.  Displacement ellipsoids are scaled to the 50%  
probability level. 
 
 At this stage the remainder of the synthesis entailed installation of the carbonyl 
and the methyl poised at C-20 as well as oxidation of wilforic acid (127) to afford 
celastrol (1) (Figure 2.6).  Stereochemical analysis of the crystal structure delineated that 
the last methyl would be difficult to install because of sterics.  A retrosynthetic analysis 
was conceived based on the literature precedence regarding installing methyls in crowded 
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environments using cyclopropanation strategies.47,51,53,59-61,120   A substrate guided 
cyclopropanation of methyl enol ether 196 provides 197, which an acid mediated ring 
opening and oxidation sequence affords the acid 128.  Deprotection of the methyl ethers 
then generates wilforic acid.  This strategy introduces the remaining carbons in a 
stereoselective fashion from 197, which is accessed through a Wittig olefination of 
ketone 175.  If sterics precluded this transformation then a Peterson olefination of the 
methoxymethyl trimethylsilyl alcohol 198 could also provide access to the enol ether.  
Literature precedent established by Magnus and co-workers to access methyl enol ethers 
from sterically demanding ketones not amenable to Wittig olefinations further 
corroborated the viability of this approach.121-123  Alternatively, the ketone 175 could be 
used in a carbonylation sequence to access 199 which provides a synthon to install the 
remaining methyl through an enolate alkylation strategy delivering 128.      
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MeO
MeO
Me
Me
Me
H MeH
Me
OMe
MeO
MeO
Me
Me
Me
H MeH
Me
O
H
Me
Me
Me
RO
RO
CO2HMe
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Figure 2.6. Retrosynthesis to access wilforic acid (127) and celastrol (1) from ketone  
175. 
 
 The ability of ketone 175 to undergo nucleophilic addition was examined with a 
variety of nucleophiles.  The methyl positioned at C-17 posed a significant problem as it 
blocked the necessary trajectory for nucleophilic addition.  To further complicate this 
issue, the ketone is flanked by two -carbons bearing protons susceptible to enolization.  
Large reagents such as the ylides methoxymethyl triphenylphosphorane and methyl 
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triphenylphosphorane did not react with the ketone in a productive manner despite using 
various equilibrating or non-equilibrating bases as well as different solvents and reaction 
temperatures.  This also proved to be the case for the anions of methoxymethyl 
trimethylsilane, chloromethyl trimethylsilane, trimethyl sulfonium iodide, and trimethyl 
sulfoxonium iodide.121-124  However, treating the ketone with methyl lithium at 23 °C 
generated the carbinol 200 in 72% yield as a single diastereomer, with the remaining 
material consisting of the starting ketone 175.  This enlightening result illustrates that 
small nucleophiles react diastereoselectively as initially postulated showcasing the 
potential of the enolate alkylation strategy. 
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Table 2.7. Selected attempts to access methyl enol ether 196 or alcohols 198 and 200. 
 
MeO
MeO
O
Me
Me
Me
H MeH
Me
MeO
MeO
Me
Me
Me
H MeH
Me
OMe
Conditions
Base Solvent Temperature (°C) Result
23
23
23
23
0 23
23
No Reaction
trace
No Reaction
No Reaction
No Reaction
trace
Reagent
Ph3PCH2OMeCl
Ph3PCH2OMeCl
Ph3PCH2OMeCl
Ph3PCH2OMeCl
Ph3PCH2OMeCl
Ph3PCH2OMeCl
23 110 tracePh3PMeBr
THF
THF/Bu2O
THF
THF/t-BuOH
PhMe
PhMe
PhMe
LiHMDS
PhLi
NaHMDS
t-BuOK
KOC(Me)2CH2Me
KOC(Me)2CH2Me
KOC(Me)2CH2Me
78 0
0 Decomposition
MeOCH2SiMe3
MeOCH2SiMe3
THF
THF
s-BuLi
s-BuLi
trace
55 0ClCH2SiMe3 THF/TMEDAs-BuLi trace
23 72% Product (200), 28% SMMeLi THF----------
MeMgBr trace23THF----------
or
MeO
MeO
Me
Me
Me
H MeH
Me
OHR
R = CH(OMe)SiMe3 (198)
R = Me (200)
196175
23
23
No Reaction
No Reaction
Me3SI
Me3SI
THF
DMSO/THF
n-BuLi
NaH
traceMe3SOI DMSO/THFNaH 23 60
traceMe3SOI THFn-BuLi 23 60  
 
 To examine the enolate alkylation strategy the syntheses of acid 199 and ester 201 
were required.  After the azeotropic removal of water with toluene, the ketone was 
deprotonated with a 1 M solution of LiHMDS in THF at −78 °C.  After 1 hour the 
resultant enolate was trapped with N-phenyl-bis(trifluromethanesulfonimide) to afford 
the enol triflate 202 in 99% yield as a 2:1 mixture of olefinic isomers (Scheme 2.14).  
The isomeric mixture was carried forward because the olefin would ultimately be 
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reduced.  The carbonylation proceeded smoothly using palladium(dppf) dichloride and 
triethylamine in methanol heated to reflux under an atmosphere of carbon monoxide to 
provide the -unsaturated ester 203 in an 84% yield.  To facilitate maximum 
conversion of the starting material, 45 mol% of palladium(dppf) dichloride was needed.  
This is because only approximately 50% conversion was observed when lower amounts 
of the catalyst were used whereas other palladium catalysts rendered minimal success.  
Unfortunately, sterics made this material resistant to reduction using hydrogenation with 
platinum, palladium on carbon, or Pearlman’s catalyst.  Nickel boride, Stryker’s reagent, 
and Lipshutz’s modified Stryker’s reagent likewise did not afford the reduced product, 
only unreacted starting material was returned.125-127  A dissolving metal reduction in 
liquid ammonia reduced the enoate 203, but amidation of the ester was observed.  So, the 
ester was saponified, and as a solution in THF the acid 204 was added to a dark blue 
solution of sodium in liquid ammonia at −78 °C which generated the reduced product 199 
as a 3:1 mixture of diastereomers in 98% yield over two steps.  Presuming the dianionic 
enolate alkylation would be difficult, the acid was treated with trimethylsilyl 
diazomethane in a 1:1 mixture of methanol/benzene at 23 °C to afford the ester 201 as a 
white amorphous solid in quantitative yield.128  
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Scheme 2.14. Synthesis of the saturated acid 199 and ester 201. 
 
 
 The original plan centered on converting the ester to its silyl or methyl ketene 
acetal (205) followed by cyclopropanation.  Acid mediated hydrolysis would reveal the 
alkylated ester 206 or acid 128 as a single diastereomer.  Initially, the ester proved 
reluctant to silyl ketene acetal formation using soft as well as hard enolization techniques 
(Table 2.8).  LDA was too bulky of a base to promote full enolization, however, treating 
the ester with tert-butyldimethylsilyl trifluoromethane sulfonate in THF at 23 °C for one 
minute and then adding a freshly prepared solution of LDA in THF generated the desired 
silyl ketene acetal in ~75% yield.  The other 25% of the material was the minor 
diastereomer of unreacted starting material which did not react with LDA as proven by 
treating this compound with freshly prepared LDA in THF at 23 °C for one hour, and 
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then neutralizing this reaction at different temperatures.  After an aqueous work-up, 1H-
NMR analysis showed pure starting material, revealing no enolization had occurred.  
 The silyl ketene acetal 205 was unfortunately resistant to cyclopropanation.  
Focus was then placed on generating the dimethyl variant as I hypothesized that this 
compound might be a more competent participant in the subsequent cyclopropanation.  
Despite using dimethyl sulfate, which prefers O-alkylation over C-alkylation, as well as 
using distilled HMPA as a co-solvent, the ketene acetal was not observed and only a trace 
amount of the alkylated adduct 206 was produced.129  Subjecting the ester to a freshly 
prepared solution of lithium diethyl amide in THF at 23 °C for five minutes followed by 
the addition of iodomethane generated the alkylated product as a single diastereomer in 
25% yield.  The low yield is attributed to amidation of the starting ester.  To circumvent 
this issue the reaction was cooled to −78 °C and then treated with freshly prepared 
lithium diethyl amide in order to promote enolization.  The mixture was gradually 
warmed to 23 °C and iodomethane was added to the golden brown solution, however, 
this afforded the amidated product in a greater yield of approximately 90%.              
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Table 2.8. Alkylation of ester 201 and attempted formation of ketene acetals 205 and  
      ester 206. 
 
 
 Compelled by the successful diastereoselective alkylation of the ester, heavy 
focus was centered on synthesizing the acid 128.  After azeotropic removal of water with 
toluene, the solid acid 199 was dissolved in THF, and this clear colorless solution was 
treated with an excess of freshly prepared LDA at 23 °C for 1 hour to provide a dark 
golden yellow solution of the dianionic enolate.  Addition of iodomethane induced an 
exothermic reaction alkylating the enolate to afford 128 in 25% yield (Table 2.9).  The 
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residual material consisted of ~25% of the undesired diastereomer of 128 and ~50% of 
the starting material as an approximate 1:1.5 mixture of diastereomers.  The recovery of 
starting material was surprising as 20 equivalents of LDA were used.  Based on work 
conducted by Tamm, Seebach, and Meyers on the behavior of lithium enolates in 
solution, excess amide base should promote full alkylation.129,130  Even more surprising 
was that the alkylation proceeded with no observed diasteroselectivity.   
 In order to solve the first issue, freshly prepared lithium diethyl amide was used to 
promote the full enolization of 199.  Despite using lithium diethyl amide in combination 
with n-butyllithium to deprotonate the two equivalents of diethyl amine generated in 
producing the dianion, enolized starting material was always recovered.  The use of 
distilled HMPA as a co-solvent to break lithium aggregates or using stronger methylating 
agents only promoted O-alkylation to afford the ester 201.129  Neither the product 128 nor 
dimethyl ketene acetal 205 were observed.  To insure 205 was not being hydrolyzed, a 
basic work-up as well as freshly base-washed glassware were used and the crude material 
was then analyzed by 1H-NMR using C6D6.  In an effort to enhance the 
diastereoselectively, the alkylation step was conducted at −78 °C and allowed to warm 
gradually to 23 °C.  This however only afforded trace amounts of the desired product.  
Interestingly, when the reaction mixture was placed in a 23 °C water bath and the dianion 
was treated with iodomethane, only a trace amount of the desired product was observed; 
enolized starting material was returned in both cases.  The exothermicity of the alkylation 
when the reaction was initially conducted at 23 °C without the water bath proved to be a 
highly critical observation.  So, the starting acid was treated with an excess of a freshly 
prepared solution of lithium diethyl amide in THF at 23 °C for 30 minutes, and the 
resulting dark golden yellow solution was placed in an oil bath heated to 70 °C for 30 
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minutes.  Iodomethane was then added, producing a heterogeneous mixture which was 
kept at 70 °C for 30 minutes which afforded the alkylated product in high yields, but with 
minimal diastereoselectivity.  The alkylated acid was then dissolved in a 1:1 mixture of 
methanol/benzene and treated with a 2 M solution of trimethylsilyl diazomethane in 
ether.  The ester was then purified by silica gel chromatography to afford the alkylated 
adduct 206 in an isolated yield of 47% over the two steps.  The undesired diastereomer 
was also isolated in 36% yield.  The esterification was conducted to aid the isolation and 
chromatographical separation of the diastereomers.  The structure of the major product 
206 was assigned using 2D-NMR spectroscopy (see Experimental Section). 
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Table 2.9. Synthesis of acid 128 through the dianionic alkylation of 199. 
 
 
  
 The ester 206 was saponified using potassium hydroxide in dioxane/water heated 
to reflux (Scheme 2.15).  Treating the acid 128 with boron tribromide in methylene 
chloride at 0 °C for five minutes afforded wilforic acid (127) as a white amorphous solid 
in 68% yield over two steps after recrystallization.  1H-NMR analysis of this material in 
deuterated pyridine matched the reported chemical shifts for wilforic acid (see 
Experimental Section) representing the first total synthesis of wilforic acid.131  The 
catechol was then oxidized instantaneously in CDCl3 with two equivalents of DDQ to 
provide the ortho-quinone 208 as observed by 1H-NMR.  After placing the NMR tube in 
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an oil bath heated to 65 °C for two hours the unsaturated quinone 209 was produced from 
the oxidation of 208.  Unfortunately, prolonged heating or the use of acids did not 
promote tautomerization to afford celastrol (1), only decomposition of the material was 
observed.  Alternatively, ester 206 was oxidized to the benzyl ketone using Jones reagent 
which was then further oxidized to the enone 210 in a 74% yield over three steps using a 
selenoxide elimination.  This is where the project currently lies.  The final strategy is to 
reduce the enone to the benzyl alcohol using a Luche reduction, and the activated alcohol 
is foreseen to rapidly eliminate in situ during the deprotection of the methyl ethers to 
ultimately provide celastrol in a single step. 
 
  
87 
 
Scheme 2.15. Synthesis of wilforic acid (127), enone 210, and the final strategy. 
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Conclusion 
 
 The total synthesis of celastrol (1) remains a work in progress.  The arduous 
process of developing a strategy to access the natural product ultimately culminated in 
one of the fastest, highest yielding syntheses of a polyene to date.  More importantly, a 
polyene cyclization that constructs the friedelin pentacyclic core in a diastereoselective 
fashion on one gram scale was developed providing rapid access to these complex 
frameworks.  This is the highest scale a polyolefin cascade has been conducted to access 
a tetracyclic or pentacyclic terpenoid to date. Commencing from 2,3-dimethyl butadiene, 
the polyene 174 is accessed routinely in 5 gram quantities in 11 steps with an overall 21% 
yield (Scheme 2.16).  Using ferric chloride and a slow addition protocol, the pentacycle 
191 is generated in a single operation on 1 gram scale in a 38% yield improving the 
strategy originally exploited by Ireland.  The alkene is then used to install the remaining 
functionality with the proper stereoselectivity highlighted by a carbonylation and a 
dianionic enolate alkylation.  This strategy successfully completed the first total synthesis 
of wilforic acid (127); which unfortunately could not be oxidized to celastrol (1).  A new 
strategy to synthesize celastrol from enone 210 that invokes an in situ deprotection and 
elimination is under development. 
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Scheme 2.16. Overall synthetic strategy to access wilforic acid (127) and enone 210. 
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1. General Information 
 
 All reactions were performed in flame-dried round-bottomed or modified Schlenk 
flasks fitted with rubber septa under a positive pressure of argon, unless otherwise noted.    
Air- and moisture-sensitive liquids and solutions were transferred via syringe or stainless 
steel cannula.  Solvents (methylene chloride, ether, tetrahydrofuran, benzene, and 
toluene) were purified using a Pure-Solv MD-5 Solvent Purification System (Innovative 
Technology).  Where necessary, solvents were deoxygenated by sparging with nitrogen 
for at least 1 hour unless otherwise noted.  All other reagents were used directly from the 
supplier without further purification unless otherwise noted.  Organic solutions were 
concentrated by rotary evaporation at ~25 mbar in a water bath heated to 40 °C unless 
otherwise noted.  The molarity of n-butyllithium and methyllithium were determined by 
titration against diphenylacetic acid.  Analytical thin-layer chromatography (TLC) was 
carried out using 0.2 mm commercial glass-coated silica gel plates (silica gel 60, F254, 
EMD chemical). Thin layer chromatography plates were visualized by exposure to 
ultraviolet light and/or exposure to an acidic solution of ceric ammonium molybdate or a 
basic solution of potassium permanganate followed by heating on a hot plate.  Infrared 
spectra were recorded on a Nicolet 380 FTIR using neat thin film technique.  High-
resolution mass spectra (HRMS) were obtained on a Karatos MS9 and reported as m/z 
(relative intensity).  Accurate masses are reported for the molecular ion [M+Na]+, 
[M+H]+, [M−H]−, [M−AcOH]−, [M], or [M+2H]2+.  Nuclear magnetic resonance spectra 
(1H-NMR and 13C-NMR) were recorded with a Varian Gemini (400 MHz, 1H at 400 
MHz, 13C at 100 MHz, 500 MHz, 1H at 500 MHz, 13C at 125 MHz, or 600 MHz, 1H at 
600 MHz, 13C at 150 MHz).  For CDCl3 and C6D6 solution, chemical shifts are reported 
as parts per million (ppm) referenced to residual protium or carbon of the solvent; CHCl3 
 7.26 ppm, CDCl3  77.0 ppm, C6D5H ppm, C6D6 128.0ppm, C5D4HN  7.19 
ppm, C5D5N  135.9 ppm, and CD2HCN  1.93 ppm.  Coupling constants are reported in 
Hertz (Hz). Data for 1H-NMR spectra are reported as follows: chemical shift (ppm, 
referenced to protium; (bs = broad singlet, s = singlet, br d = broad doublet, d = doublet, t 
= triplet, q = quartet, dd = doublet of doublets, td = triplet of doublets, ddd = doublet of 
doublet of doublets, m = multiplet, integration, and coupling constants (Hz)). 
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2. Synthesis of Wilforic Acid (127) and the Enone 210 
 
 
 
 A solution of 2,3-dimethylbutadiene (10.1 g, 13.9 mL, 124 mmol, 1.00 eq.) in 
CH2Cl2 (88 mL) was placed in a bath cooled to −78 °C and allowed to stir vigorously 
(600 rpm) for 30 minutes.  A solution of bromine (19.8 g, 6.3 mL, 124 mmol, 1.00 eq.) in 
CH2Cl2 (36 mL) was added dropwise via addition funnel over 4 hours.  The 
heterogeneous and pale yellow colored mixture was allowed to stir for 2 hours after the 
complete addition of bromine at −78 °C upon which the golden yellow mixture was 
removed from the cooling bath and concentrated via rotary evaporation. (Note: The 
product readily sublimes and is a lachrymator.  The pressure of the rotary evaporator was 
reduced to no lower than 100 mbar and the flask was submerged into an ice water bath).  
After complete evacuation of CH2Cl2, the golden yellow solution was allowed to stand at 
23 °C in the dark upon which the colorless solid crystallized out of solution.  Cooling in a 
freezer chilled to −20 °C aids full recovery of the crystalline solid.  Removal of the 
mother liquor afforded the dibromide 123 as a colorless crystalline solid (27.5 g, 113 
mmol, 91% yield).  The spectral data matches that of the reported compound (Farkas, F.; 
Wellauer, T.; Esser, T.; and Sequin, U. Helvetica Chimica Acta 1991, 74, 1511).  
 
1H-NMR (400 MHz, CDCl3): δ 4.00 (s, 4H), 1.88 (s, 6H) 
  
13C-NMR (100MHz, CDCl3): δ 131.90, 35.00, 17.20  
 
M.P.: 45 – 46 °C 
93 
 
 
   
 A solution of diisoproplyamine (12.9 g, 17.8 mL, 127 mmol, 2.05 eq.) in THF 
(300 mL) was placed in a bath cooled to −78 °C for 30 minutes.  n-Butyllitium (55.7 mL, 
2.28 M in hexanes, 127 mmol, 2.05 eq.) was added dropwise over 5 minutes.  After 5 
minutes the colorless solution was placed in an ice water bath cooled to 0 °C for 20 
minutes, and placed back into the bath cooled to −78 °C for 30 minutes.  A solution of 
N,N-dimethylacetamide (11.1 g, 11.8 mL, 127 mmol, 2.05 eq.) in THF (100 mL) was 
placed in a bath cooled to −78 °C for 30 minutes and then added to the pale yellow 
solution of freshly prepared LDA by cannula over 1 hr.  The residual N,N-
dimethylacetamide in the reaction vessel was dissolved THF (10 mL) and transferred via 
cannula to the solution of LDA.  This was repeated once more and the pale yellow 
solution was stirred for 30 minutes to provide a freshly prepared solution of lithium 
dimethyl acetamide.   
 A pale yellow solution of the dibromide 123 (15.0 g, 62.0 mmol, 1.00 eq.) in THF 
(270 mL) was placed in a bath cooled to −78 °C for 30 minutes and then added to the 
solution of lithium dimethyl acetamide dropwise under nitrogen via cannula over 90 
minutes.  Residual dibromide was dissolved in THF (10 mL) and transferred via cannula 
to the reaction solution.  This process was repeated once more.  After 20 minutes the 
excess enolate was quenched with brine (200 mL), the reaction vessel was quickly 
removed from the cooling bath, and the white mixture was allowed to stir vigorously 
(1000 rpm) at 23 °C for 1 hr.  EtOAc (500 mL) was added to the biphasic mixture which 
was poured into a separatory funnel, partitioned, and the residual organics were extracted 
from the aqueous layer using EtOAc (4 x 100 mL).  (Note: The product is soluble in 
water, so brine (50 mL) is added during each extraction).  The combined organic extracts 
were washed with brine (2 x 50 mL), dried over solid Na2SO4, decanted, and 
concentrated.  Recrystallization of the yellow solid from hexane-ethyl ether (3:2, 50 mL) 
afforded the diamide 181 as colorless crystalline solid (14.4 g, 56.5 mmol, 91%).   
 
Rf = 0.35 (5% MeOH in CH2Cl2) 
1H-NMR (400 MHz, CDCl3): δ 3.00 (s, 6H), 2.94 (s, 6H), 2.33 (s, 8H), 1.67 (s, 6H)  
13C-NMR (100 MHz, CDCl3): δ 173.06, 128.36, 37.48, 35.55, 31.98, 30.44, 18.11 
IR (neat film, cm-1): 3479, 2929, 1637, 1398  
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HRMS (EC-CI): calcd. for C14H27N2O2 [M+H]+ 255.2073, found 255.2074.  
M.P.: 69 – 71 °C. 
 
 
 
A solution of diamide 181 (8.5 g, 33.4 mmol, 1.00 eq.) in deoxygenated THF (334 
mL) was placed into a bath cooled to −78 °C for 1 hour upon which the clear colorless 
solution became a white heterogeneous mixture.  While stirring vigorously (700 rpm) 
methyllithium (50.0 mL, 73.5 mmol, 1.47 M in ethyl ether, 2.20 eq.) was added dropwise 
over 15 minutes.  5 minutes after the complete addition of methyllithium the 
heterogeneous mixture had changed to a yellow homogeneous solution.  After 15 minutes 
the yellow solution had changed to a white heterogeneous mixture upon which excess 
methyllithium was quenched with an aqueous phosphate buffer (100 mL, pH = 7, 0.2 M).  
The reaction vessel was removed from the cooling bath and allowed to warm to 23 °C 
over 30 minutes.  The biphasic mixture was poured into a separatory funnel, partitioned, 
and the organics were extracted from the aqueous layer with ethyl ether (3 x 50 mL).  
Combined organics were washed with brine (1 x 50 mL), dried over solid Na2SO4, 
decanted, and concentrated under vacuum.  The resulting yellow solid was purified by 
silica gel chromatography; 10 → 30% EtOAc in hexane to afford 171 as a white 
crystalline solid (5.9 g, 29.9 mmol, 89%).  Crystals suitable for X-ray diffraction were 
grown from hexane by slow cold evaporation under a stream of nitrogen.   
 
Rf  =  0.43 (30% EtOAc in hexane) 
  
1H-NMR (400 MHz, CDCl3): δ 2.49 (dd, 4H, J = 7.2, 8.6 Hz), 2.26 (dd, 4H, J = 7.2, 8.6 
Hz), 2.14 (s, 6H), 1.62 (s, 6H) 
  
13C-NMR (100 MHz, CDCl3): δ 208.96, 127.92, 42.19, 30.04, 28.94, 17.93  
 
IR (neat film, cm-1) 2360, 2340, 1708, 1364 
   
HRMS (EC-CI): calcd. for C12H21O2 [M+H]+ 197.1542, found 197.1544.  
 
M.P.: 55 – 57 °C 
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Crystal Structure of Diketone 171: 
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A solution of triethylacetophosphonate (5.6 g, 5.0 mL, 25 mmol, 1.35 eq.) in 
toluene (90 mL) was cooled to 0 °C in an ice bath.  After stirring for 20 minutes 
NaHMDS (12.5 mL, 2.0 M in THF, 25 mmol, 1.35 eq.) was added dropwise over 3 
minutes.  After 30 minutes a solution of the diketone 171 (3.63 g, 18.5 mmol, 1.0 eq.) in 
toluene (74 mL) was cooled to 0 °C in an ice bath, stirred for 20 minutes, and to this clear 
solution was transferred the phosphonate via cannula over 15 minutes.  Remaining 
phosphonate in the vessel was dissolved in toluene (7.0 mL) and transferred via cannula 
to the reaction solution.  This process was repeated twice more.  The golden-yellow 
solution was allowed to gradually warm to 23 °C over 60 minutes, stirred vigorously 
(1000 rpm) for 60 minutes at 23 °C, and the golden yellow solution was placed in an oil 
bath heated to 60 °C. After 22 hours the heterogeneous golden-orange mixture was 
removed from the oil bath and excess phosphonate was quenched with an aqueous 
phosphate buffer (10 mL, pH = 7, 0.2 M).  The biphasic mixture was stirred vigorously 
(1000 rpm) for 10 minutes followed by which solid Na2SO4 was added and stirred for 10 
minutes.  The solid Na2SO4 was suction filtered over a pad of solid Na2SO4 and the 
golden-yellow filtrate solution was concentrated under vacuum.  The resulting brown oil 
was purified by silica gel chromatography; hexane→20% Et2O in hexane to afford the 
enoate 176 as a clear yellow oil as a 6:1 mixture of trans : cis isomers (2.9 g, 10.9 mmol, 
59%).  Further elution with 20% EtOAc in hexane affords the starting diketone 171 (0.4 
g, 2.2 mmol, 12%).   
 
Mixture of Isomers: (*) denotes cis isomer 
 
Rf =  0.21 (15% EtOAc in hexane)  
 
1H-NMR (400 MHz, CDCl3): δ 5.63 (s, 1H), 4.13 (q, 2H, J = 2.4 Hz), 4.12* (q, 2H, J = 
2.4 Hz) 2.44 (dd, 2H, J = 7.5, 8.6 Hz), 2.27 (dd, 2H, J = 7.2, 8.6 Hz), 2.16* (d, 3H, J = 
1.4 Hz), 2.14 (s, 2H), 2.13 (s, 4H), 1.88* (d, 3H, J = 1.4 Hz), 1.68* (s, 3H), 1.66* (s, 3H), 
1.63 (s, 3H), 1.60 (s, 3H), 1.26 (t, 3H, J = 7.0 Hz), 1.25 (t, 3H, J = 7.0 Hz)  
 
1H-NMR (400 MHz, C6D6): δ 5.77 (s, 1H), 5.71* (s, 1H), 4.02 (q, 2H, J = 7.0 Hz), 3.90* 
(q, 2H, J = 7.1 Hz), 2.22* (s, 2H), 2.20* (s, 3H), 2.18 (s, 3H), 2.01 (dd, 2H, J = 7.2, 8.6 
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Hz), 1.96 – 1.84 (m, 4H), 1.69* (s, 3H), 1.64* (s, 3H), 1.63 (s, 3H), 1.51* (s, 3H), 1.43 (s, 
3H), 1.39 (s, 3H), 0.98 (t, 3H, J = 6.9 Hz)  
 
13C-NMR (100 MHz, CDCl3): δ 208.95, 166.90 (166.37*), (160.23*) 159.60, (129.01*) 
128.29, 127.98 (127.59*), (116.30*) 115.78, 59.59, 42.28, 39.45, (33.49*) 33.07, 
(32.13*) 30.06, (29.05*) 28.97, (25.56*), 19.05, 18.17 (18.13*), 17.98, 14.51  
 
IR (neat film, cm-1): 2980, 2930, 1717, 1647, 1446, 1366, 1224, 1145  
 
HRMS (EC-CI): calcd. for C16H27O3 [M+H]+ 267.1960, found 267.1961. 
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 A white suspension of methyl triphenylphosphonium bromide (18.1 g, 50.7 mmol, 
1.25 eq.) in THF (205 mL) was placed in an ice water bath cooled to 0 °C and stirred 
vigorously (600 rpm) for 20 minutes.  n-butyllithium (22.3 mL, 2.07 M in hexane, 46.2 
mmol, 1.14 eq.) was added dropwise over 5 minutes and the resulting orange 
heterogeneous mixture was stirred for 30 minutes.  The cooling bath was removed and 
the mixture was stirred for 10 minutes at 23 °C, and placed back into the ice water bath.  
After 10 minutes a solution of 176 (10.8 g, 40.5 mmol, 1.00 eq.) in THF (170 mL) was 
added dropwise via cannula over 15 minutes.  Residual enoate 176 was dissolved THF 
(10 mL) and transferred via cannula to the now pale yellow reaction mixture.  This 
process was repeated twice more.  After 45 minutes excess ylide was quenched with an 
aqueous phosphate buffer (3 mL, pH = 7, 0.2 M) followed by the addition of pentane 
(100 mL).  The biphasic mixture was stirred vigorously (600 rpm) for 10 minutes 
followed by which solid Na2SO4 was added.  Vigorous stirring was continued for 10 
minutes, and the solid Na2SO4, residual methyl triphenylphosphonium bromide, and 
triphenylphosphonium oxide were suction filtered over a pad of celite using pentane as 
the eluent.  The resulting yellow solution was concentrated under vacuum to 
approximately 20 mL.  Residual triphenylphosphonium oxide was triturated with pentane 
(100 mL).  The resulting yellow mixture was suction filtered over a pad of celite using 
pentane and concentrated. The crude yellow oil was purified by silica gel 
chromatography; hexane → 2% EtOAc in hexane to afford the triene 183 as a clear 
yellow oil as a mixture of trans : cis isomers (10.7 g, 40.1 mmol, 99%).  The isomers 
were then separated by silica gel chromatography; benzene.   
 
Trans Isomer 183:  
 
Rf =  0.49 (15% EtOAc in hexane) and 0.45 (benzene):  
 
1H-NMR (400 MHz, CDCl3): δ 5.66 (s, 1H), 4.69 (s, 1H), 4.67 (s, 1H), 4.15 (q, 2H, J = 
7.2 Hz), 2.18 (d, 3H, J = 1.1 Hz), 2.16 (s, 4H), 2.14 – 2.11 (m, 2H), 2.04 – 2.00 (m, 2H), 
1.74 (s, 3H), 1.64 (s, 6H), 1.27 (t, 3H, J = 7.2 Hz)  
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1H-NMR (400 MHz, C6D6): δ 5.79 (s, 1H), 4.77 (s, 2H), 4.01 (q, 2H, J = 7.2 Hz), 2.20 
(d, 3H, J = 1.0 Hz), 2.11 – 2.07 (m, 2H), 2.01 (m, 4H), 1.93 – 1.89 (m, 2H), 1.64 (s, 3H), 
1.48 (s, 6H), 0.98 (t, 3H, J = 7.2 Hz)  
13C-NMR (100 MHz, CDCl3): δ 167.08, 160.30, 146.36, 129.44, 127.37, 115.74, 109.83, 
59.65, 39.67, 36.44, 33.44, 33.19, 22.74, 19.13, 18.24, 18.18, 14.55  
 
IR (neat film, cm-1): 2979, 2934, 2867, 1717, 1649, 1446, 1373, 1223, 1144  
 
HRMS (EC-CI): calcd. for C17H28O2 [M+H]+ 264.2089, found 264.2089.  
 
 
Cis Isomer 184:  
 
Rf =  0.49 (15% EtOAc in hexane) and 0.51 (benzene)  
 
1H-NMR (400 MHz, CDCl3): δ 5.64 (s, 1H), 4.69 (s, 1H), 4.68 (s, 1H), 4.14 (q, 2H, J = 
7.2 Hz), 2.64 (dd, 2H, J = 7.9, 8.6 Hz), 2.16 (m, 4H), 2.04 – 2.00 (m, 2H), 1.90 (s, 3H), 
1.74 (s, 3H), 1.70 (s, 3H), 1.69 (s, 3H), 1.27 (t, 3H, J = 7.2 Hz)  
 
1H-NMR (400 MHz, C6D6): δ 5.72 (s, 1H), 4.78 (s, 1H), 4.77 (s, 1H), 4.00 (q, 2H, J = 
7.2 Hz), 2.77 (dd, 2H, J = 7.9, 8.6 Hz), 2.23 (d, 1H, J = 8.2 Hz), 2.21 (d, 1H, J = 8.2 Hz), 
2.18 – 2.13 (m, 2H), 2.05 – 2.00 (m, 2H), 1.74 (s, 3H), 1.73 (s, 3H), 1.64 (s, 3H), 1.53 (d, 
3H, J = 1.4 Hz), 0.96 (t, 3H, J = 7.2 Hz)  
 
IR (neat film, cm-1) 2979, 2934, 2867, 1717, 1649, 1446, 1373, 1223, 1144  
 
HRMS (EC-CI): calcd. for C17H28O2 [M+H]+ 264.2089, found 264.2089. 
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To a clear colorless solution of freshly prepared sodium ethoxide (prepared from 
sodium metal (1.65 g, 72.2 mmol, 10.0 eq.) and anhydrous ethanol (52 mL)) was added 
the cis-isomer 184 (1.91 g, 7.22 mmol, 1.0 eq.) as a solution in ethanol (20 mL) via 
cannula.  After 24 hours the solution had changed to a golden orange color and excess 
sodium ethoxide was quenched with an aqueous phosphate buffer (100 mL, pH = 7, 0.2 
M).  The ethanol was removed via rotary evaporation, and the resultant yellow mixture 
was diluted with ethyl ether (100 mL) and water (50 mL), poured into a separatory 
funnel, partitioned, and the organics were washed with water (1 x 50 mL).  Residual 
organics were back extracted from the aqueous layer with ethyl ether (2 x 50 mL), 
washed with brine (1 x 25 mL), dried over sodium sulfate, decanted, concentrated and the 
resulting golden yellow oil was purified via silica gel chromatography; benzene to afford 
triene 183 (0.97 g, 3.68 mmol, 51%) as a clear golden yellow oil and the starting cis-
isomer 184 (0.92 g, 3.47 mmol, 48%) as a clear golden yellow oil. 
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 A yellow solution of the triene 183 (9.18 g, 34.7 mmol, 1.00 eq.) in ethyl ether 
(346 mL) was cooled to -78 °C and allowed to stir for 60 minutes.  Lithium Aluminum 
Hydride (17.3 mL, 4 M in ethyl ether, 69.4 mmol, 2.00 eq.) was added dropwise over 5 
minutes.  The yellow solution was allowed to warm to −20 °C over 5 hours upon which 
the slightly white heterogeneous mixture was diluted with 300 mL of ethyl ether and 
excess lithium aluminum hydride was quenched by the sequential dropwise addition of 
water (5 mL), aqueous 15% NaOH  solution (5 mL), and water (10 mL).  The mixture 
was placed in an ice water bath cooled to 0 °C, stirred for 5 minutes, and an aqueous 
phosphate buffer (10 mL, pH = 7, 0.2 M) was added to the white heterogeneous mixture.  
The mixture was stirred vigorously (900 rpm) for 15 minutes and the cold bath was 
removed.  Solid Na2SO4 was added and the heterogeneous mixture was stirred vigorously 
(1000 rpm) for 5 minutes, suction filtered over a pad of solid Na2SO4, and concentrated 
to reveal the alcohol 172 as a clear colorless oil (7.16 g, 32.2 mmol, 93%) which is 
submitted into the next reaction without further purification.  An analytical sample was 
attained by purification via silica gel chromatography; 10% dioxane in hexane.   
 
Rf =  0.56 (25% dioxane in hexane)  
 
1H-NMR (400 MHz, CDCl3): δ 5.41 (dt, 1H, J = 7.2, 6.6 Hz), 4.68 (s, 1H), 4.67 (s, 1H), 
4.14 (d, 2H, J = 6.6 Hz), 2.14 – 2.09 (m, 4H), 2.05 – 1.99 (m, 4H), 1.73 (s, 3H), 1.69 (s, 
3H), 1.64 (s, 6H) 
 
13C-NMR (100 MHz, CDCl3): δ 146.3, 140.2, 128.4, 128.0, 123.1, 109.5, 59.4, 38.0, 
36.3, 33.3, 33.2, 22.5, 18.01, 17.98, 16.37 
 
IR (neat film, cm-1): 3325, 2930, 2863, 1652, 1648, 1456, 1373, 1002, 885  
 
HRMS (EC-CI): calcd. for C15H28O [M+2H]2+ 224.2140, found 224.2140. 
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 A solution of the alcohol 172 (6.95 g, 31.3 mmol, 1.00 eq.) in ethyl ether (104 
mL) was placed in a bath cooled to −20 °C and stirred for 20 minutes.  PBr3 (1.65 mL, 
16.4 mmol, 0.51 eq.) was added dropwise over 2 minutes and the resulting pale yellow 
solution was stirred for 2 hours gradually warming to 0 °C.  The solution was diluted 
with hexane (100 mL) and then the HBr was slowly neutralized with a saturated aqueous 
mixture of NaHCO3 (20 mL).  The biphasic mixture was poured into a separatory funnel 
and partitioned. (NOTE: The separatory funnel was swirled, not shaken, to avoid 
emulsion.  If emulsion occurs, wash with copious amounts of water).  The organic layer 
was washed with water (3 x 50 mL), and the residual organics were extracted from the 
aqueous layer using hexane (2 x 50 mL).  The combined organics were washed with brine 
(2 x 30 mL), dried over solid Na2SO4, decanted, and concentrated under vacuum.  The 
resulting clear pale yellow oil (8.90 g, 31.2 mmol, 100%) was used directly in the next 
reaction without further purification. 
 A solution of stannane 152 (13.0 g, 28.6 mmol, 1.20 eq.) in deoxygenated THF 
(177 mL) was placed in a bath cooled to −78 °C and stirred for 1 hour.  n-Butyllithium 
(14.6 mL, 1.96 M in hexane, 28.6 mmol, 1.20 eq.) was added dropwise over 15 minutes 
and the color of the resulting solution changed to golden orange.  After stirring for 30 
minutes, a solution of the triene allylic bromide (6.8 g, 23.9 mmol, 1.00 eq.) in 
deoxygenated THF (40 mL) was added dropwise over 1 hour to the golden orange 
soltuion.  Residual bromide was dissolved in deoxygenated THF (10 mL) and transferred 
to the now golden yellow reaction solution.  This process was repeated once more.  After 
stirring for 1 hour the excess benzyl anion was quenched with water (200 mL) and 
allowed to warm to room temperature while stirring for 30 minutes.  The biphasic 
solution was poured into a separatory funnel containing water (200 mL) and hexane (300 
mL).  (NOTE: If emulsion occurs, add copious amounts of water and swirl the mixture, 
do not shake).  The organics were washed with water (2 x 100 mL).  Residual organics 
were extracted from the aqueous layer using hexane (2 x 100 mL), washed with brine (1 
x 100 mL), dried over solid Na2SO4, decanted, and concentrated under vacuum.  The 
resulting clear colorless oil was purified by silica gel chromatography; hexane (1 L) and 
then 2% benzene in toluene.  Impure product is purified again by silica gel 
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chromatography; 2% benzene in toluene to afford the triene 173 as a clear colorless oil 
(7.0 g, 19.0 mmol, 79%).   
 
Rf =  0.36 (2% benzene in toluene)  
 
1H-NMR (400 MHz, CDCl3): δ 6.85 (d, 1H, J = 8.2 Hz), 6.70 (d, 1H, J = 8.2), 5.20 (dd, 
1H, J = 7.2, 6.5 Hz), 4.69 (s, 1H), 4.68 (s, 1H), 3.84 (s, 3H), 3.79 (s, 3H), 2.55 (dd, 2H, J 
= 7.5, 5.8 Hz), 2.24 (s, 3H), 2.24 – 2.18 (m, 2H), 2.15 – 2.07 (m, 4H), 2.05 – 1.97 (m, 
4H), 1.75 (s, 3H), 1.65 (s, 6H), 1.59 (s, 3H)  
 
13C-NMR (100 MHz, CDCl3): δ 151.02, 147.47, 146.62, 136.24, 134.13, 130.47, 128.62, 
128.34, 124.29, 123.80, 109.76, 109.52, 60.42, 55.92, 38.41, 36.57, 33.89, 33.52, 33.50, 
29.33, 22.83, 18.31, 18.25, 16.32, 11.97  
 
IR (neat film, cm-1): 1490, 1453, 1271, 1086  
 
HRMS (EC-CI): calcd. for C25H38O2 [M] 370.2872, found 370.2871. 
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 A solution of the triene 173 (7.0 g, 18.9 mmol, 1.00 eq.) in THF (73 mL) was 
placed in an ice water bath cooled to 0 °C and stirred vigorously (500 rpm) for 20 
minutes.  Crystalline 9-BBN dimer (2.4 g, 9.8 mmol, 0.52 eq.) was added under a stream 
of nitrogen and the heterogeneous mixture was stirred (500 rpm) for 4 hours upon which 
the cooling bath had warmed to 23 °C.  The clear solution was placed in an ice bath 
cooled to 0 °C and stirred for 20 minutes.  Excess 9-BBN was quenched with water (31 
mL) followed by the addition of an aqueous solution of H2O2 (30% w/v in water, 9.7 mL, 
94.0 mmol, 5.00 eq.) and NaOH (4 N, 23.6 mL, 94.0 mmol, 5.00 eq.).  The biphasic 
mixture was stirred vigorously (800 rpm) and allowed to gradually warm to 23°C.  After 
60 hours, excess H2O2 was quenched with a saturated aqueous mixture of Na2S2O3 (100 
mL).  After stirring for 10 minutes excess hydroxide was quenched with an aqueous 
phosphate buffer (50 mL, pH = 7, 0.2 M).  The biphasic mixture was poured into a 
separatory funnel, partitioned, and residual organics were extracted from the aqueous 
layer using ethyl acetate (4 x 50 mL).  The combined organics were washed with brine (1 
x 100 mL), dried over Na2SO4, decanted, and concentrated under vacuum.  The resulting 
clear colorless oil was purified by silica gel chromatography; 1 → 12% EtOAc in hexane 
to afford the alcohol 185 as a clear colorless oil (6.48 g, 16.6 mmol, 88%) and the starting 
triene 173 as a clear colorless oil (0.70 g, 1.9 mmol, 10%).   
 
Rf =  0.50 (50% EtOAc in hexane):  
 
1H-NMR (400 MHz, CDCl3): δ 6.85 (d, 1H, J = 8.2 Hz), 6.70 (d, 1H, J = 8.2), 5.20 (dd, 
1H, J = 7.2, 6.8 Hz), 3.83 (s, 3H), 3.78 (s, 3H), 3.52 (dd, 1H, J = 5.8 Hz), 3.43 (dd, 1H, J 
= 6.5, 6.8 Hz), 2.55 (dd, 2H, J = 7.5, 5.8 Hz), 2.24 (s, 3H), 2.24 – 2.18 (m, 2H), 2.10 – 
1.94 (m, 6H), 1.64 (s, 6H), 1.59 (s, 3H), 1.51 (m, 2H), 1.31 (bs, 1H), 1.19 – 1.09 (m, 1H), 
0.95 (d, 3H, J = 6.5 Hz)  
 
13C-NMR (100 MHz, CDCl3): δ 150.78, 147.29, 136.00, 133.91, 130.21, 128.38, 128.10, 
124.04, 123.55, 109.38, 68.35, 60.16, 55.71, 38.15, 35.88, 36.65, 33.23, 32.04, 31.55, 
29.07, 18.06, 17.96, 16.60, 16.05, 11.70  
 
IR (neat film, cm-1): 3391, 1490, 1453, 1270, 1085  
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HRMS (EC-CI): calcd. for C25H40O3 [M] 388.2977, found 388.2978. 
  
 
 
 A solution of the alcohol (6.48 g, 16.8 mmol, 1.00 eq.) in methylene chloride (162 
mL) was placed in an ice bath cooled to 0 °C.  After 20 minutes, solid NaHCO3 (5.45 g, 
64.9 mmol, 4.00 eq.), Dess-Martin periodinane (14.1 g, 33.6 mmol, 2.00 eq.), and water 
(2 drops) were added sequentially and the mixture was stirred vigorously (700 rpm).  
After 80 minutes residual acetic acid was neutralized with a saturated aqueous mixture of 
NaHCO3 (100 mL) and excess Dess-Martin periodinane was quenched with a saturated 
aqueous mixture of Na2S2O3 (200 mL).  The biphasic mixture was removed from the 
cooling bath, stirred vigorously (1000 rpm) for 60 minutes at 23 °C, poured into a 
separatory funnel, and partitioned.  The organic layer was washed with a saturated 
mixture of Na2S2O3 and NaHCO3 (2 x 50 mL, 1:1).  Residual organics were extracted 
from the aqueous layer using methylene chloride (3 x 50 mL).  The combined organics 
were washed with brine (1 x 25 mL), dried over solid Na2SO4, filtered, and concentrated 
under vacuum.  The resulting clear pale yellow oil was purified by silica gel 
chromatography; hexane → 5% EtOAc in hexane to afford the aldehyde 186 as a clear 
colorless oil (5.73 g, 14.8 mmol, 88%).   
 
Rf =  0.65 (50% EtOAc in hexane):  
 
1H-NMR (400 MHz, CDCl3): δ 9.62 (d, 1H, J = 2.1 Hz), 6.85 (d, 1H, J = 8.2 Hz), 6.70 
(d, 1H, J = 8.2), 5.20 (dd, 1H, J = 7.2, 6.8 Hz), 3.84 (s, 3H), 3.78 (s, 3H), 2.55 (dd, 2H, J 
= 7.9, 5.8 Hz), 2.31 (ddd, 1H, J = 1.7 Hz), 2.23 (s, 3H), 2.24 – 2.18 (m, 2H), 2.10 – 1.96 
(m, 6H), 1.78 (m, 1H), 1.64 (s, 6H), 1.59 (s, 3H), 1.40 (m, 1H), 1.11 (d, 3H, J = 7.2 Hz)  
 
13C-NMR (100 MHz, CDCl3): δ 205.26, 151.02, 147.47, 136.10, 134.05, 130.42, 129.49, 
127.56, 124.29, 123.88, 109.54, 60.38, 55.89, 46.37, 38.30, 33.86, 33.47, 32.12, 29.32, 
29.17, 18.42, 18.14, 16.28, 13.72, 11.96  
 
IR (neat film, cm-1): 1724, 1490, 1454, 1271, 1085  
 
HRMS (EC-CI): calcd. for C25H38O3 [M] 386.2821, found 386.2822. 
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 To a solution of the aldehyde 186 (5.73 g, 14.8 mmol, 1.00 eq.) in toluene (100 
mL) in a reaction vessel equipped with a Dean-Stark trap was added pyrrolidine (15.2 
mL, 185.0 mmol, 12.50 eq.).  The yellow solution was stirred for 8 hours at 23 °C and 
then placed in an oil bath heated to 140 °C for 24 hours.  The golden-yellow solution was 
removed from the oil bath, cooled to 23 °C, and concentrated under vacuum to remove 
excess pyrrolidine.  The viscous orange oil was dissolved in toluene (100 mL) and then 
methyl vinyl ketone (2.4 mL, 29.6 mmol, 2.00 eq.) was added.  The orange solution was 
stirred at 23 °C for 24 hours and then placed in an oil bath heated to 82 °C.  After 48 
hours, a solution of sodium acetate (4.0 g) and acetic acid (6.1 mL) in water (6.1 mL) was 
added to the dark red solution.  The biphasic mixture was placed in an oil bath heated to 
82 °C and stirred vigorously (700 rpm) for 6 hours.  The reaction vessel was removed 
from the oil bath, cooled to 23 °C, and diluted with an aqueous phosphate buffer (50 mL, 
pH = 4, 0.2 M) and ethyl acetate (50 mL).  The biphasic mixture was poured into a 
separatory funnel and partitioned.  The organic layer was washed with an aqueous 
phosphate buffer (50 mL, pH = 4, 0.2 M) and then residual organics were extracted from 
the aqueous layer using ethyl acetate (3 x 50 mL).  The combined organics were washed 
with brine (1 x 100 mL), dried over solid Na2SO4, decanted, and concentrated under 
vacuum.  The resulting viscous red-brown oil was purified by silica gel chromatography; 
hexane → 10% EtOAc in hexane to afford the cyclohexenone 174 as a viscous clear 
amber oil (5.41 g, 12.3 mmol, 83%).   
 
Rf  =  0.37 (30% EtOAc in hexane)  
 
1H-NMR (400 MHz, CDCl3): δ 6.85 (d, 1H, J = 8.2 Hz), 6.70 (d, 1H, J = 7.9 Hz), 6.69 
(d, 1H, J = 11.6 Hz), 5.90 (d, 1H, J = 10.3 Hz), 5.19 (t, 1H, J = 6.8 Hz), 3.83 (s, 3H), 3.78 
(s, 3H), 2.55 (dd, 2H, J = 7.5, 5.8 Hz), 2.47 (dd, 1H, J = 2.4, 3.4 Hz), 2.45 (d, 1H, J = 6.2 
Hz), 2.23 (s, 3H), 2.24 – 2.17 (m, 2H), 2.10 – 1.96 (m, 8H), 1.80 – 1.76 (m, 1H), 1.633 (s, 
3H), 1.628 (s, 3H), 1.58 (s, 3H), 1.47 (m, 1H), 1.16 (s, 3H)  
 
13C-NMR (100 MHz, CDCl3): δ 199.97, 159.51, 151.02, 147.47, 136.11, 134.07, 130.44, 
128.84, 127.95, 127.60, 124.27, 123.87, 109.53, 60.42, 55.92, 39.29, 38.32, 35.88, 34.40, 
33.83, 33.56, 33.47, 29.55, 29.33, 24.96, 18.37, 18.25, 16.31, 11.97  
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IR (neat film, cm-1): 1683, 1490, 1454, 1271, 1084  
 
HRMS (ESI): calcd. for C29H42O3 [M+Na]+ 461.3026, found 461.3027. 
  
 
 
 
 Anhydrous ferric chloride (1.12 g, 6.90 mmol, 3.00 eq.) was crushed under 
vacuum by stirring the solid vigorously (600 rpm) for 30 minutes.  Deoxygenated CH2Cl2 
(550 mL) was added and the suspension was vigorously stirred (600 rpm) at 23 °C for 20 
minutes.  Stirring was stopped and the residual powder was allowed to settle on the 
bottom of the reaction vessel and the yellow-green liquid was decanted by cannulation 
under nitrogen to a separate flask.  The solubility of ferric chloride in deoxygenated 
CH2Cl2 was measured to be 1.1 mg / mL. 
 A solution of the enone 174 (1.00 g, 2.28 mmol, 1.00 eq.) in deoxygenated 
CH2Cl2 (2.3 L) was placed in an ice water bath cooled to 0 °C and stirred for 1 hour.  The 
solution of FeCl3 in CH2Cl2 was added dropwise over 70 minutes.  The resulting yellow-
orange solution was allowed to stir for 8 hours at 0 °C and then diluted with an aqueous 
phosphate buffer (400 mL, pH = 4, 0.2 M).  The biphasic mixture was stirred vigorously 
(1000 rpm) for 60 minutes, poured into a separatory funnel, and the organic layer was 
removed.  Residual organics were extracted from the aqueous layer using methylene 
chloride (3 x 100 mL).  The combined organics were washed with brine, dried over solid 
Na2SO4, decanted, and concentrated.  The resulting brown oil was purified by silica gel 
chromatography; hexane → 2% acetone in hexane to afford the ketone 188 as a colorless 
viscous foam (0.65 g, 1.50 mmol, 65%, d.r. = 3:1).  The diastereomers were separated by 
silica gel chromatography several times; 3% 1,4-dioxane in hexane.   
 
Major Diastereomer: 
 
Rf = 0.43 (30% EtOAc in hexane) and 0.58 (10% 1,4-dioxane in hexane)   
 
1H-NMR (400 MHz, CDCl3): δ 6.70 (s, 1H), 3.77 (s, 3H), 3.75 (s, 3H), 2.59 – 2.41 (m, 
2H), 2.32 (dd, 2H, J = 9.2, 9.6 Hz), 2.23 (dt, 2H, J = 4.5, 4.8 Hz), 2.13 (s, 3H), 2.03 (d, 
1H, J = 10.2 Hz), 1.89 – 1.70 (m, 8H), 1.53 – 1.35 (m, 5H), 1.26 (s, 3H), 1.06 (s, 3H), 
1.02 (s, 3H), 0.83 (s, 3H) 
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13C-NMR (100 MHz, CDCl3): δ 213.86, 150.24, 144.83, 140.17, 129.51, 128.77, 107.95, 
60.25, 55.65, 52.74, 50.84, 49.05, 44.50, 39.76, 37.72, 37.16, 36.47, 36.24, 36.03, 35.89, 
34.63, 32.07, 30.97, 29.70, 27.59, 23.20, 19.44, 16.65, 11.90  
 
IR (neat film, cm-1): 1692, 1489, 1456, 1089  
 
HRMS (EC-CI): calcd. for C29H42O3 [M] 438.3134, found 438.3130.   
 
 
Minor Diastereomer:  
 
Rf = 0.43 (30% EtOAc in hexane) and 0.52 (10% 1,4-dioxane in hexane)  
 
1H-NMR (400 MHz, CDCl3): δ 6.68 (s, 1H), 3.81 (s, 3H), 3.74 (s, 3H), 2.53 (dt, 1H, J = 
5.5, 5.9 Hz), 2.48 – 2.44 (m, 1H), 2.41 (d, 1H, J = 10.4 Hz), 2.36 – 2.19 (m, 3H), 2.12 – 
2.10 (m, 1H), 2.11 (s, 3H), 1.88 – 1.65 (m, 8H), 1.56 – 1.40 (m, 5H), 1.23 (s, 3H), 1.09 
(s, 3H), 1.03 (s, 3H), 0.82 (s, 3H)  
 
13C-NMR (100 MHz, CDCl3): δ 213.82, 150.27, 144.86, 140.66, 129.43, 128.21, 108.24, 
60.27, 55.73, 52.97, 50.92, 49.02, 44.45, 39.77, 37.57, 36.68, 36.53, 36.28, 36.06, 35.81, 
34.61, 32.11, 30.21, 29.77, 27.43, 23.45, 19.36, 16.87, 11.88  
 
IR (neat film, cm-1): 1694, 1489, 1456, 1088  
 
HRMS (EC-CI): calcd. for C29H42O3 [M] 438.3134, found 438.3130. 
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 A yellow solution of the enone 174 (2.35 g, 5.36 mmol, 1.00 eq.) in ethyl ether 
(54 mL) was placed in an ice bath cooled to 0 °C and stirred for 20 minutes.  LiAlH4 (1.4 
mL, 4 M in ethyl ether, 5.62 mmol, 1.05 eq.) was added dropwise over 2 minutes.  After 
5 minutes the clear colorless solution was diluted with ethyl ether (30 mL) and excess 
lithium aluminum hydride was quenched by the sequential dropwise addition of water 
(0.5 mL), aqueous NaOH (15%, 0.5 mL), and water (1.5 mL).  After stirring for 5 
minutes an aqueous phosphate buffer (1.5 mL, pH = 7, 0.2 M) was added to the white 
heterogeneous mixture and stirred vigorously (900 rpm) for 15 minutes.  The cold bath 
was removed and the mixture was allowed to warm to 23 °C.  Solid Na2SO4 was added 
and the heterogeneous mixture was stirred vigorously for 10 minutes, suction filtered 
over a pad of Na2SO4, and concentrated to reveal the alcohol 190 as a clear colorless oil 
(2.35 g, 5.33 mmol, 99%, d.r. = 1.4 : 1). 
 
Major Diastereomer:  
 
Rf = 0.24 (50% Et2O in hexane) 
 
1H-NMR (400 MHz, CDCl3): δ 6.85 (d, 1H, J = 8.2 Hz), 6.70 (d, 1H, J = 8.2), 5.63 (dd, 
1H, J = 2.3, 9.8 Hz), 5.52 (d, 1H, J = 10.2 Hz), 5.19 (t, 1H, J = 7.0 Hz), 4.14 (m, 1H), 
3.83 (s, 3H), 3.78 (s, 3H), 2.55 (m, 1H), 2.23 (s, 3H), 2.21 (m, 1H), 2.09 – 1.84 (m, 8H), 
1.64 (s, 3H), 1.62 (s, 3H), 1.58 (s, 3H), 1.74 – 1.24 (m, 5H), 1.02 (s, 3H)  
 
13C-NMR (100 MHz, CDCl3): δ 150.76, 139.98, 139.15, 135.96, 133.87, 128.64, 128.49, 
127.85, 127.56, 124.05, 123.56, 109.30, 66.58, 60.18, 55.68, 40.37, 38.13, 34.70, 33.58, 
33.25, 31.34, 29.27, 29.17, 29.10, 26.47, 18.13, 17.95, 16.08, 11.72  
 
IR (neat film, cm-1): 3370, 2931, 1490, 1454, 1270, 1084  
 
HRMS (EC-CI): calcd. for C29H44O3 [M] 440.3290, found 440.3288. 
 
Minor Diastereomer:  
 
Rf = 0.24 (50% Et2O in hexane) 
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1H-NMR (400 MHz, CDCl3): δ 6.85 (d, 1H, J = 8.2 Hz), 6.70 (d, 1H, J = 8.2), 5.67 (dd, 
1H, J = 3.6, 10.2 Hz), 5.57 (d, 1H, J = 10.2 Hz), 5.19 (t, 1H, J = 7.0 Hz), 4.14 (m, 1H), 
3.83 (s, 3H), 3.78 (s, 3H), 2.55 (m, 1H), 2.23 (s, 3H), 2.21 (m, 1H), 2.09 – 1.84 (m, 8H), 
1.64 (s, 3H), 1.62 (s, 3H), 1.58 (s, 3H), 1.74 – 1.24 (m, 5H), 0.96 (s, 3H)  
13C-NMR (100 MHz, CDCl3): δ 147.22, 139.98, 139.15, 135.98, 130.20, 128.64, 128.47, 
127.87, 127.56, 124.06, 123.56, 109.30, 65.32, 60.18, 55.68, 40.22, 38.13, 34.58, 33.58, 
33.25, 30.39, 29.40, 29.10, 28.17, 26.00, 18.15, 16.08, 15.28, 11.72.  
 
IR (neat film, cm-1): 3370, 2931, 1490, 1454, 1270, 1084  
 
HRMS (EC-CI): calcd. for C29H44O3 [M] 440.3290, found 440.3288. 
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 Ferric chloride (1.10 g, 6.81 mmol, 3.00 eq.) was added into a flame-dried round-
bottomed flask in a glove box, removed, and crushed under vacuum by stirring the solid 
vigorously for 30 minutes.  Freshly deoxygenated CH2Cl2 (550 mL) was added and the 
suspension was vigorously stirred (600 rpm) at 23 °C for 30 minutes.  Stirring was 
stopped and the residual powder was allowed to congregate on the bottom of the reaction 
vessel.  The yellow liquid was decanted by cannulation under nitrogen to a separate 
flame-dried flask. 
 A solution of the alcohol 190 (1.00 g, 2.27 mmol, 1.00 eq.) in freshly 
deoxygenated CH2Cl2 (4.15 L) was placed in a bath cooled to −78 °C and stirred (500 
rpm) for 1 hr.  The solution of FeCl3 in CH2Cl2 was added via cannula under nitrogen 
over 20 minutes.  The golden yellow solution was stirred (500 rpm) for 6 hrs while 
gradually warming to −20 °C affording a purple-red solution.  The excess FeCl3 was 
quenched with an aqueous phosphate buffer (300 mL, pH = 7, 0.2 M), and the biphasic 
mixture was immediately removed from the cold bath, stirred vigorously (1000 rpm) for 
60 minutes, poured into a separatory funnel, and the organic layer was removed.  
Residual organics were extracted from the aqueous layer using methylene chloride (2 x 
100 mL), combined, dried over solid Na2SO4, decanted, and concentrated.  The resulting 
golden yellow amorphous oil was purified by silica gel chromatography; benzene to 
afford the pentacycle 191 as a white solid which was ~65% pure determined by GC (300 
°C) and 1H-NMR (0.57 g, 0.86 mmol, 38%).  Further purification using trituration, 
recrystallization, silica gel chromatography, or preparative TLC did not afford a more 
pure product.  The impure compound was carried onto the next step without full 
structural characterization.   
 
Rf = 0.64 (5% EtOAc in benzene) 
 
1H-NMR (400 MHz, CDCl3): δ 6.69 (s, 1H), 5.70 (m, 2H), 3.83 (s, 3H), 3.75 (s, 3H), 
2.72 (dd, 1H, J = 4.8, 13.0 Hz), 2.54 (q, 1H, J = 8.5 Hz), 2.11 (s, 3H), 2.00 – 1.52 (m, 
12H), 1.44 – 1.28 (m, 4H), 1.26 (s, 3H), 1.03 (s, 3H), 0.95 (s, 3H), 0.92 (s, 3H)  
 
HRMS (ESI): calc’d. for C29H42O2Na [M+Na]+ 445.3077, found 445.3082. 
 
M.P.: 49 – 53 °C 
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 A solution of the impure pentacycle 191 (0.25 g, 0.58 mmol, 1.00 eq.) in THF 
(5.8 mL) was placed in a bath cooled to −78 °C and stirred for 1 hour.  A solution of 
borane in THF (1 M, 5.22 mL, 5.22 mmol, 9.00 eq.) was added to the pale yellow 
solution and stirred for 12 hrs. warming gradually to 23 °C.  The clear solution was 
placed in an ice water bath cooled to 0 °C for 10 minutes and an aqueous solution of 
H2O2 (30% w/v, 7.0 mL) and NaOH (4 N, 7.0 mL) was added.  The biphasic mixture was 
stirred for 8 hrs and excess peroxide was quenched with a saturated aqueous mixture of 
Na2S2O3 (10 mL).  An aqueous phosphate buffer (10 mL, pH = 7, 0.2 M) and EtOAc (10 
mL) were added, the mixture was poured into a separatory funnel, partitioned, residual 
organics were extracted from the aqueous layer with EtOAc (2 x 15 mL), combined, 
washed with brine (1 x 10 mL), dried over solid Na2SO4, decanted, and concentrated.  
The crude alcohol was then submitted into the next reaction without purification or 
characterization. 
 A solution of the crude alcohol (0.26 g) in acetone (28.9 mL) was placed in a bath 
cooled to −78 °C and stirred for 30 minutes.  Jones reagent (1.53 M, 0.40 mL, 0.61 
mmol, 1.05 eq.) was added and the red-brown solution was allowed to warm gradually to 
−10 °C over 2 hrs.  Excess chromic acid was quenched with 2-propanol (10 mL) and the 
green mixture was diluted with ethyl ether (30 mL) and an aqueous phosphate buffer (10 
mL, pH = 7, 0.2 M).  The biphasic mixture was poured into a separatory funnel, 
partitioned, and the organic layer was washed with a saturated aqueous mixture of 
NaHCO3 (2 x 10 mL).  The residual organics were extracted from the aqueous layer with 
ethyl ether (3 x 20 mL), combined, washed with brine (1 x 10 mL), dried over solid 
Na2SO4, decanted, and concentrated.  The crude green mixture was purified by silica gel 
chromatography; 5% EtOAc in hexane to afford the pentacyclic ketone 175 as a white 
solid (0.152 g, 0.35 mmol, 60%). 
 
Rf = 0.71 (40% EtOAc in hexane) 
 
1H-NMR (400 MHz, CDCl3): δ 6.66 (s, 1H), 3.83 (s, 3H), 3.75 (s, 3H), 2.72 (dd, 1H, J = 
6.5, 17.6 Hz), 2.56 (dd, 1H, J = 7.3, 17.6 Hz), 2.53 – 2.27 (m, 5H), 2.10 (s, 3H), 2.04 – 
2.00 (m, 2H), 1.92 (ddd, 1H, J = 4.4, 13.7 Hz), 1.85 (m, 2H), 1.73 – 1.33 (m, 8H), 1.28 
(s, 3H), 1.23 (s, 3H), 1.00 (s, 3H), 0.88 (s, 3H)  
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13C-NMR (100 MHz, CDCl3): δ 213.80, 150.44, 146.86, 144.93, 129.45, 126.33, 105.83, 
60.29, 55.86, 47.98, 43.58, 40.10, 39.55, 37.72, 37.68, 37.56, 37.17, 35.06, 33.78, 31.50, 
31.22, 29.42, 28.11, 27.88, 27.84, 18.13, 16.29, 15.02, 11.73 
 
IR (neat film, cm-1): 2935, 1709, 1487, 1091 
 
HRMS (EC-CI): calcd. for C29H42O3 [M] 438.3134, found 438.3129. 
 
M.P.: 58 – 62 °C 
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 The ketone was dried by the azeotropic removal of water using toluene (3 x 3 mL) 
prior to use.  A solution of the ketone 175 (114 mg, 0.26 mmol, 1.00 eq.) in THF (3.7 
mL) was placed in a bath cooled to −78 °C and stirred for 1 hr.  A solution of LiHMDS 
(1 M, 1.00 mL, 1.04 mmol, 4.00 eq.) was added and the pale yellow solution was stirred 
for 1 hr.  A solution of N-phenyl-bis(trifluoromethanesulfonimide) (371 mg, 1.04 mmol, 
4.00 eq.) in THF (1.5 mL) was added to the enolate in a dropwise manner by cannula 
under nitrogen.  The golden yellow solution was stirred for 20 minutes, the cold bath was 
removed, and the solution was allowed to gradually warm to 23 °C over 1 hr.  An 
aqueous phosphate buffer (5 mL, pH = 10, 0.2 M) was added to neutralize excess 
LiHMDS and the biphasic mixture was poured into a separatory funnel containg Et2O (10 
mL).  The organic layer was washed with a saturated aqueous mixture of NaHCO3 (2 x 
10 mL).  Residual organics were extracted from the aqueous layer using Et2O (2 x 10 
mL), combined, dried over solid Na2SO4, decanted, and concentrated.  The crude pale 
orange solid was purified by silica gel chromatography; 2% Et2O in hexane to provide the 
enol triflate 202 as a white solid (0.146 g, 0.26 mmol, 99%, 2:1 mixture of olefin 
isomers). 
 
Mixture of Isomers: (*) denotes minor isomer 
 
Rf = 0.51 (15% Et2O in hexane) 
 
1H-NMR (400 MHz, CDCl3): δ 6.67 (s, 1H), 5.77* (m, 1H), 5.64 (m, 1H), 3.82 (s, 3H), 
3.75 (s, 3H), 2.72 (dd, 1H, J = 6.5, 17.6 Hz), 2.66 – 2.20 (m, 8H), 2.10 (s, 3H), 2.05 – 
1.40 (m, 8H), 1.25* (s, 3H), 1.23 (s, 3H), 1.05 (s, 3H), 1.03* (s, 3H), 1.01 (s, 3H), 1.00* 
(s, 3H), 0.93* (s, 3H), 0.92 (s, 3H)  
 
13C-NMR (100 MHz, CDCl3): δ 150.43 (150.44*), 148.98 (148.89*), 146.94 (146.69*), 
144.91 (144.87*), 129.45 (129.48*), 126.28 (126.32*), 119.09 (120.13*), 116.73, 105.70 
(105.79*), 60.30, 55.78, (47.25*), (43.94*), 43.73, 43.39, (40.34*), 39.94, 39.84, 
(39.10*), (37.39*), 37.35, 37.11, 34.38 (34.52*), 34.08 (33.87*), 32.54, (31.12*), 30.55 
(29.68*), 29.60 (29.45*), 28.31 (28.26*), 27.92, 27.82, 27.76, 24.44 (24.67*), 18.05 
(18.21*), 16.91, 15.14 (15.09*), 13.83, 11.76 
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IR (neat film, cm-1): 2924, 1413, 1207, 1143 
 
HRMS (EC-CI): calcd. for C30H41O5F3S [M+H]+ 570.2627, found 570.2622. 
 
M.P.: 54 – 56 °C 
 
 
 
  
 
 A mixture of the enol triflate 202 (109.0 mg, 0.19 mmol, 1.00 eq.) and 
Pd(dppf)Cl2-CH2Cl2 (31.5 mg, 0.04 mmol, 0.20 eq.) was evacuated and then refilled with 
nitrogen.  To the dry red mixture was added triethylamine (0.54 mL, 3.83 mmol, 20.0 eq.) 
and methanol (3 mL).  The reaction vessel was stoppered with a plastic PTFE cap under a 
positive flow of carbon monoxide.  The vessel was placed under an atmosphere of carbon 
monoxide (balloon), the dark red solution was placed in an oil bath heated to 65 and 
stirred (500 rpm) for 12 hrs.  The black mixture was removed from the oil bath, cooled to 
23 °C, and a second loading of Pd(dppf)Cl2-CH2Cl2 (38.8 mg, 0.05 mmol, 0.25 eq.) was 
added.  The black mixture was purged, placed under an atmosphere of carbon monoxide 
(balloon), and placed into the oil bath heated to 65 °C.  After 24 hrs. the black mixture 
was removed from the oil bath, concentrated, and residual methanol was azeotropically 
removed with chloroform (3 x 3 mL).  The black solid was dissolved in chloroform and 
hexane (2 mL, 3:1), loaded directly onto silica gel, and purified by silica gel 
chromatography; hexane → 10% EtOAc in hexane to afford the enoate 203 as a white 
solid (77.4 mg, 0.16 mmol, 84%). 
 
Mixture of Isomers: (*) denotes minor isomer 
 
Rf = 0.48 (35% Et2O in hexane)  
 
1H-NMR (400 MHz, CDCl3): δ 7.06* (d, 1H, J = 4.5 Hz), 6.89 (m, 1H), 6.67 (s, 1H), 
3.82 (s, 3H), 3.75 (s, 3H), 3.73 (s, 3H), 2.72 – 2.68 (m, 1H), 2.58 – 2.48 (m, 2H), 2.40 – 
2.34* (m, 1H), 2.30 – 2.20 (m, 1H), 2.10 (s, 3H), 2.02 – 1.35 (m, 17H), 1.27* (s, 3H), 
1.23 (s, 3H), 1.05* (s, 3H), 1.03 (s, 3H), 0.96 (s, 3H), 0.90* (s, 3H), 0.88* (s, 3H), 0.80 
(s, 3H) 
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13C-NMR (100 MHz, CDCl3): δ (167.97*) 167.86, (150.47*) 150.38, 147.19 (146.85*), 
(144.87*) 144.80, 140.97, 138.70, (129.54*), (129.47*), (129.41*) 129.39, (126.42*) 
126.37, (105.82*) 105.75, 60.30, 55.79, 51.51, (48.10*), (43.91*) 43.40, 41.78, (40.75*) 
40.04, 39.92, (39.35*) 38.74, (37.40*) 37.14, (35.24*) 34.97, 34.13 (33.96*), (33.47*) 
33.02, (31.58*) 31.38, 30.27 (29.57*), 29.52 (29.50*), 28.41 (28.37*), (27.96*) 27.88, 
(22.66*), (21.45*) 20.91, (18.21*) 18.01, (17.64*), 15.30 (15.29*), (15.26*) 13.89, 11.75 
 
IR (neat film, cm-1): 3368, 2925, 1712, 1251, 1091 
 
HRMS (EC-CI): calcd. for C31H44O4 [M+H]+, 480.3240 found. 480.3241  
 
M.P.: 83 – 87 °C 
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 To a white mixture of the ester 203 (97.0 mg, 0.20 mmol, 1.00 eq.) in methanol 
(4.5 mL) and water (1.5 mL) was added KOH (227 mg, 4.04 mmol, 20.0 eq.).  The 
reaction vessel was equipped with a plastic PTFE cap under a purging flow of nitrogen 
and placed in an oil bath heated to 65 °C.  After stirring (500 rpm) for 2 hrs. the clear 
colorless solution was removed from the oil bath, allowed to cool to 23 °C, acidified to 
pH = 2 using 1 N HCl, diluted with EtOAc (5 mL), poured into a separatory funnel 
containing an aqueous phosphate buffer (10 mL, pH = 2, 0.2 M), and partitioned.  The 
organic layer was washed with water (1 x 10 mL).  The residual organics were extracted 
from the aqueous layer with EtOAc (2 x 10 mL), combined, dried over solid Na2SO4, 
decanted, and concentrated to afford the acid 204 as a white solid (92.2 mg, 0.20 mmol, 
99%, 2:1).  The product was carried onto the next step without further purification.     
 
Mixture of Isomers: (*) denotes minor isomer 
 
Rf = 0.31 (50% EtOAc in hexane) 
 
1H-NMR (400 MHz, CDCl3): δ 7.22* (s, 1H), 7.06 (s, 1H), 6.67 (s, 1H), 3.82 (s, 3H), 
3.75 (s, 3H), 2.71 (dd, 1H, J = 5.0, 16.1 Hz), 2.54 (m, 2H), 2.41 – 2.10 (m, 2H), 2.10 (s, 
3H), 2.06 – 1.91 (m, 4H), 1.88 – 1.57 (m, 7H), 1.48 – 1.31 (m, 3H), 1.27* (s, 3H), 1.23 
(s, 3H), 1.06* (s, 3H), 1.03 (s, 3H), 0.98 (s, 3H), 0.92* (s, 3H), 0.89* (s, 3H), 0.81 (s, 3H) 
 
13C-NMR (100 MHz, CDCl3): δ (172.80*) 172.71, (150.41*) 150.38, 147.18 (146.83*), 
(144.86*) 144.80, (143.85*) 141.53, (129.49*) 129.43, (129.08*) 128.91, (126.42*) 
126.39, (105.84*) 105.77, 60.33, 55.81, (48.34*), (43.89*) 43.39, 41.70 (40.91*), 40.06, 
39.92 (39.39*), (39.97*), (37.41*) 37.15, (35.18*) 34.94, 34.11 (33.94*), (33.41*), 33.06, 
(31.40*), 30.26, (29.71*), (29.61*) 29.54, 29.48, 28.41, (27.96*), 27.88, (21.07*) 20.49, 
(18.22*) 18.01, 17.74, 15.31 (15.28*), 13.94, 11.77 
 
IR (neat film, cm-1): 2946, 2636, 2527, 2250, 1683, 1486, 1278, 1092, 910, 732 
 
HRMS (EC-CI): calcd. for C30H42O4 [M+H]+, 466.3083 found. 466.3075 
 
M.P.: 159 – 162 °C 
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 To a solution of liquid ammonia (5 mL) in a bath cooled to −78 °C was added 
sodium metal (46.0 mg, 2.00 mmol, 10.0 eq.) under a positive flow of nitrogen.  The blue 
heterogeneous mixture was stirred (800 rpm) for 10 minutes upon which a solution of the 
acid 204 (92.2 mg, 0.20 mmol, 1.00 eq.) in THF (6 mL) was added over 1 minute via 
cannula under nitrogen.  The blue heterogeneous mixture was stirred for 30 minutes and 
then t-BuOH (1.9 mL) was added to quench the excess sodium metal, sodium amide, and 
the enolate.  After 30 minutes the mixture was slowly acidified to pH = 2 using 
concentrated HCl and then diluted with EtOAc (20 mL).  The biphasic solution was 
removed from the cold bath, warmed to 23 °C, poured into a separatory funnel containing 
an aqueous phosphate buffer (10 mL, pH = 2, 0.2 M), and partitioned.  The organics were 
extracted from the aqueous layer with EtOAc (2 x 20 mL), combined, washed with brine, 
dried over solid Na2SO4, decanted, and concentrated.  The crude off-white solid was 
purified by silica gel chromatography; 2% EtOAc and 2% AcOH in hexane to afford the 
acid 199 as a white solid (91.7 mg, 0.20 mmol, 99%, d.r. = 3:1). 
 
Mixture of Isomers: (*) denotes minor isomer 
 
Rf = 0.66 (40% EtOAc and 2% AcOH in hexane) 
 
1H-NMR (400 MHz, CDCl3): δ 6.69 (s, 1H), 3.84 (s, 3H), 3.76 (s, 3H), 2.75 – 2.65 (m, 
2H), 2.57 – 2.50 (m, 1H), 2.11 (s, 3H), 2.02 (d, 1H, J = 7.2 Hz), 1.90 – 1.46 (m, 16H), 
1.38 – 1.32 (m, 2H), 1.26* (s, 3H), 1.23* (s, 3H), 1.19 (s, 6H), 1.11* (s, 3H), 1.10* (s, 
3H), 1.07 (s, 3H), 0.98 (s, 3H) 
 
13C-NMR (100 MHz, CDCl3): δ 183.59, 150.41, 146.52, 144.84, 129.54, 126.61 
(126.52*), 106.10, 60.33, 55.85, 46.24, 44.94, 43.26, (40.10*), (39.68*), 39.40, 38.30, 
37.42, 37.26, 36.43, 35.47, 34.27, 33.07, 32.17 (31.51*), 30.62, 30.27 (29.71*), 28.57 
(28.07*), (27.83*), 26.50, 24.30, 21.10, (20.19*) 20.13, 16.96, (15.07*), 11.78 
 
IR (neat film, cm-1): 2932, 2871, 1699, 1486, 910, 734 
 
HRMS (EC-CI): calcd. for C30H44O4 [M], 468.3240 found. 468.3239 
 
M.P.: 179 – 183 °C  
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 A solution of diethylamine (0.25 mL, 2.42 mmol, 1.00 eq.) in THF (4.7 mL) was 
placed in a bath cooled to −78 °C and stirred (500 rpm) for 20 minutes.  n-Butyllithium 
(1.26 mL, 2.42 mmol, 1.92 M in hexane, 1.00 eq.) was added, the pale yellow solution 
was stirred for 30 minutes at −78 °C, the cold bath was removed, and allowed to warm 
gradually to 23 °C over 20 minutes to provide a freshly prepared solution of lithium 
diethylamide (0.4 M). 
 Acid 199 was azeotroped with toluene (3 x 3 mL) and dried in vacuo prior to use. 
To a solution of the acid 199 (28.0 mg, 0.06 mmol, 1.00 eq.) in THF (1 mL) at 23 °C in a 
vessel equipped with a Claisen adapter and reflux condenser was added a freshly 
prepared solution of lithium diethylamide (3.00 mL, 1.19 mmol, 20.0 eq., 0.4 M in THF).  
The resultant golden yellow solution was stirred for 30 minutes and then placed in an oil 
bath heated to 70 °C.  After 30 minutes iodomethane (0.17 mL, 2.68 mmol, 45.0 eq.) was 
added to the golden yellow solution.  The now pale yellow mixture was stirred for 30 
minutes, removed from the oil bath, cooled to 23 °C, and the mixture was acidified to a 
pH = 2 with an aqueous phosphate buffer (10 mL, pH = 2, 0.2 M).  The biphasic mixture 
was diluted with EtOAc (10 mL), poured into a separatory funnel, partitioned, and the 
organic layer washed with an aqueous phosphate buffer (1 x 10 mL, pH = 2, 0.2 M).  
Residual organics were extracted from the aqueous layer with EtOAc (2 x 10 mL), 
combined, dried over solid Na2SO4, decanted, concentrated, and the crude golden yellow 
mixture was purified using silica gel chromatography; toluene (50 mL) and then 2% 
EtOAc and 2% AcOH in hexane (150 mL) to afford a mixture of the starting acid 199 
and the methylated acid 128 (Rf = 0.75 (40% EtOAc and 2% AcOH in hexane)) as a 
white solid.   
 This mixture was azeotroped with toluene (3 x 3 mL), dried in vacuo, and 
subjected to the identical reaction conditions above.  After aqueous work-up, the 
concentrated crude golden yellow mixture was purified by silica gel chromatography; 
toluene (50 mL) and then 2% EtOAc and 2% AcOH in hexane (150 mL) to afford the 
alkylated acid as a white solid which was dissolved in a solution of methanol-benzene (2 
mL, 1 : 1).  A solution of trimethylsilyl diazomethane (0.20 mL, 0.40 mmol, 6.67 eq., 2 
M in Et2O) was added.  After 5 minutes the golden yellow solution was concentrated and 
purified by silica gel chromatography; 1% acetone in hexane to afford the ester 206 as a 
white amorphous foam (14.1 mg, 0.03 mmol, 47%). 
 
Rf = 0.54 (10% acetone in hexane) 
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1H-NMR (400 MHz, CDCl3): δ 6.68 (s, 1H), 3.84 (s, 3H), 3.75 (s, 3H), 3.60 (s, 3H), 2.72 
(dd, 1H, J = 5.1, 17.1 Hz), 2.55 – 2.48 (m, 1H), 2.42 – 2.34 (m, 1H), 2.19 – 2.13 (m, 1H), 
2.10 (s, 3H), 2.04 – 1.98 (m, 3H), 1.82 – 1.30 (m, 13H), 1.20 (s, 3H), 1.19 (s, 3H), 1.10 
(s, 3H), 0.95 (s, 3H), 0.80 (s, 3H)   
 
13C-NMR (100 MHz, CDCl3): δ 179.25, 150.35, 146.87, 144.81, 129.52, 126.61, 105.84, 
60.31, 55.83, 51.52, 44.46, 43.98, 40.56, 39.47, 38.90, 37.24, 36.51, 36.24, 34.02, 32.01, 
31.83, 30.60, 30.25, 30.17, 29.70, 28.90, 28.31, 27.33, 18.45, 17.35, 15.89, 11.75 
 
IR (neat film, cm-1): 2978, 2869, 1732, 1487, 1464, 1093 
 
HRMS (EC-CI): calc’d. for C32H48O4 [M], 496.3553 found. 496.3551 
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 To a solution of the acid 199 (10.0 mg, 21.4 μmol, 1.00 eq.) in methanol and 
benzene (1 mL, 1:1) was added trimethylsilyl diazomethane (11.5 μL, 22.4 μmol, 1.05 
eq., 2 M in Et2O) at 23 °C.  After 5 minutes the benzene and methanol were evaporated 
from the golden yellow solution by a continous flow of nitrogen and the resultant pale 
yellow residue was fully concentrated in vacuo to afford the ester 201 as a white 
amorphous foam (10.3 mg, 21.4 μmol, 100%). 
 
Mixture of Isomers: (*) denotes minor isomer 
 
Rf = 0.55 (20% EtOAc in hexane) 
 
1H-NMR (400 MHz, C6D6): δ 6.73* (s, 1H), 6.72 (s, 1H), 3.72 (s, 3H), 3.71* (s, 3H), 
3.54* (s, 3H), 3.49 (s, 3H), 3.40 (s, 3H), 3.39* (s, 3H), 2.62 – 2.52 (m, 2H), 2.48 – 2.34 
(m, 1H), 2.14 (s, 3H), 2.13* (s, 3H), 2.10 – 2.05 (m, 1H), 1.98 – 1.57 (m, 10H), 1.50 – 
1.24 (m, 7H), 1.21* (s, 3H), 1.20 (s, 3H), 1.00 (s, 3H), 0.99* (s, 3H), 0.92 (s, 3H), 0.89* 
(s, 3H), 0.80* (s, 3H), 0.77 (s, 3H) 
 
13C-NMR (100 MHz, C6D6): δ 176.62, 151.02, 146.12, 145.81, 129.29, 126.48, 106.75 
(106.28*), 59.61, 55.35, 50.82 (50.68*), 46.30, 44.76, 43.35, (39.93*), (39.47*), 39.15, 
38.11, (37.27*), 37.22, (37.04*), 36.48 (36.38*), 35.47, 34.33 (33.96*), 32.74, 32.05 
(31.24*), 30.37, (30.12*) 30.04, 28.56 (28.03*), (27.66*) 26.39, (24.63*) 24.53, (23.68*) 
21.29, 19.87 (19.75*), 18.47 (18.40*), 16.58 (14.85*), 11.69 
 
IR (neat film, cm-1): 2944, 1734, 1487, 1093 
 
HRMS (EC-CI): calcd. for C31H46O4 [M], 482.3396 found. 482.3391 
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 A solution of diethylamine (0.25 mL, 2.42 mmol, 1.00 eq.) in THF (4.7 mL) was 
placed in a bath cooled to −78 °C and stirred (500 rpm) for 20 minutes.  n-Butyllithium 
(1.26 mL, 2.42 mmol, 1.92 M in hexane, 1.00 eq.) was added, the pale yellow solution 
was stirred for 30 minutes at −78 °C, the cold bath was removed, and allowed to warm 
gradually to 23 °C over 20 minutes to provide a freshly prepared solution of lithium 
diethylamide (0.4 M). 
 Ester 201 was azeotroped with toluene (3 x 3 mL) and dried in vacuo prior to use. 
To a solution of the ester 201 (10.3 mg, 21.4 μmol, 1.00 eq.) in THF (1 mL) at 23 °C was 
added a freshly prepared solution of lithium diethylamide (27 μL, 107 μmol, 5.00 eq., 0.4 
M in THF).  The resultant golden yellow-brown solution was stirred for 5 minutes and 
then iodomethane (16 μL, 256 μmol, 12.0 eq.) was added to the golden brown solution.  
The now pale yellow mixture was stirred for 30 minutes and diluted with an aqueous 
phosphate buffer (5 mL, pH = 7, 0.2 M).  The biphasic mixture was diluted with EtOAc 
(10 mL), poured into a separatory funnel, partitioned, and the organic layer washed with 
an aqueous phosphate buffer (2 x 10 mL, pH = 7, 0.2 M).  Residual organics were 
extracted from the aqueous layer with EtOAc (2 x 10 mL), combined, dried over solid 
Na2SO4, decanted, concentrated, and the crude golden brown mixture was purified using 
silica gel chromatography; 1% acetone in hexane to afford the mixture of the ester 206 as 
a white amorphous film (2.7 mg, 5.4 μmol, 25%)   
 
Rf = 0.54 (10% acetone in hexane) 
 
1H-NMR (400 MHz, CDCl3): δ 6.68 (s, 1H), 3.84 (s, 3H), 3.75 (s, 3H), 3.60 (s, 3H), 2.72 
(dd, 1H, J = 5.1, 17.1 Hz), 2.55 – 2.48 (m, 1H), 2.42 – 2.34 (m, 1H), 2.19 – 2.13 (m, 1H), 
2.10 (s, 3H), 2.04 – 1.98 (m, 3H), 1.82 – 1.30 (m, 13H), 1.20 (s, 3H), 1.19 (s, 3H), 1.10 
(s, 3H), 0.95 (s, 3H), 0.80 (s, 3H)   
 
13C-NMR (100 MHz, CDCl3): δ 179.25, 150.35, 146.87, 144.81, 129.52, 126.61, 105.84, 
60.31, 55.83, 51.52, 44.46, 43.98, 40.56, 39.47, 38.90, 37.24, 36.51, 36.24, 34.02, 32.01, 
31.83, 30.60, 30.25, 30.17, 29.70, 28.90, 28.31, 27.33, 18.45, 17.35, 15.89, 11.75 
 
IR (neat film, cm-1): 2978, 2869, 1732, 1487, 1464, 1093 
 
HRMS (EC-CI): calc’d. for C32H48O4 [M], 496.3553 found. 496.3551 
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 To a solution of the ester 206 (4.0 mg, 8.05 μmol, 1.00 eq.) in 1,4-dioxane and 
water (3 mL, 1:1) was added KOH (9.0 mg, 161 μmol, 20.0 eq.) under a positive flow of 
nitrogen and the reaction vessel was equipped with a plastic PTFE cap.  The clear 
colorless solution was placed in an oil bath heated to 110 °C for 4 hrs., removed from the 
oil bath, and allowed to cool to 23 °C.  The clear pale yellow solution was acidified to pH 
= 2 with an aqueous phosphate buffer (5 mL, pH = 2, 0.2 M) affording a white mixture 
which was diluted with EtOAc (10 mL), poured into a separatory funnel, and partitioned.  
The organic layer was washed with an aqueous phosphate buffer (1 x 5 mL, pH = 2, 0.2 
M).  The residual organics were extracted from the aqueous layer with EtOAc (2 x 10 
mL), combined, dried over solid Na2SO4, decanted, and concentrated to afford the acid 
128 as a crude white amorphous foam which was carried onto the next reaction without 
further purification (3.9 mg, 7.97 μmol, 99%). 
 
Rf = 0.75 (40% EtOAc and 2% AcOH in hexane) 
 
1H-NMR (500 MHz, CDCl3): δ 6.68 (s, 1H), 3.83 (s, 3H), 3.77 (s, 3H), 2.72 (dd, 1H, J = 
6.1, 17.1 Hz), 2.56 – 2.48 (m, 1H), 2.37 – 2.33 (m, 1H), 2.10 (s, 3H), 1.98 (br d, 2H, J = 
12.9 Hz), 1.83 – 1.61 (m, 8H), 1.46 – 1.36 (m, 5H), 1.28 – 1.22 (m, 2H), 1.22 (s, 6H), 
1.16 (s, 3H), 1.11 (s, 3H), 0.96 (s, 3H),   
 
13C-NMR (125 MHz, CDCl3): δ 184.42, 150.36, 146.87, 144.81, 129.47, 126.55, 105.85, 
60.29, 55.81, 44.21, 39.41, 39.00, 37.24, 36.57, 36.19, 34.05, 31.82, 31.50, 30.45, 30.29, 
30.15, 29.69, 29.65, 29.58, 29.16, 28.28, 27.27, 18.47, 17.81, 16.29, 11.76 
 
IR (neat film, cm-1): 2929, 2870, 1697, 1487, 1463, 1270, 1093, 734 
 
HRMS (EC-CI): calc’d. for C31H46O4 [M], 482.3396 found. 482.3406 
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 A solution of the crude acid 128 (3.9 mg, 7.97 μmol, 1.00 eq.) in methylene 
chloride (1 mL) was placed in an ice water bath cooled to 0 °C.  After stirring for 20 
minutes neat BBr3 (3.0 μL, 24.0 μmol, 3.00 eq.) was added.  The golden yellow-orange 
solution was stirred for 5 minutes, acidified with 1 N HCl (3 mL), and the cold bath was 
removed.  The orange mixture was diluted with EtOAc (10 mL) and an aqueous 
phosphate buffer (5 mL, pH = 2, 0.2 M), stirred vigorously for 2 minutes, poured into a 
separatory funnel containing EtOAc (10 mL), and the organics were washed with an 
aqueous phosphate buffer (2 x 10 mL, pH = 2, 0.2 M).  Residual organics were extracted 
from the aqueous layer with EtOAc (3 x 10 mL), washed with brine (1 x 10 mL), dried 
over solid Na2SO4, decanted, and concentrated.  (NOTE: Throughout the work-up the 
catechol 127 remained under a positive flow of nitrogen to prevent oxidative 
degradation).  The crude golden yellow mixture was dissolved in methylene chloride (0.5 
mL), placed in an ice water bath cooled to 0 °C, and hexane (10 mL) was added to 
triturate the white solid product.  After stirring for 2 minutes the mixture was 
concentrated by rotary evaporation to ~3 mL (100 mBar, no water bath) and hexane (10 
mL) was added.  The mixture was concentrated by rotary evaporation to ~3 mL (100 
mBar, no water bath).  This was repeated once more upon which hexane (5 mL) was 
added to the white mixture, and the suspension was placed in an ice water bath cooled to 
0 °C for 20 minutes.  The cold yellow liquid was decanted by syringe.  The white solid 
was washed with hexane (2 x 3 mL) which was decanted by syringe to afford wilforic 
acid (127) as a white solid (2.5 mg, 5.50 μmol, 69%).  The spectral data matches that of 
the reported compound (Li, K.; Duan, H.; Kawazoe, K.; and Takashi, Y. Phytochemistry 
1997, 45, 791.).131 
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1H-NMR Shifts of Wilforic Acid in C5D5N: 
 
Isolated Synthesized Deviation 
7.07 (s, 1H) 7.07 (s, 1H) 0.00 
2.78 (dd, 1H) 2.78 (dd, 1H) 0.00 
2.66 (dd, 1H) 2.66 (dd, 1H) 0.00 
2.59 (m, 1H) 2.57 (m, 1H) − 0.02 
2.52 (m, 1H) 2.52 (m, 1H) 0.00 
2.39 (s, 3H) 2.38 (s, 3H) − 0.01 
2.31 (ddd, 1H) 2.30 (ddd, 1H) − 0.01 
1.98 (br d, 1H) 1.99 (br d, 1H) + 0.01 
1.44 (s, 3H) 1.42 (s, 3H) − 0.02 
1.29 (s, 3H) 1.26 (s, 3H) − 0.03 
1.19 (s, 3H) 1.17 (s, 3H) − 0.02 
1.16 (s, 3H) 1.13 (s, 3H) − 0.03 
1.01 (s, 3H) 0.94 (s, 3H) − 0.07 
 
1H-NMR (400 MHz, CD3CN): δ 6.59 (s, 1H), 3.37 (bs, 2H), 2.67 (dd, 1H, J = 5.9, 6.8 
Hz), 2.52 – 2.42 (m, 3H), 2.36 – 2.28 (m, 4H), 2.00 (s, 3H), 1.76 – 1.24 (m, 13H), 1.17 (s, 
3H), 1.13 (s, 3H), 1.09 (s, 3H), 0.94 (s, 3H), 0.89 (s, 3H) 
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 A clear colorless solution of the ester 206 (10.0 mg, 19.6 μmol, 1.00 eq.) in 
acetone (1.5 mL) was placed in an ice water bath cooled to 0 °C for 20 minutes.  Jones 
reagent (27.0 μL, 41.1 μmol, 2.10 eq., 1.53 M) was added and after 2 minutes the red-
brown mixture was removed from the cold bath.  After 5 minutes the brown mixture was 
diluted with isopropanol (1 mL) to quench excess Jones reagent.  The green mixture was 
diluted with Et2O (10 mL) and an aqueous phosphate buffer (5 mL, pH = 7, 0.2 M), 
poured into a separatory funnel, partitioned, and the organic layer was washed with water 
(2 x 10 mL).  Residual organics were extracted from the aqueous layer with Et2O (2 x 10 
mL), combined, dried over solid Na2SO4, decanted, and concentrated.  The crude green 
mixture was purified by silica gel chromatography; hexane → 10% EtOAc in hexane to 
afford the benzyl ketone as a white amorphous foam (8.7 mg, 17.0 μmol, 87%). 
 
Rf = 0.51 (30% EtOAc in hexane) 
 
1H-NMR (400 MHz, CDCl3): δ 6.69 (s, 1H), 3.93 (s, 3H), 3.74 (s, 3H), 3.61 (s, 3H), 2.53 
(d, 2H, J = 7.4 Hz), 2.51 (s, 3H), 2.42 – 2.38 (m, 1H), 2.30 (d, 1H, J = 7.4 Hz), 2.24 (dd, 
1H, J = 5.9, 12.9 Hz), 2.16 (br d, 1H, J = 14.4 Hz), 2.05 – 1.93 (m, 4H), 1.72 – 1.28 (m, 
8H), 1.19 (s, 3H), 1.16 (s, 3H), 1.09 (s, 3H), 1.02 (s, 3H), 0.81 (s, 3H) 
 
13C-NMR (100 MHz, CDCl3): δ 200.42, 179.35, 155.94, 155.52, 134.77, 128.22, 124.48, 
103.79, 60.24, 55.59, 51.62, 44.63, 42.38, 40.59, 39.41, 38.74, 37.66, 37.43, 36.15, 36.03, 
33.24, 32.40, 31.71, 30.64, 30.26, 29.82, 29.76, 28.35, 25.53, 16.92, 15.35, 13.94 
 
IR (neat film, cm-1): 2924, 2852, 1734, 1669, 1585, 1484, 1287, 1099, 1020 
 
HRMS (EC-CI): calc’d. for C32H46O5 [M], 510.3345 found. 510.3346 
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 To a solution of the ketone (8.7 mg, 17.0 μmol, 1.00 eq.) in methylene chloride (1 
mL) was added freshly distilled Hunig’s base (12.0 μL, 68.0 μmol, 4.00 eq.) and 
trimethylsilyl trifluoromethane sulfonate (16.0 μL, 85.0 μmol,, 5.00 eq.) sequentially.  
After 1 hr. the clear golden yellow solution was concentrated in vacuo to afford the crude 
silyl enol ether as a golden yellow solid mixture.   
 A solution of the crude silyl enol ether in THF (1 mL) was placed in a bath cooled 
to −78 °C for 30 minutes upon which a solution of PhSeCl (16.3 mg, 85.0 μmol, 5.00 eq.) 
in THF (1 mL) was added over 1 minute under nitrogen via cannula.  After 30 minutes 
the yellow solution was removed from the cooling bath and allowed to gradually warm to 
23 °C.  After 1 hr the yellow solution was placed in an ice water bath for 20 minutes and 
then an aqueous solution of H2O2 (5.0 μL, 170.0 μmol, 10.0 eq., 30% w/v) was added.  
The pale yellow solution was stirred for 10 minutes, the cooling bath was removed, and 
after 10 minutes a saturated aqueous mixture of Na2S2O3 (3 mL) was added followed by 
an aqueous phosphate buffer (3 mL, pH = 7, 0.2 M) and EtOAc (10 mL).  The biphasic 
mixture was poured into a separatory funnel, partitioned, and the organic layer was 
washed with water (2 x 5 mL).  The residual organics were extracted from the aqueous 
layer with EtOAc (2 x 10 mL), dried over solid Na2SO4, decanted, and concentrated.  The 
crude yellow solid was purified by silica gel chromatography; hexane → 10% EtOAc in 
hexane to afford the enone 210 as a pale yellow amorphous foam (7.6 mg, 14.9 μmol, 
88%). 
 
Rf = 0.65 (35% EtOAc in hexane) 
 
1H-NMR (400 MHz, CDCl3): δ 6.82 (s, 1H), 6.23 (s, 1H), 3.91 (s, 3H), 3.75 (s, 3H), 3.52 
(s, 3H), 2.63 (s, 3H), 2.42 (bd d, 1H, J = 15.7 Hz), 2.26 – 2.23 (m, 1H), 2.17 (br d, 1H, J 
= 14.4 Hz), 2.05 (dd, 1H, J = 4.1, 14.1 Hz), 2.01 (dd, 1H, J = 4.1, 8.0 Hz), 1.97 (dd, 1H, J 
= 5.0, 13.6 Hz), 1.86 (ddd, 1H, J = 6.2, 14.1 Hz), 1.82 (m, 1H), 1.72 – 1.56 (m, 4H), 1.54 
(s, 3H), 1.49 (dd, 1H, J = 5.0, 16.0 Hz), 1.40 – 1.34 (m, 2H), 1.28 (s, 3H), 1.16 (s, 3H), 
1.08 (s, 3H), 0.57 (s, 3H) 
 
13C-NMR (100 MHz, CDCl3): δ 187.25, 178.97, 170.83, 155.63, 154.01, 145.93, 133.69, 
126.29, 123.29, 105.41, 60.33, 55.61, 51.55, 44.68, 44.28, 40.49, 40.43, 38.94, 37.61, 
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36.68, 34.84, 34.23, 32.85, 31.60, 30.93, 30.53, 29.88, 29.76, 29.69, 28.53, 20.87, 18.35, 
13.98 
 
IR (neat film, cm-1): 2924, 1734, 1653, 1457, 1294, 1093 
 
HRMS (EC-CI): calc’d. for C32H45O5 [M+H]+, 509.3267 found. 510.3252 
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3. Preparation of the Benzyl Stannane 152 
 
 
 
 
 To a solution of vanillyl alcohol (56.0 g, 363 mmol, 1.00 eq.) in methanol (560 
mL) at 23 °C was added p-toluenesulfonic acid monohydrate (3.5 g, 18.2 mmol, 0.05 
eq.).  After 6 hours the golden-yellow solution was diluted with an aqueous phosphate 
buffer (200 mL, pH = 4, 0.2 M) and brine (200 mL).  Excess methanol was removed by 
rotary evaporation and the mixture was further diluted with EtOAc (400 mL).  The 
biphasic mixture was poured into a separatory funnel, partitioned, and the organic layer 
was washed with water (1 x 100 mL).  Residual organics were extracted from the 
aqueous layer using EtOAc (3 x 150 mL), combined, washed with brine (1 x 100 mL), 
dried over solid Na2SO4, filtered, and concentrated.  The resulting golden-brown oil was 
dissolved in EtOAc (100 mL) and purified by elution through a short plug of silica gel 
using ethyl acetate (1.5 L) to afford the dimethyl ether 147 as a light yellow oil (59.3 g, 
352 mmol, 97%).  The spectral data matches that of the reported compound (Cook, S.P. 
and Danishefsky, S.J. Organic Letters 2006, 8, 5693).   
 
1H-NMR (400 MHz, CDCl3): δ 6.86 (m, 3H), 5.76 (s, 1H), 4.38 (s, 2H), 3.88 (s, 3H), 
3.37 (s, 3H)  
 
13C-NMR (100 MHz, CDCl3) : δ 146.2, 144.8, 129.6, 120.3, 113.6, 110.0, 74.3, 57.3, 
55.4;  
 
IR (film, cm-1): 3390, 2935, 1606, 1515, 1464, 1431, 1368, 1276, 1241, 1188, 1154, 
1089.  
 
HRMS (FAB): calcd. for C9H12O3 [M]+ 168.0786, found 168.0789 
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 The phenol 147 (62.3 g, 0.37 mol, 1.00 eq.) was azeotroped with toluene (3 x 50 
mL) and dissolved in THF (570 mL).  The clear solution was placed in a bath cooled to 
−20 °C.  After 30 minutes n-butyllithium (529 mL, 2.17 M in hexanes, 1.15 mol, 3.10 
eq.) was added dropwise over 2.5 hours.  The dark golden-yellow solution was placed in 
an ice bath cooled to 0 °C for 2.5 hours.  The dark red-orange mixture was placed in a 
bath cooled to −20 °C for 30 minutes upon which iodomethane (92.0 mL, 1.48 mol, 4.00 
eq.) was added dropwise over 30 minutes while stirring vigorously (800 rpm).  The pale 
yellow solution was placed in a bath cooled to 0 °C for 30 minutes and then acidified to a 
pH = 7 with 1 N HCl (500 mL).  The biphasic mixture was diluted with EtOAc (200 mL), 
poured into a separatory funnel and partitioned.  Residual organics were extracted from 
the aqueous layer using ethyl acetate (4 x 200 mL).  The combined organics were washed 
with brine (1 x 200 mL), dried over solid Na2SO4, decanted, and concentrated to afford 
the product as a crude brown oil (67.4 g) which was used directly in the next reaction 
without purification.  The spectral data matches that of the reported compound (Cook, 
S.P. and Danishefsky, S.J. Organic Letters 2006, 8, 5693). 
 
1H-NMR (400 MHz, CDCl3): δ 6.96 (d, 1H, J = 8.2 Hz), 6.77 (d, 1H, J = 8.2 Hz), 5.72 
(bs, 1H), 4.36  (s, 2H), 3.77  (s, 3H), 3.37  (s, 3H), 2.29  (s, 3H)  
 
13C-NMR (100 MHz, CDCl3) : δ 148.2, 145.2, 130.0, 128.5, 125.6, 111.8, 72.8, 60.4, 
57.5, 11.2  
 
IR (film, cm-1): 3367, 2928, 1603, 1491, 1460, 1290, 1177, 1070.  
 
HRMS (FAB): calcd. For C10H14O3 [M] 182.0943, found 182.0947. 
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 To a solution of the crude brown oil (67.4 g, 370 mmol, 1.00 eq) in acetone (1.2 
L) was added potassium carbonate (102 g, 740 mmol, 2.00 eq.) and dimethyl sulfate 
(56.0 mL, 444 mmol, 1.49 eq) sequentially.  The mixture was placed in an oil bath heated 
to 56 °C and stirred vigorously (800 rpm) for 48 hours.  The heterogeneous mixture was 
removed from the oil bath, filtered over a pad of celite using acetone, and concentrated.  
The resulting brown oil was purified by silica gel chromatography; toluene → 4% EtOAc 
in toluene to afford the trimethyl ether 148 as a clear pale yellow oil (64.0 g, 294 mmol, 
84% two steps).   
 
Rf =  0.43 (30% EtOAc in hexane)  
 
1H-NMR (400 MHz, CDCl3): δ 7.00 (d, 1H, J = 8.2 Hz), 6.72 (d, 1H, J = 8.2 Hz), 4.37 
(s, 2H), 3.84 (s, 3H), 3.78 (s, 3H), 3.37 (s, 3H), 2.27 (s, 3H)  
 
13C-NMR (100MHz, CDCl3): δ 152.7, 147.6, 131.5, 129.6, 125.1, 109.1, 73.4, 60.4, 58.2, 
55.9, 11.5  
 
IR (neat film, cm-1): 2932, 2821, 1604, 1492, 1456, 1380, 1271, 1223, 1083, 1007, 805  
 
HRMS (EC-CI): calcd. for C11H16O3 [M] 196.1099, found 196.1097. 
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 A solution of the trimethyl ether 148 (9.8 g, 50.0 mmol, 1.00 eq.) in toluene (125 
mL) was placed in an ice water bath cooled to 0 °C, stirred vigorously (1000 rpm) for 20 
minutes, and then concentrated HBr (48% w/v, 29.4 mL, 260 mmol, 5.20 eq.) was added.  
The brown biphasic mixture was stirred for 2 hours upon which the excess acid was 
slowly quenched with a saturated aqueous mixture of NaHCO3 (100 mL).  The biphasic 
mixture was poured into a separatory funnel, partitioned, and residual organics were 
extracted from the aqueous layer using toluene (3 x 50 mL).  The combined organics 
were washed with brine (1 x 50 mL), dried over solid Na2SO4, decanted, and 
concentrated.  Recrystallization of the brown solid from hexane (30 mL) provided the 
bromide 134 as white needles (9.8 g, 40.0 mmol, 80%).   
 
1H-NMR (400 MHz, CDCl3): δ 7.06 (d, 1H, J = 8.2 Hz), 6.72 (d, 1H, J = 8.2 Hz), 4.52 
(s, 2H), 3.85 (s, 3H), 3.79 (s, 3H), 2.33 (s, 3H)  
 
13C-NMR (100 MHz, CDCl3): δ 153.49, 147.82, 132.00, 129.12, 126.07, 109.67, 60.54, 
55.89, 33.66, 11.67  
 
IR (neat film, cm-1): 1602, 1456, 1441, 1313, 1276, 1083, 1000, 807, 684, 661  
 
HRMS (EC-CI): calcd. for C10H14O2Br(79) [M+H]+ 245.0177, found 245.0179  
 
HRMS (EC-CI): calcd. for C10H14O2Br(81) [M+H]+ 247.0157, found 245.0154   
 
M.P.: 66 – 68 °C. 
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 A solution of diisoproplyamine (10.4 mL, 74.1 mmol, 1.10 eq.) in THF (340 mL) 
was placed in a bath cooled to −78 °C for 30 minutes.  n-Butyllitium (37.8 mL, 74.1 
mmol, 1.10 eq., 1.96 M in hexane) was added dropwise over 15 minutes.  The clear 
colorless solution was stirred for 5 minutes, placed in an ice water cooling bath, and 
stirred for 30 minutes.  Tri-n-butyltin hydride (19.9 mL, 74.1 mmol, 1.10 eq.) was added 
dropwise over 10 minutes to the clear pale yellow solution of LDA and stirred for 20 
minutes.  The olive green solution was placed in a bath cooled to −78 °C for 30 minutes 
upon which a solution of the bromide 134 (16.5 g, 67.4 mmol, 1.00 eq.) in THF (310 mL) 
was added under nitrogen via cannula to the olive green solution over 3 hrs.  Residual 
bromide 152 in the vessel was dissolved in THF (10 mL) and transferred via cannula to 
the now pale yellow colored reaction solution.  This process was repeated twice more.  
After 1 hr. the pale yellow solution was placed in an ice bath cooled to 0 °C, stirred for 
10 minutes, and excess tri-n-butylstannyl lithium was quenched with an aqueous 
phosphate buffer (100 mL, pH = 7, 0.2 M).  The biphasic mixture was poured into a 
separatory funnel, partitioned, and residual organics were extracted from the aqueous 
layer with ethyl ether (3 x 50 mL).  The combined organics were washed with brine (1 x 
100 mL), dried over solid Na2SO4, decanted, and concentrated.  The crude pale yellow oil 
was purified using silica gel chromatography; hexane (1.5 L) and then toluene to provide 
the stannane 152 as a clear colorless oil (25.4 g, 55.9 mmol, 83%).   
 
Rf = 0.69 (30% EtOAc in hexane)  
 
1H-NMR (400 MHz, CDCl3): δ 6.68 (d, 1H, J = 8.2 Hz), 6.63 (d, 1H, J = 8.2 Hz), 3.81 
(s, 3H), 3.75 (s, 3H), 2.22 (s, 2H), 2.12 (s, 3H), 1.43 – 1.35 (m, 6H), 1.27 – 1.21 (q, 6H, J 
= 7.3 Hz), 0.85 (t, 9H, J = 7.3 Hz), 0.77 (dd, 6H, J = 8.2, 6.5 Hz)  
 
13C-NMR (100 MHz, CDCl3): δ 149.11, 147.66, 135.57, 127.93, 122.57, 110.15, 60.40, 
56.11, 29.25, 27.60, 15.80, 13.91, 12.75, 9.90  
 
IR (neat film, cm-1): 2955, 2925, 1486, 1465, 1456, 1272, 1086, 1223, 1083, 1007, 805  
 
HRMS (EC-CI): calcd. for C22H40O2Sn [M] 456.2050, found 456.2057. 
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4. Crystollagraphic Information for Pentacyclic Ketone 175  
 
Crystal Structure of ketone 175.  View of 175 showing the atom labeling scheme.  
Displacement ellipsoids are scaled to the 50% probability level.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 The crystals grew as large colorless prisms by slow evaporation from methanol.  
The data crystal was cut from a larger crystal and had approximate dimensions; 0.25 x 
0.16 x 0.12 mm.  The data were collected on a Rigaku AFC12 diffractometer with a 
Saturn 724+ CCD using a graphite monochromator with MoK radiation ( = 
0.71073Å).  A total of 1832 frames of data were collected using -scans with a scan 
range of 0.5 and a counting time of 36 seconds per frame.  The data were collected at 
100 K using a Rigaku XStream low temperature device.  Details of crystal data, data 
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collection and structure refinement are listed in Table 1.  Data reduction were performed 
using the Rigaku Americas Corporation’s Crystal Clear version 1.40.1  The structure was 
solved by direct methods using SIR972 and refined by full-matrix least-squares on F2 
with anisotropic displacement parameters for the non-H atoms using SHELXL-97.3  
Structure analysis was aided by use of the programs PLATON984 and WinGX.5  The 
hydrogen atoms on carbon were calculated in ideal positions with isotropic displacement 
parameters set to 1.2xUeq of the attached atom (1.5xUeq for methyl hydrogen atoms).    
The function, w(|Fo|2 - |Fc|2)2, was minimized, where w = 1/[((Fo))2 + 
(0.0503*P)2 + (0.8402*P)] and P = (|Fo|2 + 2|Fc|2)/3.  Rw(F2) refined to 0.107, with 
R(F) equal to 0.0409 and a goodness of fit, S, = 1.04.  Definitions used for calculating 
R(F), Rw(F2) and the goodness of fit, S, are given below.6  The data were checked for 
secondary extinction effects but no correction was necessary.  Neutral atom scattering 
factors and values used to calculate the linear absorption coefficient are from the 
International Tables for X-ray Crystallography (1992).7  All figures were generated using 
SHELXTL/PC.8  Tables of positional and thermal parameters, bond lengths and angles, 
torsion angles and figures are found elsewhere.   
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Table 2.10.  Crystal data and structure refinement for 175. 
 
Empirical formula  C29 H42 O3 
Formula weight  438.62 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  monoclinic 
Space group  P 21/n 
  Unit cell dimensions a = 15.2493(6) Å = 90°. 
 b = 7.6076(3) Å = 98.2440(10)°. 
 c = 20.7445(8) Å  = 90°. 
Volume 2381.71(16) Å3 
Z 4 
Density (calculated) 1.223 Mg/m3 
Absorption coefficient 0.077 mm-1 
F(000) 960 
Crystal size 0.250 x 0.160 x 0.120 mm3 
Theta range for data collection 2.999 to 27.485°. 
Index ranges -19<=h<=19, -9<=k<=9, -26<=l<=26 
Reflections collected 41833 
Independent reflections 5445 [R(int) = 0.0534] 
Completeness to theta = 25.242° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00 and 0.810 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5445 / 0 / 296 
Goodness-of-fit on F2 1.040 
Final R indices [I>2sigma(I)] R1 = 0.0409, wR2 = 0.1029 
R indices (all data) R1 = 0.0482, wR2 = 0.1070 
Extinction coefficient n/a 
Largest diff. peak and hole 0.298 and -0.172 e.Å-3 
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Table 2.11.  Atomic coordinates  (x 104) and equivalent  isotropic displacement  
parameters (Å2x 103) for 1.  U(eq) is defined as one third of  the trace of the 
orthogonalized Uij tensor. 
________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________   
C1 2648(1) 5262(2) 3690(1) 17(1) 
C2 3181(1) 6309(2) 3364(1) 17(1) 
C3 4104(1) 6050(2) 3467(1) 18(1) 
C4 4477(1) 4749(2) 3890(1) 18(1) 
C5 3924(1) 3632(1) 4199(1) 16(1) 
C6 4350(1) 2158(2) 4623(1) 19(1) 
C7 3696(1) 831(2) 4832(1) 20(1) 
C8 2878(1) 1785(1) 5009(1) 15(1) 
C9 2368(1) 2642(2) 4380(1) 16(1) 
C10 3007(1) 3902(1) 4103(1) 16(1) 
C11 1547(1) 3625(2) 4552(1) 20(1) 
C12 996(1) 2535(2) 4968(1) 21(1) 
C13 1530(1) 1885(1) 5612(1) 16(1) 
C14 2312(1) 707(1) 5438(1) 16(1) 
C15 2871(1) 180(2) 6088(1) 21(1) 
C16 2342(1) -936(2) 6514(1) 24(1) 
C17 1415(1) -246(2) 6615(1) 20(1) 
C18 935(1) 743(2) 6000(1) 17(1) 
C19 110(1) 1726(2) 6173(1) 20(1) 
C20 243(1) 2810(2) 6785(1) 20(1) 
C21 705(1) 1873(2) 7374(1) 24(1) 
C22 1539(1) 902(2) 7236(1) 23(1) 
C23 1855(1) 3546(2) 6007(1) 19(1) 
C24 2051(1) 1364(2) 3811(1) 24(1) 
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Table 2.11, continued. 
C25 1990(1) -1021(2) 5086(1) 24(1) 
C26 1933(1) 7580(2) 2713(1) 24(1) 
C27 4740(1) 8805(2) 3293(1) 26(1) 
C28 5472(1) 4503(2) 4004(1) 22(1) 
C29 853(1) -1860(2) 6745(1) 27(1) 
O1 4633(1) 7001(1) 3105(1) 23(1) 
O2 2868(1) 7565(1) 2916(1) 21(1) 
O3 -50(1) 4295(1) 6806(1) 29(1) 
________________________________________________________________________
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Table 2.12.   Bond lengths [Å] and angles [°] for 175. 
_____________________________________________________  
C1-C2  1.3824(15) 
C1-C10  1.4037(15) 
C1-H1  0.95 
C2-O2  1.3704(13) 
C2-C3  1.4061(15) 
C3-O1  1.3828(13) 
C3-C4  1.3896(16) 
C4-C5  1.4142(15) 
C4-C28  1.5134(15) 
C5-C10  1.3985(15) 
C5-C6  1.5138(15) 
C6-C7  1.5249(16) 
C6-H6A  0.99 
C6-H6B  0.99 
C7-C8  1.5326(15) 
C7-H7A  0.99 
C7-H7B  0.99 
C8-C14  1.5595(15) 
C8-C9  1.5632(15) 
C8-H8  1.00 
C9-C10  1.5362(15) 
C9-C11  1.5436(15) 
C9-C24  1.5507(15) 
C11-C12  1.5319(15) 
C11-H11A  0.99 
C11-H11B  0.99 
C12-C13  1.5430(15) 
C12-H12A  0.99 
C12-H12B  0.99 
C13-C23  1.5485(15) 
C13-C18  1.5604(15) 
C13-C14  1.5745(15) 
C14-C15  1.5407(15) 
C14-C25  1.5497(15) 
C15-C16  1.5338(16) 
C15-H15A  0.99 
C15-H15B  0.99 
C16-C17  1.5509(16) 
C16-H16A  0.99 
C16-H16B  0.99 
C17-C29  1.5434(16) 
C17-C22  1.5452(16) 
C17-C18  1.5681(15) 
C18-C19  1.5491(16) 
C18-H18  1.00 
C19-C20  1.5038(16) 
C19-H19A  0.99 
C19-H19B  0.99 
C20-O3  1.2179(15) 
C20-C21  1.5001(17) 
C21-C22  1.5340(17) 
C21-H21A  0.99 
C21-H21B  0.99 
C22-H22A  0.99 
C22-H22B  0.99 
C23-H23A  0.98 
C23-H23B  0.98 
C23-H23C  0.98 
C24-H24A  0.98 
C24-H24B  0.98 
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Table 2.12, continued. 
 
C24-H24C  0.98 
C25-H25A  0.98 
C25-H25B  0.98 
C25-H25C  0.98 
C26-O2  1.4277(14) 
C26-H26A  0.98 
C26-H26B  0.98 
C26-H26C  0.98 
C27-O1  1.4301(15) 
 
 
C27-H27A  0.98 
C27-H27B  0.98 
C27-H27C  0.98 
C28-H28A  0.98 
C28-H28B  0.98 
C28-H28C  0.98 
C29-H29A  0.98 
C29-H29B  0.98 
C29-H29C  0.98 
C2-C1-C10 121.18(10) 
C2-C1-H1 119.4 
C10-C1-H1 119.4 
O2-C2-C1 124.15(10) 
O2-C2-C3 116.37(10) 
C1-C2-C3 119.42(10) 
O1-C3-C4 119.83(10) 
O1-C3-C2 119.54(10) 
C4-C3-C2 120.42(10) 
C3-C4-C5 119.77(10) 
C3-C4-C28 119.87(10) 
C5-C4-C28 120.34(10) 
C10-C5-C4 119.82(10) 
C10-C5-C6 121.91(10) 
C4-C5-C6 118.27(10) 
C5-C6-C7 114.32(9) 
C5-C6-H6A 108.7 
C7-C6-H6A 108.7 
C5-C6-H6B 108.7 
C7-C6-H6B 108.7 
H6A-C6-H6B 107.6 
C6-C7-C8 110.05(9) 
C6-C7-H7A 109.6 
C8-C7-H7A 109.6 
C6-C7-H7B 109.6 
C8-C7-H7B 109.6 
H7A-C7-H7B 108.2 
C7-C8-C14 115.08(9) 
C7-C8-C9 108.81(9) 
C14-C8-C9 116.49(9) 
C7-C8-H8 105.1 
C14-C8-H8 105.1 
C9-C8-H8 105.1 
C10-C9-C11 111.29(9) 
C10-C9-C24 104.63(9) 
C11-C9-C24 107.79(9) 
C10-C9-C8 107.77(8) 
C11-C9-C8 109.38(9) 
C24-C9-C8 115.94(9) 
C5-C10-C1 119.29(10) 
C5-C10-C9 122.04(10) 
C1-C10-C9 118.37(9) 
C12-C11-C9 113.38(9) 
C12-C11-H11A 108.9 
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Table 2.12, continued 
 
C9-C11-H11A 108.9 
C12-C11-H11B 108.9 
C9-C11-H11B 108.9 
H11A-C11-H11B 107.7 
C11-C12-C13 113.38(9) 
C11-C12-H12A 108.9 
C13-C12-H12A 108.9 
C11-C12-H12B 108.9 
C13-C12-H12B 108.9 
H12A-C12-H12B 107.7 
C12-C13-C23 106.62(9) 
C12-C13-C18 110.58(9) 
C23-C13-C18 110.29(9) 
C12-C13-C14 107.92(9) 
C23-C13-C14 112.96(9) 
C18-C13-C14 108.45(9) 
C15-C14-C25 106.88(9) 
C15-C14-C8 110.77(9) 
C25-C14-C8 109.90(9) 
C15-C14-C13 106.85(9) 
C25-C14-C13 113.09(9) 
C8-C14-C13 109.30(9) 
C16-C15-C14 112.17(10) 
C16-C15-H15A 109.2 
C14-C15-H15A 109.2 
C16-C15-H15B 109.2 
C14-C15-H15B 109.2 
H15A-C15-H15B 107.9 
C15-C16-C17 117.05(9) 
C15-C16-H16A 108.0 
C17-C16-H16A 108.0 
C15-C16-H16B 108.0 
 
 
C17-C16-H16B 108.0 
H16A-C16-H16B 107.3 
C29-C17-C22 107.94(9) 
C29-C17-C16 107.16(10) 
C22-C17-C16 107.39(10) 
C29-C17-C18 108.56(9) 
C22-C17-C18 113.18(9) 
C16-C17-C18 112.36(9) 
C19-C18-C13 113.68(9) 
C19-C18-C17 110.10(9) 
C13-C18-C17 116.69(9) 
C19-C18-H18 105.1 
C13-C18-H18 105.1 
C17-C18-H18 105.1 
C20-C19-C18 116.40(9) 
C20-C19-H19A 108.2 
C18-C19-H19A 108.2 
C20-C19-H19B 108.2 
C18-C19-H19B 108.2 
H19A-C19-H19B 107.3 
O3-C20-C21 122.92(11) 
O3-C20-C19 122.21(11) 
C21-C20-C19 114.73(10) 
C20-C21-C22 112.44(10) 
C20-C21-H21A 109.1 
C22-C21-H21A 109.1 
C20-C21-H21B 109.1 
C22-C21-H21B 109.1 
H21A-C21-H21B 107.8 
C21-C22-C17 114.98(10) 
C21-C22-H22A 108.5 
C17-C22-H22A 108.5 
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Table 2.12, continued. 
 
C21-C22-H22B 108.5 
C17-C22-H22B 108.5 
H22A-C22-H22B 107.5 
C13-C23-H23A 109.5 
C13-C23-H23B 109.5 
H23A-C23-H23B 109.5 
C13-C23-H23C 109.5 
H23A-C23-H23C 109.5 
H23B-C23-H23C 109.5 
C9-C24-H24A 109.5 
C9-C24-H24B 109.5 
H24A-C24-H24B 109.5 
C9-C24-H24C 109.5 
H24A-C24-H24C 109.5 
H24B-C24-H24C 109.5 
C14-C25-H25A 109.5 
C14-C25-H25B 109.5 
H25A-C25-H25B 109.5 
C14-C25-H25C 109.5 
H25A-C25-H25C 109.5 
H25B-C25-H25C 109.5 
O2-C26-H26A 109.5 
O2-C26-H26B 109.5 
 
 
 
H26A-C26-H26B 109.5 
O2-C26-H26C 109.5 
H26A-C26-H26C 109.5 
H26B-C26-H26C 109.5 
O1-C27-H27A 109.5 
O1-C27-H27B 109.5 
H27A-C27-H27B 109.5 
O1-C27-H27C 109.5 
H27A-C27-H27C 109.5 
H27B-C27-H27C 109.5 
C4-C28-H28A 109.5 
C4-C28-H28B 109.5 
H28A-C28-H28B 109.5 
C4-C28-H28C 109.5 
H28A-C28-H28C 109.5 
H28B-C28-H28C 109.5 
C17-C29-H29A 109.5 
C17-C29-H29B 109.5 
H29A-C29-H29B 109.5 
C17-C29-H29C 109.5 
H29A-C29-H29C 109.5 
H29B-C29-H29C 109.5 
C3-O1-C27 113.96(9) 
C2-O2-C26 116.20(9) 
_____________________________________________________________  
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Table 2.13.  Anisotropic displacement parameters  (Å2x 103) for 1.  The anisotropic 
displacement factor exponent takes the form:  -22[ h2 a*2U11 + ...  + 2 h k 
a* b* U12 ] 
________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
________________________________________________________________________ 
C1 14(1)  20(1) 17(1)  0(1) 4(1)  0(1) 
C2 20(1)  17(1) 15(1)  -1(1) 4(1)  0(1) 
C3 18(1)  20(1) 18(1)  -4(1) 8(1)  -4(1) 
C4 15(1)  22(1) 17(1)  -6(1) 4(1)  -2(1) 
C5 16(1)  18(1) 16(1)  -4(1) 3(1)  0(1) 
C6 15(1)  22(1) 21(1)  -1(1) 3(1)  3(1) 
C7 19(1)  19(1) 22(1)  0(1) 4(1)  4(1) 
C8 15(1)  15(1) 16(1)  0(1) 2(1)  1(1) 
C9 14(1)  18(1) 16(1)  1(1) 1(1)  -2(1) 
C10 15(1)  17(1) 15(1)  -3(1) 3(1)  -1(1) 
C11 14(1)  25(1) 20(1)  7(1) 3(1)  2(1) 
C12 14(1)  28(1) 20(1)  7(1) 2(1)  0(1) 
C13 15(1)  16(1) 16(1)  1(1) 2(1)  -1(1) 
C14 17(1)  15(1) 17(1)  0(1) 2(1)  0(1) 
C15 20(1)  22(1) 21(1)  4(1) 2(1)  4(1) 
C16 26(1)  22(1) 24(1)  8(1) 5(1)  5(1) 
C17 22(1)  18(1) 19(1)  3(1) 4(1)  -1(1) 
C18 17(1)  18(1) 17(1)  0(1) 2(1)  -4(1) 
C19 16(1)  25(1) 19(1)  3(1) 3(1)  -4(1) 
C20 16(1)  22(1) 24(1)  1(1) 8(1)  -4(1) 
C21 26(1)  28(1) 17(1)  -1(1) 4(1)  -3(1) 
C22 24(1)  27(1) 16(1)  3(1) 1(1)  -1(1) 
C23 19(1)  17(1) 23(1)  -1(1) 7(1)  -2(1) 
C24 26(1)  28(1) 18(1)  -1(1) 2(1)  -10(1) 
C25 29(1)  18(1) 26(1)  -3(1) 7(1)  -4(1) 
C26 20(1)  27(1) 23(1)  8(1) 1(1)  -1(1) 
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Table 2.13, continued. 
 
C27 26(1)  25(1) 29(1)  2(1) 6(1)  -7(1) 
C28 16(1)  29(1) 23(1)  -4(1) 5(1)  -1(1) 
C29 33(1)  20(1) 29(1)  5(1) 9(1)  -4(1) 
O1 22(1)  26(1) 22(1)  -1(1) 11(1)  -6(1) 
O2 19(1)  24(1) 22(1)  7(1) 4(1)  -2(1) 
O3 31(1)  26(1) 33(1)  1(1) 13(1)  2(1) 
________________________________________________________________________
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Table 2.14.  Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 
10 3) for 175. 
________________________________________________________________________ 
 x  y  z  U(eq) 
________________________________________________________________________ 
  
H1 2027 5467 3634 20 
H6A 4697 2675 5018 23 
H6B 4770 1528 4382 23 
H7A 3984 159 5213 24 
H7B 3515 -8 4473 24 
H8 3118 2796 5288 18 
H11A 1744 4715 4790 24 
H11B 1167 3968 4144 24 
H12A 748 1505 4712 25 
H12B 492 3256 5069 25 
H15A 3395 -493 5997 25 
H15B 3085 1256 6330 25 
H16A 2703 -1067 6947 29 
H16B 2267 -2124 6318 29 
H18 694 -207 5692 20 
H19A -112 2510 5804 24 
H19B -358 848 6212 24 
H21A 291 1018 7527 29 
H21B 871 2738 7727 29 
H22A 1751 143 7614 27 
H22B 2008 1780 7197 27 
H23A 2268 4198 5776 29 
H23B 2156 3197 6437 29 
H23C 1347 4295 6058 29 
H24A 1849 2041 3416 36 
H24B 1562 645 3924 36 
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Table 2.14, continued. 
 
H24C 2543 599 3735 36 
H25A 2497 -1637 4949 36 
H25B 1558 -747 4702 36 
H25C 1713 -1772 5383 36 
H26A 1734 6397 2575 35 
H26B 1791 8399 2349 35 
H26C 1633 7956 3077 35 
H27A 4156 9351 3283 39 
H27B 5071 9421 2990 39 
H27C 5066 8879 3735 39 
H28A 5755 5452 3789 34 
H28B 5623 3369 3825 34 
H28C 5684 4530 4473 34 
H29A 1177 -2568 7096 40 
H29B 732 -2571 6349 40 
H29C 291 -1465 6875 40 
________________________________________________________________________
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Table 2.15.  Torsion angles [°] for 175. 
________________________________________________________________  
C10-C1-C2-O2 174.68(10) 
C10-C1-C2-C3 -2.43(16) 
O2-C2-C3-O1 -2.30(15) 
C1-C2-C3-O1 175.03(10) 
O2-C2-C3-C4 -177.01(10) 
C1-C2-C3-C4 0.31(16) 
O1-C3-C4-C5 -172.15(10) 
C2-C3-C4-C5 2.55(16) 
O1-C3-C4-C28 6.26(16) 
C2-C3-C4-C28 -179.04(10) 
C3-C4-C5-C10 -3.34(16) 
C28-C4-C5-C10 178.26(10) 
C3-C4-C5-C6 176.21(10) 
C28-C4-C5-C6 -2.19(15) 
C10-C5-C6-C7 10.20(15) 
C4-C5-C6-C7 -169.35(10) 
C5-C6-C7-C8 -40.62(13) 
C6-C7-C8-C14 -160.82(9) 
C6-C7-C8-C9 66.37(11) 
C7-C8-C9-C10 -58.27(11) 
C14-C8-C9-C10 169.67(9) 
C7-C8-C9-C11 -179.38(9) 
C14-C8-C9-C11 48.55(12) 
C7-C8-C9-C24 58.53(12) 
C14-C8-C9-C24 -73.53(12) 
C4-C5-C10-C1 1.28(16) 
C6-C5-C10-C1 -178.26(10) 
C4-C5-C10-C9 174.84(10) 
C6-C5-C10-C9 -4.70(16) 
C2-C1-C10-C5 1.62(16) 
C2-C1-C10-C9 -172.18(10) 
C11-C9-C10-C5 148.44(10) 
C24-C9-C10-C5 -95.42(12) 
C8-C9-C10-C5 28.53(14) 
C11-C9-C10-C1 -37.93(13) 
C24-C9-C10-C1 78.21(12) 
C8-C9-C10-C1 -157.85(9) 
C10-C9-C11-C12 -166.91(9) 
C24-C9-C11-C12 78.90(12) 
C8-C9-C11-C12 -47.96(12) 
C9-C11-C12-C13 57.12(13) 
C11-C12-C13-C23 61.70(12) 
C11-C12-C13-C18 -178.39(9) 
C11-C12-C13-C14 -59.93(12) 
C7-C8-C14-C15 59.42(12) 
C9-C8-C14-C15 -171.47(9) 
C7-C8-C14-C25 -58.46(12) 
C9-C8-C14-C25 70.66(12) 
C7-C8-C14-C13 176.88(9) 
C9-C8-C14-C13 -54.00(12) 
C12-C13-C14-C15 176.24(9) 
C23-C13-C14-C15 58.63(11) 
C18-C13-C14-C15 -63.94(11) 
C12-C13-C14-C25 -66.45(11) 
C23-C13-C14-C25 175.94(9) 
C18-C13-C14-C25 53.38(12) 
C12-C13-C14-C8 56.33(11) 
C23-C13-C14-C8 -61.28(11) 
C18-C13-C14-C8 176.15(8) 
C25-C14-C15-C16 -58.41(12) 
C8-C14-C15-C16 -178.11(9) 
C13-C14-C15-C16 62.93(12) 
C14-C15-C16-C17 -48.94(14) 
C15-C16-C17-C29 152.96(11) 
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Table 2.15, continued. 
 
C15-C16-C17-C22 -91.29(12) 
C15-C16-C17-C18 33.80(14) 
C12-C13-C18-C19 -58.99(12) 
C23-C13-C18-C19 58.69(12) 
C14-C13-C18-C19 -177.14(9) 
C12-C13-C18-C17 171.19(9) 
C23-C13-C18-C17 -71.14(12) 
C14-C13-C18-C17 53.04(12) 
C29-C17-C18-C19 73.28(11) 
C22-C17-C18-C19 -46.53(12) 
C16-C17-C18-C19 -168.38(9) 
C29-C17-C18-C13 -155.22(10) 
C22-C17-C18-C13 84.97(12) 
 
 
 
 
C16-C17-C18-C13 -36.88(13) 
C13-C18-C19-C20 -85.46(12) 
C17-C18-C19-C20 47.60(13) 
C18-C19-C20-O3 134.71(11) 
C18-C19-C20-C21 -49.38(13) 
O3-C20-C21-C22 -136.65(12) 
C19-C20-C21-C22 47.47(14) 
C20-C21-C22-C17 -48.16(14) 
C29-C17-C22-C21 -71.28(13) 
C16-C17-C22-C21 173.48(10) 
C18-C17-C22-C21 48.89(13) 
C4-C3-O1-C27 -111.35(12) 
C2-C3-O1-C27 73.90(13) 
C1-C2-O2-C26 -9.63(16) 
C3-C2-O2-C26 167.55(10) 
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5. Experimental Procedures for the Synthesis of the Iodo-enoate 143 
 
 
 
 A solution of geranyl acetate (5.20 g, 5.7 mL, 26.3 mmol, 1.00 eq.) in methylene 
chloride (176 mL) was placed in an ice water bath cooled to 0 °C for 20 minutes.  m-
CPBA (6.49 g, 26.3 mmol, 70% w/w, 1.00 eq.) was added in three separate portions over 
15 minutes.  After 45 minutes a saturated aqueous mixture of NaHCO3 (25 mL) and a 
saturated aqueous mixture of Na2S2O3 (25 mL) were added sequentially to the white 
heterogeneous reaction mixture.  The biphasic mixture was poured into a separatory 
funnel, partitioned, and the organic layer was washed with a saturated aqueous mixture of 
Na2S2O3 (1 x 20 mL) and a saturated aqueous mixture of NaHCO3 (2 x 20 mL).  Residual 
organics were extracted from the aqueous with methylene chloride (3 x 20 mL), dried 
over solid Na2SO4, decanted, and concentrated to afford the crude epoxide as a clear 
colorless oil (5.58 g) which was carried onto the next reaction without further 
purification. 
 
Rf = 0.30 (10% EtOAc in hexane) 
 
1H-NMR (400 MHz, CDCl3): δ 5.40 – 5.36 (m, 1H), 4.59 (d, 2H, J = 7.2 Hz), 2.70 (t, 
1H, J = 6.1 Hz), 2.26 – 2.10 (m, 2H), 2.05 (s, 3H), 1.72 (s, 3H), 1.70 – 1.63 (m, 2H), 1.30 
(s, 3H), 1.29 (s, 3H)  
 
13C-NMR (100 MHz, CDCl3): δ 170.81, 141.04, 118.87, 63.72, 61.06, 58.18, 36.07, 
26.94, 24.70, 20.86, 18.62, 16.32 
 
IR (neat film, cm-1): 1739, 1378, 1233, 1025  
 
HRMS (EC-CI): calc’d. for C10H17O [M-AcOH]−, 153.1279 found. 153.1278 
 
151 
 
 
 
 A biphasic solution of the crude epoxide (5.58 g, 26.3 mmol, 1.00 eq.) in THF-
water (130 mL, 1:1) was placed in an ice water bath cooled to 0 °C for 20 minutes.  
Periodic acid (6.59 g, 28.9 mmol, 1.10 eq.) was added in four separate portions over 20 
minutes.  After 1 hr the excess acid was neutralized with a saturated aqueous mixture of 
NaHCO3 (25 mL).  The colorless biphasic solution was diluted with ethyl ether (50 mL), 
poured into a separatory funnel, and partitioned.  The residual organics were extracted 
from the aqueous layer with ethyl ether (4 x 25 mL), dried over solid Na2SO4, decanted, 
and concentrated.  The crude pale yellow oil was purified by silica gel chromatography; 
15% EtOAc in hexane to afford the aldehyde 138 as a clear colorless oil (3.81 g, 22.4 
mmol, 85%). 
 
Rf = 0.37 (20% EtOAc in hexane) 
 
1H-NMR (400 MHz, CDCl3): δ 9.78 (t, 1H, J = 1.7 Hz), 5.36 (tq, 1H, J = 1.4 Hz), 4.57 
(d, 2H, J = 7.2 Hz), 2.59 – 2.54 (m, 2H), 2.38 (t, 2H, J = 7.5 Hz), 2.05 (s, 3H), 1.72 (s, 
3H) 
 
13C-NMR (100 MHz, CDCl3): δ 201.91, 171.23, 140.20, 119.50, 61.29, 41.91, 31.62, 
21.21, 16.80 
 
IR (neat film, cm-1): 1733, 1384, 1025 
 
HRMS (EC-CI): calc’d. for C7H10O [M-AcOH]−, 110.0732 found. 110.0732 
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 A solution of the aldehyde (76.0 mg, 0.45 mmol, 1.00 eq.) in ethyl ether (4.5 mL) 
was placed in an ice water bath cooled to 0 °C for 30 minutes.  Methyl 
magnesiumbromide (0.21 mL, 0.63 mmol, 1.40 eq., 3 M in ethyl ether) was added via 
syringe.  After 15 minutes an aqueous phosphate buffer (5 mL, pH = 7, 0.2 M) was added 
to the white heterogenous mixture to neutralize the excess Grignard and alkoxide.  The 
biphasic mixture was poured into a separatory funnel, and partitioned.  The residual 
organics were extracted from the aqueous layer with ethyl ether (3 x 10 mL), combined, 
dried over solid Na2SO4, decanted, and concentrated.  The crude pale yellow oil was 
purified by silica gel chromatography; 15% EtOAc in hexane to afford the alcohol (71.4 
mg, 0.38 mmol, 86%) as a clear colorless oil. 
 
 Rf = 0.19 (30% EtOAc in hexane) 
 
1H-NMR (400 MHz, CDCl3): δ 5.37 (dt, 1H, J = 1.0, 7.1 Hz), 4.58 (d, 2H, J = 7.1 Hz), 
3.79 (q, 1H, J = 6.1 Hz), 2.21 – 2.06 (m, 2H), 2.05 (s, 3H), 1.71 (s, 3H), 1.62 – 1.54 (m, 
2H), 1.39 (bs, 1H), 1.20 (d, 3H, J = 6.1 Hz) 
 
13C-NMR (100 MHz, CDCl3): δ 171.07, 142.06, 110.30, 67.60, 61.21, 36.86, 35.66, 
23.41, 20.93, 16.33 
 
IR (neat film, cm-1): 3411, 2966, 2930, 1739, 1235 
 
HRMS (EC-CI): calc’d. for C10H19O3 [M+H]+, 187.1334 found. 187.1331 
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 To a mixture of the alcohol (0.30 g, 1.61 mmol, 1.00 eq.) and solid NaHCO3 (0.54 
g, 6.44 mmol, 4.00 eq.) in methylene chloride (16.0 mL) was added Dess-Martin 
periodinane (0.82 g, 1.93 mmol, 1.20 eq.).  After two hours a saturated aqueous mixture 
of NaHCO3 (20 mL) and a saturated aqueous mixture of Na2S2O3 (20 mL) were added to 
the white heterogeneous reaction mixture to quench the residual acetic acid and Dess-
Martin periodinane.  The biphasic mixture was stirred vigorously (1000 rpm) for 30 
minutes, poured into a separatory funnel, and partitioned.  The organic layer was washed 
with a saturated aqueous mixture of Na2S2O3 (2 x 20 mL) and a saturated aqueous 
mixture of NaHCO3 (1 x 20 mL).  The residual organics were extracted from the aqueous 
layer with methylene chloride (2 x 20 mL), dried over solid Na2SO4, decanted, and 
concentrated.  The crude pale yellow mixture was purified by silica gel chromatography; 
15% EtOAc in hexane to provide the ketone 135 as a clear colorless oil (0.28 g, 1.50 
mmol, 93%). 
 
Rf = 0.51 (30% EtOAc in hexane) 
 
1H-NMR (400 MHz, CDCl3): δ 5.33 (dt, 1H, J = 1.3 Hz), 4.57 (d, 2H, J = 6.8 Hz), 2.57 
(t, 2H, J = 7.2 Hz), 2.31 (t, 2H, J = 7.2 Hz), 2.16 (s, 3H), 2.05 (s, 3H), 1.70 (s, 3H) 
 
13C-NMR (100 MHz, CDCl3): δ 207.95, 170.98, 140.64, 118.73, 61.11, 41.62, 33.00, 
29.91, 20.97, 16.54 
 
IR (neat film, cm-1): 1738, 1718, 1367, 1234, 1024 
 
HRMS (EC-CI): calc’d. for C8H13O [M-AcOH]−, 125.0966 found. 125.0963 
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 A solution of the aldehyde 138 (3.47 g, 20.4 mmol, 1.00 eq.), ethylene glycol 
(12.7 g, 11.4 mL, 204 mmol, 10.0 eq.), and p-toluenesulfonic acid monohydrate (0.09 g, 
0.41 mmol, 0.02 eq.) in benzene (68 mL) was placed in an oil bath heated to 80 °C.  After 
24 hrs the pale yellow solution was removed from oil bath, cooled to 23 °C, and an 
aqueous phosphate buffer (20 mL, pH = 7, 0.2 M) was added.  The biphasic solution was 
poured into a separatory funnel, partitioned, and the organic layer was washed with water 
(2 x 20 mL).  Residual organics were extracted from the aqueous layer with EtOAc (3 x 
25 mL), dried over solid Na2SO4, decanted, and concentrated.  The crude yellow oil was 
purified by silica gel chromatography; 10% EtOAc in hexane to afford the dioxolane 146 
as a clear colorless oil (4.15 g, 19.4 mmol, 95%). 
 
Rf = 0.53 (30% EtOAc in hexane) 
 
1H-NMR (400 MHz, CDCl3): δ 5.37 (tq, 1H, J = 1.4, 6.8 Hz), 4.86 (t, 1H, 4.8 Hz), 4.58 
(d, 2H, J = 6.8 Hz), 3.97 – 3.83 (m, 4H), 2.16 (m, 2H), 2.05 (s, 3H), 1.79 (m, 2H), 1.71 
(s, 3H) 
 
13C-NMR (100 MHz, CDCl3): δ 170.93, 141.31, 118.33, 103.91, 64.77, 61.51, 33.46, 
31.83, 20.91, 16.35 
 
IR (neat film, cm-1): 2955, 2885, 1738, 1234, 1141, 1027 
 
HRMS (EC-CI): calc’d. for C9H15O2 [M-AcOH]−, 155.1072 found. 155.1068 
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 To a solution of the acetate 146 (2.53 g, 11.81 mmol, 1.00 eq.) in methanol (40 
mL) was added solid K2CO3 (3.25 g, 23.62 mmol, 2.00 eq.).  After 15 minutes an 
aqueous phosphate buffer (20 mL, pH = 7, 0.2 M) and EtOAc (50 mL) was added to the 
white heterogenous mixture.  The biphasic solution was poured into a separatory funnel, 
partitioned, and the organic layer was washed with water (2 x 30 mL).  The residual 
organics were extracted from the aqueous layer with EtOAc (3 x 20 mL), combined, 
dried over solid Na2SO4, decanted, and concentrated.  The crude colorless oil was 
purified by silica gel chromatography; 25% EtOAc in hexane to provide the alcohol 
product as a clear colorless oil (1.97 g, 11.44 mmol, 97%). 
 
Rf = 0.42 (60% EtOAc in hexane) 
 
1H-NMR (400 MHz, CDCl3): δ 5.45 (dt, 1H, J = 1.0, 6.8 Hz), 4.86 (t, 1H, J = 4.8 Hz), 
4.15 (d, 2H, J = 6.8 Hz), 3.99 – 3.84 (m, 4H), 2.15 (dd, 2H, J = 7.6, 8.5 Hz), 1.79 (m, 
2H), 1.69 (s, 3H), 1.20 (bs, 1H) 
 
13C-NMR (100 MHz, CDCl3): δ 130.10, 123.72, 104.07, 64.76, 58.92, 33.57, 31.90, 
16.17 
 
IR (neat film, cm-1): 3401, 2955, 2920, 1403, 1140, 1030 
 
HRMS (EC-CI): calc’d. for C9H15O3 [M+H]+, 171.1021 found. 171.1022 
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 A solution of CBr4 (4.17 g, 12.58 mmol, 1.10 eq.) in methylene chloride (10 mL) 
was placed in an ice water bath cooled to 0 °C for 20 minutes and then solid Ph3P (3.30 g, 
12.58 mmol, 1.10 eq.) was added under a positive flow of nitrogen.  After 10 minutes a 
solution of the alcohol (1.97 g, 11.44 mmol, 1.00 eq.) was added via syringe to the golden 
yellow reaction solution.  After 2 hrs the golden yellow solution was removed from the 
cold bath and allowed to stir for 30 minutes at 23 °C upon which pentane (50 mL) was 
added.  The heterogeneous mixture was suction filtered through a pad of celite and 
concentrated to ~10 mL.  Pentane (50 mL) was added and the mixture was placed in an 
ice water bath cooled to 0 °C for 10 minutes, suction filtered cold through a pad of celite, 
and concentrated to ~10 mL.  This process was repeated once more to afford the bromide 
154 as a pale yellow oil (2.58 g, 10.98 mmol, 96%).  The bromide was carried onto the 
next reaction without characterization. 
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 A solution of the benzyl stannane 152 (100.0 mg, 0.22 mmol, 1.00 eq.) in freshly 
deoxygenated THF (1.1 mL) was placed in a bath cooled to −78 °C.  After 30 minutes n-
butyllithium (0.11 mL, 0.24 mmol, 1.10 eq., 2.20 M in hexane) was added dropwise by 
syringe over 1 minute.  After 1 hr the bromide 154 (72.3 mg, 0.31 mmol, 1.40 eq.) was 
added neat to the red-orange solution.  After 1 hr the cold bath was removed and the 
golden yellow solution was warmed gradually to 23 °C.  After 20 minutes the excess 
tolyl anion was neutralized with an aqueous phosphate buffer (10 mL, pH = 7, 0.2 M), the 
biphasic solution was poured into a separatory funnel, and partitioned.  The residual 
organics were extracted from the aqueous layer with ethyl ether (3 x 10 mL), dried over 
solid Na2SO4, decanted, and concentrated.  The crude pale yellow oil was purified by 
silica gel chromatography; hexane → 15% 1,4-dioxane in hexane to afford the arene 151 
as a clear colorless oil (40.0 mg, 0.13 mmol, 57%). 
 
Rf = 0.55 (20% 1,4-dioxane in hexane) 
 
1H-NMR (400 MHz, CDCl3): δ 6.83 (d, 1H, J = 8.2 Hz), 6.69 (d, 1H, J = 8.2 Hz), 5.24 
(m, 1H), 4.84 (t, 1H, J = 4.8 Hz), 3.99 – 3.84 (m, 4H), 3.83 (s, 3H), 3.77 (s, 3H), 2.55 (t, 
2H, J = 8.5 Hz), 2.23 (s, 3H), 2.20 – 2.08 (m, 4H), 1.78 – 1.73 (m, 2H), 1.57 (s, 3H),  
 
13C-NMR (100 MHz, CDCl3): δ 151.01, 147.45, 135.07, 133.97, 130.44, 124.32, 109.51, 
104.56, 65.09, 60.40, 55.89, 34.11, 33.38, 32.63, 29.19, 16.20, 11.95 
 
IR (neat film, cm-1): 2930, 1490, 1453, 1270, 1084 
 
HRMS (EC-CI): calc’d. for C19H28O4 [M], 320.1988 found. 320.1985 
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 A biphasic solution of the dioxolane 151 (1.09 g, 3.39 mmol, 1.00 eq.) in THF (17 
mL) and 1 N HCl (17 mL) was placed in an oil bath heated to 65 °C.  After 12 hrs the 
pale yellow biphasic solution was removed from the oil bath, neutralized to pH = 7 using 
an aqueous phosphate buffer (50 mL, pH = 7, 0.2 M), poured into a separatory funnel 
containing ethyl ether (30 mL), and partitioned.  Residual organics were extracted from 
the aqueous layer with ethyl ether (4 x 10 mL), washed with brine (1 x 20 mL), dried 
over solid Na2SO4, decanted, and concentrated.  The crude pale yellow oil was purified 
by silica gel chromatography; 10% EtOAc in hexane to afford the aldehyde 145 as a clear 
colorless oil (0.92 g, 3.33 mmol, 98%). 
 
Rf = 0.55 (20% 1,4-dioxane in hexane) 
 
1H-NMR (400 MHz, CDCl3): δ 9.75 (t, 1H, J = 1.7 Hz), 6.82 (d, 1H, J = 8.6 Hz), 6.69 (d, 
1H, J = 8.6 Hz), 5.25 – 5.20 (m, 1H), 3.84 (s, 3H), 3.78 (s, 3H), 2.58 – 2.49 (m, 5H), 2.40 
– 2.35 (m, 1H), 2.32 (t, 2H, J = 7.5 Hz), 2.28 (s, 3H), 1.56 (s, 3H) 
 
13C-NMR (100 MHz, CDCl3): δ 202.85, 151.08, 147.50, 133.88, 133.73, 130.42, 124.34, 
109.52, 60.42, 55.92, 42.33, 33.27, 32.03, 29.12, 16.26, 11.96 
 
IR (neat film, cm-1): 2933, 2835, 1723, 1489, 1455, 1418, 1270, 1224, 1083, 1005, 804 
 
HRMS (EC-CI): calc’d. for C17H24O3 [M], 276.1725 found. 276.1725 
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 A mixture of the aldehyde 145 (0.93 g, 3.33 mmol, 1.00 eq.) and K2CO3 (1.62 g, 
11.73 mmol, 3.50 eq.) in methanol (16.8 mL) was placed in an ice water bath cooled to 0 
°C for 20 minutes and then the Bestman-Ohira reagent 156 (1.61 g, 8.38 mmol, 2.50 eq.) 
was added neat.  The yellow heterogeneous mixture was rapidly stirred (800 rpm) for 12 
hrs warming gradually to 23 °C, diluted with an aqueous phosphate buffer (20 mL, pH = 
7, 0.2 M) and EtOAc (20 mL), poured into a separatory funnel, and partitioned.  The 
organic layer was washed with water (1 x 20 mL).  Residual organics were extracted 
from the aqueous layer with EtOAc (3 x 10 mL), washed with brine (1 x 10 mL), dried 
over solid Na2SO4, decanted, and concentrated.  The crude pale yellow oil was purified 
by silica gel chromatography; benzene to afford the enyne 157 as a clear colorless oil 
(0.78 g, 2.88 mmol, 86%). 
 
Rf = 0.43 (benzene) 
 
1H-NMR (400 MHz, CDCl3): δ 6.85 (d, 1H, J = 8.2 Hz), 6.70 (d, 1H, J = 8.2 Hz), 5.26 (t, 
1H, J = 7.2 Hz), 3.84 (s, 3H), 3.77 (s, 3H), 2.60 – 2.54 (m, 2H), 2.30 – 2.23 (m, 2H), 2.23 
(s, 3H), 2.23 – 2.18 (m, 4H), 1.96 (t, 1H, J = 2.8 Hz), 1.57 (s, 3H) 
 
13C-NMR (100 MHz, CDCl3): δ 150.81, 147.24, 133.87, 133.65, 130.21, 125.04, 124.11, 
109.28, 84.38, 68.39, 60.16, 55.68, 38.40, 33.11, 28.92, 17.55, 15.73, 11.73 
 
IR (neat film, cm-1): 2929, 1492, 1270, 1085 
 
HRMS (EC-CI): calc’d. for C18H24O2 [M], 272.1776 found. 272.1777 
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 A clear colorless solution of the enyne 157 (0.44 g, 1.62 mmol, 1.00 eq.) in THF 
(16.2 mL) was placed in a bath cooled to −78 °C for 30 minutes.  n-Butyllithium (1.00 
mL, 2.26 mmol, 1.40 eq., 2.2 M in hexane) was added via syringe.  After 1 hr ethyl 
chloroformate (0.35 g, 0.31 mL, 3.23 mmol, 2.00 eq.) was added neat to the clear 
colorless solution.  After 30 minutes the solution was diluted with an aqueous phosphate 
buffer (10 mL, pH = 7, 0.2 M) and the mixture was removed from the cold bath, diluted 
with ethyl ether (20 mL), poured into a separatory funnel, and partitioned.  Residual 
organics were extracted from the aqueous layer with ethyl ether (3 x 10 mL), dried over 
solid Na2SO4, decanted, and concentrated.  The crude clear colorless oil was purified by 
silica gel chromatography; benzene to afford the ynoate product as a clear colorless oil 
(0.46 g, 1.34 mmol, 83%). 
 
Rf = 0.33 (benzene) 
 
1H-NMR (400 MHz, CDCl3): δ 6.84 (d, 1H, J = 8.6 Hz), 6.70 (d, 1H, J = 8.6 Hz), 5.27 (t, 
1H, J = 6.8 Hz), 4.21 (q, 2H, J = 7.2 Hz), 3.84 (s, 3H), 3.77 (s, 3H), 2.57 (t, 2H, J = 8.2 
Hz), 2.41 (t, 7.9 Hz), 2.29 – 2.19 (m, 4H), 2.23 (s, 3H), 1.56 (s, 3H), 1.30 (t, 3H, J = 7.1 
Hz) 
 
13C-NMR (100 MHz, CDCl3): δ 153.82, 150.83, 147.24, 133.52, 133.11, 130.15, 125.68, 
124.13, 109.29, 88.99, 73.47, 61.75, 60.15, 55.66, 37.30, 33.03, 28.91, 17.82, 15.67, 
14.04, 11.70 
 
IR (neat film, cm-1): 2933, 2234, 1711, 1492, 1250, 1082 
 
HRMS (EC-CI): calc’d. for C21H28O4 [M], 344.1988 found. 344.1985 
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 A suspension of CuI (34.0 mg, 0.18 mmol, 2.05 eq.) in THF (0.46 mL) under 
nitrogen was placed in an ice water bath cooled to 0 °C.  After 20 minutes methyl lithium 
(0.32 mL, 0.35 mmol, 4.00 eq., 1.10 M in Et2O) was added.  After 10 minutes the clear 
colorless solution was placed in a bath cooled to −78 °C.  After 10 minutes a solution of 
the ynoate (30.0 mg, 0.09 mmol, 1.00 eq.) in THF (0.15 mL) was added by syringe in a 
dropwise fashion.  After 1 hr a solution of iodine (66.3 mg, 0.26 mmol, 3.00 eq.) in THF 
(0.15 mL) was added under nitrogen via cannula in a dropwise fashion to the clear golden 
yellow solution.  The purple solution was warmed to −45 °C and after 1 hr a saturated 
aqueous mixture of NH4Cl (5 mL) was added.  The blue mixture was removed from the 
cooling bath, diluted with Et2O (5 mL), poured into a separatory funnel, partitioned, and 
the organic layer was washed with a saturated aqueous mixture of NH4Cl (2 x 10 mL).  
Residual organics were extracted with Et2O (2 x 10 mL), dried over solid Na2SO4, 
decanted, and concentrated.  The crude brown amorphous oil was purified by silica gel 
chromatography; 2% benzene in toluene to afford the iodo-enoate 143 as a clear colorless 
oil (25.9 mg, 0.05 mmol, 61%). 
 
Rf = 0.72 (10% Et2O in benzene) 
 
1H-NMR (400 MHz, CDCl3): δ 6.84 (d, 1H, J = 8.6 Hz), 6.70 (d, 1H, J = 8.6 Hz), 5.21 (t, 
1H, J = 6.5 Hz), 4.24 (q, 2H, J = 7.2 Hz), 3.83 (s, 3H), 3.77 (s, 3H), 2.57 – 2.53 (m, 3H), 
2.23 (s, 3H), 2.23 – 2.12 (m, 5H), 2.06 (s, 3H), 1.56 (s, 3H), 1.31 (t, 3H, J = 7.2 Hz) 
 
13C-NMR (100 MHz, CDCl3): δ 165.89, 154.30, 151.05, 147.50, 134.71, 134.63, 130.45, 
124.61, 109.54, 85.68, 62.11, 60.39, 55.90, 38.33, 35.80, 33.43, 29.93, 29.68, 29.19, 
16.07, 14.30, 11.96 
 
IR (neat film, cm-1): 2919, 1706, 1489, 1270, 1237, 1085 
 
HRMS (EC-CI): calc’d. for C22H31O4I [M], 486.1267 found. 486.1263 
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6. Experimental Procedures for Synthesis of Triene 165    
 
 
 
 A solution of benzoic acid (5.23 g, 42.8 mmol, 1.00 eq.) in THF (210 mL) was 
placed in a bath cooled to −78 °C and liquid ammonia (500 mL) was condensed.  Lithium 
wire (0.95 g, 137 mmol, 3.20 eq.) was added as small chunks over 1 minute.  After two 
hours iodomethane (30.4 g, 13.3 mL, 214 mmol, 5.00 eq.) was added to the blue mixture.  
The resultant white heterogeneous mixture was removed from the cold bath and the 
ammonia was evaporated using a positive flow of nitrogen.  The mixture was placed in an 
ice water bath cooled to 0 °C and water (150 mL) was added.  The white mixture was 
acidified to pH = 3 using 1 N HCl, diluted with ethyl ether (100 mL), poured into a 
separatory funnel, and partitioned.  Residual organics were extracted from the aqueous 
layer with ethyl ether (3 x 50 mL), washed with brine (1 x 50 mL), dried over solid 
Na2SO4, decanted, and concentrated.  The pale yellow oil was then purified by distillation 
under vacuum to afford the acid 160 as a clear pale amber oil (5.74 g, 41.5 mmol, 97%, 
b.p. = 85 – 92 °C at 0.1 mmHg). 
 
Rf = 0.46 (5% MeOH in CH2Cl2) 
 
1H-NMR (400 MHz, CDCl3): δ 10.75 (bs, 1H), 5.85 (dt, 2H, J = 3.1, 10.2 Hz), 5.77 (dt, 
2H, J = 1.7, 10.2 Hz), 2.66 (m, 2H), 1.36 (s, 3H) 
 
13C-NMR (100 MHz, CDCl3): δ 181.67, 128.08, 124.90, 43.65, 27.22, 25.85 
 
IR (neat film, cm-1): 3035 - 2817, 1699, 1415, 1294, 1260, 1126, 942, 702 
 
HRMS (EC-CI): calc’d. for C8H11O2 [M+H]+, 139.0759 found. 139.0759 
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 A solution of the acid 160 (5.92 g, 42.8 mmol, 1.00 eq.) in ethyl ether (214 mL) 
was placed in a bath cooled to −78 °C for 30 minutes.  Lithium aluminum hydride (24.0 
mL, 96.0 mmol, 2.24 eq., 4.0 M in ethyl ether) was added dropwise by syringe over 5 
minutes.  After 10 minutes the colorless solution was diluted with ethyl ether (200 mL), 
placed in an ice water bath cooled to 0 °C, and residual LiAlH4 was quenched by the 
cautious, slow sequential addition of water (5 mL), NaOH (5 mL, 15% in water), and 
water (15 mL).  After 5 minutes an aqueous phosphate buffer (10 mL, pH = 7, 0.2 M) 
was added.  After 2 minutes solid Na2SO4 was added and the solid mixture was stirred 
vigorously (1000 rpm).  After 20 minutes the white mixture was suction filtered through 
a pad of solid Na2SO4 and concentrated to afford the pure alcohol as a clear colorless oil 
(4.84 g, 38.95 mmol, 91%).  NOTE: The product is slightly volatile under reduced 
pressure. 
 
Rf = 0.36 (50% Et2O in hexane) 
 
1H-NMR (400 MHz, CDCl3): δ 5.87 (dt, 2H, J = 3.4, 10.6 Hz), 5.43 (dt, 2H, J = 2.1, 10.6 
Hz), 3.29 (d, 2H, J = 5.4 Hz), 2.63 (m, 2H), 1.60 (t, 1H, J = 5.4 Hz), 0.98 (s, 3H) 
 
13C-NMR (100 MHz, CDCl3): δ 131.34, 126.24, 71.08, 39.25, 26.65, 25.01 
 
IR (neat film, cm-1): 3363, 3015, 2958, 2924, 2865, 2818, 1421, 1376, 1040, 711 
 
HRMS (EC-CI): calc’d. for C8H13O [M+H]+, 125.0966 found. 125.0967 
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 A solution of the alcohol (4.84 g, 39.0 mmol, 1.00 eq.) and N,N-dimethylamino 
pyridine (10.47 g, 86.0 mmol, 2.21 eq.) in ethyl ether (430 mL) was placed in an ice 
water bath cooled to 0 °C for 30 minutes upon which acetic anhydride (12.0 mL, 129 
mmol, 4.46 eq.) was added by syringe over 2 minutes.  After 20 minutes the golden 
yellow solution was removed from the cold bath, warmed gradually to 23 °C over 20 
minutes, and an aqueous phosphate buffer (100 mL, pH = 4, 0.2 M) was added.  The 
biphasic solution was poured into a separatory funnel, partitioned, and the organic layer 
was washed with an aqueous phosphate buffer (2 x 50 mL, pH = 4, 0.2 M).  Residual 
organics were extracted from the aqueous with ethyl ether (2 x 25 mL), combined, and 
washed with a saturated aqueous mixture of NaHCO3 (2 x 50 mL).  Residual organics 
were extracted from the aqueous NaHCO3 layer with ethyl ether (1 x 25 mL), washed 
with brine (1 x 100 mL), dried over solid Na2SO4, decanted, and concentrated to afford 
the acetate 161 as a pure clear colorless oil (6.28 g, 37.8 mmol, 97%). 
 
Rf = 0.67 (50% Et2O in hexane) 
 
1H-NMR (400 MHz, CDCl3): δ 5.75 (dt, 2H, J = 3.1, 10.2 Hz), 5.48 (dt, 2H, J = 2.1, 10.2 
Hz), 3.85 (s, 2H), 2.60 (m, 2H), 2.02 (s, 3H), 1.04 (s, 3H) 
 
13C-NMR (100 MHz, CDCl3): δ 171.27, 130.93, 124.98, 71.74, 36.90, 26.55, 25.46, 
21.12 
 
IR (neat film, cm-1): 3018, 2964, 2872, 1743, 1382, 1235, 1038 
 
HRMS (EC-CI): calc’d. for C8H11 [M-AcOH]−, 107.0861 found. 107.0858 
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 To a mixture of the acetate 161 (2.00 g, 12.03 mmol, 1.00 eq.), activated crushed 
mol sieves (1.0 g), and t-BuOOH (7.75 g, 8.3 mL, 60.2 mmol, 5.00 eq., 70% w/v) in 
EtOAc (80 mL) was added manganese triacetate dihydrate (0.32 g, 1.20 mmol, 0.10 eq.).  
The reaction vessel was equipped with a plastic PTFE cap and placed under an 
atmosphere of oxygen (balloon).  The brown mixture was placed in an oil bath heated to 
77 °C and stirred vigorously (800 rpm).  After 12 hrs. the brown mixture was removed 
from the oil bath, cooled to 23 °C, suction filtered, concentrated, and purified by silica 
gel chromatography; 10% EtOAc in hexane → 30% EtOAc in hexane to afford the 
dienone 162 as a clear yellow oil (2.12 g, 11.8 mmol, 98%). 
 
Rf = 0.41 (40% EtOAc in hexane) 
 
1H-NMR (400 MHz, CDCl3): δ 6.78 (d, 2H, J = 10.5 Hz), 6.26 (d, 2H, J = 10.5 Hz), 4.08 
(s, 2H), 1.97 (s, 3H), 1.23 (s, 3H) 
 
13C-NMR (100 MHz, CDCl3): δ 185.69, 170.52, 151.94, 129.80, 68.31, 41.92, 21.70, 
20.65 
 
IR (neat film, cm-1): 1743, 1668, 1628, 1403, 1378, 1248, 1042, 862 
 
HRMS (ESI): calc’d. for C10H12O3Na [M+Na]+, 203.0679 found. 203.6810 
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 A solution of the dienone 162 (99.0 mg, 0.55 mmol, 1.00 eq.) in methanol (5.5 
mL) was placed in a bath cooled to −60 °C for 30 minutes.  Cerium trichloride 
heptahydrate (614 mg, 1.65 mmol, 3.00 eq.) was added and the mixture was stirred 
vigorously (800 rpm) for 30 minutes upon which the reaction mixture had become a clear 
pale yellow homogeneous solution and then solid NaBH4 (22.9 mg, 0.60 mmol, 1.10 eq.) 
was added.  After 30 minutes excess NaBH4 and the alkoxide were quenched with an 
aqueous phosphate buffer (10 mL, pH = 7, 0.2 M).  The mixture was removed from the 
cold bath, diluted with EtOAc (20 mL), poured into a separatory funnel, partitioned, and 
the organic layer was washed with an aqueous phosphate buffer (2 x 10 mL).  Residual 
organics were extracted from the aqueous layer with EtOAc (3 x 15 mL), washed with 
brine (1 x 10 mL), dried over solid Na2SO4, decanted, and concentrated.  The crude pale 
yellow oil was purified by silica gel chromatography; 20% EtOAc in hexane to afford the 
alcohol as a clear pale yellow oil (73.0 mg, 0.40 mmol, 73%, d.r. = 1.5:1).  Note: The 
crude alcohol can be carried on to the next step without purification. 
 
Mixture of Isomers: (*) denotes minor isomer 
 
Rf = 0.39 (40% EtOAc in hexane) 
 
1H-NMR (400 MHz, CDCl3): δ 5.94 (m, 2H), 5.71 (t, 2H, J = 10.2 Hz), 5.49 (br d, 1H, J 
= 12.6 Hz), 3.92* (s, 2H), 3.87 (s, 2H), 2.05* (s, 3H), 2.02 (s, 3H), 1.58 (bs, 1H), 1.12* 
(s, 3H), 1.07 (s, 3H) 
 
13C-NMR (100 MHz, CDCl3): δ 170.94 (170.90*), 133.67, 133.20, 128.46, 128.14, 
(70.59*) 70.04, (62.22*) 62.06, (37.68*) 37.55, 24.27, 23.68, (20.90*) 20.85 
 
IR (neat film, cm-1): 3399, 2966, 1741, 1254, 1037 
 
HRMS (ESI): calc’d. for C10H14O3Na [M+Na]+, 205.0835 found. 205.0840 
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 A solution of the alcohol (60.0 mg, 0.33 mmol, 1.00 eq.) in acetonitrile (3.3 mL) 
was placed in an ice water bath cooled to 0 °C for 10 minutes upon which a mixture of 
TBSCl (54.6 mg, 0.36 mmol, 1.10 eq.) and imidazole (29.0 mg, 0.43 mmol, 1.30 eq.) was 
added together.  After 2 minutes the white mixture was removed from the cold bath and 
allowed to stir (500 rpm) at 23 °C.  After 2 hrs the heterogeneous mixture was diluted 
with an aqueous phosphate buffer (10 mL, pH = 7, 0.2 M) and EtOAc (10 mL), poured 
into a separatory funnel, partitioned, and the organic layer was washed with an aqueous 
phosphate buffer (1 x 10 mL, pH = 7, 0.2 M).  Residual organics were extracted with 
EtOAc (2 x 10 mL), dried over solid Na2SO4, decanted, and concentrated.  The crude 
pale yellow mixture was purified by silica gel chromatography; 2% EtOAc in hexane to 
afford the silyl ether product as a clear pale yellow oil (97.0 mg, 0.33 mmol, 99%).   
 
Mixture of Isomers: (*) denotes minor isomer 
 
Rf = 0.75 (10% EtOAc in hexane) 
 
1H-NMR (400 MHz, CDCl3): δ 5.80 (ddd, 2H, J = 2.8, 10.2 Hz), 5.66* (dd, 2H, J = 1.7, 
10.2 Hz), 5.61 (dd, 2H, J = 2.1, 10.2 Hz), 4.61 (m, 1H), 3.93* (s, 2H), 3.85 (s, 2H), 2.04* 
(s, 3H), 2.02 (s, 3H), 1.13 (s, 3H), 1.03* (s, 3H), 0.91 (s, 9H), 0.90* (s, 9H), 0.11* (s, 
6H), 0.98 (s, 3H), 0.97 (s, 3H) 
 
13C-NMR (100 MHz, CDCl3): δ (171.07*) 170.88, 132.23, 131.87, 129.43, 128.79, 70.92 
(70.04*), 63.20 (63.07*), (37.56*) 37.43, 25.93 (25.90*), 25.65, 24.42, 23.33, 20.94 
(20.86*), (18.35*) 18.24 
 
IR (neat film, cm-1): 2957, 2930, 2857, 1747, 1253, 1056, 873, 837 
 
HRMS (ESI): calc’d. for C16H28O3SiNa [M+Na]+, 319.1700 found. 319.1750 
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 To a solution of the silyl ether (1.07 g, 3.61 mmol, 1.00 eq.) in methanol (36 mL) 
was added K2CO3 (0.55 g, 3.97 mmol, 1.10 eq.) and the mixture was rapidly stirred (800 
rpm) at 23 °C.  After 1 hr. the heterogeneous mixture was diluted with an aqueous 
phosphate buffer (20 mL, pH = 7, 0.2 M) and EtOAc (20 mL), poured into a separatory 
funnel, partitioned, and the organic layer was washed with water (2 x 10 mL).  Residual 
organics were extracted from the aqueous layer with EtOAc (2 x 20 mL), dried over solid 
Na2SO4, decanted, and concentrated.  The crude yellow oil was purified by silica gel 
chromatography; 5% EtOAc in hexane to afford the alcohol 163 as a clear pale yellow oil 
(0.88 g, 3.46 mmol, 96%).  
 
Mixture of Isomers: (*) denotes minor isomer 
 
Rf = 0.33 (10% EtOAc in hexane) 
 
1H-NMR (400 MHz, CDCl3): δ 5.89 (m, 2H), 5.65* (dd, 2H, J = 1.2, 10.0 Hz), 5.61 (dd, 
2H, J = 2.0, 10.1 Hz), 4.65 (m, 1H), 4.60* (m, 1H), 3.38 (s, 2H), 3.34* (s, 2H), 1.80 (bs, 
1H), 1.07 (s, 3H), 1.01* (s, 3H), 0.91 (s, 9H), 0.89* (s, 9H), 0.11 (s, 6H), 0.10* (s, 6H) 
 
13C-NMR (100 MHz, CDCl3): δ 133.79, 132.30, 130.31, 129.71, (70.30*) 69.03, 63.12 
(62.58*), 40.04 (39.88*), 25.96 (25.90*), (23.88*) 22.92, 18.37 (18.24*), −4.34 (−4.43*) 
 
IR (neat film, cm-1): 3401, 2956, 2929, 2857, 1256, 1056, 872, 836, 776 
 
HRMS (EC-CI): calc’d. for C14H27O2Si [M+H]+, 255.1780 found. 255.1780 
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 A solution of oxalyl chloride (1.76 g, 1.2 mL, 13.8 mmol, 4.00 eq.) in THF (5 
mL) was placed in a bath cooled to −78 °C for 30 minutes upon which dimethyl sulfoxide 
(2.16 g, 2.0 mL, 27.7 mmol, 8.00 eq.) was added dropwise by syringe over 2 minutes.  
After 10 minutes a solution of the alcohol 163 (0.88 g, 3.46 mmol, 1.00 eq.) in THF (12 
mL) was added by syringe over 5 minutes to the slightly heterogeneous mixture.  After 1 
hr triethylamine (7.00 g, 9.7 mL, 69.2 mmol, 20.0 eq.) was added by syringe to the pale 
yellow mixture.  After 1 hr the yellow solution was removed from the cold bath and 
allowed to stir (500 rpm) at 23 °C.  After 1 hr the golden yellow solution was diluted with 
an aqueous phosphate buffer (20 mL, pH = 7, 0.2 M) and ethyl ether (20 mL), poured 
into a separatory funnel, partitioned, and the organic layer was washed with water (2 x 10 
mL).  Residual organics were extracted from the aqueous layer with ethyl ether (3 x 15 
mL), washed with brine (1 x 10 mL), dried over solid Na2SO4, decanted, and 
concentrated.  The crude pale yellow oil was purified by silica gel chromatography; 
hexane → 2% EtOAc in hexane to afford the aldehyde 164 as a pale yellow oil (0.73 g, 
2.91 mmol, 84%). 
 
Mixture of Isomers: (*) denotes minor isomer 
 
Rf = 0.53 (5% EtOAc in hexane) 
 
1H-NMR (400 MHz, CDCl3): δ 9.26* (s, 1H), 9.01 (s, 1H), 6.01 (m, 2H), 5.65* (d, 2H, J 
= 9.9 Hz), 5.52 (dd, 2H, J = 2.0, 10.2 Hz), 4.72 – 4.70 (m, 1H), 4.69 – 4.67* (m, 1H), 
1.30 (s, 3H), 1.19* (s, 3H), 0.92 (s, 9H), 0.91* (s, 9H), 0.13 (s, 6H), 0.12* (s, 6H) 
 
13C-NMR (100 MHz, CDCl3): δ (198.81*), 197.19, 131.64, 131.33, 128.30, 126.27, 
(62.57*) 62.54, 51.64 (50.55*), 25.87, (20.97*) 19.33, 18.31 (18.24*), (−4.33*) −4.47 
 
IR (neat film, cm-1): 2966, 2929, 2857, 1728, 1069, 868, 836, 776 
 
HRMS (EC-CI): calcd. for C14H25O2Si [M+H]+, 253.1624 found. 253.1624 
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 A mixture of Ph3PMeBr (1.36 g, 3.81 mmol, 1.00 eq.) in THF (15 mL) was 
placed in a bath cooled to −78 °C for 20 minutes upon which n-butyllithium (1.97 mL, 
3.36 mmol, 1.10 eq., 1.70 M in hexane) was added.  After 20 minutes the orange 
heterogeneous mixture was removed from the cold bath and allowed to warm to 23 °C.  
After 20 minutes the orange mixture was placed in an ice water bath cooled to 0 °C for 30 
minutes upon which a solution of the aldehyde 164 (0.77 g, 3.05 mmol, 1.00 eq.) in THF 
(15 mL) was added dropwise by syringe over 2 minutes.  After 1 hr the pale yellow 
mixture was removed from the cold bath.  After 30 minutes at 23 °C an aqueous 
phosphate buffer (20 mL, pH = 7, 0.2 M) was added to the pale yellow mixture to quench 
the excess ylide.  The mixture was diluted with ethyl ether (20 mL), poured into a 
separatory funnel, and partitioned.  Residual organics were extracted from the aqueous 
with ethyl ether (2 x 20 mL), dried over solid Na2SO4, suction filtered over a pad of 
celite, and concentrated.  The crude pale yellow mixture was purified by silica gel 
chromatography; hexane → 2% EtOAc in hexane to afford the triene 165 as a pale 
yellow oil (0.71 g, 2.83 mmol, 93%). 
 
Mixture of Isomers: (*) denotes minor isomer 
 
Rf = 0.84 (5% EtOAc in hexane) 
 
1H-NMR (400 MHz, CDCl3): δ 5.83 – 5.62 (m, 5H), 5.06 – 4.91 (m, 2H), 4.63 – 4.61 (m, 
1H), 1.20 (s, 3H), 1.12* (s, 3H), 0.92 (s, 9H), 0.91* (s, 9H), 0.11 (s, 6H), 0.10* (s, 6H) 
 
13C-NMR (100 MHz, CDCl3): δ 144.73 (144.09*), (134.21*) 133.76, 126.90 (126.69*), 
(112.44*) 111.75, 63.22 (63.05*), 40.07 (39.53*), 26.95, 25.99, 18.37 (18.36*), (−4.23*) 
−4.33 
 
IR (neat film, cm-1): 2958, 2928, 2857, 1253, 1063, 873, 836, 775 
 
HRMS (EC-CI): calc’d. for C15H27OSi [M+H]+, 251.1831 found. 251.1823 
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7. Catalog of Spectra 
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Chapter 3 – Aryl Hydroxylation Mediated by  
4,5-Dichlorophthaloyl Peroxide 
 
 Phenols are fundamentally important molecules which possess broad utility and 
perform a suite of applications in the pharmaceutical, agricultural, and commodity 
chemical industries.132  Phenols are pharmacologically ubiquitous in drugs which serve a 
wide range of biological purposes.133  During metabolism various aromatic compounds 
are also oxidized to phenols to increase their excretion from the body.  The FDA 
mandates that metabolites generated in higher than 10% must be examined to elucidate 
their potential toxicity or side effects.134  An effective synthetic protocol capable of 
accessing phenolic derivatives and potential metabolites of native pharmaceutical agents 
in an efficient, economical fashion would be an essential chemical and biological tool.  
Despite their vast importance, a procedure for the general, straightforward conversion of 
arenes to phenols does not exist.   A protocol emulating cytochrome P450 which directly 
oxidizes aryl C-H bonds to C-OH bonds in a mild, selective manner is most ideal, but this 
rather rudimentary transformation poses many synthetic challenges.135,136  The major 
problem in developing hydroxylation reactions is that the phenolic products are more 
reactive than the starting materials which leads to over-oxidation.  A protocol that is also 
tolerant to a multitude of functional groups also remains elusive.137   
 Early hydroxylation reactions employed peroxides, but had limited success in 
generating mono-hydroxylated products, and when successful they had a limited 
scope.138-145  Methods to circumvent this problem using super acids to both activate the 
peroxides and subsequently deactivate the arenes were investigated.146-149  These 
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approaches lack generality because many functional groups cannot tolerate these 
exceptionally strong acids.  Transition metal catalyzed oxidations of aromatics have 
improved upon the early acid-mediated processes which utilize peroxides, but these 
strategies are not ideal since they require precious metals and usually invoke directing 
groups to promote reactivity.150-161  The use of directing groups inherently minimizes the 
substrate scope and the types of substituted phenols that can be accessed.  The directing 
groups that are employed often need to be installed as well as removed creating an 
overall inefficient process with regard to step economy.  Strategies that oxidize aryl 
silanes and aryl boronic acids or esters are also utilized to deliver phenols.162-166  
Although potentially high yielding, these strategies require multiple steps starting from 
halogenated arenes and predominantly use transition metal catalysis to install the silane 
or boronate.  Late-stage halogenations and the subsequent oxidation of the silanes or 
boronates on highly functionalized molecules can pose significant problems often 
rendering these strategies inferior to the widely used Friedel-Crafts/Baeyer-Villiger 
sequences for the installation of oxygen into arenes.  Although effective, this multi-step 
process utilizes reagents that may not be suitable to latent functionality in the later stages 
of a synthetic strategy.167-169 
 Phthaloyl peroxide (211), a reagent studied in detail by Greene in the 1950’s, was 
recently shown to mono-hydroxylate arenes with a high degree of functional group 
tolerance.170,171  A major limitation to this protocol, however, is that electronically rich 
arenes are needed.  Interestingly, computational analysis dictates that the reaction 
proceeds through a novel diradical reverse-rebound mechanism, not the expected 
electrophilic aromatic substitution (EAS) pathway.  This is perplexing and several 
mechanistic questions remain since there is no experimental evidence to substantiate 
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these findings.  Mechanistic evaluation and probing of different peroxide reagents could 
enhance this protocol thereby expanding the generality of the substrate scope to provide a 
more applicable strategy with higher utility.    
 
Synthetic Protocols to Access Phenols 
  
 The monooxygenase super family of proteins that encompasses the cytochrome 
P450 catalyzes the oxidation of small molecules.  These enzymes play an integral role in 
the biosynthesis of important compounds such as steroids and lipids, but they also 
metabolize drugs and foreign organic molecules to facilitate their excretion and clearance 
from the body.135,136  They are responsible for the oxidation of arenes like benzene and 
various poly-aromatic hydrocarbons (PAHs) through the direct conversion of the arene to 
an epoxide which undergoes an NIH shift to afford the phenolic metabolites (Scheme 
3.1).  The oxirane intermediate 212 can undergo another pathway involving covalent 
modification via nucleophilic addition of cysteine residues ultimately leading to the 
carcinogenic properties of these aromatics.  Despite the deleterious toxicity, the overall 
transformation is fascinating from a synthetic perspective.  An iron-oxygen complex 
containing an iron (V) core effects this overall transformation inside the active site of the 
enzyme which directly oxidizes the arene.  
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Scheme 3.1. CYP450 mediated hydroxylation of arenes.135,136 
 
 
 
 Emulating this transformation chemically has proven to be quite difficult.  
Fenton’s reagent affects this transformation but acts as an indiscriminate oxidant.  It has 
limited utility because the arene is used in excess and the oxidant is the limiting reagent.  
Since the phenolic products are more reactive to further oxidation.  Over-oxidation 
coupled with functional group liability severely limits this protocol.  Its indiscriminate 
oxidation potential, however, has warranted its use in water purification to remove PAHs 
as well as other toxic organic molecules like tri- and tetrachloroethylene.138  The use of 
strong acids, Lewis or Brønsted, in combination with peroxides has also affected this 
transformation, but again functional group liability severely limits these processes 
(Scheme 3.2).139-149  Additionally, these protocols typically use simple arenes in excess or 
as the solvent, further limiting the widespread synthetic utility of these approaches.  
Despite the major limitations these early developments laid significant groundwork in 
arene hydroxylation reactions. 
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Scheme 3.2. Early peroxide mediated hydroxylation of arenes.138-149 
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 Remarkable achievements in the syntheses of phenols have recently been made 
using transition metal catalysis by researchers such as Crabtree, Sanford, Yu, Ritter, 
Gevorgyan, Dong, and Rao (Scheme 3.3).150-161  These protocols can be effective, but 
tend to lack broad application due to the use of directing groups or contrived systems.  
The oxidation of aryl silanes or boronates is commonly implemented to provide phenols.  
Aryl silanes and boronic acids or esters, which essentially are masked phenols, are 
derived from the aryl halides through a cross-coupling approach such as the Miyauri 
boration or through anion mediated nucleophilic addition reactions.167  Fleming-Tamao 
and boronate oxidation ultimately unmasks the phenols.162-166  These strategies can be 
highly effective early in a synthetic strategy, but unselective aryl halogenation and 
peroxide mediated oxidations can be deleterious to common functional groups in the later 
stages of a synthetic strategy.  This causes undesirable protecting group steps or 
alternative approaches.  The universal protocol to synthesize a phenol is the Friedel-
Crafts/Baeyer Villiger sequence.168,169  Although effective, this strategy usually requires 
protecting group manipulations and compatible functional groups which often limit its 
generality. 
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Scheme 3.3. Transition metal catalyzed and Friedel-Crafts/Baeyer Villiger syntheses of  
phenols. 
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Phthaloyl Peroxide Mediated Hydroxylation  
  
 Phthaloyl peroxide (211), originally studied in detail by Greene in the 1950’s, has 
recently been exploited by our laboratory to oxidize arenes to phenols, converting C-H 
bonds to C-OH bonds (Table 3.1).170,171  The reaction is predictable, occurring in a 
similar fashion to the Friedel-Crafts reaction to afford the phenol in a two step sequence 
with minimal over-oxidation.  The reaction is controlled by the formation of mixed 
phthaloyl ester-acid 254 which is reluctant to another oxidation by a second equivalent of 
phthaloyl peroxide.  The mixed phthalate is then hydrolyzed using aqueous sodium 
bicarbonate in warm, deoxygenated methanol in the second step to provide the phenol.  
Remarkably, the peroxide and the overall protocol possess excellent functional group 
tolerance.  Aldehydes, ketones, esters, alkenes, boronic esters, nitriles, allenes, alkynes, 
cyclopropanes, and cyclobutanes are all tolerated under these conditions.  This protocol is 
also applicable to the late-stage oxidation of complex molecules and natural products 
including phenolic derivatives of tocopherol 255 as well as the advanced 
clovanemagnolol intermediate 256.  The major limitations to this protocol are that the 
reaction only works on electronically moderate to rich arenes and the ortho/para 
selectivity is low. 
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Table 3.1. Scope of arenes hydroxylated by phthaloyl peroxide.171 
 
 
 It was initially hypothesized that the reaction proceeded through an ionic 
pathway.  This was substantiated by the selective oxidation of the arene over the alkyl 
substituents possessing benzylic hydrogens.  In fact, no benzylic oxidation was observed 
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throughout the hydroxylation reaction in the cases of substrates 259-261, 264, 270, 276, 
or 277.  However, an ionic pathway contradicts the fact that no over-oxidation products 
were observed.  The mixed phthaloyl ester-acid intermediate 254 would be more prone to 
oxidation than the starting arene through an EAS mechanism.172  These contradicting 
results prompted computational analysis to determine the most plausible mechanistic 
pathway.  There are potentially four major reaction pathways: ionic, direct hydrogen 
abstraction, single electron transfer (SET), or a diradical reverse-rebound addition.  
Density functional theory (DFT) and ab initio calculations dictate that the lowest 
energetic reaction pathway is the diradical reverse-rebound.  The energy required for this 
mechanism is 30.5 kcal/mol, which is approximately 5.2 kcal/mol lower than the ionic 
pathway.171 
 The reaction’s selectivity for oxidizing the arene over the benzylic C-H bonds is 
rather surprising if a diradical process is actually occurring.  Further DFT analysis using 
mesitylene (220) illustrated that benzylic oxidation via hydrogen abstraction is 
approximately 5.5 kcal/mol higher than aryl C-H oxidation (~10 kcal/mol), accounting 
for the arene selectivity (Scheme 3.4).  The cyclohexadienyl diradical 281 then undergoes 
rearomatization via hydrogen abstraction which is expedited by the adjacent benzoyloxy 
radical to afford the mixed phthaloyl ester acid 283 as the sole product. 
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Scheme 3.4. CPCM-(U)B3LYP/6-31+G(d) computed free energy surfaces for aryl and  
 benzylic functionalization of mesitylene using phthaloyl peroxide. 
 
 
 
 Phthaloyl peroxide is a special reagent in this process because peroxides such as 
benzoyl peroxide promote benzylic oxidation, not aryl oxidation (Scheme 3.5).  
Experimental observations confirm this result as no arene oxidation is observed when 
benzoyl peroxide is reacted with mesitylene.  DFT and ab initio calculations on this 
process indicate that the aryl oxidation pathway for a mono-radical peroxide is lower in 
energy compared to the hydrogen abstraction pathway which forms the mesityl benzyl 
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radical (13.3 kcal/mol versus 18.9 kcal/mol).171  However, the energy associated with the 
rearomatization (25.8 kcal/mol) creates a barrier that is much higher compared to 
benzylic oxidation.  Abstraction of the hydrogen from the cyclohexadienyl radical 287 
requires a second benzoyloxy radical (288).  This is entropically disfavored and causes 
the high energy penalty.  Traversing this entropy barrier is nearly impossible under the 
reaction conditions so the only experimentally observed product is benzylic oxidation.  
Benzoyl peroxide is therefore a great oxidant in radical halogenations such as the Wohl-
Ziegler reaction.173  This entropic penalty does not exist when phthaloyl peroxide is used 
because the hydrogen abstraction is intramolecular. 
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Scheme 3.5. CPCM-(U)B3LYP/6-31+G(d) computed free energy surfaces for aryl and  
          benzylic functionalization of mesitylene using benzoyl peroxide. 
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Development of an Arene Hydroxylation Protocol using  
4,5-Dichlorophthaloyl Peroxide 
 
 Phthaloyl peroxide is a special oxidant which our laboratory has exploited to 
perform dihydroxylations of styrenes and, most notably, to oxidize arenes to phenols 
directly from the aryl C-H bond.171,174  The latter is of specific interest because it provides 
access to phenols in a functional group tolerant fashion amenable to late-stage 
hydroxylation reactions.  This protocol can rapidly deliver small molecules that are 
potential metabolites as well as oxidized analogs of drugs and pharmaceutical agents.  
The restricted scope of the reaction warrants further development of peroxides with the 
capability to access new arenes.  There is also minimal experimental evidence to 
substantiate the DFT and ab initio calculations that dictate the most energetically 
favorable mechanistic pathway is a diradical reverse-rebound addition.  A stronger 
peroxide reagent could also help provide this experimental evidence that remains elusive. 
 In the pursuit of new phthaloyl peroxide reagents, computational analysis and 
prior research regarding the dihydroxylation of styrenes illustrated that symmetrically 
halogenated phthaloyl peroxides possessed the highest potential for effecting the arene 
hydroxylation.174  In 2011, our laboratory had shown that 4,5-dichlorophthaloyl peroxide 
(296) dihydroxylated styrenes as well as non-styrenyl alkenes, a reaction not observed 
using other types of phthaloyl peroxides.  Computational analysis using DFT and ab 
initio calculations conducted in collaboration with Yong Liang and Ken Houk dictated 
that this reagent could potentially be a more powerful oxidant than phthaloyl peroxide in 
the arene hydroxylation as well (Figure 3.1).  Through comparing their reactivities with 
three separate arenes: mesitylene, benzene, and 1,3,5-trichlorobenzene, the calculations 
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delineated that the electron-rich arene is more reactive than the electron-deficient arene.  
This is predicated on the HOMO-SOMO interaction in the transition state illustrated by 
frontier molecular orbital (FMO) analysis.  The energetic barrier for the transition state is 
lowered by enhancing the favorability of this interaction in elevating the HOMO energy 
of the arene.  The barriers for the reactions are lowered by ~1-2 kcal/mol using 4,5-
dichlorophthaloyl peroxide.  The chlorides decrease the SOMO energy by approximately 
0.2 eV as indicated by FMO analysis.  This decrease in energy results in an increasingly 
favorable HOMO-SOMO interaction in the transition state.  Overall, this suggests that 
4,5-dichlorophthaloyl peroxide could react with benzene, an arene previously 
inaccessible in our hydroxylation reaction using phthaloyl peroxide. 
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Figure 3.1. Arene reactivity difference between 4,5-dichloro- and phthaloyl peroxide via 
 diradical addition. 
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Further computational investigation deciphered that 3,6-dichlorophthaloyl 
peroxide (305) would be a viable candidate for arene oxidation as well.  Based on 
calculations conducted by Liang, the energetic barrier is only 16.7 kcal/mol for the 
oxidation of 1,3,5-trichlorobenzene using this reagent whereas the oxidation is 22.5 
kcal/mol using 4,5-dichlorophthaloyl peroxide (Figure 3.2). 
 
Figure 3.2. 4,5- and 3,6-dichlorophthaloyl peroxide oxidation of 1,3,5-trichlorobenzene. 
 
 The computational results combined with the previously observed reactivity 
mitigated by the dihydroxylation of alkenes provided plausibility for the synthesis of 
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various halogenated peroxides.  Phthaloyl peroxide is synthesized in one step from the 
cheap, commercially available phthaloyl chloride (308) using solid sodium percarbonate 
in wet methylene chloride (Scheme 3.6).  This can be achieved on 30 gram scale to 
deliver the peroxide in 62% yield as a white, fluffy solid.  This protocol has proven safe 
in repeatedly providing mass quantities of the peroxide without the occurrence of an 
explosion.  4,5-Dichlorophthaloyl peroxide was synthesized in a similar manner, but 
starting from the cheap, commercially available 4,5-dichlorophthalic acid (309).  The 
diacid is first converted to the dichloride 310 by heating the solid acid to 165 °C in neat 
phosphorus pentachloride.  After a three stage distillation the dichloride is afforded in 
92% yield on 50 gram scale as a white, lacrimating solid.  The dichloride was treated 
with solid sodium percarbonate in wet methylene chloride to afford the peroxide 296 in 
60% yield as a white, flaky solid after recrsytallization from benzene and pentane.  It is 
important to note that both peroxides (211 and 296) can be stored under nitrogen in a 
freezer cooled to −20 °C for prolonged periods of time (months up to one year) without 
degradation or loss of reactivity.   
 The tetrachloro-, tetrabromo-, and 3,6-dichlorophthaloyl chlorides (311 and 312) 
could not be synthesized due to instability of the diacyl chlorides.175  Therefore, the 
corresponding peroxides could not be synthesized.  However, the tetrafluorophthaloyl 
dichloride was afforded by heating the diacid 313 to 165 °C in neat phosphorus 
pentachloride.  After distillation, the product was accessed in 25% yield.  Due to 
instability and resultant decomposition, the reaction forming the peroxide needed to be 
closely monitored by 13C-NMR.  The tetrafluorophthaloyl peroxide (314) could not be 
purified or isolated due to degradation thereby the peroxide was treated in situ with 
mesitylene in methylene chloride at 23 °C.  After five hours the solvent was removed and 
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the resulting viscous orange oil was dissolved in a solution of benzene/methanol (3:1) 
and treated with excess trimethylsilyl diazomethane to afford the crude mixed phthaloyl 
ester 315.  The golden yellow oil was purified by silica gel chromatography to provide 
the mixed ester in 30% yield over the three steps.  The low yield is attributed to the 
decomposition of the tetrafluorophthaloyl peroxide in the peroxide formation reaction.   
 Despite the low yield, this was a good result because this type of reactivity was 
never observed using the parent phthaloyl peroxide or in non-fluorinated solvents.  
Fluorinated solvents such as HFIP and TFE at elevated temperatures are required when 
using phthaloyl peroxide to effect the arene hydroxylation in appreciable yields. 
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Scheme 3.6. Syntheses of different phthaloyl peroxides. 
 
 
  With multigram quantities of 4,5-dichlorophthaloyl peroxide available, its 
potential to hydroxylate arenes was initially examined using p-anisaldehyde (319).  In 
comparison studies, the aldehyde was treated with four equivalents of phthaloyl peroxide 
in HFIP at 75 °C, however, this only promoted 6% conversion after 36 hours.  Under 
identical conditions, but using the dichloroperoxide, p-anisaldehyde was oxidized with 
80% conversion.  After hydrolyzing the intermediate phthaloyl ester-acid, isovanillin 
(321) was isolated in a 69% yield (Table 3.2). 
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Table 3.2. Reactivity comparison between peroxides 211 and 296 using p-anisaldehyde. 
 
 
  
The use of four equivalents of the peroxide was surprising, but necessary as using 
less equivalents resulted in lower conversion of the starting material.  The high 
temperature proved necessary because the reaction was sluggish at temperatures below 
75 °C, but this temperature also warranted the use of excess peroxide due to a higher 
degree of peroxide decomposition.  1H-NMR experiments were then conducted to 
analyze the cause of decomposition and the rate at which it was occurring.  First, the 
peroxide was heated in deuterated HFIP at 50 and 75 °C.  This showed that 15-20% and 
35-40% decomposition of the peroxide occurred in deuterated HFIP at 50 and 75 °C 
respectively over 48 hours.  By conducting the same experiment in HFIP and then 
analyzing the crude reaction material by 1H-NMR, it was found that the peroxide had 
converted to the mixed phthaloyl ester acid 322 (Scheme 3.7).  In order to confirm this 
result, the crude acid was esterified using trimethylsilyl diazomethane to provide the 
diester 323 which was purified and then fully characterized (see Experimental Section).  
Also observed in both NMR experiments was the formation of 4,5-dichlorophthaloyl 
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anhydride at the expense of the peroxide.  The current hypothesis is that the peroxide 
oxidizes the solvent, leading to the diacid which is observed in both NMR experiments, 
and this material is then slowly converted to the anhydride (324) by the acidic reaction 
media.  HFIP then reacts with the anhydride to form the ester 322, and this was also 
confirmed by heating the anhydride in HFIP to 75 °C in a separate experiment.  After 12 
hours the solvent was removed and 1H-NMR of the resultant crude yellow solid showed 
~25% of the ester 322 and ~75% of the starting anhydride. 
 
Scheme 3.7. Decomposition pathway of 4,5-dichlorophthaloyl peroxide in HFIP. 
 
 
 
 This decomposition was not observed in the original oxidation protocol developed 
by Changxia Yuan dictating that phthaloyl peroxide is more stable in fluorinated 
solvents.  To understand the potential risks and dangers associated with using the new 
peroxide, DFT calculations were conducted to compare the thermal stabilities between 
the two oxidants (Scheme 3.8).  Surprisingly, despite the enhanced reactivity, 4,5-
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dichlorophthaloyl peroxide possesses slightly more thermal stability than phthaloyl 
peroxide, however, these computational experiments show another pathway for the 
peroxide decomposition.  It is important to note that this type of decomposition was not 
observed in the original experiments examining the degradation, however, this internal 
decomposition has been observed during hydroxylation reactions on a small number of 
substrates using 4,5-dichlorophthaloyl peroxide.  
 
Scheme 3.8. Thermal stability of 4,5-dichlorophthaloyl peroxide and phthaloyl peroxide. 
 
 
  
 The thermal stability of 4,5-dichlorophthaloyl peroxide was also investigated 
using thermogravimetric analysis (Figure 3.3).  The TGA data indicates that the peroxide 
has a point of decomposition at 135 °C confirming that it is slightly more stable than 
phthaloyl peroxide which decomposes at 130 °C.  These oxidants have remarkable 
thermal stability compared to benzoyl peroxide, which begins to gradually decompose at 
105 °C.  Unfortunately, both phthaloyl peroxides show a sharp decrease in mass at these 
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respective temperatures indicating that when they are heated above these points a 
potential explosion could occur.  In light of this, all experiments were conducted at or 
below 75 °C.  
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Figure 3.3. TGA data for 4,5-dichlorophthaloyl peroxide. 
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 A full understanding of 4,5-dichlorophthaloyl peroxide’s decomposition in HFIP, 
its thermal explosive potential, and the enhanced reactivity predicated on the oxidation of 
anisaldehyde, the hydroxylation reaction was next examined on previously inaccessible 
substrates.  Two general sets of reaction conditions were developed.  The oxidations were 
carried out using either 1.3 equivalents of 4,5-dichlorophthaloyl peroxide at 50 °C or 2.5 
equivalents heated to 75 °C in HFIP.  Operationally the reaction proceeds without the 
need for special exclusion of air or moisture and the use of commercial grade HFIP is 
sufficient.  Karl Fisher titration on the HFIP routinely used in these reactions contained 
924 ppm of water.  Using purified HFIP rendered no difference in reactivity.   
 The products in Table 3.3 demonstrate the range of substituted arenes that can be 
successfully hydroxylated and the functional groups that are tolerated, adding to those 
already known.171  Primary and secondary alcohols are tolerated providing phenols 327 
and 328.  Substrates possessing tertiary alcohols can be hydroxylated, but the yields are 
low due to ionization of the alcohols in these arenes.  A series of hydrocinnamyl 
derivatives with higher degrees of oxidation participated well in the reaction to afford the 
phenols of the aldehyde 329, ketone 330, ester 331, acid 332, and nitrile 333.  Removal 
of one methylene led to a diminished yield of 48% for the oxidation to generate the ester 
334.   
 After examining different nitrogen protecting groups, the trifluoroacetamide 335, 
sulfonamide 336, and dinitrosulfonamide 337 were all produced in moderate to good 
yield representing some of the first substrates containing nitrogens successfully 
hydroxylated under this manifold.  After testing additives it was found that amines (in 
their ammonium form) are also tolerated.  The addition of p-toluenesulfonic acid 
monohydrate (1.0 equivalent) prior to that of 4,5-dichlorophthaloyl peroxide leads to 
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successful hydroxylation providing the aminophenol 338 in 85% yield.  Hydroxylation of 
biphenyl (339), diphenyl ether (340), 6-methoxy tetralone (341) as well as methyl m-
anisate (342) and methyl o-anisate (343) occurred in moderate to good yields, but 
provided mixtures of isomeric products.  Single regioisomers were obtained in the 
hydroxylation of acetanisole (344), p-anisaldehyde (319), and methyl p-anisate (345) 
driven by synergistic regiochemical directing effects of the methyl ether and carbonyls.  
However, upon conducting the reaction using p-methoxy aryl amides, double 
hydroxylation of the arene occurred to afford the quinone 346.  Attempts to minimize this 
reaction to affect only mono-hydroxylation unfortunately were ineffective.  Interchanging 
the methoxy group with a methyl or alkyl substituent rendered an unreactive arene and 
only returned the starting amide. 
 The oxidation of tert-butyl benzene delivered the ortho, meta, and para phenols 
347 with the para isomer being the major product.  This represented the first time a meta 
product was generated in the reaction and it potentially arose through rearrangement 
before aromatization to relieve steric strain of the o-phthalate intermediate.  Butyl 
benzene (348) was converted in higher efficiency using 4,5-dichlorophthaloyl peroxide in 
73% yield compared to 49% conversion using phthaloyl peroxide.  A series of 
halogenated alkyl benzene derivatives (349-351) were oxidized to demonstrate the 
regioselectivities possible within these systems.  As expected, the halogens were not as 
strong of a directing group as the alkyl substituents, and within these substrates fluorine 
is a stronger director than chlorine which in turn is more effective than bromine.  
Interestingly, the ipso products were formed in 2-5% yield replacing the halogen with a 
phenol. 
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Table 3.3. Hydroxylation of arenes mediated by 4,5-dichlorophthaloyl peroxide. 
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 Since the oxidation proved highly tolerant to several functional groups, the 
protocol was applied to the syntheses of the phenolic derivatives of drugs as well as 
biocides in their native state (Table 3.4).  Hydroxylation of the free acid as well as the 
esters of naproxen, nabumetone, and ibuprofen was achieved to generate the phenols 358, 
359, and 360 in modest yield.  Air oxidation of the electron rich naphthol led to the lower 
yields for the phenol 358.  Protection of the amine as the dinitrosulfonamide followed by 
oxidation provided the acetate derivative of desipramine (361) in 17% yield over three 
steps.  The insipient phenol was protected as the acetate in order to separate the isomer 
from other minor isomers and to attain an accurate yield due to slight decomposition of 
the phenol during purification.  Anilines do not participate well in the oxidation often 
leading to low selectivity as well as over-oxidized adducts and decomposition.  As free 
alcohols were tolerated, guaifenesin and chlorphenesin glycol were hydroxylated to 
provide the phenols 362 and 363 in 35% and 52% yield respectively.  The related 
carbonate and carbamate were similarly reacted to provide the corresponding phenols 364 
and 365 in 52% and 63% yield.  The NSAID flurbiprofen was also hydroxylated in 31% 
yield to provide the para phenol 366.  This phenol is a metabolite of flurbiprofen and has 
previously been synthesized through a Friedel-Crafts/Baeyer-Villiger sequence in an 
overall six steps and 20% yield, further substantiating the efficiency of our developed 
hydroxylation protocol.176,177  Treating the ester of mefenamic acid with 2 equivalents of 
the peroxide delivered the para phenol which was immediately protected to afford the 
acetate 367 in 20% yield over the three steps.  The phenol was protected as the acetate in 
order to attain an accurate yield which had been difficult due to decomposition of the 
phenol during purification.  Minimal conversion of the starting material was observed if 
only one equivalent was used.  The hydroxylation strategy also provided an alternative 
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approach to access one of the metabolites of the NSAID fenoprofen 368 as well as the 
widely used household antibacterial and antifungal agent triclosan (369).178,179  
Hydroxylation of 2,4,4’-trichlorodiphenylether was achieved regioselectively to 
synthesize triclosan in 52% yield.  Adapalene, an effective drug for treating acne, was 
hydroxylated to afford the phenolic derivative 370 in 46% yield without any observation 
of adamantyl hydrogen abstraction or decomposition.180  The residual material consisted 
of phenolic isomers as well as those associated with ipso substitution, replacing the 
adamantyl substituent with a phenol.   
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Table 3.4. Hydroxylation of drugs to provide phenolic derivatives and metabolites using  
       phthaloyl and 4,5-dichlorophthaloyl peroxide. 
 
MeO
Me
OR
O
R = H or Me
naproxen, 40%
MeO
Me
O
OH
nabumetone, 68%
Me
Me
Me
OR
O
OH
ibuprofen, 61% (2:1)*
R = H or Me
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O
OH
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OMe
O
OH
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O OH
OHOH
chlorphenesin, 52% (12% SM)
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HO
F
Me
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O
R = H or Me
flurbiprofen, 31%
MeO
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O
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OH
HO
BuO
O
N
HO
dyclonine, 33%
ON
Me
F3C O Me
OH
atomoxetine
trifluoroacetamide, 12%
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O OMe
Me
Me
mefenamic methyl
ester, 20%
O
HO
MeMeO2C
fenoprofen methyl
ester, 36% (1:1)*
desipramine
sulfonamide, 17%
N
N
Me
S
O2N
OO
O2N
AcO
1. 211 or 296, HFIP, 0 75 °C
2. MeOH / sat. NaHCO3 (9/1), 50 °C
FG FG
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H
H H
HO
2
deoxyestrone,
72% (20% SM)
(2:2:1:1)*
Cl
O
OH
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O
O
O
358 359 360
362
361
363 364 365
366 371 367 368
370 372 373 374 369
2
3
4
6
H OH
257 258
O
O
O
O211
O
O
O
O296
Cl
Cl
The regioisomeric position is labeled with the respective carbon atom number
*The ratio of the isomers are in parentheses
OH
OH
 
 Although the hydroxylation proceeds well in a broadly functional group tolerant 
manner, incompatible functionality does exist (Table 3.5).  Pyridines, thioethers, and aryl 
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iodides are oxidized at the heteroatom.  Pyridines are oxidized quantitatively to the N-
oxides, which are in turn reluctant to react further with the peroxides.  Aryl thioethers are 
selectively oxidized to the sulfoxide using 1 equivalent of the peroxide, whereas 2 
equivalents provide the sulfone quantitatively.  Unfortunately, arenes containing aryl, 
benzyl, or alkyl amides do not react with the peroxide in a productive manner; only 
unreacted starting material is returned.  The peroxide is fully consumed throughout the 
course of the reaction, but as to why no product is attained remains an unsolved problem.  
NMR experiments conducted in deuterated HFIP provided no evidence as to what was 
occurring or how the peroxide was decomposing.  The use of different additives, either 
Brønsted or Lewis acids, did not aid this process.   
 Aryl nitriles, benzyl ethers, and arenes containing trifluoromethyl or nitro groups 
are extremely sluggish in the reaction.  Alternatively, pyrroles and indoles react violently 
with the peroxide to afford no desirable product, only black tar.  Lastly, extremely 
electron rich arenes such as diclofenac (375) and colchicine (376) were destroyed beyond 
structural assignment under the reaction conditions. 
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Table 3.5. Incompatible functional groups and arenes that are not oxidized using 4,5- 
dichlorophthaloyl peroxide.   
    
 
  
 The majority of previous arene oxidation procedures have focused on the 
hydroxylation of simple aromatics such as benzene, which is typically used as solvent 
and substrate.  To showcase the unique reactivity of 4,5-dichlorophthaloyl peroxide, 
benzene, fluorobenzene, chlorobenzene, and bromobenzene were reacted with 2.5 
equivalents of the peroxide in HFIP at 75 °C.  p-Trimethylsilyl toluene was also reacted 
with the peroxide, but TFE was used instead because HFIP promoted desilylation (Table 
3.6).  As the phenolic products were volatile, the intermediate mixed phthaloyl ester-
acids were esterified using trimethylsilyl diazomethane to generate the mixed phthalate 
esters 396 – 400.  After purifying these adducts via silica gel chromatography, they were 
then fully characterized.  While the yields were modest, the reactivity of 4,5-
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dichlorophthaloyl peroxide with these less reactive arenes is noteworthy as secondary 
oxidation of the products was not found to be competitive.  Also, p-trimethylsilyl toluene 
was oxidized to afford the ester 400 as the major product.  The minor product was the 
adduct containing the phthalate ester ortho to the silyl group which was isolated in 12% 
yield.  The residual material is unreacted starting silane.  No ipso substitution product 
was observed, which is interesting as aryl silanes tend to react through an EAS pathway 
with electrophiles to provide products of ipso substitution.181   
 
Table 3.6. Oxidation of halobenzenes and p-trimethylsilyl toluene using 4,5- 
dichlorophthaloyl peroxide. 
 
 
  
 Early computational analysis indicated that the phthaloyl peroxide mediated arene 
oxidation proceeded through a diradical reverse-rebound reaction pathway.171  The 4,5-
dichlorophthaloyl peroxide oxidation was initially hypothesized to proceed through an 
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ionic or EAS pathway.  However, the reactions producing the phenols of the dimethyl-
methylbenzoates 354-356 (Table 3.3) and the phthalate ester of trimethylsilyl toluene 
contradict this theory.  In light of these results and to fully elucidate the mechanism of 
this unique reaction, linear free energy relationships were examined to probe the 
transition state.  Using the observed reactivity of benzene and the halobenzenes 397-399, 
these relationships were assessed by reacting 5 equivalents of the corresponding arene 
and 5 equivalents of benzene with 1 equivalent of 4,5-dichlorophthaloyl peroxide in 
HFIP at 75 °C for 36 hours.  The reaction mixture was then concentrated, re-dissolved in 
a mixture of benzene/methanol (3:1), and esterified using an excess of trimethylsilyl 
diazomethane.  After concentration, the ratios of the crude phthalate esters were 
determined using 1H-NMR.  These experiments were conducted in duplicate to insure 
accuracy.   
 Examination of the reaction using the linear free energy relationships with  vs. 
 values established a linear trend with a low negative rho value (−3.92), corresponding 
best using values which supports a single electron process (Figure 3.4).  This is in 
juxtaposition to EAS which best fits to + values with large observed rho values (e.g. 
bromination, rho = −13).182   
 DFT and ab initio calculations on the barriers for diradical addition and 
electrophilic aromatic substitution show a similar reactivity trend to that depicted in the 
Hammett plot.  The calculations show that the EAS pathway is sensitive for electron-rich 
arenes.  The activation free energy difference is approximately 7 kcal/mol for the 
reactions using anisole and benzene, whereas the activation energy difference is only 
about 4 kcal/mol for the diradical addition.  This further substantiates that the slope 
obtained from the Hammett plot is closer to that for the diradical addition.  Further 
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analysis of the transition state using kinetic isotope experiments (KIE) delineated that 
rearomatization via hydrogen abstraction is not the rate determining step extrapolated by 
the low KIE of 1.22.     
 
Figure 3.4. Linear free energy plot for the 4,5-dichlorophthaloyl peroxide mediated      
        arene oxidation, computational analysis for the EAS and diradical addition  
        pathways and KIE experiments depicting the major mechanistic pathway. 
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 Hexamethylbenzene (407) was treated with 4,5-dichlorophthaloyl peroxide in 
HFIP at 23 °C to further indicate a diradical mechanism (Scheme 3.9).  After 
concentration, the crude solid mixture was dissolved in a solution of benzene/methanol 
and esterified using trimethylsilyl diazomethane.  The mixture was purified 
chromatographically to afford the ether 408 and the dibenzylester 409 which were then 
fully characterized.  No products of ipso substitution or arene oxidation were observed. 
  
Scheme 3.9. Reaction between hexamethylbenzene and 4,5-dichlorophthaloyl peroxide. 
 
 
 
 A surplus of evidence supports the major mechanistic pathway is the reverse-
rebound diradical addition.  To further confirm the presence of radicals, a series of 
benzylic oxidation experiments were conducted using mesitylene and both peroxides in 
different solvents at different temperatures.  The hydroxylation reaction works optimally 
in the fluorinated solvents HFIP and TFE as the highest degree of oxidation is observed 
when using HFIP.  These polar solvents can stabilize ionic intermediates and therefore 
can promote ionic reaction pathways.  However, the experiments used to probe the 
transition state depict that the major reaction pathway is not ionic, but it is through a 
diradical addition process.  HFIP and TFE can also stabilize radical intermediates through 
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hydrogen bonding effects which cause a remarkable increase in their persistence.183,184  
This stabilization effect could in turn enhance the reaction’s selectivity for arene 
oxidation over benzylic oxidation, whereas other solvents would not provide this 
stabilization (Schemes 3.4 and 3.5 depict the energetic barriers to effect these 
transformations).  The hypothesis for these experiments is that if non-fluorinated solvents 
are used then significant amounts of benzylic oxidation should be observed compared to 
the use of HFIP and TFE.  The use of non-protic halogenated solvents could potentially 
switch the mechanism to an ionic pathway, but if this were to occur then minimal 
benzylic oxidation should be observed, if any.  This hypothesis proved to be correct as 
depicted in Table 3.7.  When an excess of mesitylene was reacted with either peroxide in 
fluorinated or non-fluorinated solvents at different temperatures, a range of ratios for aryl 
versus benzylic oxidation was obtained.  These ratios were assessed by 1H-NMR analysis 
of the crude mixture and then confirmed by isolating the pure mixed phthalate esters after 
esterification.  In HFIP at 23, 50 or 65 °C, this ratio was 99:1.  The use of DCE at 65 °C 
promoted greater benzylic oxidation as observed by the ratio of 9:1.  Using either 
cylcohexane or CCl4 promoted more benzylic oxidation.  Lastly, switching the solvent to 
benzene or conducting the reaction in neat mesitylene also increased the amount of 
benzylic oxidation. 
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Table 3.7. Phthaloyl peroxide mediated benzylic oxidation experiments using mesitylene. 
 
  
 If the major reaction pathway was ionic then 4,5-dichlorophthaloyl peroxide 
should react much faster than phthaloyl peroxide, precluding the latter’s reaction with a 
substrate especially in an ionizing solvent such as HFIP or TFE.  However, this does not 
occur when a competition reaction is conducted using both peroxides (Table 3.8).  
Mesitylene was treated with 1 equivalent of phthaloyl peroxide and 1 equivalent of 4,5-
dichlorophthaloyl peroxide in the same reaction vessel in different solvents at 23 or 65 
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°C.  After concentration and esterification, the ratios of the phthalate adducts were 
determined by 1H-NMR of the crude reaction mixture.  As the solvent was changed from 
DCE to benzene, cyclohexane, and CCl4 the ratio of phthalate adducts diminished 
drastically from 99:1 to 2:1.  Also, when the reaction was conducted in HFIP or TFE at 
23 °C the ratios were only 4.1:1 and 3.5:1 respectively.  The experiments were also 
conducted using dimethoxy methylvanillate (414) at 23 and 65 °C as well.  The same 
trend is observed thereby providing further evidence that the predominant pathway for 
the arene hydroxylation reaction using either peroxide is a diradical reverse-rebound 
addition.  This does not exclude the possibility of an ionic mechanism, but this pathway 
is minor if it does occur. 
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Table 3.8. Competition experiments using mesitylene and dimethoxy methylvanillate  
       comparing the rates of reactivity between 4,5-dichlorophthaloyl peroxide and  
       phthaloyl peroxide in different solvents and temperatures. 
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Conclusion 
 
 A new protocol utilizing 4,5-dichlorophthaloyl peroxide has been developed to 
provide a novel, selective, and reliable strategy that oxidizes arenes to phenols.  With 
enhanced reactivity relative to the parent phthaloyl peroxide, this reagent can hydroxylate 
a wide range of substrates.  In addition, a variety of functional groups including alcohols, 
diols, amines, nitriles, carbamates, esters, aldehydes, ketones, and carboxylic acids are 
compatible, consistent with the hydroxylation reaction having broad applicability in 
synthesis.  This enhanced protocol is amenable for rapidly accessing various phenolic 
derivatives of drugs constituting that the strategy efficiently generates oxygenated 
analogs and metabolites.    
 Computational analysis conducted by Houk and Liang depicted that the major 
reaction pathway is a diradical reverse-rebound addition.  Experiments probing the 
transition state were conducted using linear free energy relationships.  The resultant 
Hammett plot supported the diradical addition mechanism as the major pathway as 
predicted by DFT and ab initio calculations.  This was further corroborated using a series 
of benzylic oxidation and competition experiments that provided substantial evidence of 
the diradical intermediate.  These mechanistic insights provide valuable information 
regarding a novel protocol that achieves selective C-H functionalization thereby creating 
a platform for the discovery of new chemical transformations using diradicals.    
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1.  Safety Information 
 
All peroxides can be dangerous when not handled correctly. The following procedures 
should be carried out by knowledgeable laboratory practitioners of organic synthesis. 
While we have not had a reaction using 4,5-dichlorophthaloyl peroxide detonate it is 
recommended that all reactions should be conducted with appropriate shielding as a 
precaution. Thermogravimetric analysis (TGA) data showed that 4,5-dichlorophthaloyl 
peroxide is stable below 115 ºC, however, there is a rapid loss in mass at ~135 °C 
indicating a potential exothermic decomposition. Earlier work with 4,5-dichlorophthaloyl 
peroxide also describes the stability and proper handling of this compound.1 
 
2. General 
 
Commercial reagents were purchased at the highest purity available and used without 
further purification.  Trimethylsilyl diazomethane (TMSCHN2) was purchased from 
Sigma-Aldrich as a 2.0 M solution in Et2O.  Reactions with 4,5-dichlorophthaloyl 
peroxide were performed without exclusion of air, other reactions were conducted under 
an atmosphere of N2 unless otherwise indicated.  Solvents (CH2Cl2 and Et2O) were 
purified using a Pure-Solv MD-5 Solvent Purification System (Innovative Technology).  
1,1,1,3,3,3-Hexafluoroisopropanol (HFIP) and 2,2,2-trifluoroethanol (TFE) were 
purchased from Oakwood Products and used without purification.  Deoxygenated 
solvents were deoxygenated by sparging with nitrogen for at least 1 hour while stirring 
vigorously at a rate of 1000 rpm unless otherwise noted.  HFIP, TFE, and methanol were 
removed by evaporation by positive flow of nitrogen.  Other organic solutions were 
concentrated by evaporation using Buchi or Heidolph rotary evaporators.  Analytical 
thin-layer chromatography (TLC) was carried out using 0.2 mm commercial glass-coated 
silica gel plates (silica gel 60, F254, EMD chemical). Thin layer chromatography plates 
were visualized by exposure to ultraviolet light and/or exposure to iodine powder, an 
acidic solution of ceric ammonium molybdate, or a basic solution of potassium 
permanganate followed by heating on a hot plate.  The chromatographic purification of 
products was achieved using silica gel chromatography with positive N2 pressure as 
described by Still.2  Infrared spectral data were recorded on a Nicolet 380 FTIR using neat 
thin film technique.  High-resolution mass spectral data (HRMS) were obtained on a 
Karatos MS9 and reported as m/z (relative intensity).  Accurate masses are reported for 
the molecular ion [M+Na]+, [M+H]+, [M+2H]2+, [M], or [M−H]−.  Nuclear magnetic 
resonance spectral data (1H NMR and 13C NMR) were recorded with a Varian Gemini 
(400 MHz, 1H at 400 MHz, 13C at 100 MHz, 500 MHz, 1H at 500 MHz, 13C at 125 MHz, 
or 600 MHz, 1H at 600 MHz, 13C at 150 MHz).  For CDCl3, C6D6, CD3OD, and C3D6O 
solutions, chemical shifts are reported as parts per million (ppm) referenced to residual 
protium or carbon of the solvent; CHCl3  7.26 ppm, CDCl3  77.00 ppm, C6D5H 
ppm, C6D6 128.00ppm, CD2HOH  4.85 ppm, CD3OD  47.60 ppm, C3D5HO  
2.05 ppm, and C3D6O  29.00 ppm.  Coupling constants are reported in Hertz (Hz). Data 
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for 1H-NMR spectral data are reported as follows: chemical shift (ppm, referenced to 
protium); bs = broad singlet, s = singlet, br d = broad doublet, d = doublet, t = triplet, q = 
quartet, dd = doublet of doublets, dt = doublet of triplets, ddd = doublet of doublet of 
doublets, dddd = doublet of doublet of doublet of doublets, m = multiplet, integration, 
and coupling constant (Hz).  Melting points were measured on a MEL-TEMP device with 
calibration using Benzoic Acid (M.P. = 122 °C) as the standard.  Thermogravimetric 
analysis (TGA) was obtained from a TGA Q500 V20.13 analyzer. 
 
  
326 
 
3. Experimental Procedure for 4,5-dichlorophthaloyl peroxide 
 
 
 
Solid 4,5-dichlorophthalic acid (309) (50.0 g, 213 mmol, 1.00 eq.) and solid phosphorus 
pentachloride (89.0 g, 427 mmol, 2.00 eq.) were added to a reaction vessel equipped 
under a continuous flow of nitrogen equipped with a reflux condenser and an outport 
leading to a saturated aqueous mixture of NaHCO3.  The solid mixture was placed in an 
oil bath heated to 180 °C and stirred vigorously (600 rpm). Caution: HCl Gas 
Evolution.  After 12 hrs the reaction vessel was removed from the oil bath, cooled to 23 
°C, equipped with a fractional distillation apparatus and the dark grey-black liquid was 
purified by fractional distillation in vacuo to afford the dichloride 310 (55.1 g, 192 mmol, 
90%, b.p. = 155 – 160 °C at 0.1 mmHg) as a clear colorless oil which solidified upon 
cooling to 23 °C.  The spectral data and physical properties match that for 4,5-
dichlorophthaloyl chloride.3  
 
1H-NMR (400 MHz, CDCl3): δ 7.98 (s, 2H)  
 
M.P. = 34 °C  
 
B.P. = 155 – 160 °C (0.1 mmHg). 
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 A mixture of solid 4,5-dichlorophthaloyl chloride 310 (25.5 g, 94 mmol, 1.00 eq.) 
and sodium percarbonate (16.2 g, 103 mmol, 1.10 eq.) were diluted with unpurified 
CH2Cl2 (469 mL).  The white heterogeneous mixture was placed under an atmosphere of 
N2 and stirred vigorously (1000 rpm).  After 24 hrs the mixture was filtered over a pad of 
celite and carefully concentrated by rotary evaporation (water bath set to 23 °C) to afford 
a pale yellow solid.  The solid was dissolved in benzene (110 mL) and then pentane (220 
mL) was slowly added to the stirring solution inducing a slow precipitation of a white 
solid.  The mixture was placed in an ice water bath cooled to 0 °C for 1 hr and filtered 
cold to afford the peroxide 296 as a white flakey solid (9.3 g, 40 mmol, 43%, 86% pure 
with 14% 4,5-dichlorophthaloyl anhydride).  A second precipitation of the filtrate 
solution after concentration provided the peroxide 296 (2.7 g, 12 mmol, 13%, 86% pure 
with 14% 4,5-dichlorophthaloyl anhydride).  Concentration of the filtrate solution after 
the second crop provided the starting 4,5-dichlorophthaloyl dichloride (5.7 g, 21 mmol, 
22%).  The spectral data data of 296 matches that for 4,5-dichlorophthaloyl peroxide.4 
 
1H NMR (400 MHz, CDCl3): δ 8.34 (s, 2H)  
 
13C NMR (100 MHz, CDCl3): δ 160.4, 142.4, 131.8, 122.6  
 
IR (neat film, cm-1) 1748, 906 cm-1 
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4. Experimental Procedures 
 
General Procedure A: 
 
To a flame-dried borosilicate flask equipped with a magnetic stir bar was added the 
corresponding arene as a solid or neat followed by the syringe addition of HFIP to 
provide a clear homogeneous solution with a substrate concentration of 0.1 M.  In some 
cases, when noted, CHCl3 was added to aid homogeneity.  Solid 4,5-dichlorophthaloyl 
peroxide 296 was then added in one portion unless otherwise noted. After stirring at a 
rate of 500 rpm at 23 °C for 1 minute to provide full dissolution of the peroxide, the 
reaction vessel was capped with a polyethylene stopper, clamped, placed in an oil bath 
heated to 50 °C, and stirred at a rate of 500 rpm.  After 24 or 48 hrs the reaction was 
removed from the oil bath and allowed to cool to 23 °C, the stopper was removed 
carefully, and the HFIP was evaporated by a continous flow of N2 to reveal a yellow, 
orange, or deep red solid mixture.  The crude solid mixture was then placed under an 
atmosphere of N2, and a deoxygenated mixture of MeOH and saturated aqueous NaHCO3 
(9:1) was added by syringe under N2 to provide an overall reaction concentration of 0.1 
M.  The heterogeneous mixture was placed in an oil bath heated to 50 °C and stirred at a 
rate of 500 rpm.  After 1 hr the methanol was removed by a continuous flow of N2, and to 
the mixture was added Et2O or EtOAc (10 mL) and an aqueous phosphate buffer (10 mL, 
0.2 M, pH = 7).  The mixture was vigorously stirred (800 rpm) at 23 °C for 2 minutes to 
provide a biphasic solution which was poured into a separatory funnel and partitioned.  
The organic layer was washed with an aqueous phosphate buffer (4 x 30 mL, 0.2 M, pH = 
7) or with the combination of an aqueous saturated mixture of NaHCO3 and brine (3 x 30 
mL, 1:1).  The residual organics were extracted from the aqueous layer with Et2O (3 x 25 
mL) or EtOAc (3 x 25 mL), dried over solid Na2SO4, decanted, and concentrated 
carefully (NOTE: Some of phenolic products are volatile).  The crude material was then 
purified by silica gel chromatography using the noted solvent mixture to afford the 
phenolic products. 
 
General Procedure B: 
 
To a flame-dried borosilicate flask equipped with a magnetic stir bar was added the 
corresponding arene as a solid or neat followed by the syringe addition of HFIP to 
provide a clear homogeneous solution with a substrate concentration of 0.1 M.  In some 
cases, when noted, CHCl3 was added to aid homogeneity.  Solid 4,5-dichlorophthaloyl 
peroxide 296 was then added in one portion. After stirring at a rate of 500 rpm at 23 °C 
for 1 minute to provide full dissolution of the peroxide, the reaction vessel was capped 
with a polyethylene stopper, clamped, placed in an oil bath heated to 75 °C, and stirred at 
a rate of 500 rpm.  After 36 or 48 hours the reaction was removed from the oil bath and 
allowed to cool to 23 °C, the stopper was removed carefully, and the HFIP was 
evaporated by a continous flow of N2 to reveal a yellow, orange, or deep red solid 
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mixture.  The crude solid mixture was then placed under an atmosphere of N2, and a 
deoxygenated mixture of MeOH and saturated aqueous NaHCO3 (9:1) was added by 
syringe under N2 to provide an overall reaction concentration of 0.1 M.  The 
heterogeneous mixture was then placed in an oil bath heated to 50 °C and stirred at a rate 
of 500 rpm.  After 1 hr the methanol was removed by a continuous flow of N2, and the 
mixture was diluted with Et2O or EtOAc (10 mL) and an aqueous phosphate buffer (10 
mL, 0.2 M, pH = 7).  The mixture was vigorously stirred (800 rpm) at 23 °C for 2 
minutes to provide a biphasic solution which was poured into a separatory funnel and 
partitioned.  The organic layer was washed with an aqueous phosphate buffer (4 x 30 mL, 
0.2 M, pH = 7) or with the combination of an aqueous saturated mixture of NaHCO3 and 
brine (3 x 30 mL, 1:1).  The residual organics were extracted from the aqueous layer with 
Et2O (3 x 25 mL) or EtOAc (3 x 25 mL), dried over solid Na2SO4, decanted, and 
concentrated carefully (NOTE: Some of the phenolic products are volatile).  The crude 
material was then purified by silica gel chromatography using the noted solvent mixture 
to provide the phenolic products. 
 
General Procedure C:  
 
To a flame-dried borosilicate flask equipped with a magnetic stir bar was added the 
corresponding arene as a solid or neat followed by the syringe addition of HFIP to 
provide a clear homogeneous solution with a substrate concentration of 0.1 M.  Solid 4,5-
dichlorophthaloyl peroxide was then added in one portion. After stirring at a rate of 500 
rpm at 23 °C for 1 minute to provide full dissolution of the peroxide, the reaction vessel 
was capped with a polyethylene stopper, clamped, placed in an oil bath heated to 75 °C, 
and stirred at a rate of 500 rpm.  After 36 hours the reaction was removed from the oil 
bath and allowed to cool to 23 °C.  The stopper was removed carefully and the HFIP was 
evaporated to dryness by a continous flow of N2 to reveal a yellow solid mixture.  The 
crude mixture was then dissolved in a benzene/methanol solution (3:1) providing an 
overall substrate concentration of 0.1 M and the clear yellow homogeneous solution was 
stirred at a rate of 500 rpm.  TMSCHN2 (5.00 eq., 0.2 M in Et2O) was added in a slow 
dropwise fashion over 1 minute. Caution: Rapid N2 gas evolution.  After 30 minutes the 
deep yellow–orange solution was evaporated by a continuous flow of N2 to provide a 
yellow–orange foam which was purified by silica gel chromatography using the noted 
solvent mixture to provide the mixed phthalate ester products. 
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Diol 327a and 327b: Prepared following General Procedure A using hydrocinnamyl 
alcohol (100.0 mg, 0.73 mmol, 1.00 eq), 4,5-dichlorophthaloyl peroxide (256.0 mg, 0.96 
mmol, 1.30 eq., 86%), and HFIP (7.3 mL) at 50 °C for 48 hrs.  The crude brown foam 
was purified by silica gel chromatography; 2 – 30% EtOAc in CH2Cl2 and hexane (1:1) 
to provide the title compounds 327a and 327b (56.0 mg, 0.37 mmol, 50%, 327a : 327b = 
2 : 1) as an orange foam and the starting alcohol (39.2 mg, 0.29 mmol, 39%) as a clear 
colorless oil.  The spectral data of the title compounds match that for 327a and 327b.5-8 
 
Major Isomer (327a):  
 
1H-NMR (400 MHz, CDCl3): δ 7.07 (d, 1H, J  =  8.6 Hz), 6.76 (d, 1H, J  =  8.6 Hz), 3.67 
(t, 2H, J = 6.5 Hz), 2.64 (t, 2H, J = 7.9 Hz), 1.92 – 1.82 (m, 2H).5-7 
 
Minor Isomer (327b):  
 
1H-NMR (400 MHz, CDCl3): δ 7.10 (d, 2H, J  =  7.5 Hz), 6.88 (d, 1H, J  =  7.5 Hz), 6.85 
(d, 1H, J = 7.5 Hz), 3.66 (t, 2H, J = 5.8 Hz), 2.78 (dd, 2H, J = 6.5, 7.2 Hz), 1.92 – 1.82 
(m, 2H).8 
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Diols 328a and 328b: Prepared following General Procedure A using methyl 
hydrocinnamyl alcohol (100.0 mg, 0.67 mmol, 1.00 eq), 4,5-dichlorophthaloyl peroxide 
(232.0 mg, 0.96 mmol, 1.30 eq., 87%), and HFIP (6.7 mL) at 50 °C for 48 hrs.  The crude 
brown foam was purified by silica gel chromatography; 2 – 30% EtOAc in CH2Cl2 and 
hexane (1:1) to provide the title compounds 328a and 328b (59.0 mg, 0.36 mmol, 53%, 
328a : 328b = 1.4 : 1) as an orange foam and the starting alcohol (24.0 mg, 0.16 mmol, 
24%) as a clear colorless oil.  The spectral data of the title compounds match that for 
328a and 328b.9-10 
 
Major Isomer (328a):  
 
1H-NMR (400 MHz, CDCl3): δ 7.07 (d, 2H, J  =  8.6 Hz), 6.75 (d, 2H, J  =  8.6 Hz), 3.82 
(m, 1H), 2.89 (m, 2H), 2.72 – 2.57 (m, 2H), 1.22 (d, 3H, J = 6.1 Hz).9   
  
Minor Isomer (328b):  
 
1H-NMR (400 MHz, CDCl3): δ 7.09 (m, 2H), 6.88 (m, 2H), 3.76 (m, 1H), 2.89 (m, 2H), 
2.72 – 2.57 (m, 2H), 1.22 (d, 3H, J = 6.1 Hz).10 
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Aldehyde 329a and Lactol 329b: Prepared following General Procedure B using the 
hydrocinnamyl aldehyde (100.0 mg, 0.71 mmol, 1.00 eq., 95% pure), 4,5-
dichlorophthaloyl peroxide (480.0 mg, 1.77 mmol, 2.50 eq., 86%), and HFIP (7.1 mL) at 
75 °C for 36 hrs.  The crude brown foam was purified by silica gel chromatography; 1 – 
5% Et2O in CH2Cl2 / hexane (1:1) to provide the aldehyde 329a (21.0 mg, 0.14 mmol, 
20%) and the lactol 329b (21.0 mg, 0.14 mmol, 20%) as yellow foams.  The spectral data 
of the title compounds match that for 329a and 329b.11-12 
 
Aldehyde 329a:  
 
1H-NMR (400 MHz, CDCl3): δ 9.81 (t, 1H, J  =  1.7 Hz), 7.06 (d, 2H, J  =  8.6 Hz), 6.76 
(d, 2H, J = 8.6 Hz), 4.59 (bs, 1H), 2.89 (t, 2H, J = 7.5 Hz), 2.74 (dd, 2H, J = 1.7, 7.5 
Hz).11   
 
Lactol 329b:  
 
1H-NMR (400 MHz, CDCl3): δ 7.12 (t, 1H, J = 7.9 Hz), 7.07 (d, 1H, J = 7.2 Hz), 6.89 (t, 
1H, J = 7.2 Hz), 6.82 (d, 1H, J = 7.9 Hz), 5.62 (m, 1H), 3.03 (bs, 1H,), 2.99 (m, 1H), 2.71 
(dt, 1H, J = 5.1, 5.5 Hz), 2.06 – 1.99 (m, 2H).12 
  
333 
 
 
 
Ketones 330a and 330b:  Prepared following General Procedure B using the 
hydrocinnamyl aryl ketone (100.0 mg, 0.48 mmol, 1.00 eq.), 4,5-dichlorophthaloyl 
peroxide (322.0 mg, 1.19 mmol, 2.50 eq., 86%), and HFIP (4.8 mL) at 75 °C for 36 
hours.  The crude brown foam was purified by silica gel chromatography; 1 – 10% 
Et2O in CH2Cl2 / hexane (1:1) to provide the ketone 330a (32.3 mg, 0.14 mmol, 30%) 
and the ketone 330b (30.0 mg, 0.13 mmol, 28%) as orange foams.  The spectral data of 
the title compounds match that for 330a and 330b.13-14 
 
Major Isomer (330a):  
 
1H-NMR (400 MHz, CDCl3): δ 7.98 (d, 2H, J = 7.2 Hz), 7.88 (bs, 1H), 7.58 (t, 1H, J = 
7.2 Hz), 7.45 (t, 2H, J = 7.5 Hz), 7.11 (dd, 2H, J = 7.2, 7.5 Hz), 6.91 (d, 1H, J = 7.9 
Hz), 6.85 (t, 1H, J = 7.5 Hz), 3.46 (dd, 2H, J = 5.8, 6.2 Hz), 3.04 (dd, 2H, J = 5.8, 6.2 
Hz).13 
 
Minor Isomer (330b):  
 
1H-NMR (400 MHz, CDCl3): δ 7.95 (d, 2H, J = 6.8 Hz), 7.56 (t, 1H, J = 7.5 Hz), 7.45 
(t, 2H, J = 7.5 Hz), 7.12 (d, 2H, J = 8.6 Hz), 6.77 (d, 2H, J = 8.6 Hz), 4.58 (bs, 1H), 
3.26 (t, 2H, J = 7.7 Hz), 3.00 (dd, 2H, J = 7.7 Hz).14 
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Esters 331a and 331b: Prepared following General Procedure B using the 
hydrocinnamyl methyl ester (100.0 mg, 0.61 mmol, 1.00 eq.), 4,5-dichlorophthaloyl 
peroxide (399.0 mg, 1.52 mmol, 2.50 eq., 89%), and HFIP (6.1 mL) at 75 °C for 36 hrs.  
The crude brown foam was purified by silica gel chromatography; 1 – 5% Et2O in 
CH2Cl2 / hexane (1:1) to provide the esters 331a and 331b (81.3 mg, 0.55 mmol, 74%, 
331a : 331b = 1.6 : 1) as a pale yellow foam and the starting ester (5.1 mg, 0.03 mmol, 
5%) as a clear colorless oil.  The spectral data of the title compounds match that for 
331a and 331b.15-16  
 
Major Isomer (331a):  
 
1H-NMR (400 MHz, CDCl3): δ 7.26 (bs, 1H), 7.06 (d, 2H, J  = 8.6 Hz), 6.88 (d, 2H, J 
= 8.6 Hz), 3.69 (s, 3H), 2.91 (t, 2H, J = 6.8 Hz), 2.73 (t, 2H, J = 6.8 Hz).15 
 
Minor Isomer (331b):  
 
1H-NMR (400 MHz, CDCl3): δ 7.11 (m, 2H), 6.75 (d, 2H, J = 8.6 Hz), 3.66 (s, 3H), 
2.88 (t, 2H, J = 7.9 Hz), 2.59 (t, 2H, J = 7.9 Hz).16  
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Acids 332a and 332b: Prepared following General Procedure B using hydrocinnamic 
acid (100.0 mg, 0.67 mmol, 1.00 eq.), 4,5-dichlorophthaloyl peroxide (451.0 mg, 1.67 
mmol, 2.50 eq., 86%), CHCl3 (1.7 mL), and HFIP (5.0 mL) at 75 °C for 48 hrs.  After 
removal of the HFIP and CHCl3 by continuous positive flow of nitrogen, the mixed 
phthalate diacid was placed under an atmosphere of N2, suspended in 1,4-dioxane (6.0 
mL) added via syringe, and then a saturated aqueous mixture of NaHCO3 (0.7 mL) was 
added via a syringe.  The red-orange suspension was placed in an oil bath heated to 50 
°C and stirred vigorously (700 rpm).  After 1 hour the red solution was removed from 
the oil bath, acidified to a pH = 2 using 1 N HCl (3 mL), diluted with EtOAc (20 mL), 
poured into a separatory funnel containing brine (20 mL), and the layers were 
partioned.  The organics were washed with an aqueous phosphate buffer (2 x 20 mL, 
0.2 M, pH = 4) and the residual organics were extracted from the aqueous layer with a 
mixture of EtOAc and brine (4 x 30 mL, 1:1).  The combined organics were dried over 
solid Na2SO4, decanted, and concentrated to reveal an orange solid.  The orange solid 
was suspended in CH2Cl2 (30 mL), heated for 5 minutes with a heat gun, and sonicated 
for 1 minute.  The residual orange mixture was filtered to remove the insoluble white 
solid 4,5-dichlorophthalic acid.  The orange filtrate solution was concentrated to reveal 
an orange solid which was purified by silica gel chromatography; 1% CH3OH and 1% 
AcOH in CH2Cl2 to provide the acids 332a and 332b (71.8 mg, 0.43 mmol, 65%, 332a 
: 332b = 1 : 1) as an orange solid mixture and the starting acid (12.0 mg, 0.08 mmol, 
12%) as a white solid.  The spectral data of the title compounds match that for 332a 
and 332b.17,18 
 
Acid 332a:  
 
1H-NMR (400 MHz, CDCl3): δ 7.08 (d, 2H, J = 8.6 Hz), 6.76 (d, 2H, J = 8.6 Hz), 2.90 
(t, 2 H, J = 7.5 Hz), 2.65 (t, 2 H, J = 7.5 Hz).17 
 
Acid 332b:  
 
1H-NMR (400 MHz, CDCl3): δ 7.11 (d, 2H, J = 8.6 Hz), 6.82 – 6.89 (m, 2H, J = 8.6 
Hz), 2.92 (t, 2 H, J = 6.5 Hz), 2.78 (t, 2 H, J = 6.5 Hz).18 
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Nitriles 333a and 333b: Prepared following General Procedure B using the 
hydrocinnamyl nitrile (100.0 mg, 0.76 mmol, 1.00 eq.), 4,5-dichlorophthaloyl peroxide 
(516.0 mg, 1.91 mmol, 2.50 eq., 86%), and HFIP (7.6 mL) at 75 °C for 36 hrs.  The 
crude brown foam was purified by silica gel chromatography; 1 – 10% Et2O in CH2Cl2 
/ hexane (1:1) to provide the nitriles 333a (23.1 mg, 0.16 mmol, 21%) and 333b (21.0 
mg, 0.14 mmol, 19%) as pale yellow foams and the starting nitrile (25.8 mg, 0.20 
mmol, 26%) as a clear colorless oil.  The spectral data of the title compounds match 
that for 333a and 333b.19,20 
 
Nitrile 333a:  
 
1H-NMR (400 MHz, CDCl3): δ 7.11 (d, 2H, J = 8.6 Hz), 6.80 (d, 2H, J = 8.6 Hz), 4.67 
(bs, 1H), 2.89 (t, 2H, J = 7.5 Hz), 2.58 (t, 2H, J = 7.5 Hz).19  
 
Nitrile 333b:  
1H-NMR (400 MHz, CDCl3): δ 7.17 (dd, 1H, J = 1.7, 7.2 Hz), 7.13 (dd, 1H, J = 1.7, 7.9 
Hz), 6.91 (dt, 1H, J = 1.7, 7.2 Hz), 6.73 (d, 1H, J = 7.9 Hz), 4.85 (bs, 1H), 2.98 (t, 2H, J 
= 7.5 Hz), 2.67 (t, 2H, 7.5 Hz).20 
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Esters 334a and 334b:  Prepared following General Procedure B using the starting 
methyl ester (100.0 mg, 0.67 mmol, 1.00 eq.), 4,5-dichlorophthaloyl peroxide (436.0 mg, 
1.67 mmol, 2.50 eq., 89%), and HFIP (6.7 mL) at 75 °C for 36 hrs.  The crude orange 
foam was purified by silica gel chromatography; 1 – 10% Et2O in CH2Cl2 / hexane (1:1) 
to provide the esters 334a and 334b (52.4 mg, 0.32 mmol, 48%, 334a : 334b = 1.4 : 1) as 
a pale yellow foam and the starting ester (27.1 mg, 0.18 mmol, 27%) as a clear colorless 
oil.  The spectral data of the title compounds match that for 334a and 334b.21-22 
Major Isomer (334a):  
1H-NMR (400 MHz, CDCl3): δ 7.33 (bs, 1H), 7.20 (m, 1H), 7.10 (dd, 1H, J = 1.6, 7.4 
Hz), 6.94 (d, 1H, J = 8.2 Hz), 6.89 (dt, 1H, J = 1.2, 7.4 Hz), 3.75 (s, 3H), 3.68 (s, 2H).21 
Minor Isomer (334b):  
1H-NMR (400 MHz, CDCl3): δ 7.15 (d, 2H, J = 8.2 Hz), 6.78 (d, 2H, J = 8.2 Hz), 3.72 
(s, 3 H), 3.58 (s, 2 H).22 
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Amides 335a and 335b:  Prepared following General Procedure B using the starting 
trifluoroacetamide (100.0 mg, 0.46 mmol, 1.00 eq.), 4,5-dichlorophthaloyl peroxide 
(523.0 mg, 1.84 mmol, 4.00 eq., 82%), and HFIP (4.6 mL) at 75 °C for 72 hrs.  After 
removal of the HFIP by continuous positive flow of nitrogen, the mixed phthalate ester-
acid was placed under an atmosphere of N2, THF (2.3 mL) was added via syringe, and an 
aqueous phosphate buffer (2.3 mL, pH = 7, 0.2 M) was added via syringe.  The yellow 
biphasic solution was stirred vigorously (1000 rpm) at 23 °C.  After 24 hrs the solution 
was diluted with EtOAc (20 mL), poured into a separatory funnel containing an aqueous 
phosphate buffer (10 mL, pH = 7, 0.2 M), and the layers were partioned.  The organics 
were washed with an aqueous phosphate buffer (4 x 20 mL, 0.2 M, pH = 7) and the 
residual organics were extracted from the aqueous layer with EtOAc (4 x 30 mL).  The 
combined organics were dried over solid Na2SO4, decanted, and concentrated.  The crude 
brown foam was purified by silica gel chromatography; hexane → 25% acetone in 
hexane to provide the amides 335a (28.8 mg, 0.12 mmol, 27%) and 335b (23.6 mg, 0.10 
mmol, 22%) as pale yellow foams.23 
Amide 335a:  
1H-NMR (400 MHz, CDCl3): δ 7.17 – 7.10 (m, 2H), 7.05 (bs, 1H), 6.91 (dt, 1H, J = 1.0, 
7.5 Hz), 6.80 (d, 1H, 8.2 Hz), 3.60 (q, 2H, J = 6.5 Hz), 2.93 (t, 2H, J = 6.5 Hz) 
Amide 335b: 
1H-NMR (400 MHz, CDCl3): δ 7.05 (d, 2H, J = 8.2 Hz), 6.80 (d, 2H, J = 8.2 Hz), 6.25 
(bs, 1H), 3.58 (q, 2H, J = 6.5 Hz), 2.81 (t, 2H, J = 6.5 Hz). 
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Sulfonamides 336a and 336b:  Prepared following General Procedure B using the 
sulfonamide (100.0 mg, 0.38 mmol, 1.00 eq.), 4,5-dichlorophthaloyl peroxide (265.0 mg, 
0.96 mmol, 2.50 eq., 84%), and HFIP (3.8 mL) at 75 °C for 72 hrs.  The crude orange 
foam was purified by silica gel chromatography; hexane – 25% acetone in hexane to 
provide the sulfonamide 336a (34.8 mg, 0.13 mmol, 33%) as a yellow amorphous foam 
and 336b (27.8 mg, 0.10 mmol, 26%) as a white solid. 
Sulfonamide 336a:  
Rf = 0.40 (35% acetone in hexane) 
1H-NMR (400 MHz, CDCl3): δ 7.78 (d, 2H, J = 7.2 Hz), 7.53 (d, 1H, J = 7.9 Hz), 7.45 
(dt, 2H, J = 7.2, 7.9 Hz), 7.08 (t, 1H, 7.9 Hz), 6.97 (dd, 1H, J = 1.4, 7.5 Hz), 6.81 (t, 1H, 
J  = 7.5 Hz), 6.75 (d, 1H, J = 7.9 Hz), 5.62 (bs, 1H), 4.99 (bs, 1H), 3.23 (m, 2H), 2.79 (t, 
2H, J = 6.5 Hz) 
13C-NMR (100 MHz, CDCl3): δ 153.86, 139.46, 132.80, 132.60, 130.92, 129.07, 128.21, 
127.00, 126.38, 124.40, 120.94, 115.60, 43.58, 30.39 
IR (neat film, cm-1): 3274, 1457, 1447, 1322, 1157, 1093, 755 
HRMS (EC-CI): calcd. for C14H15NO3S [M] 277.0773, found 277.0779.  
Sulfonamide 336b: 
Rf = 0.33 (35% acetone in hexane) 
1H-NMR (400 MHz, C3D6O): δ 8.14 (bs, 1H), 7.85 (m, 2H), 7.60 (m, 3H), 6.97 (d, 2H, J 
= 8.6 Hz), 6.71 (d, 2H, J = 8.6 Hz), 6.45 (bs, 1H), 3.09 (m, 2H), 2.67 (t, 2H, J = 7.2 Hz) 
13C-NMR (100 MHz, CDCl3): δ 156.73, 142.01, 133.06, 130.51, 130.21, 129.88, 127.71, 
115.99, 45.70, 35.86 
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IR (neat film, cm-1): 3391, 3019, 2924, 1215, 757 
 
HRMS (EC-CI): calcd. for C14H15NO3S [M] 277.0773, found 277.0776.  
 
M.P.: 116 – 121 °C 
 
 
 
 A solution of phenethylamine (0.29 g, 0.30 mL, 2.36 mmol, 2.10 eq.) in 
methylene chloride (11 mL) was placed in an ice water bath cooled to 0 °C for 20 
minutes upon which solid dinitrobenzene sulfonyl chloride (0.30 g, 1.13 mmol, 1.00 eq.) 
was added under a positive flow of nitrogen.  After 2 hrs the golden yellow-orange 
solution was diluted with an aqueous phosphate buffer (20 mL, pH = 7, 0.2 M), poured 
into a separatory funnel, partitioned, and the organic layer was washed with an aqueous 
phosphate buffer (2 x 10 mL, pH = 7, 0.2 M).  Residual organics were extracted from the 
aqueous layer with methylene chloride (2 x 10 mL), dried over solid Na2SO4, decanted, 
and concentrated.  The crude yellow-orange solid mixture was purified by silica gel 
chromatography; 10% acetone in hexane to afford the dinitrobenzene sulfonamide 
product as a yellow solid (0.32 g, 0.90 mmol, 80%). 
Rf = 0.61 (50% acetone in hexane) 
1H-NMR (400 MHz, CDCl3): δ 8.59 (d, 1H, J = 2.0 Hz), 8.45 (dd, 1H, J = 2.4, 8.6 Hz), 
8.19 (d, 1H, J = 8.6 Hz), 7.21 – 7.13 (m, 3H), 7.08 – 7.06 (m, 2H), 5.36 (t, 1H, J = 5.8 
Hz), 3.50 (q, 2H, J = 6.5 Hz), 2.85 (t, 2H, J = 6.5 Hz) 
13C-NMR (100 MHz, CDCl3): δ 149.58, 147.80, 139.30, 137.15, 132.26, 128.76, 128.71, 
127.13, 127.02, 120.73, 45.38, 36.01 
IR (neat film, cm-1): 1549, 1537, 1349, 1167, 747 
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HRMS (EC-CI): calcd. for C14H13N3O6S [M] 352.0603, found 352.0602. 
M.P.: 117 – 120 °C  
 
Sulfonamides 337a and 337b:  Prepared following General Procedure B using the 
starting dinitrosulfonamide (100.0 mg, 0.29 mmol, 1.00 eq.), 4,5-dichlorophthaloyl 
peroxide (197.0 mg, 0.71 mmol, 2.50 eq., 84%), and HFIP (2.9 mL) at 75 °C for 72 hrs.  
The crude orange foam was purified by silica gel chromatography; hexane – 25% acetone 
in hexane to provide the dinitrosulfonamides 337a (34.1 mg, 0.09 mmol, 33%) and 337b 
(33.2 mg, 0.09 mmol, 32%) as yellow solids and the starting dinitrosulfonamide as a 
yellow solid (22.7 mg, 0.07 mmol, 23%). 
Sulfonamide 337a:  
Rf = 0.56 (50% acetone in hexane) 
1H-NMR (400 MHz, C3D6O): δ 8.70 (d, 1H, J = 2.4 Hz), 8.59 (dd, 1H, J = 2.4, 8.9 Hz), 
8.27 (d, 1H, J = 8.9 Hz), 7.04 (dd, 1H, 1.7, 7.5 Hz), 6.95 (dt, 1H, J = 1.7, 7.5 Hz), 6.71 
(dd, 1H, J  = 1.0, 7.5 Hz), 6.63 (dt, 1H, J = 1.0, 7.5 Hz), 3.49 (t, 2H, J = 7.1 Hz), 2.85 (t, 
2H, J = 7.1 Hz) 
13C-NMR (100 MHz, CDCl3): δ 155.13, 149.58, 147.80, 138.80, 132.04, 130.92, 127.75, 
127.14, 124.44, 120.31, 119.55, 114.80, 43.58, 30.60 
IR (neat film, cm-1): 3349, 1538, 1350, 1167, 748 
HRMS (EC-CI): calcd. for C14H13N3O7S [M] 367.0474, found 367.0471. 
M.P.: 128 – 130 °C  
Sulfonamide 336b: 
Rf = 0.53 (50% acetone in hexane) 
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1H-NMR (400 MHz, C3D6O): δ 8.70 (d, 1H, J = 1.2 Hz), 8.57 (m, 1H), 8.16 (dd, 1H, J = 
1.6, 8.6 Hz), 6.97 (d, 2H, J = 8.2 Hz), 6.58 (d, 2H, J = 8.2 Hz), 3.46 (t, 2H, J = 7.1 Hz), 
2.77 (t, 2H, J = 7.1 Hz) 
13C-NMR (100 MHz, CDCl3): δ 139.02, 132.01, 129.89, 128.93, 127.25, 120.22, 115.03, 
45.62, 34.82 
IR (neat film, cm-1): 3391, 1538, 1350, 1165, 747 
HRMS (EC-CI): calcd. for C14H13N3O7S [M] 367.0474, found 367.0470. 
M.P.: 134 – 136 °C 
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 To a solution of methyl 4-(3-chloropropoxy)-3-methoxybenzoate (1.37 g, 5.30 
mmol, 1.00 eq.) in dimethylformamide (28.5 mL) was added NaI (1.59 g, 10.59 mmol, 
2.00 eq.) and diethylamine (1.64 mL, 15.89 mmol, 3.00 eq.). The flask was purged with 
N2 and placed in an oil bath heated to 80 °C.  After 24 hrs the solution was removed from 
the oil bath and allowed to cool to 23 °C, poured into a separatory funnel containing 3 N 
LiCl (150 mL), partitioned, and the organics were extracted from the aqueous layer with 
EtOAc (4 x 50 mL). The combined organics were washed with 3 N LiCl (1 x 50 mL) to 
remove residual DMF, washed with brine (1 x 50 mL), dried over solid Na2SO4, 
decanted, and concentrated.  The crude mixture was purified by silica gel 
chromatography; 1% CH3OH and 1% Et3N in CH2Cl2 to provide the amine as an amber 
oil (1.25 g, 4.24 mmol, 80%).   
 
Rf = 0.40 (2% CH3OH and 2% Et3N in CH2Cl2) 
 
1H-NMR (400 MHz, CDCl3): δ 7.64 (dd, 1H, J = 2.0, 8.6 Hz), 7.53 (d, 1H, J =2.0 Hz), 
6.90 (d, 1H, J = 8.2 Hz), 4.12 (t, 2H, J = 6.6 Hz), 3.90 (s, 3H), 3.89 (s, 3H), 2.61 (t, 2H, J 
= 7.1 Hz), 2.54 (q, 4H, J = 7.4 Hz), 1.99 (m, 2H), 1.01 (t, 6H, J = 7.4 Hz)  
 
13C-NMR (100 MHz, CDCl3): δ 166.92, 152.53, 148.81, 123.49, 122.4, 112.28, 111.52, 
67.39, 56.01, 51.93, 49.07, 46.92, 26.61, 11.70  
 
IR (neat film, cm-1): 2967, 2809, 1717, 1293  
 
HRMS (EC-CI): [M+Na]+ calc’d for C16H25NO4: 318.16758.  Found: 318.16729.  
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 To a stirred solution of the starting amine (75.0 mg, 0.254  mmol, 1.00 eq.) in 
HFIP (2.5 mL) at 23 °C was added p-toluenesulfonic acid (43.7 mg, 0.254 mmol, 1.00 
eq.).  After 2 minutes 4,5-dichlorophthaloyl peroxide (89.0 mg, 0.33 mmol, 1.30 eq., 
86%) was added.  After 4 hrs the solvent was removed by a continuous flow of N2 
providing the mixed phthalate acid as a red solid. The crude solid was placed under an 
atmosphere of N2, suspended in a deoxygenated mixture of methanol and saturated 
aqueous NaHCO3 (9:1, 2.5 mL), and placed in an oil bath heated to 50 °C for 1 hr.  The 
mixture was removed from the oil bath, cooled to 23 °C and an aqueous phosphate buffer 
(5 mL, 0.2 M, pH = 10) was added.   The biphasic mixture was poured into a separatory 
funnel, partitioned, and the residual organics were extracted from the aqueous layer with 
EtOAc (3 x 5 mL).  The combined organics were washed with an aqueous phosphate 
buffer (1 x 5 mL, 0.2 M, pH = 10), brine (1 x 5 mL), dried over solid Na2SO4, and 
concentrated.  The crude mixture was purified by silica gel chromatography; 1% 
methanol and 1% triethylamine in CH2Cl2 to afford the phenol 338 as a clear colorless oil 
(67.7 mg, 0.22 mmol, 85%).  
Rf = 0.40 (2% methanol and 2% triethylamine in CH2Cl2)  
1H NMR (400 MHz, CDCl3): δ 10.79 (s, 1 H), 7.55 (d, 1H, J = 9.0 Hz), 6.48 (d, 1H, J = 
9.0 Hz), 4.12 (m, 2H), 3.92 (s, 3H), 3.87 (s, 3H), 2.65 (t, 2H, J = 7.0 Hz), 2.57 (q, 4H, J 
= 7.0 Hz), 1.99 (t, 2H, J = 7.0 Hz), 1.04 (t, 6H, J = 7.0 Hz)  
13C NMR (100 MHz, CDCl3): δ 170.14, 157.28, 155.71, 136.35, 125.27, 106.52, 103.90, 
66.84, 60.31, 51.76, 48.86, 46.66, 26.37, 11.21 
IR (neat film, cm -1): 3369, 2966, 2917, 1720, 1240  
HRMS (EC-CI): [M+H]+ calc’d for C16H26NO5: 312.1806; found: 312.1800. 
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Phenols 339a and 339b:  Prepared following General Procedure A using biphenyl (100.0 
mg, 0.65 mmol, 1.00 eq.), 4,5-dichlorophthaloyl peroxide (226.0 mg, 0.84 mmol, 1.30 
eq., 87%), and HFIP (6.5 mL) at 40 °C for 24 hrs.  The crude orange foam was purified 
by silica gel chromatography; 1 – 10% Et2O in CH2Cl2 / hexane (1:1) to afford the 
phenols 339a (35.0 mg, 0.21 mmol, 32%) and 339b (31.0 mg, 0.18 mmol, 28%) as pale 
yellow solids and the starting biphenyl as a white solid (21.1 mg, 0.13 mmol, 21%).  The 
spectral data of the title compounds match that of the phenols 339a and 339b.5 
Phenol 339a: 
1H NMR (400 MHz, CDCl3):  δ 7.53 (m, 2H), 7.48 (d, 2H, J = 8.6 Hz), 7.41 (t, 2H, J 
=7.9 Hz), 7.30 (t, 1H, J = 7.9 Hz), 7.25 (m, 1H), 6.91 (d, 2H, J = 8.6 Hz), 4.70 (bs, 1H) 
Phenol 339b: 
1H NMR (400 MHz, CDCl3):  δ 7.48 (m, 4H), 7.40 (m, 1H), 7.26 (m, 2H), 7.00 (dt, 1H, J 
= 1.3, 6.1 Hz), 6.99 (d, 1H, J = 7.8 Hz), 5.18 (bs, 1H) 
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Phenols 340a and 340b:  Prepared following General Procedure A using diphenyl ether 
(100.0 mg, 0.59 mmol, 1.00 eq.), 4,5-dichlorophthaloyl peroxide (207.0 mg, 0.76 mmol, 
1.30 eq., 86%), and HFIP (6.5 mL) at 50 °C for 24 hrs.  The crude orange foam was 
purified by silica gel chromatography; 1 – 10% Et2O in CH2Cl2 / hexane (1:1) to afford 
the phenols 340a (37.6 mg, 0.20 mmol, 35%) and 340b (29.0 mg, 0.16 mmol, 27%) as 
pale yellow amorphous oils and the starting diphenyl ether as a clear colorless oil (18.6 
mg, 0.11 mmol, 19%).  The spectral data of the title compounds match that of the phenols 
340a and 340b.5 
Phenol 340a: 
1H NMR (400 MHz, CDCl3):  δ 7.30 (m, 2H), 7.04 (t, 1H, J = 7.5 Hz), 6.93 (m, 4H, J 
=7.9 Hz), 6.81 (d, 1H, J = 9.2 Hz) 4.56 (bs, 1H) 
Phenol 340b: 
1H NMR (400 MHz, CDCl3):  δ 7.34 (dd, 2H, J = 7.5, 8.5 Hz), 7.12 (t, 1H, J = 7.5 Hz), 
7.04 (m, 4H), 6.90 – 6.84 (m, 2H), 5.55 (bs, 1H) 
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Phenol 352:  Prepared following General Procedure B using 2,6-dimethyl 
methylbenzoate (100.0 mg, 0.61 mmol, 1.00 eq.), 4,5-dichlorophthaloyl peroxide (422.0 
mg, 1.52 mmol, 2.50 eq., 84%), and HFIP (6.1 mL) at 75 °C for 48 hrs.  The crude 
orange foam was purified by silica gel chromatography; pentane and then hexane → 15% 
acetone in hexane to afford the phenol 352 as a pale yellow amorphous oil (63.0 mg, 0.35 
mmol, 58%). 
Rf = 0.46 (50% Et2O in hexane) 
1H NMR (400 MHz, CDCl3):  δ 6.91 (d, 1H, J = 8.2 Hz), 6.72 (d, 1H, J = 8.2 Hz), 4.64 
(bs, 1H), 3.91 (s, 3H), 2.22 (s, 3H), 2.18 (s, 3H) 
13C NMR (100 MHz, CDCl3): δ 170.77, 151.81, 135.07, 128.30, 126.50, 121.10, 116.06, 
52.14, 18.87, 12.85 
IR (neat film, cm -1): 3399, 2360, 2341, 1706, 1293, 1047   
HRMS (EC-CI): calcd. for C10H12O3 [M] 180.0786, found 180.0787. 
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Phenols 353a and 353b: Prepared following General Procedure B using 2,4-dimethyl 
methylbenzoate (150.0 mg, 0.91 mmol, 1.00 eq.), 4,5-dichlorophthaloyl peroxide (649.0 
mg, 2.28 mmol, 2.50 eq., 82%), and HFIP (9.1 mL) at 75 °C for 48 hrs.  The crude 
orange foam was purified by silica gel chromatography; pentane and then hexane → 30% 
EtOAc in hexane to afford the phenol 353a as a pale yellow amorphous oil (63.2 mg, 
0.35 mmol, 38%) and phenol 353b as a pale yellow oil (57.4 mg, 0.22 mmol, 35%).  The 
spectral data for the title compound matches that of phenol 353a.24 
Phenol 353a: 
1H NMR (400 MHz, CDCl3):  δ 7.36 (s, 1H), 6.99 (s, 1H), 3.86 (s, 3H), 2.48 (s, 3H), 2.25 
(s, 3H) 
Phenol 353b: 
1H NMR (400 MHz, CDCl3):  δ 7.37 (d, 1H, J = 7.8 Hz), 7.00 (d, 1H, J = 7.8 Hz), 4.91 
(bs, 1H), 3.87 (s, 3H), 2.48 (s, 3H), 2.28 (s, 3H) 
13C NMR (100 MHz, CDCl3): δ 168.41, 152.57, 132.98, 129.10, 127.63, 124.65, 122.46, 
51.87, 16.44, 12.63 
IR (neat film, cm -1): 3477, 2952, 1702, 1435, 1273, 1054   
HRMS (EC-CI): calcd. for C10H13O3 [M+H]+ 181.0865, found 181.0865. 
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Phenols 354a, 354b, and 354c: Prepared following General Procedure B using 2,3-
dimethyl methylbenzoate (100.0 mg, 0.61 mmol, 1.00 eq.), 4,5-dichlorophthaloyl 
peroxide (422.0 mg, 1.52 mmol, 2.50 eq., 84%), and HFIP (6.1 mL) at 75 °C for 48 hrs.  
The crude orange foam was purified by silica gel chromatography; 1 – 5% Et2O in 
hexane / CH2Cl2 (1:1) to afford the phenols 354a as a pale yellow amorphous oil (25.9 
mg, 0.14 mmol, 24%), 354b as a pale yellow amorphous oil (21.8 mg, 0.12 mmol, 20%), 
and 354c as a pale yellow foam (14.9 mg, 0.08 mmol, 14%).  The spectral data for the 
title compounds matches that for phenols 354a and 354b.25, 26 
Phenol 354a: 
1H NMR (400 MHz, CDCl3):  δ 7.65 (d, 1H, J = 8.2 Hz), 6.63 (d, 1H, J = 8.2 Hz), 3.85 
(s, 3H), 2.51 (s, 3H), 2.20 (s, 3H) 
Phenol 354b: 
1H NMR (400 MHz, CDCl3):  δ 10.58 (bs, 1H), 7.28 (d, 1H, J = 7.8 Hz), 7.13 (d, 1H, J = 
7.8 Hz), 3.88 (s, 3H), 2.45 (s, 3H), 2.32 (s, 3H) 
Phenol 354c: 
1H NMR (400 MHz, CDCl3):  δ 7.10 (d, 1H, J = 2.7 Hz), 6.80 (d, 1H, J = 2.7 Hz), 5.25 
(bs, 1H), 3.87 (s, 3H), 2.35 (s, 3H), 2.26 (s, 3H) 
13C NMR (125 MHz, CDCl3): δ 168.74, 152.61, 139.69, 131.72, 129.79, 120.41, 114.08, 
51.99, 20.69, 15.80 
IR (neat film, cm-1): 3398, 1718, 1436, 1225   
HRMS (EC-CI): calcd. for C10H13O3 [M] 180.0786, found 180.0785. 
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Phenols 355a, 355b, and 355c: Prepared following General Procedure B using 2,5-
dimethyl methylbenzoate (100.0 mg, 0.61 mmol, 1.00 eq.), 4,5-dichlorophthaloyl 
peroxide (422.0 mg, 1.52 mmol, 2.50 eq., 84%), and HFIP (6.1 mL) at 75 °C for 48 hrs.  
The crude orange foam was purified by silica gel chromatography; pentane and then 
hexane → 15% acetone in hexane to afford the phenols 355a (27.7 mg, 0.15 mmol, 25%) 
and 355b (14.5 mg, 0.08 mmol, 13%) as pale yellow foams, and 355c as a pale yellow 
solid (13.9 mg, 0.08 mmol, 13%).  The spectral data for the title compounds matches that 
for phenols 355a, 355b, and 355c.27, 28 
Phenol 355a: 
1H NMR (400 MHz, CDCl3):  δ 7.23 (s, 1H), 6.77 (s, 1H), 5.22 (bs, 1H), 3.88 (s, 3H), 
2.40 (s, 3H), 2.27 (s, 3H) 
Phenol 355b: 
1H NMR (400 MHz, CDCl3):  δ 7.77 (s, 1H), 6.62 (s, 1H), 5.57 (bs, 1H), 3.85 (s, 3H), 
2.52 (s, 3H), 2.22 (s, 3H) 
Phenol 355c: 
1H NMR (400 MHz, CDCl3):  δ 11.58 (bs, 1H), 7.15 (d, 1H, J = 7.5 Hz), 6.62 (d, 1H, J = 
7.5 Hz), 3.95 (s, 3H), 2.50 (s, 3H), 2.22 (s, 3H) 
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Phenols 356a and 356b: Prepared following General Procedure B using 3,5-dimethyl 
methylbenzoate (100.0 mg, 0.61 mmol, 1.00 eq.), 4,5-dichlorophthaloyl peroxide (422.0 
mg, 1.52 mmol, 2.50 eq., 84%), and HFIP (6.1 mL) at 75 °C for 48 hrs.  The crude 
orange foam was purified by silica gel chromatography; pentane and then hexane → 15% 
acetone in hexane to afford the phenol 356a (44.0 mg, 0.24 mmol, 40%) as a white solid 
and the phenol 355b (7.8 mg, 0.04 mmol, 7%) as a pale yellow foam.  The spectral data 
for the title compounds matches that for phenols 356a and 356b.26, 29 
Phenol 356a: 
1H NMR (400 MHz, CDCl3):  δ 10.83 (bs, 1H) 7.48 (bs, 1H), 7.15 (bs, 1H), 3.93 (s, 3H), 
2.25 (s, 3H), 2.23 (s, 3H) 
Phenol 356b: 
1H NMR (400 MHz, CDCl3):  δ 7.80 (s, 2H), 5.34 (bs, 1H), 3.87 (s, 3H), 2.27 (s, 6H) 
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Tetralones 341a and 341b: Prepared following General Procedure B using 6-methoxy 
tetralone (100.0 mg, 0.57 mmol, 1.00 eq.), 4,5-dichlorophthaloyl peroxide (367.0 mg, 
1.42 mmol, 2.50 eq., 90%), and HFIP (5.7 mL) at 75 °C for 36 hrs.  The crude brown 
foam was purified by silica gel chromatography; 1 – 20% EtOAc in CH2Cl2 / hexane 
(1:1) to afford the phenols 341a (41.0 mg, 0.21 mmol, 38%) and 341b (29.0 mg, 0.15 
mmol, 48%) as yellow solids and the starting tetralone (13.0 mg, 0.07 mmol, 13%) as a 
pale yellow solid.  The spectra of the title compounds match that for 341a and 341b.30,31 
Major Isomer (341a):  
1H-NMR (400 MHz, CDCl3): δ 7.68 (d, 1H, J = 8.6 Hz), 6.84 (d, 1H, J = 8.6 Hz), 5.71 
(bs, 1H), 3.96 (s, 3H), 2.93 (t, 2H, J = 6.2 Hz), 2.60 (t, 2H, J = 6.2 Hz), 2.11 (ddd, 2H, J 
= 6.2 Hz).30 
Minor Isomer (341b):  
1H-NMR (400 MHz, CDCl3): δ 7.56 (s, 1H), 6.66 (s, 1H), 5.52 (bs, 1H), 3.95 (s, 3H), 
2.88 (t, 2H, J = 6.5 Hz), 2.59 (t, 2H, J = 6.5 Hz), 2.10 (ddd, 2H, J = 6.5 Hz).31 
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Phenols 342a, 342b, and 342c: Prepared following General Procedure A using 3-
methoxy methylbenzoate (100.0 mg, 0.60 mmol, 1.00 eq.), 4,5-dichlorophthaloyl 
peroxide (212.0 mg, 0.78 mmol, 1.30 eq., 86%), and HFIP (6.0 mL) at 50 °C for 24 hrs.  
The crude brown foam was purified by silica gel chromatography; 1 – 20% Et2O in 
CH2Cl2 / hexane (1:1) to provide the phenols 342a (22.1 mg, 0.12 mmol, 20%), 342b 
(19.7 mg, 0.11 mmol, 18%), 342c (18.8 mg, 0.10 mmol, 17%) as pale yellow solids and 
the starting benzoate (20.9 mg, 0.13 mmol, 21%) as a clear colorless oil.  The spectra of 
the title compounds match that for 342a, 342b, and 342c.5,6,32, 33 
Major Isomer (342a):  
1H-NMR (400 MHz, CDCl3): δ 10.37 (bs, 1H), 7.29 (d, 1H, J = 3.3 Hz), 7.08 (dd, 1H, J 
= 3.3, 8.9 Hz), 6.92 (d, 1H, J = 8.9 Hz), 3.95 (s, 3H), 3.78 (s, 3H).32 
Minor Isomer (342b):  
1H-NMR (400 MHz, CDCl3): δ 11.00 (bs, 1H), 7.43 (dd, 1H, J = 1.5, 8.2 Hz), 7.04 (d, 
1H, J = 8.2 Hz), 6.83 (t, 1H, J = 8.2 Hz), 3.95 (s, 3H), 3.91 (s, 3H).5,6, 33 
Minor Isomer (342c):  
1H-NMR (400 MHz, CDCl3): δ 7.64 (d, 1H, J = 8.2 Hz), 7.55 (d, 1H, J = 2.1 Hz), 6.94 
(d, 1H, J = 8.2 Hz), 5.97 (bs, 1H), 3.95 (s, 3H), 3.89 (s, 3H).5, 6 
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Phenols 343a and 343b: Prepared following General Procedure A using methyl 
salicylate (100.0 mg, 0.60 mmol, 1.00 eq.), 4,5-dichlorophthaloyl peroxide (212.0 mg, 
0.78 mmol, 1.30 eq., 86%), and HFIP (6.0 mL) at 50 °C for 24 hrs.  The crude brown 
foam was purified by silica gel chromatography; 1 – 20% Et2O in CH2Cl2 and hexane 
(1:1) to afford the phenols 343a (31.0 mg, 0.17 mmol, 28%) and 343b (27.2 mg, 0.15 
mmol, 25%) as yellow solids and the starting salicylate (25.6 mg, 0.15 mmol, 26%) as a 
clear colorless oil.  The spectra of the title compounds match that for 343a and 343b.34, 35 
Major Isomer (343a):  
1H-NMR (400 MHz, CDCl3): δ 7.40 (dd, 1H, J = 1.7, 8.2 Hz), 7.15 (dd, 1H, J = 1.7, 8.2 
Hz), 7.05 (t, 1H, J = 8.2 Hz), 5.91 (bs, 1H), 3.93 (s, 3H), 3.92 (s, 3H).34 
 
Minor Isomer (343b):  
1H-NMR (400 MHz, CDCl3) δ 7.29 (d, 1H, J = 3.4 Hz), 6.97 (dd, 1H, J = 3.4, 8.9 Hz), 
6.88 (d, 1H, J = 8.9 Hz), 4.52 (bs, 1H), 3.89 (s, 3H), 3.86 (s, 3H).35 
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Isovanillin 321: Prepared following General Procedure B using p-anisaldehyde (319) 
(30.0 mg, 0.22 mmol, 1.00 eq.), 4,5-dichlorophthaloyl peroxide (239.0 mg, 0.88 mmol, 
4.00 eq., 86%), and HFIP (2.2 mL) at 75 °C for 36 hrs.  The crude golden orange foam 
was purified by silica gel chromatography; 1 – 10% Et2O in CH2Cl2 and hexane (1:1) to 
afford isovanillin (321) (23.0 mg, 0.15 mmol, 69%) as a yellow solid.  The spectra of the 
title compound matches that for 321.5, 6 
 
1H-NMR (400 MHz, CDCl3): δ 9.85 (s, 1H), 7.45 (s, 1H), 7.44 (dd, 1H, J = 2.1, 6.5 Hz), 
6.98 (d, 1H, J = 9.9 Hz), 6.72 (s, 1H), 3.99 (s, 3H).5, 6 
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Ketone 344: Prepared following General Procedure B using 4-methoxy acetophenone 
(100.0 mg, 0.67 mmol, 1.00 eq.), 4,5-dichlorophthaloyl peroxide (446.0 mg, 1.67 mmol, 
2.50 eq., 86%), and HFIP (6.7 mL) at 75 °C for 36 hrs.  The crude brown foam was 
purified by silica gel chromatography; 1 – 10% Et2O in CH2Cl2 and hexane (1:1) to 
afford the ketone 344 (68.5 mg, 0.41 mmol, 62%) as a yellow solid and the starting 
acetophenone (18.8 mg, 0.13 mmol, 19%) as a white solid.  The spectra of the title 
compound matches that for 344.36 
 
1H-NMR (400 MHz, CDCl3): δ 7.54 (dd, 1H, J = 2.1, 10.6 Hz), 7.53 (s, 1H), 6.89 (d, 1H, 
J = 8.2 Hz), 5.64 (bs, 1H), 3.97 (s, 3H), 2.55 (s, 3H).36 
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Phenol 345: Prepared following General Procedure B using 4-methoxy methylbenzoate 
(100.0 mg, 0.60 mmol, 1.00 eq.), 4,5-dichlorophthaloyl peroxide (408.0 mg, 1.50 mmol, 
2.50 eq., 86%), and HFIP (6.0 mL) at 75 °C for 36 hrs.  The crude brown foam was 
purified by silica gel chromatography; 1 – 20% Et2O in CH2Cl2 and hexane (1:1) to 
afford the phenol 345 (70.0 mg, 0.39 mmol, 64%) as a yellow solid and the starting 
benzoate (5.0 mg, 0.03 mmol, 5%) as a white solid.  The spectra of the title compound 
matches that for 345.37 
1H-NMR (400 MHz, CDCl3): δ 7.62 (dd, 1H, J = 2.0, 8.6 Hz), 7.59 (d, 1H, J = 2.0 Hz), 
6.87 (d, 1H, J = 8.6 Hz), 5.61 (s, 1H), 3.95 (s, 3H), 3.88 (s, 3H).37 
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p-Quinone 346: Prepared following General Procedure B using 4-methoxy 
diisopropylamide (90.0 mg, 0.35 mmol, 1.00 eq.), 4,5-dichlorophthaloyl peroxide (259.0 
mg, 0.96 mmol, 2.50 eq., 86%), and HFIP (3.8 mL) at 75 °C for 36 hrs.  The crude brown 
foam was purified by silica gel chromatography; 1 – 30% EtOAc in CH2Cl2 and hexane 
(1:1) to afford the quinone 346 (50.0 mg, 0.19 mmol, 49%) as a dark yellow solid and the 
starting amide (33.7 mg, 0.14 mmol, 37%) as a viscous yellow oil. 
1H-NMR (500 MHz, C3D6O): δ 6.56 (s, 1H), 6.04 (s, 1H). 3.87 (s, 3H), 3.79 (ddd, 1H, J 
= 6.6 Hz), 3.56 (ddd, 1H, J = 6.9 Hz), 1.44 (bs, 6H), 1.14 (bs, 1H) 
13C-NMR (500 MHz, C3D6O): δ 186.09, 182.53, 163.92, 160.03, 145.74, 129.05, 107.78, 
56.80, 51.68, 46.24, 20.71, 20.59, 20.45, 20.17 
IR (neat film, cm-1): 3419, 1637 
HRMS (EC-CI): calcd. for C14H21NO4 [M+2H]2+ 267.1471, found 267.1474. 
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Phenol 357: Prepared following General Procedure A using 4-bromoanisole (100.0 mg, 
0.54 mmol, 1.00 eq.), 4,5-dichlorophthaloyl peroxide (186.0 mg, 0.70 mmol, 1.30 eq., 
87%), and HFIP (5.4 mL) at 50 °C for 24 hrs.  The crude brown foam was purified by 
silica gel chromatography; 1 – 10% Et2O in CH2Cl2 and hexane (1:1) to afford the phenol 
357 (50.0 mg, 0.25 mmol, 46%) as a pale yellow amorphous oil and the starting 4-
bromoanisole (11.0 mg, 0.05 mmol, 11%) as a clear colorless oil.  The spectra of the title 
compound matches that for 357.38  
1H-NMR (400 MHz, CDCl3): δ 7.06 (d, 1H, J = 2.4 Hz), 6.96 (dd, 1H, J = 2.4, 8.6 Hz), 
6.71 (d, 1H, J = 8.6 Hz), 5.63 (bs, 1H), 3.87 (s, 3H).38  
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Phenols 347a, 347b, and 347c: Prepared following General Procedure A using tert-butyl 
benzene (100.0 mg, 0.75 mmol, 1.00 eq.), 4,5-dichlorophthaloyl peroxide (259.0 mg, 
0.97 mmol, 1.30 eq., 87%), and HFIP (7.5 mL) at 50 °C for 24 hrs.  The crude brown 
foam was purified by silica gel chromatography; 1 – 5% Et2O in CH2Cl2 and hexane (1:1) 
to afford the phenols 347a and 347b (53.4 mg, 0.36 mmol, 48%, 347a : 347b = 9 : 1) as 
an orange foam and 347c (12.6 mg, 0.08 mmol, 11%) as a pale yellow foam.  The spectra 
of the title compounds match that for 347a, 347b, and 347c.5-6 
Major Isomer (347a):  
1H-NMR (400 MHz, CDCl3): δ 7.26 (d, 2H, J = 8.9 Hz), 6.77 (d, 2H, J = 8.9 Hz), 4.54 
(bs, 1H), 1.29 (s, 9H).5 
Minor Isomer (347b):  
1H-NMR (400 MHz, CDCl3): δ 7.17 (t, 1H, J = 7.9 Hz), 6.97 (m, 1H), 6.87 (dd, 1H, J = 
2.1, 2.4 Hz), 6.64 (m, 1H), 4.60 (bs, 1H), 1.30 (s, 9H).5 
Minor Isomer (347c):  
1H-NMR (400 MHz, CDCl3): δ 7.27 (d, 1H, J = 8.6 Hz), 7.07 (t, 1H, J = 6.5 Hz), 6.88 
(dd, 1H, J = 6.5, 8.6 Hz), 6.66 (d, 1H, J = 8.6 Hz), 4.71 (bs, 1H), 1.41 (s, 9H).6 
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Phenols 348a and 348b: Prepared following General Procedure A using butyl benzene 
(100.0 mg, 0.75 mmol, 1.00 eq.), 4,5-dichlorophthaloyl peroxide (262.0 mg, 0.97 mmol, 
1.30 eq., 86%), and HFIP (7.5 mL) at 50 °C for 24 hrs.  The crude orange foam was 
purified by silica gel chromatography; 1 – 5% Et2O in CH2Cl2 and hexane (1:1) to afford 
the phenols 348a and 348b (81.1 mg, 0.54 mmol, 73%, 348a : 348b = 1.2 : 1) as a pale 
yellow foam.  The spectra of the title compounds match that for 348a and 348b.5, 6, 39 
 
Major Isomer (348a):  
 
1H-NMR (400 MHz, CDCl3): δ 7.04 (d, 2H, J = 8.6 Hz), 6.74 (d, 2H, J = 8.6 Hz), 4.56 
(bs, 1H), 2.54 (t, 2H, J = 7.8 Hz), 1.64 – 1.52 (m, 2H), 1.44 – 1.31 (m, 2H), 0.92 (t, 3H, J 
= 7.1 Hz).5, 6, 39 
 
Minor Isomer (348b):  
 
1H-NMR (400 MHz, CDCl3): δ 7.13 – 7.05 (m, 2H), 6.87 (dt, 1H, J = 1.1, 7.4 Hz), 6.77 – 
6.74 (m, 1H), 4.64 (bs, 1H), 2.61 (t, 2H, J = 7.9 Hz), 1.64 – 1.52 (m, 2H), 1.44 – 1.31 (m, 
2H), 0.94 (t, 3H, J = 7.5 Hz).6, 39  
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Fluorophenols 349a and 349b: Prepared following General Procedure B using 4-pentyl 
fluorobenzene (100.0 mg, 0.60 mmol, 1.00 eq.), 4,5-dichlorophthaloyl peroxide (403.0 
mg, 1.50 mmol, 2.50 eq., 87%), and HFIP (6.0 mL) at 75 °C for 36 hrs.  The crude brown 
foam was purified by silica gel chromatography; 1% Et2O in CH2Cl2 and hexane (1:1) to 
afford the fluorophenols 349a and 349b (64.3 mg, 0.35 mmol, 59%, 349a : 349b = 2.5 : 
1) as a yellow oil.  The spectra of the title compound matches that for 349b.40  
 
Rf  = 0.57 (3% Et2O in 49% hexane and 48% CH2Cl2); 
 
Major Isomer (349a):  
 
1H-NMR (400 MHz, CDCl3): δ 7.03 (dd, 1H, J  = 6.8, 8.6 Hz), 6.57 (dt, 1H, J = 5.8, 8.2 
Hz), 6.52 (dd, 1H, J = 2.4, 9.9 Hz), 4.82 (bs, 1H), 2.53 (q, 2H, J = 8.2 Hz), 1.58 (m, 2H), 
1.35 (m, 4H), 0.90 (m, 3H)  
 
13C-NMR (100 MHz, CDCl3): δ 161.43, 154.21, 130.66, 124.80, 107.50, 103.00, 31.59, 
29.48, 29.29, 22.54, 14.02  
 
IR (neat film, cm-1): 3391, 2929, 1609, 1514, 1279, 1112  
 
HRMS (EC-CI): calcd. for C11H15OF [M+H]+ 182.1107, found 182.1106. 
 
Minor Isomer (349b)40:  
 
1H-NMR (400 MHz, CDCl3): δ 6.95 (dd, 1H, J  = 8.2, 10.3 Hz), 6.84 (dd, 1H, J = 2.1, 
8.2 Hz), 6.66 - 6.63 (m, 1H), 5.01 (bs, 1H), 2.53 (q, 2H, J = 8.2 Hz), 1.58 (m, 2H), 1.35 
(m, 4H), 0.90 (m, 3H)  
 
13C-NMR (100 MHz, CDCl3): δ 149.28, 142.97, 139.89, 130.92, 120.52, 116.97, 114.97, 
35.26, 31.35, 31.08, 22.51, 14.02  
 
IR (neat film, cm-1): 3391, 2929, 1609, 1514, 1279, 1112  
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HRMS (EC-CI): calcd. for C11H15OF [M+H]+ 182.1107, found 182.1106 
 
 
Chlorophenols 350a and 350b: Prepared following General Procedure B using 4-butyl 
chlorobenzene (100.0 mg, 0.59 mmol, 1.00 eq.), 4,5-dichlorophthaloyl peroxide (406.0 
mg, 1.48 mmol, 2.50 eq., 85%), and HFIP (5.9 mL) at 75 °C for 36 hrs.  The crude brown 
foam was purified by silica gel chromatography; 1% Et2O in CH2Cl2 and hexane (1:1) to 
afford the chlorophenols 350a and 350b (64.4 mg, 0.35 mmol, 59%, 350a : 350b = 4 : 1) 
as a yellow oil.  
 
Rf = 0.57 (3% Et2O in 49% hexane and 48% CH2Cl2); 
 
Major Isomer (350a):  
 
1H-NMR (400 MHz, CDCl3): δ 7.02 (d, 1H, J  =  8.2 Hz), 6.5 (dd, 1H, J = 2.1, 8.2 Hz), 
6.78 (d, 1H, J = 2.1 Hz), 4.69 (bs, 1H), 2.56 (t, 2H, J = 7.5 Hz), 1.57 (ddd, 2H, J = 7.5 
Hz), 1.37 (dddd, 2H, J = 7.5 Hz), 0.94 (t, 3H, J = 7.5 Hz)  
 
13C-NMR (100 MHz, CDCl3): δ 154.20, 132.00, 131.18, 127.44, 121.10, 115.76, 31.98, 
29.38, 22.70, 14.16  
 
IR (neat film, cm-1): 3412, 2957, 2930, 1603, 1588, 1413  
 
HRMS (EC-CI): calcd. for C10H13OCl [M+H]+ 184.0655, found 184.0653. 
 
Minor Regioisomer (350b):  
 
1H-NMR (400 MHz, CDCl3): δ 7.19 (d, 1H, J  = 8.2 Hz), 6.86 – 6.83 (m, 1H), 6.69 (dd, 
1H, J = 2.05, 8.2 Hz), 5.43 (bs, 1H), 2.54 (t, 2H, J = 7.5 Hz), 1.57 (ddd, 2H, J = 7.5 Hz), 
1.37 (dddd, 2H, J = 7.5 Hz), 0.92 (t, 3H, J = 7.5 Hz)  
 
IR (neat film, cm-1): 3412, 2957, 2930, 1603, 1588, 1413  
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HRMS (EC-CI): calcd. for C10H13OCl [M+H]+ 184.0655, found 184.0653. 
 
 
 
Bromophenols 351a and 351b: Prepared following General Procedure B using 4-butyl 
bromobenzene (100.0 mg, 0.47 mmol, 1.00 eq.), 4,5-dichlorophthaloyl peroxide (321.0 
mg, 1.17 mmol, 2.50 eq., 85%), and HFIP (4.7 mL) at 75 °C for 36 hrs.  The crude brown 
foam was purified by silica gel chromatography; 1% Et2O in CH2Cl2 and hexane (1:1) to 
afford the bromophenols 351a and 351b (58.3 mg, 0.25 mmol, 54%, 351a : 351b = 10 : 
1) as a dark yellow oil.  
Rf  = 0.57 (3% Et2O in 49% hexane and 48% CH2Cl2)  
1H-NMR (400 MHz, CDCl3) δ 6.98 (d, 1H, J  = 1.7 Hz), 6.97 (bs, 1H), 6.93 (d, 1H, J = 
1.7 Hz), 4.72 (bs, 1H), 2.55 (t, 2H, J = 7.5 Hz), 1.60 – 1.53 (m, 2H), 1.42 – 1.33 (dddd, 
2H, J = 7.5 Hz), 0.93 (t, 3H, J = 7.5 Hz)  
1H-NMR (400 MHz, C6D6): δ 6.88 (dd, 1H, J = 2.1, 8.2 Hz), 6.58 (d, 1H, J = 8.2 Hz), 
6.29 (bs, 1H), 3.90 (bs, 1H), 2.36 (t, 2H, J = 7.9 Hz), 1.40 (ddd, 2H, J = 7.9 Hz), 1.17 
(dddd, 2H, J = 7.5 Hz), 0.80 (t, 3H, J = 7.5 Hz) 
13C-NMR (100 MHz, CDCl3): δ 154.45, 131.56, 128.04, 123.99, 119.63, 118.59, 31.91, 
29.45, 22.70, 14.17  
IR (neat film, cm-1): 3390, 2957, 2928, 1408, 1123  
HRMS (EC-CI): calcd. for C10H12OBr [M+H]+ 228.0150, found 228.0149. 
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Acid 358a: Prepared following General Procedure A using naproxen (100 mg, 0.43 
mmol, 1.00 eq.), 4,5-dichlorophthaloyl peroxide (153.0 mg, 0.57 mmol, 1.30 eq.), and 
HFIP (4.3 mL) at 0 °C gradually warming to 23 °C over 24 hrs. After removal of the 
HFIP by continuous positive flow of nitrogen, the mixed phthalate diacid was placed 
under an atmosphere of argon. The crude brown solid was suspended in a deoxygenated 
mixture composed of dioxane and aqueous saturated NaHCO3 (9:1, 2.1 mL) and placed 
in an oil heated to 50 °C.  After 20 minutes the brown solution was poured into an 
aqueous phosphate buffer (20 mL, 0.2 M, pH = 2) and adjusted to pH = 4.  EtOAc (20 
mL) was added and the layers were partitioned.  The residual organics were extracted 
from the aqueous layer with EtOAc (2 x 20 ml), combined, dried over solid Na2SO4, 
filtered, and concentrated. The crude brown foam was purified by silica gel 
chromatography; 40% Et2O and 1% acetic acid in hexane to afford the phenol 358a (43.0 
mg, 0.18 mmol, 40%) as a colorless solid that decomposes in air.  
Rf = 0.09 (40% Et2O and 1% AcOH in hexane)  
1H-NMR (400 MHz, CDCl3): δ 8.11 (d, 1H, J = 8.9 Hz), 7.66 (d, 1H, J = 1.4 Hz), 7.41 
(dd, 1H, J = 8.9, 1.7 Hz), 7.36 (d, 1H, J = 8.9 Hz), 7.24 (d, 1H, J = 8.9 Hz), 4.00 (s, 3H), 
3.9 (q, 1H, J = 7.2 Hz), 1.59 (d, 3H, J = 7.2 Hz)  
13C-NMR (125 MHz, CDCl3): δ 179.5, 141.3, 139.7, 135.5, 129.5, 125.9, 125.2, 123.2, 
121.9, 119.5, 113.6, 57.2, 45.2, 18.1  
IR (neat film cm -1): 3433, 2937, 1704, 1275  
HRMS (EC-CI): calcd. for C14H14O4: 246.0892, found 246.0894.  
M.P. = 132 – 134 °C. 
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Ester 358b: Prepared following General Procedure A using the naproxen methyl ester 
(150.0 mg, 0.61 mmol, 1.00 eq.) which was dissolved in HFIP (6.1 mL), placed in an ice 
water bath cooled to 0 °C for 1 hr, and then phthaloyl peroxide (131.0 mg, 0.80 mmol, 
1.30 eq.) was added over 15 minutes in six portions causing the solution to change to a 
dark turquoise color.  After 20 minutes the HFIP was removed from the black mixture by 
continuous positive flow of nitrogen.  The black mixture was placed under an atmosphere 
of nitrogen, a deoxygenated mixture of methanol and aqueous saturated NaHCO3 (9:1, 
6.1 mL) was added, and the black solution was placed in an oil bath heated to 50 °C.  
After 12 hrs the black solution was removed from the oil bath, cooled to 23 °C, diluted 
with an aqueous phosphate buffer (10 mL, pH = 7, 0.2 M) and EtOAc (10 mL), poured 
into a separatory funnel, partitioned, and the organic layer was washed with an aqueous 
phosphate buffer (3 x 20 mL, 0.2 M, pH = 7).  Residual organics were extracted from the 
aqueous layer with EtOAc (3 x 20 ml), combined, dried over solid Na2SO4, filtered, and 
concentrated. The crude dark brown mixture was purified by silica gel chromatography; 
hexane – 10% EtOAc in hexane to afford the phenol 358b (58.5 mg, 0.23 mmol, 37%) as 
an off white solid that decomposes in air.  
1H-NMR (400 MHz, CDCl3): δ  8.10 (d, 1H, J = 8.9 Hz), 7.63 (d, 1H, J = 1.7 Hz), 7.39 
(dd, 1H, J = 1.7, 8.9 Hz), 7.36 (d, 1H, J = 8.9 Hz), 7.25 (d, 1H, J = 8.9 Hz), 5.98 (bs, 1H), 
3.99 (s, 3H), 3.86 (q, 1H, J = 7.2 Hz), 3.66 (s, 3H), 1.57 (d, 3H, J = 7.2 Hz) 
13C-NMR (125 MHz, CDCl3): δ 175.11, 141.24, 139.71, 136.29, 129.56, 126.63, 125.24, 
123.06, 121.78, 119.41, 113.54, 57.15, 52.07, 45.43, 18.50 
IR (neat film cm -1): 3434, 1731, 1594, 1475, 1263, 1072  
M.P. = 78 – 79 °C. 
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Phenol 359: Prepared following General Procedure A: A clear colorless solution of 
nabumetone (250.0 mg, 1.10 mmol, 1.00 eq.) in TFE (11.0 mL) was placed in an ice 
water bath cooled to 0 °C for 1 hr.  4,5-dichlorophthaloyl peroxide (405.0 mg, 1.42 
mmol, 1.30 eq.) was added in 8 portions over 10 minutes causing the solution to change 
to a dark brown mixture.  After 1 hr the TFE was removed from the black mixture by 
continuous positive flow of nitrogen.  The brown solid mixture containing the mixed 
phthalate ester-acid was placed under an atmosphere of nitrogen and a deoxygenated 
mixture composed of methanol and aqueous saturated NaHCO3 (9:1, 11.0 mL) was 
added.  The black solution was placed in an oil bath heated to 50 °C and after 2 hrs the 
black solution was removed from the oil bath, cooled to 23 °C, diluted with an aqueous 
phosphate buffer (10 mL, pH = 7, 0.2 M) and EtOAc (10 mL), poured into a separatory 
funnel, partitioned, and the organic layer was washed with an aqueous phosphate buffer 
(3 x 30 mL, pH = 7, 0.2 M).  Residual organics were extracted from the aqueous layer 
with EtOAc (3 x 20 ml), combined, dried over solid Na2SO4, filtered, and concentrated. 
The crude dark brown foam was purified by silica gel chromatography; hexane – 30% 
EtOAc in hexane to afford the phenol 359 (183.0 mg, 0.75 mmol, 68%) as an off white 
amorphous foam that decomposes in air. 
 
Rf = 0.14 (25% EtOAc in hexane)  
 
1H-NMR (400 MHz, CDCl3): δ 8.07 (d, 1H, J = 8.9 Hz), 7.52 (bs, 1H), 7.32 (d, 1H,  J = 
8.9 Hz,), 7.28 (dd, 1H, J = 8.9, 2.1 Hz), 7.23 (d, 1H, J = 8.9 Hz),  5.99 (bs, 1H), 3.99 (s, 
3H), 3.03 (t, 2H, J = 7.9 Hz), 2.83 (t, 2H, J = 7.9 Hz), 2.15 (s, 3H)  
 
13C-NMR (100 MHz, CDCl3): δ 208.1, 140.9, 139.7, 136.7, 129.7, 126.5, 125.9, 122.5, 
121.5, 119.0, 113.5, 57.2, 45.1, 30.2, 29.8  
 
IR (neat film, cm -1): 3407, 2923, 1710, 1363, 1273  
 
HRMS (EC-CI) calcd. for C15H16O3: 244.1099. Found: 244.1100.  
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Phenol 360a: Prepared following General Procedure B using ibuprofen (50.0 mg, 0.24 
mmol, 1 eq.), HFIP (0.5 mL), and 4,5-dichlorophthaloyl peroxide (164.0 mg, 0.61 mmol, 
2.50 eq.) at 75 °C for 24 hrs.  HFIP was removed in vacuo yielding a brown solid which 
was suspended in a deoxygenated mixture composed of methanol and aqueous saturated 
NaHCO3 (9:1, 2.1 mL), placed in an oil bath heated to 50 °C, and after 1 hr the mixture 
was removed from the oil bath, cooled to 23 °C, diluted with an aqueous phosphate 
buffer (20 mL, pH = 2, 0.2 M) and adjusted to pH = 4.  Ethyl ether (20mL) was added 
and the layers were partitioned.  Residual organics were extracted from the aqueous layer 
with ether (2 x 20 mL), combined, dried over solid MgSO4, and concentrated. The crude 
brown foam was purified by silica gel chromatography; 40% Et2O and 1% AcOH in 
hexane to afford the phenol 360a as an amorphous yellow oil (17.2 mg, 0.08 mmol, 
32%).  
Rf = 0.26 (40% Et2O and 1% AcOH in hexane)  
 
1H-NMR (400 MHz, CDCl3): δ 7.02 (d, 1H, J = 7.9 Hz), 6.80 (dd, 1H, J = 7.5, 1.7 Hz), 
6.74 (d, 1H, J = 1.7 Hz), 3.66 (q, 1H, J = 7.2 Hz), 2.44 (d, 2H, J = 7.5 Hz), 1.91 (dddd, 
1H, J = 6.8 Hz), 1.48 (d, 3H, J = 7.2 Hz), 0.92 (d, 6H, J = 6.8 Hz)  
 
13C-NMR (100 MHz, CDCl3): δ 179.9, 153.7, 138.7, 131.4, 126.7, 119.8, 114.3, 44.7, 
39.0, 28.8, 22.5, 18.0  
 
IR (neat film, cm-1): 3399, 2955, 1707  
 
HRMS (EC-CI): calcd. For C13H18O3: 222.1256. Found: 222.1255. 
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Phenols 360b and 360c: Prepared following General Procedure B using ibuprofen 
methyl ester (300.0 mg, 1.36 mmol, 1.00 eq.), 4,5-dichlorophthaloyl peroxide (747.0 mg, 
2.72 mmol, 2.50 eq., 85%), and HFIP (13.6 mL) at 75 °C for 24 hrs.  The crude brown tar 
was purified by silica gel chromatography; hexane – 4% EtOAc in hexane to provide the 
starting ester (22.3 mg, 0.10 mmol, 7%) as a clear colorless oil and the phenols as a 
mixture which were then further purified by silica gel chromatography; 1 - 2 % Et2O in 
CH2Cl2 and hexane (1:1) to afford the phenol 360b (130.0 mg, 0.55 mmol, 40%) and 
360c (66.0 mg, 0.28 mmol, 21%) as pale yellow amorphous oils. 
 
Major Isomer (360b): 
 
1H-NMR (400 MHz, CDCl3): δ 7.01 (d, 1H, J = 7.7 Hz), 6.78 (dd, 1H, J = 1.6, 7.7 Hz), 
6.75 (d, 1H, J = 1.6 Hz), 5.22 (bs, 1H), 3.67 (s, 1H), 3.65 (q, 1H, J = 7.2 Hz), 2.45 (d, 2H, 
J = 7.2 Hz), 1.92 (dddd, 1H, J = 6.7 Hz), 1.47 (d, 3H, J = 7.2 Hz), 0.92 (d, 6H, J = 6.7 
Hz)  
 
13C-NMR (100 MHz, CDCl3): δ 175.46, 153.96, 139.35, 131.30, 126.57, 119.56, 114.04, 
52.13, 45.00, 38.99, 28.75, 22.53, 18.51  
 
IR (neat film, cm-1): 3401, 2953, 2360, 2342, 1715 
 
Minor Isomer (361b):  
 
1H-NMR (400 MHz, CDCl3): δ 7.43 (bs, 1H), 6.98 (d, 1H, J = 7.9 Hz), 6.71 (d, 1H, J = 
1.7 Hz), 6.67 (dd, 1H, J = 1.7, 7.9 Hz), 3.84 (q, 1H, J = 7.2 Hz) 3.73 (s, 1H), 2.39 (d, 2H, 
J = 7.2 Hz), 1.84 (dddd, 1H, J = 6.8 Hz), 1.54 (d, 3H, J = 7.2 Hz), 0.89 (d, 6H, J = 6.8 
Hz)  
 
13C-NMR (100 MHz, CDCl3): δ 177.57, 154.30, 142.84, 128.48, 122.92, 121.66, 118.33, 
52.65, 44.95, 42.03, 30.01, 22.42, 16.57  
 
IR (neat film, cm-1): 3401, 2953, 2360, 2342, 1734 
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Acetate 361: Prepared following General Procedure A: A clear yellow solution of the 
desipramine dinitrosulfonamide (95.0 mg, 0.19 mmol, 1.00 eq.) in TFE and CH2Cl2 (4.0 
mL, 1:1) was placed in an ice water bath cooled to 0 °C for 1 hr.  Phthaloyl peroxide 
(40.0 mg, 0.25 mmol, 1.30 eq.) was added in 5 portions over 5 minutes causing the 
solution to change to a dark black mixture.  After 1 hr the TFE and CH2Cl2 were removed 
from the black mixture by continuous positive flow of nitrogen.  The black solid tar 
containing the mixed phthalate ester-acid was placed under an atmosphere of nitrogen 
and a deoxygenated mixture composed of methanol and aqueous saturated NaHCO3 (9:1, 
4.0 mL) was added.  The black solution was placed in an oil bath heated to 50 °C.  After 
12 hrs the black solution was removed from the oil bath, cooled to 23 °C, diluted with an 
aqueous phosphate buffer (10 mL, pH = 7, 0.2 M) and EtOAc (10 mL), poured into a 
separatory funnel, partitioned, and the organic layer was washed with an aqueous 
phosphate buffer (3 x 30 mL, pH = 7, 0.2 M).  Residual organics were extracted from the 
aqueous layer with EtOAc (3 x 20 ml), combined, dried over solid Na2SO4, filtered, and 
concentrated. The crude black tar was dissolved in CH2Cl2 (3.0 mL), pyridine (0.5 mL) 
and acetic anhydride (0.5 mL) were added sequentially, and the brown solution was 
allowed to stir at 23 °C.  After 24 hrs the dark brown solution was diluted with an 
aqueous phosphate buffer (10 mL, pH = 4, 0.2 M) and EtOAc (10 mL), poured into a 
separatory funnel, partitioned, and the organic layer was washed with an aqueous 
phosphate buffer (2 x 10 mL, pH = 7, 0.2 M).  Residual organics were extracted from the 
aqueous layer with EtOAc (2 x 10 mL), dried over solid Na2SO4, decanted, and 
concentrated.  The crude dark brown foam was purified by silica gel chromatography; 
hexane – 20% EtOAc in hexane to afford the acetate 361 (18.2 mg, 0.03 mmol, 17%) as a 
golden yellow amorphous foam. 
 
Rf = 0.66 (50% EtOAc in hexane)  
 
1H-NMR (400 MHz, CDCl3): δ 8.38 (d, 1H, J = 2.4 Hz), 8.34 (dd, 1H, J = 2.4 Hz, 8.6 
Hz), 8.03 (d, 1H, J = 8.6 Hz), 7.11 – 7.05 (m, 3H), 6.98 (t, 2H, J = 7.4 Hz), 6.90 (dd, 1H, 
J = 2.3 Hz, 7.4 Hz), 6.84 (dt, 1H, J = 1.1 Hz, 7.4 Hz), 3.88 – 3.82 (m, 1H), 3.60 – 3.48 
(m, 2H), 3.35 – 3.24 (m, 3H), 2.93 – 2.87 (m, 1H), 2.85 (s, 3H), 2.76 (dt, 1H, J = 4.0 Hz, 
12.9 Hz), 2.33 (s, 3H), 1.74 (ddd, 2H, J = 7.3 Hz) 
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13C-NMR (125 MHz, CDCl3): δ 168.98, 149.49, 148.00, 146.33, 145.11, 142.04, 139.56, 
138.12, 132.41, 131.54, 130.38, 126.42, 126.00, 125.67, 125.57, 121.77, 121.36, 119.93, 
119.61, 49.21, 48.46, 34.48, 33.53, 31.05, 26.08, 21.21 
IR (neat film, cm-1):  1765, 1553, 1537, 1475, 1367, 1351, 1200, 1165, 750, 736 
 
HRMS (EC-CI): calc’d. for C26H27N4O8S [M+H]+: 555.1550. Found: 555.1542. 
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 A solution of desipramine hydrochloride (200.0 mg, 0.69 mmol, 1.00 eq.) in 
CH2Cl2 (6.9 mL) was placed in an ice water bath cooled to 0 °C for 20 minutes.  Freshly 
distilled triethylamine (0.15 g, 0.2 mL, 1.52 mmol, 2.20 eq.) was added followed by solid 
dinitrosulfonyl chloride (185.0 mg, 0.69 mmol, 1.00 eq.) under a positive flow of 
nitrogen.  The golden yellow solution was warmed gradually to 23 °C over 12 hrs, diluted 
with an aqueous phosphate buffer (10 mL, pH = 4, 0.2 M) and EtOAc (20 mL), poured 
into a separatory funnel, partitioned, and the aqueous layer was washed with an aqueous 
phosphate buffer (2 x 10 mL, pH = 4, 0.2 M).  Residual organics were extracted from the 
aqueous layer with EtOAc (2 x 10 mL), dried over solid Na2SO4, decanted, and 
concentrated.  The crude orange mixture was purified by silica gel chromatography; 10% 
EtOAc in hexane to afford the desipramine sulfonamide as a dark yellow-orange solid 
(267.0 mg, 0.55 mmol, 80%). 
 
Rf = 0.66 (50% EtOAc in hexane)  
 
1H-NMR (400 MHz, CDCl3): δ 8.34 (d, 1H, J = 2.0 Hz), 8.26 (dd, 1H, J = 2.0 Hz, 8.9 
Hz), 8.0 (d, 1H, J = 8.9 Hz), 7.09 (d, 3H, J = 7.5 Hz), 6.98 (d, 2H, J = 7.5 Hz), 6.90 (t, 
1H, J = 7.5 Hz), 3.71 (t, 2H, J = 6.1 Hz), 3.34 (t, 2H, J = 6.7 Hz), 3.14 (s, 4H), 2.87 (s, 
3H), 1.80 (m, 2H) 
 
13C-NMR (100 MHz, CDCl3): δ 149.49, 147.70, 138.14, 134.18, 132.30, 130.03, 126.53, 
126.03, 122.97, 119.62, 119.56, 48.19, 46.87, 34.56, 32.04, 25.43 
 
IR (neat film, cm-1):  1603, 1573, 1351, 1163, 751 
 
HRMS (EC-CI): calc’d. for C24H25N4O6S [M+H]+: 497.1495. Found: 497.1490. 
 
M.P.: 52 – 56 °C 
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Phenol 362: Prepared following General Procedure A using (±)-guaifenesin (75.0 mg, 
0.38 mmol, 1.00 eq.), 4,5-dichlorophthaloyl peroxide (133.0 mg, 0.49 mmol, 1.30 eq.) in 
HFIP (3.8 mL) at 23 °C for 24 hrs.  The crude dark brown foam was purified by silica gel 
chromatography; 50% EtOAc in hexane to afford the phenol 362 as an opaque colorless 
oil (27.9 mg, 0.13 mmol, 35%).  
 
Rf = 0.55 (100% EtOAc)  
 
1H-NMR (500 MHz, CDCl3): δ 6.94 (t, 1H, J = 8.3 Hz), 6.59 (dd, 1H, J = 1.2, 8.3 Hz), 
6.45 (dd, 1H, J = 1.2, 8.3 Hz), 4.16 (dd, 1H, J = 2.7, 10.3 Hz), 4.04 (m, 1H), 4.01 (t, 1H, 
J = 4.2 Hz), 3.85 (s, 3H), 3.82 (d, 1H, J = 3.7 Hz), 3.77 (m, 1H)  
 
13C-NMR (125 MHz, CDCl3): δ 152.92, 150.38, 135.14, 124.62, 109.22, 103.45, 74.89, 
70.76, 63.69, 55.83.  
 
IR (neat film, cm-1): 3371, 1236, 1201.  
 
HRMS (EC-CI): calc’d for C10H14O5Na [M+Na]+: 237.07334. Found: 237.07352. 
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Triol 363: Prepared following General Procedure A using chlorphenesin (95.0 mg, 0.47 
mmol, 1.00 eq.), 4,5-dichlorophthaloyl peroxide (165.0 mg, 0.61 mmol, 1.30 eq., 86%), 
and HFIP (4.7 mL) at 50 °C for 24 hrs.  The crude brown solid was purified by silica gel 
chromatography; 5 - 50% acetone in hexane to provide the triol 363 (53.0 mg, 0.24 
mmol, 52%) as a pale yellow foam and chlorphenesin (11.0 mg, 0.05 mmol, 12%) as a 
white solid.  
 
Rf  = 0.47 (50% acetone in hexane)  
 
1H-NMR (400 MHz, C3D6O): δ 8.21 (bs, 1H), 6.98 (d, 1H, J = 8.6 Hz), 6.85 (d, 1H, J = 
2.4 Hz), 6.79 (dd, 1H, J = 2.4, 8.6 Hz), 4.39 (bs, 1H), 4.14 (d, 1H, J = 5.8 Hz), 4.01 (m, 
2H), 3.84 (t, 1H, J = 5.4 Hz), 3.67 (t, 2H, J = 5.4 Hz)  
 
13C-NMR (125 MHz, C3D6O): δ 148.14, 145.93, 125.81, 119.06, 115.47, 114.63, 71.43, 
70.44, 62.88  
 
IR (neat film, cm-1): 3410, 2935, 1634, 1592, 1504, 1268, 1215  
 
HRMS (EC-ESI): calc’d. for C9H11ClNaO4 [M+Na]+ 241.0238, found 241.0234. 
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Chlorphenesin carbonate: To a white solid mixture of chlorphenesin (0.40 g, 1.97 
mmol, 1.00 eq.), 1,1’-carbonyldiimidazole (0.48 g, 3.00 mmol, 1.50 eq.), and 4-N,N’-
dimethylaminopyridine (0.01 g, 0.10 mmol, 0.05 eq.) in CH2Cl2 (19.7 mL) was added 
freshly distilled Et3N (1.00 g, 1.4 mL, 9.87 mmol, 5.00 eq.).  After 18 hrs at 23 °C the 
pale yellow homogeneous solution was diluted with Et2O (30 mL) and residual CDI, 
DMAP, and Et3N were quenched with an aqueous phosphate buffer (50 mL, pH = 7, 0.2 
M), poured into a separatory funnel, and partitioned.  The residual organics were 
extracted from the aqueous layer with Et2O (4 x 20 mL), dried over solid Na2SO4, 
decanted, and concentrated.  The crude off white solid was purified by silica gel 
chromatography; 5 – 25% acetone in hexane to afford the chlorphenesin carbonate as a 
white solid (0.30 g, 1.31 mmol, 67%).  The spectra of the title compound matches that for 
carbonate.41   
 
Rf  = (40% acetone in hexane)  
 
1H-NMR (500 MHz, CDCl3): δ 7.27 (d, 2H, J = 8.9 Hz), 6.85 (d, 2H, J = 8.9 Hz), 5.02 
(m, 1H), 4.62 (t, 1H, J = 8.6 Hz), 4.52 (dd, 1H, J = 5.8, 8.6 Hz), 4.22 (dd, 1H, J = 4.1, 
10.6 Hz), 4.12 (dd, 1H, J = 3.4, 10.6 Hz)  
 
13C-NMR (125 MHz, CDCl3): δ 156.32, 154.49, 129.60, 127.04, 115.92, 73.90, 67.25, 
66.08  
 
IR (neat film, cm-1) 1790, 1492, 1243, 1169 
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Phenol 364: Prepared following General Procedure A using chlorphenesin carbonate 
(50.0 mg, 0.22 mmol, 1.00 eq.), 4,5-dichlorophthaloyl peroxide (138.0 mg, 0.51 mmol, 
2.50 eq., 86%), and HFIP (2.0 mL) at 50 °C for 24 hrs.  The crude brown foam was 
purified by silica gel chromatography; 5 - 30% acetone in hexane to provide the phenol 
364 (28.0 mg, 0.11 mmol, 52%) as an off white solid.   
 
Rf =  0.46 (40% acetone in hexane)   
 
1H-NMR (400 MHz, CDCl3): δ 6.98 (d, 1H, J = 2.4 Hz), 6.84 (dd, 1H, J = 2.4, 8.6 Hz), 
6.78 (d, 1H, J = 8.6 Hz), 5.48 (bs, 1H), 5.07 (m, 1H), 4.66 (dd, 1H, J  = 7.8, 8.9 Hz), 4.47 
(dd, 1H, J = 5.8, 8.9 Hz), 4.30 (dd, 1H, J = 3.4, 10.9 Hz), 4.20 (dd, 1H, J = 4.4, 10.9 Hz)  
 
1H-NMR (400 MHz, C3D6O): δ 8.39 (bs, 1H), 7.01 (d, 1H, J = 8.7 Hz), 6.88 (d, 1H, J = 
2.6 Hz), 6.80 (dd, 1H, J = 2.6, 8.7 Hz), 5.20 (m, 1H), 4.71 (t, 1H, J = 8.4 Hz), 4.56 (dd, 
1H, J  = 6.9, 8.5 Hz), 4.39 (dd, 1H, J = 3.4, 11.2 Hz), 4.33 (dd, 1H, J = 4.7, 11.2 Hz)  
 
13C-NMR (100 MHz, C3D6O): δ 155.48, 148.85, 146.29, 127.20, 120.04, 116.79, 115.78, 
75.67, 69.51, 66.69  
 
IR (neat film, cm-1): 3400, 2922, 1783, 1634  
 
HRMS (EC-CI): calcd. for C10H9ClO5 [M], 244.0139, found 244.0141  
 
M.P. = 122 - 125°C. 
 
  
377 
 
 
 
 
Carbamate 365: Prepared following General Procedure A using chlorphenesin 
carbamate (85.0 mg, 0.35 mmol, 1.00 eq.), 4,5-dichlorophthaloyl peroxide (122.0 mg, 
0.45 mmol, 1.30 eq., 86%), and HFIP (3.5 mL) at 50 °C for 24 hrs.  The crude brown 
solid mixture was purified by silica gel chromatography; 5 - 35% acetone in hexane to 
afford the carbamate 365 (57.0 mg, 0.22 mmol, 63%) as an off-white solid and the 
starting chlorphenesin carbamate (10.2 mg, 0.04 mmol, 12%).   
 
Rf = 0.45 (50% acetone in hexane)  
 
1H-NMR (400 MHz, CD3OD): δ 6.88 (d, 1H, J = 8.6 Hz), 6.80 (d, 1H, J = 2.7 Hz), 6.74 
(dd, 1H, J = 2.7, 8.6 Hz), 4.16 (m, 3H), 4.06 (m, 1H), 3.98 (m, 1H)  
 
13C-NMR (100 MHz, C3D6O): δ 158.25, 147.58, 145.60, 125.98, 118.86, 115.51, 113.82, 
70.04, 68.05, 64.92  
 
IR (neat film, cm-1): 3369, 1706, 1501  
 
HRMS (EC-ESI): calc’d. for C10H12ClNNaO5 [M+Na]+ 284.0296, found 284.0293  
 
M.P. = 124 - 127°C. 
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Phenol 366: Prepared following General Procedure B using flurbiprofen methyl ester 
(210.0 mg, 0.81 mmol, 1.00 eq.), 4,5-dichlorophthaloyl peroxide (446.0 mg, 1.63 mmol, 
2.00 eq., 85%), and HFIP (8.1 mL) at 75 °C for 24 hrs.  The crude dark yellow solid 
mixture was purified by silica gel chromatography; 1% 1,4-dioxane in benzene to afford 
the phenol 366 (69.0 mg, 0.25 mmol, 31%) as a pale yellow foam and the starting 
flurbiprofen (20.9 mg, 0.08 mmol, 10%).  The spectral data of the title compound 
matches that for the phenol 366.42,43 
 
1H-NMR (400 MHz, CDCl3): δ 7.42 (dd, 2H, J = 1.5, 7.1 Hz), 7.34 (t, 1H, J = 7.4 Hz), 
7.11 (m, 2H), 6.89 (d, 2H, J = 8.6 Hz), 4.99 (bs, 1H), 3.75 (q, 2H, J = 7.0 Hz), 3.70 (s, 
3H), 1.53 (d, 3H, J = 7.0 Hz)42,43 
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Phenol 371: Prepared following General Procedure B using (±)-mephenoxalone (50.0 
mg, 0.22 mmol, 1.00 eq.), 4,5-dichlorophthaloyl peroxide (67.8 mg, 0.29 mmol, 1.30 
eq.), and HFIP (2.2 mL). The crude dark brown foam was purified by silica gel 
chromatography; 50% EtOAc in hexane to afford phenol 371 as an opaque pale yellow 
oil (13.9 mg, 0.06 mmol, 26%). 
 
Rf = 0.47 (100% EtOAc)  
 
1H-NMR (400 MHz, CDCl3): δ 6.95 (t, 1H, J = 8.2 Hz), 6.61 (dd, 1H, J = 1.6, 8.2 Hz), 
6.46 (dd,1H, J = 1.2, 8.2 Hz), 6.02 (s, 1H), 5.45 (s, 1H), 4.93 (m, 1H), 4.29 (dd, 1H, J = 
3.5, 11.0 Hz), 4.14 (dd, 1H J = 5.9, 11.0 Hz), 3.84 (s, 3H), 3.74 (t, 1H, J = 8.6 Hz), 3.58 
(t, 1H, J = 6.6 Hz).  
 
13C-NMR (100 MHz, CDCl3): δ 158.94, 152.40, 149.72, 133.87, 124.73, 108.77, 103.77, 
74.76, 73.13, 55.81, 41.90  
 
IR (neat film, cm-1): 3346, 1733, 1253, 1198  
 
HRMS (EC-CI): calc’d for C11H13NO5Na [M+Na]+: 262.06859. Found: 262.06826. 
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Acetate 367: Prepared using General Procedure A: A clear colorless solution of 
mefenamic methyl ester (50.0 mg, 0.20 mmol, 1.00 eq.) in TFE and CH2Cl2 (4.0 mL, 4:1) 
was placed in an ice water bath cooled to 0 °C for 30 minutes.  Phthaloyl peroxide (71.0 
mg, 0.43 mmol, 2.20 eq.) was added in 5 portions over 5 minutes causing the solution to 
change to a dark black mixture.  The mixture was allowed to warm gradually to 23 °C 
over 12 hrs following which the TFE and CH2Cl2 were removed from the black mixture 
by continuous positive flow of nitrogen.  The black solid tar was placed under an 
atmosphere of nitrogen and a deoxygenated mixture composed of methanol and aqueous 
saturated NaHCO3 (9:1, 4.0 mL) was added.  The black solution was placed in an oil bath 
heated to 50 °C.  After 12 hrs the black solution was removed from the oil bath, cooled to 
23 °C, diluted with an aqueous phosphate buffer (10 mL, pH = 7, 0.2 M) and EtOAc (10 
mL), poured into a separatory funnel, partitioned, and the organic layer was washed with 
an aqueous phosphate buffer (3 x 30 mL, pH = 7, 0.2 M).  Residual organics were 
extracted from the aqueous layer with EtOAc (3 x 20 mL), combined, dried over solid 
Na2SO4, decanted, and concentrated. The crude black tar was dissolved in CH2Cl2 (4.0 
mL) upon which pyridine (155.0 mg, 0.2 mL, 1.96 mmol, 10.0 eq.) and acetic anhydride 
(60.0 mg, 0.1 mL, 0.59 mmol, 3.00 eq.) were added sequentially.  After 24 hrs at 23 °C 
the dark brown solution was diluted with an aqueous phosphate buffer (10 mL, pH = 4, 
0.2 M) and EtOAc (10 mL), poured into a separatory funnel, partitioned, and the organic 
layer was washed with an aqueous phosphate buffer (2 x 10 mL, pH = 7, 0.2 M).  
Residual organics were extracted from the aqueous layer with EtOAc (2 x 10 mL), dried 
over solid Na2SO4, decanted, and concentrated.  The crude dark brown foam was purified 
by silica gel chromatography; hexane – 2% EtOAc in hexane to afford the acetate 367 
(12.3 mg, 0.04 mmol, 20%) as a golden yellow amorphous foam. 
 
Rf  = 0.59 (40% EtOAc in hexane)  
 
1H-NMR (500 MHz, CDCl3): δ 9.19 (bs, 1H), 7.95 (dd, 1H, J = 1.4, 7.1 Hz), 7.24 (m, 
1H), 7.16 (d, 1H, J = 8.3 Hz), 6.88 (d, 1H, J = 8.3 Hz), 6.71 (dd, 1H, J = 1.1, 8.3 Hz), 
6.66 (dt, 1H, J = 1.2, 5.9 Hz), 3.91 (s, 3H), 2.34 (s, 3H), 2.20 (s, 3H), 2.13 (s, 3H)  
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13C-NMR (125 MHz, CDCl3): δ 169.56, 169.11, 149.44, 146.53, 136.61, 134.60, 134.21, 
134.46, 130.05, 123.90, 119.75, 116.19, 113.67, 110.81, 51.69, 20.86, 14.63, 13.30  
 
IR (neat film, cm-1): 2918, 2360, 2340, 1760, 1703, 1252, 1195, 1090  
 
HRMS (EC-CI): calcd. for C17H16NO3 [M+H]+ 282.1130, found 282.1131. 
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Phenols 368a and 368b: Prepared following General Procedure A using fenoprofen 
methyl ester (128.0 mg, 0.50 mmol, 1.00 eq.), 4,5-dichlorophthaloyl peroxide (181.0 mg, 
0.65 mmol, 1.30 eq.), and HFIP (5.0 mL) at 50 °C for 24 hrs.  The crude orange foam 
was purified by silica gel chromatography; hexane – 12% EtOAc in hexane to afford the 
phenol 368a as a white solid (24.0 mg, 0.09 mmol, 18%) and phenol 368b as a pale 
yellow foam (24.2 mg, 0.09 mmol, 18%). 
 
Phenol 368a: 
 
Rf  = 0.56 (30% EtOAc in hexane)  
 
1H-NMR (500 MHz, CDCl3): δ 7.25 (m, 3H), 6.97 (d, 1H, J = 7.2 Hz), 6.92 (d, 2H, J = 
8.8 Hz), 6.91 (bs, 1H), 6.81 (d, 2H, J = 8.8 Hz), 3.67 (q, 1H, J = 7.2 Hz), 1.47 (d, 3H, J = 
7.2 Hz) 
 
13C-NMR (125 MHz, CDCl3): δ 175.05, 158.70, 152.03, 149.75, 142.22, 129.74, 121.47, 
121.07, 116.83, 116.33, 115.97, 52.20, 45.30, 18.43 
 
IR (neat film, cm-1): 3411, 2922, 1732, 1587, 1471, 1266, 1215  
 
HRMS (EC-CI): calcd. for C16H16O4 [M] 272.1049, found 272.1049. 
 
M.P. = 102 – 105 °C 
 
 
Phenol 368b: 
 
1H-NMR (500 MHz, CDCl3): δ 7.35 (dd, 2H, J = 1.2, 7.2 Hz), 7.13 (dt, 1H, J = 1.0, 7.2 
Hz), 7.04 (m, 2H), 6.99 (dd, 1H, J = 2.0, 7.2 Hz), 6.83 – 6.79 (m, 2H), 5.99 (bs, 1H), 4.12 
(q, 1H, J = 7.1 Hz), 3.71 (s, 3H), 1.53 (d, 3H, J = 7.1 Hz) 
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13C-NMR (125 MHz, CDCl3): δ 175.36, 156.57, 145.01, 143.86, 129.87, 128.21, 123.74, 
123.12, 120.13, 118.32, 117.07, 52.14, 39.32, 17.24 
 
IR (neat film, cm-1): 3411, 2922, 1732, 1587, 1471, 1266, 1215 
 
HRMS (EC-CI): calcd. for C16H16O4 [M] 272.1049, found 272.1050. 
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Phenol 370: Prepared using General Procedure A: A clear colorless solution of adapalene 
methyl ester (100.0 mg, 0.23 mmol, 1.00 eq.) in TFE and CHCl3 (9.4 mL, 1:1) was 
placed in an ice water bath cooled to 0 °C for 1 hr.  Phthaloyl peroxide (46.0 mg, 0.28 
mmol, 1.20 eq.) was added in 10 portions over 10 minutes changing the colorless solution 
to a dark brown mixture.  After 2 hrs the TFE and CHCl3 were removed from the brown 
mixture by continuous positive flow of nitrogen.  The black solid containing the mixed 
phthalate ester-acid was placed under an atmosphere of nitrogen and a deoxygenated 
mixture composed of methanol and aqueous saturated NaHCO3 (9:1, 4.0 mL) was added.  
The brown solution was placed in an oil bath heated to 50 °C.  After 12 hrs the brown 
solution was removed from the oil bath, cooled to 23 °C, diluted with an aqueous 
phosphate buffer (10 mL, pH = 7, 0.2 M) and EtOAc (10 mL), poured into a separatory 
funnel, partitioned, and the organic layer was washed with an aqueous phosphate buffer 
(3 x 30 mL, pH = 7, 0.2 M).  Residual organics were extracted from the aqueous layer 
with EtOAc (3 x 20 mL), combined, dried over solid Na2SO4, filtered, and concentrated.  
The crude dark brown foam was purified by silica gel chromatography; hexane – 20% 
EtOAc in hexane and then purified again by silica gel chromatography; 12% 1,4-dioxane 
in hexane to afford the phenol 370 as a white solid (48.0 mg, 0.11 mmol, 46%). 
 
Rf = 0.78 (40% 1,4-dioxane in hexane) 
 
1H-NMR (400 MHz, CDCl3): δ 8.62 (s, 1H), 8.07 (d, 1H, J = 8.6 Hz), 8.00 (s, 1H), 7.98 
(d, 1H, J = 8.6 Hz), 7.91 (d, 1H, J = 8.6 Hz), 7.76 (d, 1H, J = 8.6 Hz), 7.20 (d, 1H, 2.0 
Hz), 5.41 (bs, 1H), 3.99 (s, 3H), 3.90 (s, 3H), 2.15 (bs, 7H), 2.12 (bs, 2H), 1.81 (bs, 6H) 
 
13C-NMR (100 MHz, CDCl3): δ 167.31, 149.96, 147.28, 143.88, 140.97, 136.45, 135.79, 
131.50, 130.82, 129.73, 128.33, 127.16, 126.42, 125.25, 118.24, 113.35, 61.36, 52.25, 
41.78, 37.65, 36.91, 29.70, 29.10 
 
IR (neat film, cm-1): 3445, 1656  
 
M.P. = 240 – 242 °C    
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 To a solution of p-bromophenol (750.0 mg, 4.34 mmol, 1.00 eq.) in CH2Cl2 (2.2 
mL) and AcOH (1.25 mL) was added sulfuric acid (0.3 mL, 4.69 mmol, 1.08 eq., 98%) 
and then 1-adamantyl alcohol (660.0 mg, 4.34 mmol, 1.00 eq.) at 23 °C.  After 36 hrs the 
pale yellow solution was poured into a separatory funnel containing an aqueous 
phosphate buffer (30 mL, pH = 7, 0.2 M) and CH2Cl2 (20 mL), partitioned, and the 
organics were washed with a saturated aqueous mixture of NaHCO3 (1 x 20 mL).  
Residual organics were extracted from the aqueous layer with CH2Cl2 (2 x 10 mL), 
combined, washed with brine (2 x 10 mL), dried over solid Na2SO4, decanted, and 
concentrated.  The phenolic product was carried into the next reaction without further 
purification or characterization. 
  A mixture of the crude adamantyl p-bromophenol, K2CO3 (1.80 g, 13.0 mmol, 
3.00 eq.), and Me2SO4 (0.41 mL, 4.34 mmol, 1.00 eq.) in acetone (44 mL) was purged 
with nitrogen and stoppered with a plastic PTFE cap.  The mixture was placed in an oil 
bath heated to 60 °C and stirred vigorously (1000 rpm).  After 24 hrs the white 
heterogeneous mixture was removed from the oil bath, cooled to 23 °C, suction filtered 
over a pad of celite, and concentrated.  The pale yellow foam was dissolved in Et2O (20 
mL), poured into a separatory funnel, and washed with an aqueous NaOH solution (3 x 
20 mL, 1 N) to remove the unreacted phenol.  Residual organics were extracted from the 
aqueous layer with Et2O (2 x 15 mL), combined, dried over solid Na2SO4, decanted, and 
fully concentrated in vacuo to remove any residual unreacted p-bromoanisole to afford 
the adamantyl p-bromoanisole as a pale yellow solid (1.10 g, 3.42 mmol, 79%, two 
steps).  The spectral data of the title compound matches that of 3-adamantyl p-
bromoanisole.44    
 
1H-NMR (400 MHz, CDCl3): δ 7.29 – 7.24 (m, 2H), 6.73 (d, 1H, J = 8.6 Hz), 3.81 (s, 
3H), 2.05 bs, 9H), 1.75 (bs, 6H) 
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 To a solution of 3-adamantyl p-bromoanisole (320.0 mg, 1.00 mmol, 1.00 eq.), 
KOAc (303.0 mg, 3.09 mmol, 3.10 eq.), and B2Pin2 (278.0 mg, 1.10 mmol, 1.10 eq.) in 
1,4-dioxane (10 mL) was added Pd(dppf)Cl2-CH2Cl2 (49.0 mg, 0.06 mmol, 0.06 eq.) 
under a positive flow of nitrogen.  The red mixture was sparged with nitrogen, stoppered 
with a plastic PTFE cap, and placed into an oil bath heated to 110 °C.  After 4 hrs the 
black mixture was removed from the oil bath, cooled to 23 °C, concentrated, and residual 
1,4-dioxane was azeotropically removed with CHCl3 (3 x 3 mL).  The black mixture was 
dissolved in a solution of CHCl3 and hexane (2 mL, 1:1), loaded directly onto silica gel, 
and purified by silica chromatography; hexane – 5% EtOAc in hexane to afford the 
boronic ester as a pale yellow foam which solidified upon standing at 23 °C (340.0 mg, 
0.92 mmol, 93%).  The boronic ester was carried onto to the next reaction without full 
characterization. 
1H-NMR (400 MHz, CDCl3): δ 7.66 – 7.64 (m, 2H), 6.86 (d, 1H, J = 7.8 Hz), 3.85 (s, 
3H), 2.12 bs, 6H), 2.05 (bs, 3H), 1.76 (bs, 6H), 1.32 (s, 12H) 
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 To a solution of the boronic ester (340.0 mg, 0.92 mmol, 1.00 eq.) in 1,4-dioxane 
and water (9.2 mL, 9:1) was added Pd(dppf)Cl2-CH2Cl2 (75.0 mg, 0.09 mmol, 0.10 eq.) 
and Cs2CO3 (932.0 mg, 2.86 mmol, 3.10 eq.) under a positive flow of nitrogen.  6-bromo-
methylnaphthoate (269.0 mg, 1.02 mmol, 1.10 eq.) was added under a positive flow of 
nitrogen to the now black mixture.  After stirring rapidly (800 rpm) at 23 °C for 16 hrs 
the black mixture was poured into a separatory funnel containing CH2Cl2 (20 mL) and 
brine (10 mL), partitioned, and the residual organics were extracted from the aqueous 
layer with CH2Cl2 (1 x 10 mL), dried over solid Na2SO4, suction filtered over a pad of 
celite, and concentrated.  The crude pale yellow mixture was purified by silica gel 
chromatography to afford the adapalene methyl ester as a white solid (241.0 mg, 0.57 
mmol, 61%).  The spectral data of the title compound matches that of the adapalene 
methyl ester.44 
 
1H-NMR (400 MHz, CDCl3): δ 8.61 (s, 1H), 8.07 (dd, 1H, J = 1.4, 8.9 Hz), 8.01 (d, 1H, 
J = 1.4 Hz), 7.98 (d, 1H, J = 8.6 Hz), 7.92 (d, 1H, J = 8.2 Hz), 7.79 (dd, 1H, J = 1.7, 8.6 
Hz), 7.60 (d, 1H, J = 2.3 Hz), 7.54 (dd, 1H, J = 2.4, 8.6 Hz), 7.00 (d, 1H, J = 8.2 Hz), 
3.99 (s, 3H), 3.91 (s, 3H), 2.18 (bs, 6H), 2.10 (bs, 3H), 1.80 (bs, 6H) 
  
388 
 
 
 
 
Phenol 372: Prepared following General Procedure A: To a solution of dyclonine (131.0 
mg, 0.45 mmol, 1.00 eq.) in HFIP (4.5 mL) was added p-toluenesulfonic acid 
monohydrate (86.0 mg, 0.45 mmol, 1.00 eq.).  The pale yellow solution was stirred for 2 
minutes at 23 °C upon which 4,5-dichlorophthaloyl peroxide (514.0 mg, 1.81 mmol, 4.00 
eq., 82%) was added.  The pale yellow solution was stoppered with a plastic PTFE cap 
and placed in an oil bath heated to 50 °C.  After 12 hrs the red solution was removed 
from the oil bath, cooled to 23 °C, and HFIP was removed by a continuous flow of 
nitrogen.  The dark red mixture was placed under an atmosphere of nitrogen upon which 
a deoxygenated mixture of methanol and a saturated aqueous mixture of NaHCO3 (4.5 
mL, 9:1) was added.  The dark red solution was placed in an oil bath heated to 50 °C.  
After 2 hrs the dark red solution was removed from the oil bath, cooled to 23 °C, diluted 
with a saturated aqueous mixture of NaHCO3 (10 mL) and EtOAc (10 mL), poured into a 
separatory funnel, partitioned, and the aqueous layer was washed with a saturated 
aqueous mixture of NaHCO3 and brine (3 x 30 mL, 1:1).  Residual organics were 
extracted from the aqueous layer with a combination of EtOAc and brine (3 x 30 mL, 
2:1), combined, dried over solid Na2SO4, decanted, and concentrated.  The crude black 
foam was purified by silica gel chromatography; 1 – 5% MeOH in CH2Cl2, then 1% 
MeOH and 1% Et3N in CH2Cl2 to afford the aminophenol 372 as a red solid (50.6 mg, 
0.15 mmol, 33%, 90% pure by 1H-NMR). 
 
Rf = 0.50 (5% MeOH in CH2Cl2) 
 
1H-NMR (400 MHz, CDCl3): δ 7.58 (dd, 1H, J = 2.0, 8.2 Hz), 7.56 (d, 1H, 2.0 Hz), 6.86 
(d, 1H, J = 8.2 Hz), 4.12 (t, 2H, J = 6.8 Hz), 3.64 (t, 2H, J = 6.8 Hz), 3.36 (t, 2H, J = 6.8 
Hz), 3.03 (bs, 4H), 1.97 (bs, 4H), 1.83 (ddd, 2H, J = 7.8 Hz), 1.63 (bs, 2H), 1.51 (ddd, 
2H, J = 7.8 Hz), 1.00 (t, 3H, J = 7.8 Hz) 
 
13C-NMR (100 MHz, CDCl3): δ 195.14, 151.12, 145.90, 129.10, 122.04, 114.15, 110.83, 
68.83, 53.73, 52.27, 33.07, 30.97, 22.92, 22.18, 19.12, 13.78  
 
IR (neat film, cm-1): 3401, 2957, 2873, 1673, 1604, 1435, 1276,   
 
M.P. = 140 – 144 °C 
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Phenols 374a – 374d: Prepared following General Procedure A using deoxyestrone 
(100.0 mg, 0.39 mmol, 1.00 eq.), 4,5-dichlorophthaloyl peroxide (142.0 mg, 0.51 mmol, 
1.30 eq., 84%), and HFIP (3.9 mL) at 50 °C for 24 hrs.  The crude pale yellow solid was 
purified by silica gel chromatography; 5 - 20% EtOAc in CH2Cl2 and hexane (1:1) to 
afford the mixture of estrone phenols 374a, 374b, 374c, and 374d (76.4 mg, 0.28 mmol, 
72%, 374a : 374b : 374c : 374d = 2.1:2:1:1) as a white solid and the starting 
deoxyestrone as a white solid (19.5 mg, 0.08 mmol, 20%).  The spectra of the title 
compounds match that for 374a, 374b, 374c, and 374d.45,46  
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Triclosan (369): Prepared following General Procedure B using 2,4,4’-
trichlorophenylether (95.0 mg, 0.35 mmol, 1.00 eq.), 4,5-dichlorophthaloyl peroxide 
(188.0 mg, 0.70 mmol, 2.00 eq., 86%), and HFIP (3.5 mL) at 60 °C for 24 hrs.  The crude 
brown foam was purified by silica gel chromatography; 1 – 10% Et2O in pentane to 
provide triclosan (369) (52.0 mg, 0.18 mmol, 52%) as a pale yellow foam and the starting 
trichloride (8.4 mg, 0.03 mmol, 9%).  The spectra of the title compound matches that of 
triclosan (369).47   
 
1H-NMR (400 MHz, CDCl3)47: δ 7.48 (d, 1H, J = 2.2 Hz), 7.22 (dd, 1H, J = 2.2, 8.5 Hz), 
7.07 (d, 1H, J = 2.2 Hz), 6.95 (d, 1H, J = 8.5 Hz), 6.81 (dd, 1H, J = 2.2, 8.5 Hz), 6.66 (d, 
1H, J = 8.5 Hz), 5.63 (bs, 1H) 
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 The aniline (2.96 g, 11.7 mmol, 1.00 eq.) was suspended in water (9 mL) and 
concentrated HCl (7 mL, 87.0 mmol, 7.45 eq., 38%, 12.4 M).  The orange solid mixture 
was placed in an ice water bath cooled to 0 °C and stirred vigorously (400 rpm).  After 5 
minutes NaNO2 (0.88 g, 12.8 mmol, 1.10 eq.) was added all at once and the mixture 
immediately changed to a deep red-orange color.  After 25 minutes, CuCl (1.73 g, 17.5 
mmol, 1.50 eq.) was added all at once followed by concentrated HCl (1.5 mL, 18.0 
mmol, 1.55 eq., 38%, 12.4 M).  The dark red-orange solution was removed from the 
cooling bath and stirred vigorously (400 rpm) at 23 °C.  After 30 minutes the dark orange 
biphasic mixture was diluted with Et2O (20 mL), poured into a separatory funnel, 
partitioned, and the organic layer was washed with 1 N HCl (3 x 25 mL).  Residual 
organics were extracted from the aqueous layer with Et2O (3 x 25 mL), combined, dried 
over solid Na2SO4, decanted, and concentrated.  The crude dark yellow solid was purified 
by silica gel chromatography; hexane to provide the known 2,4,4’-trichlorophenylether 
(1.34 g, 4.90 mmol, 42%) as a white crystalline solid.48 The spectra of the title compound 
matches that of the trichloride.48   
 
1H-NMR (400 MHz, CDCl3): δ 7.47 (d, 1H, J = 2.7 Hz), 7.29 (d, 2H, J = 8.9 Hz), 7.21 
(dd, 1H, J = 2.7, 8.9 Hz), 6.92 (d, 1H, J = 8.9 Hz), 6.88 (d, 2H, J = 8.9 Hz) 
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 To a suspension of 2-nitro-4,4’-dichlorophenyl ether (3.43 g, 12.1 mmol, 1.00 eq.) 
in ethanol (48.3 mL) and water (48.3 mL) was added iron powder (1.82 g, 32.6 mmol, 
2.70 eq.) and solid NH4Cl (2.91 g, 54.3 mmol, 4.50 eq.).  The reaction vessel was 
equipped with a reflux condenser, purged with N2, and the black mixture was placed in 
an oil bath heated to 110 °C stirring vigorously (800 rpm).  After 12 hrs the black mixture 
was suction filtered over celite to remove the iron and the filtrate solution was 
concentrated to remove the EtOH.  The resultant yellow solid mixture was diluted with 
CH2Cl2 (50 mL) and an aqueous phosphate buffer (50 mL, 0.2 M, pH = 10), poured into a 
separatory funnel, partitioned, and the organics were washed with an aqueous phosphate 
buffer (1 x 25 mL, 0.2 M, pH = 10).  Residual organics were extracted from the aqueous 
with CH2Cl2 (2 x 30 mL), combined, dried over solid Na2SO4, decanted, and 
concentrated to provide the known aniline (2.96 g, 11.7 mmol, 96%) pure as a yellow 
solid.48    
 
1H-NMR (400 MHz, CDCl3): δ 7.26 (d, 2H, J = 5.5 Hz), 6.89 (d, 2H, J = 9.2 Hz), 6.80 
(d, 1H, J = 2.4 Hz), 6.76 (d, 1H, J = 8.6 Hz), 6.67 (dd, 1H, J = 2.4, 8.6 Hz), 3.86 (bs, 2H). 
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 The solid mixture of 1,4,-dichloro-2-nitrobenzene (2.40 g, 12.50 mmol, 1.00 eq.), 
KOH (0.74 g, 13.13 mmol, 1.05 eq.), and 4-chlorophenol (1.77 g, 13.75 mmol, 1.10 eq.) 
was suspended in water (1 mL), placed in an oil bath heated to 170 °C, and stirred rapidly 
(400 rpm).  After 2.5 hrs the reddish-brown liquid was removed from the oil bath, cooled 
to 23 °C, diluted with Et2O (20 mL), and residual 4-chlorophenol was quenched with 4 N 
NaOH (20 mL).  The biphasic mixture was then poured into a separatory funnel.  4 N 
NaOH (20 mL) and Et2O (20 mL) was added to the reaction vessel to dissolve residual 
solids with the aid of sonication, and this yellow-orange mixture was added to the 
separatory funnel.  The layers were partitioned and the organic layer was washed with 4 
N NaOH (3 x 20 mL) to remove the excess 4-chlorophenol.  The residual organics were 
extracted from the aqueous layer with Et2O (3 x 20 mL), combined, dried over solid 
Na2SO4, decanted, and concentrated to reveal the known 2-nitro-4,4’-dichlorophenyl 
ether (3.43 g, 12.07 mmol, 97%) pure as a dark yellow solid.48  
 
1H-NMR (400 MHz, CDCl3): δ 7.95 (d, 1H, J = 2.4 Hz), 7.48 (dd, 1H, J = 2.4, 8.9 Hz), 
7.35 (d, 2H, J = 8.9 Hz), 6.97 (d, 3H, J = 8.9 Hz). 
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 Concentrated H2SO4 (6.7 mL, 18 M, 98%) was slowly added to fuming HNO3 
(6.7 mL, 90%) in an ice water bath cooled to 0 °C.  After 5 minutes p-dichlorobenzene 
(2.00 g, 13.61 mmol, 1.00 eq.) was added all at once.  After 2 minutes the cold bath was 
removed and the yellow heterogeneous mixture was stirred vigorously (500 rpm) at 23 
°C.  After 15 minutes the yellow homogeneous solution was poured into ice water (250 
mL), and the resultant yellow solid was filtered.  The yellow solid was then dried in 
vacuo with heating (100 °C) for 30 minutes to remove excess H2O to afford the known 2-
nitro-4-dichlorobenzene (2.43 g, 12.66 mmol, 93%) pure as a yellow solid which 
solidified upon cooling to 23 °C.48   
 
1H-NMR (400 MHz, CDCl3): δ 7.89 (bs, 1H), 7.50 (d, 2H, J = 1.0 Hz).  
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Phthalate Ester 396: Prepared following General Procedure C using benzene (10.0 mg, 
0.13 mmol, 1.00 eq), 4,5-dichlorophthaloyl peroxide (87.0 mg, 0.32 mmol, 2.50 eq., 
86%), HFIP (1.3 mL), and TMSCHN2 (0.3 mL, 0.64 mmol, 5.00 eq., 2.0 M).  The crude 
yellow foam was purified by silica gel chromatography; benzene to provide the phthalate 
ester 396 (15.1 mg, 0.05 mmol, 36%) as a clear amorphous solid.  
 
Rf  = 0.56 (benzene)  
 
1H-NMR (400 MHz, CDCl3): δ 7.97 (s, 1H), 7.91 (s, 1H), 7.44 (t, 2H, J = 7.9 Hz), 7.29 
(t, 1H, J = 7.9), 7.25 (d, 2H, J = 7.9), 3.93 (s, 3H)  
 
13C-NMR (100 MHz, CDCl3): δ 165.93, 164.47, 150.79, 136.44, 136.37, 131.53, 131.45, 
131.40, 129.86, 128.55, 126.60, 121.47, 53.42  
 
IR (neat film, cm-1): 2955, 1733, 1436, 1288, 1069  
 
HRMS (EC-CI): calcd. for C15H10O4Cl2 [M+H]+ 325.0034, found 325.0028. 
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Phthalate Ester 397: Prepared following General Procedure C using fluorobenzene 
(10.0 mg, 0.10 mmol, 1.00 eq.), 4,5-dichlorophthaloyl peroxide (69.0 mg, 0.26 mmol, 
2.50 eq., 88%), HFIP (1.0 mL), and TMSCHN2 (0.3 ml, 0.52 mmol, 5.00 eq., 2.0 M).  
The crude yellow foam was purified by silica gel chromatography; benzene to provide 
the phthalate ester 397 (16.0 mg, 0.05 mmol, 45%) as a white solid.  
 
Rf  = 0.63 (benzene)  
 
1H-NMR (400 MHz, CDCl3): δ 7.94 (s, 1H), 7.93 (s, 1H), 7.24 – 7.21 (m, 2H,), 7.12 (dd, 
2H, J = 8.2, 8.9), 3.93 (s, 3H)  
 
13C-NMR (100 MHz, CDCl3) δ 165.76, 164.62, 161.98, 146.60, 136.52, 136.48, 131.54, 
131.36, 131.31, 131.28, 123.00, 116.23, 53.42  
 
IR (neat film, cm-1): 2924, 2356, 1733, 1503, 1291, 1116  
 
HRMS (EC-CI): calcd. for C15H9O4Cl2F [M+H]+ 342.9940, found 342.9934.  
 
M.P. = 96 – 99 °C. 
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Phthalate Ester 398: Prepared following General Procedure C using chlorobenzene 
(10.0 mg, 0.09 mmol, 1.00 eq.), 4,5-dichlorophthaloyl peroxide (60.0 mg, 0.22 mmol, 
2.50 eq., 86%), HFIP (0.88 mL), and TMSCHN2 (0.2 mL, 0.44 mmol, 5.00 eq., 2.0 M).  
The crude yellow foam was purified by silica gel chromatography; benzene to provide 
the phthalate ester 398 (10.3 mg, 0.03 mmol, 33%) as a clear foam.  
 
Rf  = 0.69 (benzene) 
 
1H-NMR (400 MHz, CDCl3): δ 7.93 (s, 2H), 7.40 (d, 2H, J = 8.9 Hz), 7.21 (d, 2H, J = 
8.9 Hz), 3.92 (s, 3H)  
 
13C-NMR (100 MHz, CDCl3): δ 165.48, 164.16, 149.00, 136.33, 136.30, 131.80, 131.33, 
131.08, 131.03, 130.99, 129.70, 122.66, 53.22  
 
IR (neat film, cm-1): 2955, 2924, 1733, 1503, 1487, 1288  
 
HRMS (EC-CI) calcd. for C15H9O4Cl3 [M+H]+ 358.9645, found 358.9636. 
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Phthalate Ester 399: Prepared following General Procedure C using bromobenzene 
(10.0 mg, 0.06 mmol, 1.00 eq.), 4,5-dichlorophthaloyl peroxide (43.0 mg, 0.16 mmol, 
2.50 eq., 86%), HFIP (0.6 mL), and TMSCHN2 (0.2 ml, 0.32 mmol, 5.00 eq., 2.0 M).  
The crude yellow foam was purified by silica gel chromatography; hexane – 3% EtOAc 
in hexane to afford the phthalate 399 (3.2 mg, 0.01 mmol, 13%) as a colorless foam.  
 
Rf  = 0.40 (10% EtOAc in hexane)  
 
1H-NMR (400 MHz, CDCl3): δ 7.93 (s, 2H), 7.55 (d, 2H, J = 8.9 Hz), 7.15 (d, 2H, J = 
8.9 Hz), 3.92 (s, 3H)  
 
13C-NMR (100 MHz, CDCl3): δ 165.48, 164.08, 149.55, 136.32, 132.68, 131.33, 131.08, 
131.02, 131.00, 123.08, 119.53, 53.22  
 
IR (neat film, cm-1) 2952, 1731, 1513, 1286  
 
HRMS (EC-ESI): calcd. for C15H9O4Cl2Br [M+Na]+ 426.8931, found 426.8923. 
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Phthalate Ester 400: Prepared following General Procedure C using p-trimethylsilyl 
toluene (30.0 mg, 0.18 mmol, 1.00 eq.), 4,5-dichlorophthaloyl peroxide (124.0 mg, 0.46 
mmol, 2.50 eq., 86%), TFE (1.8 mL), and TMSCHN2 (0.5 ml, 0.91 mmol, 5.00 eq., 2.0 
M).  The crude yellow foam was purified by silica gel chromatography; benzene to afford 
the phthalate 400 (27.1 mg, 0.07 mmol, 36%) as a colorless foam. 
  
Rf  = 0.70 (benzene)  
 
1H-NMR (400 MHz, C6D6): δ 7.74 (s, 1H), 7.59 (s, 1H), 7.42 (s, 1H), 7.25 (d, 1H, J = 
6.6 Hz), 7.08 (d, 1H, J = 6.6 Hz), 3.42 (s, 3H), 2.13 (s, 3H), 0.20 (s, 9H)  
 
13C-NMR (100 MHz, CDCl3): δ 165.64, 163.48, 149.87, 139.95, 136.25, 135.79, 132.60, 
131.63, 131.37, 131.35, 131.24, 131.23, 131.20, 126.60, 52.47, 16.22, 1.19  
 
IR (neat film, cm-1) 1738, 1287, 1249  
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